data_1tnt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tnt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.2 m95 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 t -140.05 165.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -113.54 153.11 45.83 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -52.67 -46.77 31.14 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.303 1.335 . . . . 0.0 110.558 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -59.12 -25.92 64.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.931 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.46 -25.86 30.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.008 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 12' ' ' ASN . 89.7 mt -82.47 -23.5 34.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 108.898 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.3 m120 -145.49 -9.52 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.578 -1.326 . . . . 0.0 110.666 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.2 mt -79.18 147.4 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.667 -1.271 . . . . 0.0 108.098 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.53 -64.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.059 1.173 . . . . 0.0 110.802 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.84 4.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -94.92 149.79 36.83 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.114 -1.227 . . . . 0.0 109.018 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.41 175.81 0.17 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 120.905 1.07 . . . . 0.0 109.921 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -97.04 7.87 45.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 p -133.71 130.08 37.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.46 -0.775 . . . . 0.0 109.413 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -52.84 -29.83 30.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.63 63.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.16 -35.46 23.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.75 -53.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -1.189 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.78 -45.18 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 109.121 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.2 -41.73 93.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 0.0 108.951 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.96 -25.82 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 109.114 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.86 -31.71 40.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -71.11 -29.4 65.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.234 -0.916 . . . . 0.0 109.016 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -64.86 -7.13 10.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 109.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -150.72 -64.34 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 108.843 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.1 59.47 1.05 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -57.37 145.41 32.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.081 -1.247 . . . . 0.0 108.824 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -47.63 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -103.63 119.51 39.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.427 -0.796 . . . . 0.0 109.844 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.271 -0.893 . . . . 0.0 109.156 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.4 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -135.72 128.39 30.86 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.672 HD21 ' N ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -75.7 116.07 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 108.898 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.33 59.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.614 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.672 ' N ' HD21 ' A' ' 49' ' ' ASN . 5.1 m120 -69.4 -17.17 63.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.006 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.8 m -89.61 -20.27 23.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.0 109.782 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 54' ' ' PRO . 73.9 mt -67.92 149.27 98.28 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.121 -0.987 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -57.04 -157.89 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.845 1.03 . . . . 0.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 t -94.4 -36.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -58.08 -38.81 77.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.549 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.33 -36.4 29.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.36 -42.92 78.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.595 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.44 -58.06 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -23.31 67.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.749 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 45.0 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 6' ' ' SER . 58.7 t -139.39 167.99 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.41 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 m -106.21 153.88 40.04 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.43 -0.794 . . . . 0.0 109.602 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.82 -49.72 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.481 1.454 . . . . 0.0 110.801 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.11 -23.85 22.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.564 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.18 -23.32 30.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.986 -1.071 . . . . 0.0 109.402 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.7 mt -83.65 -20.58 33.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.63 36.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.7 -0.625 . . . . 0.0 111.506 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 m120 -148.22 -11.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.343 -1.473 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -78.73 147.91 71.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.646 -1.284 . . . . 0.0 108.182 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.46 -60.71 0.28 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 120.823 1.015 . . . . 0.0 110.415 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.98 -39.57 9.07 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.4 mt -93.39 149.84 37.98 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.216 -1.167 . . . . 0.0 109.041 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.35 177.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.848 1.032 . . . . 0.0 109.97 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -101.56 8.41 41.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.429 -0.794 . . . . 0.0 109.552 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -130.09 132.96 46.36 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.525 -0.734 . . . . 0.0 109.351 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -52.82 -31.34 38.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.596 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.7 51.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -33.75 85.38 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.2 -65.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.169 . . . . 0.0 109.229 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -48.98 -41.11 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -61.66 -48.94 78.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 108.876 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.81 -36.45 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 108.959 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.33 -30.35 7.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.647 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' C ' ' H ' ' A' ' 30' ' ' GLN . 48.2 mtpt -73.77 -41.98 61.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.51 -0.744 . . . . 0.0 109.484 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -65.94 4.32 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.308 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.548 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 23.8 mt-30 -150.15 -75.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 105.35 50.39 0.92 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.548 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.6 m-90 -53.24 134.1 39.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.366 . . . . 0.0 108.463 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 105.01 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.96 -1.088 . . . . 0.0 109.513 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -104.17 124.36 48.97 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 110.282 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.47 135.38 40.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.53 112.31 12.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.123 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.87 19.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.307 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -72.11 -20.43 61.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.035 -1.041 . . . . 0.0 110.277 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.3 m -88.9 -16.65 31.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.081 -1.012 . . . . 0.0 110.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' PRO . 82.7 mt -67.73 148.13 98.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 108.962 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -56.69 -161.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.847 1.031 . . . . 0.0 109.686 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -91.2 -38.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.36 -41.15 84.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.47 -52.58 7.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.093 -1.004 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -46.69 -45.55 19.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.977 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -58.09 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.47 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.12 62.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.212 -0.93 . . . . 0.0 109.001 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 108.795 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 41.8 m95 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.29 -137.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.418 -0.801 . . . . 0.0 109.349 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -166.12 152.31 8.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 109.508 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.39 -52.02 8.02 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.312 1.341 . . . . 0.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -58.54 -25.56 62.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.69 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -84.95 -30.34 24.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.077 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 12' ' ' ASN . 28.6 mt -80.69 -25.27 38.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.039 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 30.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 t-20 -145.1 -10.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.582 -1.324 . . . . 0.0 110.562 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' LEU . 21.2 mt -78.65 147.21 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.0 107.911 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.49 -64.39 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 120.978 1.119 . . . . 0.0 110.926 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.2 -37.47 4.52 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.6 mt -95.39 150.29 37.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.157 -1.202 . . . . 0.0 109.272 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.31 173.21 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 120.908 1.072 . . . . 0.0 110.027 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.36 8.47 43.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.296 -0.878 . . . . 0.0 109.69 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.02 131.92 41.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.487 -0.758 . . . . 0.0 109.375 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -53.02 -30.56 36.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -47.69 67.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.243 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.96 -36.36 86.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.5 -63.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -1.209 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.5 -42.46 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.968 . . . . 0.0 109.1 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.12 -44.79 96.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.016 . . . . 0.0 109.015 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.42 -26.34 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.91 -28.53 9.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.851 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.6 mptp? -72.92 -35.65 67.08 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.154 -0.966 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -65.37 -3.97 4.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -150.9 -68.96 0.18 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.89 54.55 1.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.88 143.75 12.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.942 -1.328 . . . . 0.0 109.006 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -50.01 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.001 . . . . 0.0 109.078 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.5 p30 -100.06 123.44 44.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.293 -0.88 . . . . 0.0 109.82 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.43 130.02 34.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.389 -0.819 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.12 117.5 17.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.93 -28.29 66.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 110.053 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -70.02 -23.43 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -89.47 -10.63 45.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 54' ' ' PRO . 60.4 mt -66.52 153.64 92.73 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.094 -1.004 . . . . 0.0 108.527 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.5 Cg_exo -57.16 -147.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.206 -1.076 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.01 -37.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.933 -1.104 . . . . 0.0 109.457 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.83 -30.05 71.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 111.185 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 -41.42 37.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.669 -1.269 . . . . 0.0 110.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -56.7 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.122 . . . . 0.0 109.454 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.2 -48.73 23.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.284 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.89 -33.1 74.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.294 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.5 t -124.85 -138.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.509 -0.744 . . . . 0.0 109.203 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.41 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.5 m -167.04 152.55 7.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.905 -1.122 . . . . 0.0 109.609 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.35 -53.12 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.482 1.455 . . . . 0.0 110.615 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -56.47 -25.47 51.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.86 -28.06 26.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 12' ' ' ASN . 50.0 mt -81.96 -23.91 35.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.193 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.96 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.692 -0.63 . . . . 0.0 111.093 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.6 m120 -145.41 -7.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.521 -1.362 . . . . 0.0 110.745 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 17.6 mt -79.46 148.28 69.81 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.601 -1.312 . . . . 0.0 107.942 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.1 -64.12 0.12 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.889 1.059 . . . . 0.0 110.702 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.08 -38.3 4.72 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.9 mt -93.79 150.3 38.45 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.234 -1.156 . . . . 0.0 109.035 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.0 -178.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.804 1.002 . . . . 0.0 109.779 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.75 -7.78 27.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -117.3 129.81 56.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.655 -0.653 . . . . 0.0 109.284 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -53.24 -28.94 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.11 65.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.87 -35.23 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' ALA . 35.6 t -65.16 -56.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -1.157 . . . . 0.0 109.298 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.75 -43.56 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.2 -44.38 97.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.982 -1.074 . . . . 0.0 108.798 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.21 -19.09 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 109.125 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.61 -33.25 74.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 108.84 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' GLN . 21.8 mtmm -70.16 -27.61 64.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.265 -0.897 . . . . 0.0 108.761 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -64.79 -4.25 4.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.039 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LYS . 43.2 mt-30 -150.11 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.73 59.45 1.26 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.8 m-90 -56.38 147.84 20.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.037 -1.272 . . . . 0.0 108.796 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.503 HE21 HD21 ' A' ' 49' ' ' ASN . 15.7 tt0 -50.33 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p-10 -101.24 121.97 42.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 179.708 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 29.5 mm-40 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -135.45 127.29 29.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.503 HD21 HE21 ' A' ' 33' ' ' GLN . 48.8 t30 -77.69 116.36 18.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.067 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -56.39 -23.62 39.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.23 -25.17 63.26 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.081 -1.012 . . . . 0.0 109.544 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.7 m -91.86 -13.56 31.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.46 149.1 98.53 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.854 -1.154 . . . . 0.0 109.146 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.48 -155.95 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 120.973 1.115 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.7 -36.95 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.86 -39.05 83.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.31 -20.58 47.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 1.7 mmmm -75.2 -58.27 3.39 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.17 -0.956 . . . . 0.0 109.212 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.51 -44.06 55.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.102 . . . . 0.0 108.955 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.1 74.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.445 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.8 m95 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 160.53 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.314 -0.866 . . . . 0.0 109.705 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -104.53 152.92 39.46 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.49 -43.83 55.17 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.421 1.414 . . . . 0.0 110.665 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -27.26 63.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 76.0 mm-40 -84.11 -22.66 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 109.317 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.5 mt -82.74 -23.17 34.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.288 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.95 29.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.154 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.62 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -148.3 -8.52 0.39 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.437 -1.414 . . . . 0.0 111.122 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.62 ' N ' HD21 ' A' ' 12' ' ' ASN . 29.1 mt -78.41 147.42 72.07 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.492 -1.38 . . . . 0.0 108.05 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.22 -66.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.989 1.126 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.04 -34.79 2.14 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.7 mt -95.17 150.47 37.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.275 -1.132 . . . . 0.0 108.86 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.08 -173.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.867 1.044 . . . . 0.0 110.071 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 27.7 mmtp -100.71 -17.58 16.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -109.57 130.14 55.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.55 -0.719 . . . . 0.0 109.391 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.35 -29.35 23.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.55 73.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.63 81.44 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.55 -64.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -1.173 . . . . 0.0 109.335 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.07 -39.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.117 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.79 -40.19 91.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 108.602 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.3 -27.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.07 -28.53 17.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.23 -0.919 . . . . 0.0 108.723 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.69 -32.96 68.4 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 -1.15 1.83 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.457 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.95 -65.43 0.19 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.96 49.6 1.74 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -51.52 136.71 25.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.038 -1.272 . . . . 0.0 109.006 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.528 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -48.79 110.89 0.4 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.006 -1.059 . . . . 0.0 108.582 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 34' ' ' ASN . 10.1 p30 -105.09 122.13 45.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.424 -0.798 . . . . 0.0 109.624 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 109.151 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -136.3 135.3 38.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -76.99 118.91 20.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.929 -1.107 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.45 59.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.379 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -69.58 -21.61 63.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.581 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 61.6 m -91.94 -15.14 28.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.21 150.28 97.79 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 109.321 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.4 151.37 75.03 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.033 1.156 . . . . 0.0 109.621 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.1 -38.7 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.3 -37.73 78.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.861 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.03 -35.41 37.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -60.89 -62.48 1.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.49 42.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.297 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.31 74.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 108.886 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.6 m95 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.25 155.53 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 109.712 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -104.99 152.17 39.58 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.06 -46.88 30.77 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.377 1.385 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -58.37 -24.36 59.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.206 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 18.0 mm-40 -84.25 -27.65 27.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.968 -1.082 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 12' ' ' ASN . 53.7 mt -83.0 -21.68 33.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 109.334 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.91 29.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.635 . . . . 0.0 111.133 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 10' ' ' LEU . 21.7 p30 -148.48 -6.81 0.4 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.511 -1.368 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.5 mt -79.46 147.36 67.9 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.567 -1.333 . . . . 0.0 108.181 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.55 -67.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.056 1.171 . . . . 0.0 110.978 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.07 -36.14 2.62 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.8 mt -94.68 150.51 38.09 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.252 -1.146 . . . . 0.0 108.926 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.78 -176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.836 1.024 . . . . 0.0 110.055 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 11' ' ' ALA . 22.5 mtpt -101.34 -15.04 17.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.344 -0.848 . . . . 0.0 109.919 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 p -113.74 131.29 56.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.73 . . . . 0.0 109.408 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -52.88 -29.29 27.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 109.251 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.71 65.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.69 -35.57 28.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.1 -56.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -1.147 . . . . 0.0 109.198 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.12 -43.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -61.14 -44.82 96.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 108.986 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.61 -25.47 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.429 -0.794 . . . . 0.0 109.059 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.4 -31.06 32.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.206 -0.934 . . . . 0.0 108.956 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -71.57 -28.83 64.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 109.057 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -64.73 -4.85 4.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 109.445 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.41 -58.15 0.18 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 108.879 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.8 51.62 2.26 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.4 m-90 -51.02 137.35 21.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.123 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -49.94 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.084 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -99.94 121.02 40.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.433 -0.792 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.858 . . . . 0.0 109.155 179.302 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 44.6 mm-40 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.23 129.96 34.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.228 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -75.34 117.32 17.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.93 -1.106 . . . . 0.0 109.489 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.33 59.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 110.437 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -69.51 -17.83 63.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -1.0 . . . . 0.0 109.576 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m -90.66 -22.33 21.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -67.11 148.39 98.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 109.031 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.4 Cg_endo -56.41 -161.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.851 1.034 . . . . 0.0 109.654 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.9 t -93.6 -33.82 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 109.375 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.2 mp0 -59.32 -39.31 82.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 109.515 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -82.19 -34.53 28.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.874 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -58.94 -39.66 82.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 -52.57 20.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.121 -0.987 . . . . 0.0 108.96 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.13 -19.48 65.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.415 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' ALA . 19.5 tp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 108.956 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.8 m95 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.1 164.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 0.0 109.416 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -113.86 152.58 45.75 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.13 -47.94 24.81 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 121.229 1.286 . . . . 0.0 110.251 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -60.74 -24.5 65.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.985 . . . . 0.0 110.108 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -84.35 -27.15 27.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.088 -1.008 . . . . 0.0 109.488 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -82.41 -22.49 35.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 10' ' ' LEU . 35.4 m120 -145.68 -9.37 0.55 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.577 -1.327 . . . . 0.0 110.805 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.22 147.66 69.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.638 -1.289 . . . . 0.0 108.039 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.29 -65.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 120.994 1.13 . . . . 0.0 110.838 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.57 -36.82 3.47 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.4 mt -94.69 150.27 37.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.213 -1.169 . . . . 0.0 108.939 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.01 175.31 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.953 1.102 . . . . 0.0 109.99 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -97.89 5.71 48.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 p -130.66 130.15 43.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.455 -0.778 . . . . 0.0 109.278 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 p -52.16 -30.99 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.433 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.57 70.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.33 -35.23 81.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 27' ' ' ALA . 61.4 t -65.32 -59.88 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.25 -43.26 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 108.933 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.49 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.978 -1.076 . . . . 0.0 108.82 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.17 -18.24 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.67 -33.28 73.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.949 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 30' ' ' GLN . 6.0 mtpm? -70.55 -29.11 65.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 108.677 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -65.1 -1.57 2.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.444 -0.785 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 28' ' ' LYS . 36.2 mt-30 -150.39 -63.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.19 55.27 1.29 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -54.87 137.65 44.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.026 -1.279 . . . . 0.0 108.962 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.59 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.376 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 4.3 p30 -99.65 121.36 41.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.296 -0.878 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.58 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.177 -0.952 . . . . 0.0 109.167 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 49.8 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.88 128.56 32.85 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.621 ' ND2' HD22 ' A' ' 51' ' ' ASN . 49.5 t-20 -75.68 114.17 13.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.899 -1.126 . . . . 0.0 109.092 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.32 -27.05 33.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 110.796 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.621 HD22 ' ND2' ' A' ' 49' ' ' ASN . 54.5 p30 -69.03 -17.53 63.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.895 -1.128 . . . . 0.0 110.052 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 13.5 m -90.58 -18.5 25.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.138 -0.976 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 92.1 mt -68.25 149.18 98.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.37 -156.38 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 120.918 1.079 . . . . 0.0 109.629 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.34 -36.47 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -59.35 -36.68 76.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.098 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.39 -34.41 41.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 109.572 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -55.79 -48.28 75.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.28 -57.29 11.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.64 -23.06 67.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.035 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.297 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.3 m95 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.26 152.99 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -97.68 154.72 37.79 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.83 . . . . 0.0 109.579 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.51 -51.5 10.98 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.611 1.541 . . . . 0.0 112.138 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -57.81 -17.25 14.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.81 -1.181 . . . . 0.0 110.705 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 26.1 mp0 -87.14 -28.12 22.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.679 -1.263 . . . . 0.0 108.884 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 12' ' ' ASN . 48.7 mt -81.73 -22.35 37.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.855 . . . . 0.0 109.204 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 29.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.706 -0.621 . . . . 0.0 111.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.9 t-20 -146.7 -8.82 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.475 -1.39 . . . . 0.0 110.855 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.7 mt -78.94 147.82 70.94 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.551 -1.343 . . . . 0.0 108.006 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.67 -66.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 120.948 1.099 . . . . 0.0 110.923 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.81 -36.79 3.76 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.72 150.2 37.59 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.262 -1.14 . . . . 0.0 109.11 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.09 170.55 0.67 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 120.874 1.049 . . . . 0.0 110.063 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -94.17 2.89 55.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.868 . . . . 0.0 109.642 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -129.15 129.27 44.91 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.469 -0.769 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 p -52.21 -30.46 27.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.12 -35.72 59.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.234 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.46 -35.8 25.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.84 -58.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -1.134 . . . . 0.0 109.439 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -55.15 -47.07 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.187 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -61.26 -50.82 71.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.339 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -22.32 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.44 -0.787 . . . . 0.0 109.394 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.27 -30.69 18.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.102 -0.999 . . . . 0.0 109.054 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.1 mptt -71.17 -30.07 65.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.136 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -63.94 -4.14 3.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.5 mt-30 -149.96 -61.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 108.972 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.78 48.98 2.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.03 138.63 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -1.23 . . . . 0.0 109.334 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -49.93 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.854 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.8 p-10 -98.77 125.28 44.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.9 mp0 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.25 131.7 36.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.325 -0.859 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.07 114.31 13.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 109.104 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.14 57.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 110.227 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -68.33 -18.13 64.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.997 . . . . 0.0 109.834 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -89.77 -19.33 24.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 98.4 mt -67.11 149.62 98.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 108.941 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.9 Cg_endo -56.06 -162.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.71 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.36 -37.29 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.198 -0.939 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -60.15 -37.13 79.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.281 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.99 -30.09 49.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.063 . . . . 0.0 109.644 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -59.86 -54.51 45.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 109.117 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.87 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.028 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.07 -30.03 69.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.926 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 109.213 -179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 35' ' ' ARG . 47.5 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.97 -137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -169.33 151.33 4.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.06 -49.15 16.32 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.352 1.368 . . . . 0.0 110.677 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -59.4 -27.81 66.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.224 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.23 -26.57 28.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 12' ' ' ASN . 25.5 mt -82.91 -18.77 38.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.38 32.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 0.0 110.971 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.3 t-20 -146.15 -9.02 0.52 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.476 -1.39 . . . . 0.0 110.921 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.1 mt -78.56 147.55 71.76 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.358 . . . . 0.0 108.154 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.02 -65.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.996 1.13 . . . . 0.0 110.578 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.27 -37.06 4.44 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.3 mt -93.76 149.97 37.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.221 -1.164 . . . . 0.0 108.952 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.52 177.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 120.753 0.969 . . . . 0.0 109.779 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -99.08 -2.32 37.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -123.76 131.4 53.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.375 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -52.66 -30.32 31.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.17 53.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.69 -35.6 18.88 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.02 -45.85 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.71 -47.21 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.91 -41.82 96.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.05 -29.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.262 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.52 -29.27 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 108.748 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 30' ' ' GLN . 27.2 mtmt -71.9 -33.44 68.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.444 -0.785 . . . . 0.0 109.05 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -64.79 -1.74 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.2 mp0 -149.32 -68.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.358 -0.839 . . . . 0.0 108.765 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.0 55.88 1.35 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -51.3 152.08 2.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.253 . . . . 0.0 109.198 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -52.8 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.645 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -101.58 112.47 25.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.487 HH11 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.037 -1.039 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.849 0.833 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -134.01 133.03 40.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.435 -0.791 . . . . 0.0 108.941 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.57 116.66 17.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 109.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 -27.51 55.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.365 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.9 -23.12 62.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.4 m -89.83 -12.87 37.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -0.965 . . . . 0.0 110.087 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.8 150.46 97.62 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.323 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 169.12 5.14 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.988 1.126 . . . . 0.0 109.424 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.23 -37.89 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.024 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.78 -39.15 80.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.11 -39.8 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.976 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.88 -57.86 11.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.607 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.87 58.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.083 -1.011 . . . . 0.0 109.33 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.26 -28.67 68.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.386 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 42.7 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.25 158.26 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.424 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.1 m -100.63 153.36 37.78 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.494 -0.754 . . . . 0.0 109.231 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.32 -40.04 87.75 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.114 1.209 . . . . 0.0 110.183 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -58.54 -27.24 64.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.63 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 34.3 mt-10 -83.57 -24.9 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 12' ' ' ASN . 91.5 mt -83.48 -23.93 31.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.99 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.625 -0.672 . . . . 0.0 111.21 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 10' ' ' LEU . 1.3 p30 -149.42 -8.1 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.415 -1.428 . . . . 0.0 111.035 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.4 mt -78.75 147.89 71.72 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.618 -1.301 . . . . 0.0 108.118 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.97 -67.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.11 1.207 . . . . 0.0 110.989 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.16 2.19 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.35 150.36 37.47 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.29 -1.123 . . . . 0.0 108.882 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.44 -174.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 120.806 1.004 . . . . 0.0 110.021 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ALA . 65.2 mmtt -101.08 -16.56 17.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.324 -0.86 . . . . 0.0 109.558 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -110.65 131.2 55.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.478 -0.763 . . . . 0.0 109.478 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.88 -29.56 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.48 -39.62 70.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.43 56.37 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.59 -62.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mt -49.94 -40.62 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 108.673 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.36 -42.2 98.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.124 -0.985 . . . . 0.0 108.678 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -76.66 -20.45 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.499 -0.751 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.2 -39.59 60.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.08 -1.013 . . . . 0.0 110.188 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 30' ' ' GLN . 4.8 ptmt -70.91 -23.14 62.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 109.262 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.99 -4.49 2.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 108.731 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.27 -58.99 0.19 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.79 48.01 2.01 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -54.99 133.89 48.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.832 -1.393 . . . . 0.0 108.633 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.522 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -48.41 108.83 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.98 -1.075 . . . . 0.0 108.761 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.31 121.81 44.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.416 -0.802 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 35' ' ' ARG . 20.2 ttm-85 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 109.447 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 68.4 mm-40 . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -136.3 134.24 37.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.414 -0.804 . . . . 0.0 109.31 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -75.87 114.18 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.138 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.54 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.305 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 51' ' ' ASN . 1.7 m-80 -69.82 -20.77 63.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.915 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 27.8 m -90.58 -10.43 43.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.112 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 54' ' ' PRO . 76.1 mt -68.45 150.3 97.74 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.034 -1.041 . . . . 0.0 109.305 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -59.0 -155.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 120.968 1.112 . . . . 0.0 109.459 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.07 -36.62 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.48 -37.12 80.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.93 -25.49 40.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.363 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -62.02 -66.83 0.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.11 33.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.519 -0.738 . . . . 0.0 109.425 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.45 80.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.23 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--N 1.303 -1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 108.695 179.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 m95 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.64 145.65 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.112 -0.993 . . . . 0.0 109.874 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -95.46 153.28 39.58 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.348 -0.845 . . . . 0.0 109.321 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.49 -42.48 65.31 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.233 1.288 . . . . 0.0 110.458 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -59.22 -24.41 63.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 12.5 mm-40 -84.24 -24.39 30.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -83.2 -24.35 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.99 29.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 111.345 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -147.32 -9.23 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.467 -1.396 . . . . 0.0 110.919 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' LEU . 40.1 mt -79.13 147.13 68.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.533 -1.354 . . . . 0.0 108.061 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -65.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.097 1.198 . . . . 0.0 110.739 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.63 -35.63 3.09 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.28 150.01 37.0 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.23 -1.159 . . . . 0.0 109.009 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.41 175.31 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 120.803 1.002 . . . . 0.0 109.787 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -97.16 6.59 48.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 109.749 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -133.6 130.74 38.78 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.521 -0.737 . . . . 0.0 109.205 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 p -52.57 -31.26 35.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.383 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.47 56.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.81 -38.39 20.05 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.14 -63.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.264 -1.139 . . . . 0.0 109.444 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -47.87 -41.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.069 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.7 -48.35 81.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.184 -0.948 . . . . 0.0 108.703 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.57 -28.65 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.74 -31.02 10.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.15 -0.969 . . . . 0.0 108.927 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.5 mptt -72.7 -38.46 67.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 108.687 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' CB ' ' NZ ' ' A' ' 29' ' ' LYS . 4.9 ttpm? -65.36 -3.6 4.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -150.32 -70.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 108.894 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.68 54.41 1.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.91 145.24 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.09 -1.241 . . . . 0.0 109.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -52.64 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.997 . . . . 0.0 109.056 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.8 p-10 -97.63 118.25 33.73 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.24 179.632 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -133.58 132.43 40.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.384 -0.823 . . . . 0.0 109.534 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.706 HD22 HD22 ' A' ' 51' ' ' ASN . 51.7 t-20 -76.12 117.23 17.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.179 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.28 65.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.325 -0.86 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.706 HD22 HD22 ' A' ' 49' ' ' ASN . 43.1 p30 -67.44 -16.43 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.477 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 74.0 m -90.0 -16.53 29.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.1 mt -67.96 149.67 98.1 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.115 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.65 -156.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.903 1.069 . . . . 0.0 109.5 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.67 -36.76 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 109.78 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -60.24 -36.81 78.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.95 43.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 109.8 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -65.34 -65.68 0.64 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 108.744 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.56 19.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.517 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.37 80.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 108.795 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.6 m95 . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.59 155.52 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.182 -0.949 . . . . 0.0 109.781 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -101.27 153.04 38.04 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 121.446 -0.784 . . . . 0.0 109.289 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.19 -43.39 59.45 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 121.371 1.38 . . . . 0.0 110.555 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -58.37 -27.24 64.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 0.0 109.78 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 35.2 mm-40 -84.78 -24.74 28.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.17 -0.956 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.1 mt -83.53 -21.36 32.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.106 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -146.42 -4.18 0.61 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.501 -1.375 . . . . 0.0 110.642 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 12.0 mt -79.69 147.86 68.02 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.588 -1.32 . . . . 0.0 108.004 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.22 -64.52 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 120.882 1.054 . . . . 0.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.28 -35.94 7.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 30.0 mt -93.62 150.06 38.18 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.122 -1.222 . . . . 0.0 109.141 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.35 -175.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 120.876 1.051 . . . . 0.0 109.924 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -104.89 5.83 33.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.525 -0.734 . . . . 0.0 109.757 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 p -132.93 133.12 42.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -53.36 -30.62 40.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.57 62.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.82 -35.74 18.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.25 -49.72 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -65.09 -44.79 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -60.75 -41.96 96.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 108.92 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.82 -27.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.43 -0.794 . . . . 0.0 109.024 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.86 -29.31 19.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.6 -29.93 65.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.37 -0.831 . . . . 0.0 108.897 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.35 -4.13 3.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.48 -61.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.368 -0.833 . . . . 0.0 108.88 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.37 54.48 1.57 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.44 141.2 37.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.075 -1.25 . . . . 0.0 108.844 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -47.93 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.232 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.9 p30 -101.45 116.76 33.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.466 -0.772 . . . . 0.0 110.106 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.561 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 109.058 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -135.16 134.87 40.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.834 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 17.6 t-20 -76.27 115.81 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 109.298 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.58 -34.16 64.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.374 -0.828 . . . . 0.0 110.61 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -69.98 -17.03 63.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.6 m -90.03 -15.46 31.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 109.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' PRO . 96.1 mt -67.96 148.96 98.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.0 Cg_exo -54.94 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.967 1.111 . . . . 0.0 109.833 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.5 -38.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -0.931 . . . . 0.0 109.928 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -58.17 -40.3 81.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.628 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.24 -38.54 42.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.124 -0.985 . . . . 0.0 109.228 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -49.03 -60.7 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.725 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.26 63.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.599 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -23.41 67.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 109.586 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.407 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.9 m95 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.62 163.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.0 109.644 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -108.2 153.11 42.06 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.486 -0.759 . . . . 0.0 109.05 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.15 -44.55 48.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.239 1.293 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -57.68 -25.65 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.43 -24.18 29.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.128 -0.983 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.8 mt -82.96 -22.93 33.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.09 29.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.64 -0.663 . . . . 0.0 111.232 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' LEU . 10.0 t-20 -146.57 -7.47 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.513 -1.367 . . . . 0.0 110.892 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.4 mt -79.4 147.45 68.35 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 0.0 108.195 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.11 -63.97 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.962 1.108 . . . . 0.0 110.606 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.48 -38.22 5.2 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 26.2 mt -94.01 149.87 37.58 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.137 -1.214 . . . . 0.0 109.175 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.14 -178.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.875 1.05 . . . . 0.0 109.732 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -101.17 7.38 43.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -133.19 130.17 38.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.408 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -52.5 -30.64 31.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.354 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.75 -37.0 62.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.28 19.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.84 -58.78 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.275 -1.132 . . . . 0.0 109.171 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -52.4 -43.06 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -60.69 -41.76 95.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 108.933 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.96 -22.87 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.079 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.3 -29.81 66.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.192 -0.942 . . . . 0.0 108.497 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 30' ' ' GLN . 77.5 mttt -71.98 -32.79 67.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 109.065 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -65.03 2.92 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 108.888 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.1 mt-30 -150.85 -64.88 0.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.58 47.21 2.18 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -50.8 135.73 23.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.305 . . . . 0.0 108.961 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -48.27 112.21 0.55 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.008 -1.057 . . . . 0.0 108.617 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -107.51 119.55 39.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.502 -0.748 . . . . 0.0 109.832 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 20.7 ttm-85 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.169 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.5 mp0 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -136.4 134.61 37.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 0.0 109.237 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -76.89 119.85 21.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.904 -1.123 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.03 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.71 -19.13 64.35 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.012 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 44.4 m -92.0 -16.33 26.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 110.15 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.76 149.41 98.27 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 120.936 -1.103 . . . . 0.0 108.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.64 -166.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 120.864 1.043 . . . . 0.0 109.538 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.0 -35.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 109.263 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.4 mp0 -59.86 -39.47 85.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.407 -0.808 . . . . 0.0 109.515 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.6 14.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.625 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -50.34 -52.35 37.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.27 -51.96 64.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.48 67.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.453 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 108.793 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.71 -136.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.271 -0.893 . . . . 0.0 109.618 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -167.41 152.8 7.08 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.652 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.4 -51.89 8.97 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.596 1.531 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.8 42.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -0.999 . . . . 0.0 110.067 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -85.9 -25.97 25.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.034 -1.041 . . . . 0.0 109.251 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 12' ' ' ASN . 77.6 mt -82.6 -23.04 34.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 32.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.766 -0.584 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.4 t-20 -147.67 -10.97 0.4 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.43 -1.419 . . . . 0.0 111.142 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' LEU . 26.5 mt -78.89 147.35 70.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.574 -1.329 . . . . 0.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.75 -61.68 0.24 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.012 1.141 . . . . 0.0 110.758 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.09 -38.73 4.91 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' LEU . 12.1 mt -94.94 151.05 38.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.275 -1.132 . . . . 0.0 108.755 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.41 -174.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 120.747 0.965 . . . . 0.0 110.081 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -99.14 -15.67 18.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -111.09 132.31 54.37 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.599 -0.688 . . . . 0.0 109.451 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -53.23 -28.88 29.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -49.12 69.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.18 -34.18 89.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.38 -61.38 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -1.168 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.02 -43.01 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -60.19 -41.43 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.924 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.05 -25.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.46 -0.775 . . . . 0.0 108.991 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -54.32 -25.26 22.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.112 -0.993 . . . . 0.0 108.434 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -72.85 -32.76 65.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -65.19 -9.57 24.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.488 -0.757 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -150.07 -64.4 0.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.28 -0.887 . . . . 0.0 108.904 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.01 62.04 1.19 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -54.71 148.33 12.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -1.211 . . . . 0.0 109.02 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.01 98.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.2 p30 -108.4 117.75 34.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.542 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.59 123.89 21.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.304 -0.872 . . . . 0.0 109.901 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.48 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 27.6 t-20 -74.06 114.73 12.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 108.532 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.22 22.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.805 . . . . 0.0 111.315 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.658 HD21 ' H ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -71.07 -21.87 62.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.684 -1.26 . . . . 0.0 110.52 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.658 ' H ' HD21 ' A' ' 51' ' ' ASN . 36.9 m -93.71 -8.27 41.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.905 -1.122 . . . . 0.0 110.552 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -68.97 149.51 97.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 0.0 109.724 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.26 140.77 84.94 Favored 'Trans proline' 0 C--O 1.21 -0.903 0 C-N-CA 121.173 1.249 . . . . 0.0 109.324 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -42.27 -41.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.432 -0.793 . . . . 0.0 111.02 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -55.81 -48.03 76.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.005 -1.06 . . . . 0.0 109.991 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.86 -43.09 25.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -46.02 -58.01 3.95 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.358 0.599 . . . . 0.0 109.415 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.01 61.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.9 64.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.116 -0.99 . . . . 0.0 109.182 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.8 t -131.77 162.84 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.429 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.3 m -103.78 153.44 38.73 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.2 -46.64 32.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 121.377 1.385 . . . . 0.0 110.924 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HZ1' ' CB ' ' A' ' 6' ' ' SER . 23.3 pttm -59.56 -21.8 60.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.111 -0.993 . . . . 0.0 110.656 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -85.14 -25.73 27.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.6 mt -82.94 -22.66 33.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.637 -0.664 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 10' ' ' LEU . 41.6 m-80 -147.03 -10.8 0.44 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.621 -1.299 . . . . 0.0 110.936 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 16' ' ' LEU . 31.6 mt -78.27 146.89 71.6 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.531 -1.356 . . . . 0.0 108.103 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -64.86 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.028 1.152 . . . . 0.0 110.937 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.12 -36.86 2.93 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.9 mt -96.02 150.46 37.3 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.249 -1.148 . . . . 0.0 108.972 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.34 176.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.864 1.043 . . . . 0.0 110.014 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -95.19 -13.09 25.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 109.61 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -106.15 130.83 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.662 . . . . 0.0 109.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.477 ' H ' ' HG ' ' A' ' 20' ' ' SER . 1.7 m -53.0 -29.3 28.46 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.89 -55.62 32.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.792 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -36.66 52.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.89 -65.61 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.077 -1.249 . . . . 0.0 109.64 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mt -48.83 -42.31 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.211 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.75 -49.15 77.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.849 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.34 -22.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.49 -34.37 24.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 109.405 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -28.1 64.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 108.648 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -64.35 -5.27 4.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.247 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -151.25 -60.74 0.18 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.331 -0.856 . . . . 0.0 108.809 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.4 47.15 2.22 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -52.16 135.51 31.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.935 -1.333 . . . . 0.0 109.03 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.522 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -49.14 110.43 0.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.075 -1.016 . . . . 0.0 108.748 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.84 124.33 49.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.837 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 21.3 mm-40 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -136.1 133.72 37.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -76.54 117.58 18.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.961 -1.087 . . . . 0.0 108.991 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.93 61.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -21.3 62.93 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 34.4 m -90.98 -13.72 32.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.022 -1.049 . . . . 0.0 110.191 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.0 mt -67.39 149.07 98.58 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 108.986 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.3 Cg_exo -55.04 -165.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.982 1.121 . . . . 0.0 109.724 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.12 -37.61 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.35 -37.47 80.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.259 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.76 -31.62 40.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.703 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -60.93 -67.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.016 -1.052 . . . . 0.0 108.911 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.54 -42.81 16.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 109.568 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.41 84.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 179.808 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.2 m95 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.05 162.42 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -110.56 152.64 43.52 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.52 -0.737 . . . . 0.0 109.049 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.62 -43.58 54.19 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.282 1.321 . . . . 0.0 110.606 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -59.65 -25.27 64.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 109.896 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -85.03 -24.68 28.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.5 mt -81.15 -24.6 37.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 109.003 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.669 -0.645 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' LEU . 14.2 m120 -146.18 -6.8 0.56 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.566 -1.333 . . . . 0.0 110.835 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -79.48 147.74 68.62 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.599 -1.313 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 120.908 1.072 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.46 -35.69 4.08 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 25.7 mt -93.9 149.28 36.73 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.135 -1.215 . . . . 0.0 109.117 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.64 178.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.882 1.055 . . . . 0.0 109.818 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -98.28 6.43 47.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.01 129.77 40.54 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.405 -0.81 . . . . 0.0 109.332 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -52.39 -30.58 29.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.419 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.44 66.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.94 -36.73 57.14 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.58 -64.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 109.394 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -49.78 -40.94 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.93 . . . . 0.0 109.095 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.93 -40.03 91.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 108.888 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.21 -27.82 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.92 -28.73 10.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 108.718 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.3 mptt -72.43 -39.78 67.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -65.48 -0.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.393 -0.817 . . . . 0.0 109.711 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 28' ' ' LYS . 35.4 mt-30 -151.82 -69.98 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 109.055 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.31 53.95 1.53 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.2 m-90 -51.02 147.71 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.227 . . . . 0.0 109.283 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -49.47 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 108.908 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -103.0 118.27 36.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.928 . . . . 0.0 109.891 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.17 126.9 29.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.452 -0.78 . . . . 0.0 109.47 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -75.33 113.97 13.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 0.0 109.033 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.8 -25.99 21.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.205 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.562 ' H ' HD21 ' A' ' 51' ' ' ASN . 1.4 m-80 -70.38 -22.97 62.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 0.0 109.792 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 m -90.45 -17.35 27.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.104 -0.998 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.18 148.71 98.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.955 -1.091 . . . . 0.0 109.014 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.58 -160.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.919 1.079 . . . . 0.0 109.693 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.74 -36.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.12 -39.09 81.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.308 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.03 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.7 -57.14 13.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.375 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.58 76.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.44 70.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 109.849 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.3 m95 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.97 152.29 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 0.0 109.628 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.47 153.49 37.75 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.843 . . . . 0.0 109.543 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.92 -44.24 50.15 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.307 1.338 . . . . 0.0 110.497 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -58.73 -25.08 62.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -84.63 -24.98 28.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.018 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.5 mt -80.97 -23.57 38.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.191 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.648 -0.658 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' LEU . 34.4 m120 -146.27 -9.1 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.544 -1.348 . . . . 0.0 110.827 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.8 mt -79.01 147.01 69.19 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.6 -1.312 . . . . 0.0 108.159 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.24 -64.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.019 1.146 . . . . 0.0 110.751 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.9 4.04 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.8 mt -94.46 149.95 37.4 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.163 -1.198 . . . . 0.0 109.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.22 176.27 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.837 1.025 . . . . 0.0 109.837 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -97.64 7.28 46.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.18 129.99 38.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.406 -0.809 . . . . 0.0 109.29 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -52.51 -30.56 30.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.33 -39.85 64.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.21 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.95 -36.71 40.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.0 t -66.22 -61.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -1.135 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -51.37 -44.14 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 108.952 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.23 -45.0 96.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 108.925 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.15 -16.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.37 -31.1 71.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 108.747 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 30' ' ' GLN . 22.5 mtmt -71.04 -28.42 64.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.28 -0.888 . . . . 0.0 108.822 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -64.89 -3.07 3.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.177 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' LYS . 43.0 mt-30 -150.2 -61.44 0.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 108.825 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.32 53.11 1.91 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -50.76 138.05 19.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.291 . . . . 0.0 109.148 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -48.64 99.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 5.5 p30 -99.82 123.14 43.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.898 . . . . 0.0 109.653 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 38.7 ttm180 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.887 . . . . 0.0 109.226 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 10.7 mp0 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.11 133.56 37.41 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.339 -0.851 . . . . 0.0 109.439 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -76.6 117.9 18.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.018 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.31 61.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -69.94 -17.62 63.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.541 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.9 m -89.62 -21.31 22.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.59 148.41 98.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 108.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.83 -162.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 120.831 1.021 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.64 -38.36 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.21 -39.96 84.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.54 -48.35 11.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.39 -54.06 45.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.403 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.55 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.082 -1.011 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -29.02 69.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.23 -0.919 . . . . 0.0 109.248 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.7 m95 . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.01 148.13 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.171 -0.956 . . . . 0.0 110.058 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.39 153.85 37.58 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.409 -0.807 . . . . 0.0 109.241 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.81 -41.33 75.41 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.219 1.28 . . . . 0.0 110.233 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -59.53 -27.02 65.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.35 -24.78 29.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.19 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.9 mt -82.33 -25.32 34.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.865 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 30.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.6 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.1 m120 -146.54 -6.44 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.575 -1.328 . . . . 0.0 110.8 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -79.41 148.47 70.36 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.609 -1.307 . . . . 0.0 108.16 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.75 -61.06 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 120.818 1.012 . . . . 0.0 110.239 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.42 -39.25 9.87 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LEU . 36.6 mt -93.0 149.56 37.77 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.129 -1.218 . . . . 0.0 108.987 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -53.85 -177.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.782 0.988 . . . . 0.0 109.677 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -100.93 -3.34 29.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -119.54 129.46 54.69 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.653 -0.654 . . . . 0.0 109.338 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -52.81 -29.24 26.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.68 71.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.27 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -35.74 75.83 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.37 -64.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -50.43 -41.27 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.939 . . . . 0.0 109.054 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.17 -43.41 95.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.018 . . . . 0.0 108.538 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.39 -21.38 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.763 . . . . 0.0 109.008 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.93 -31.95 73.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 108.595 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.9 mttm -71.45 -31.89 67.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 108.685 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -65.67 -0.29 2.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.468 -0.77 . . . . 0.0 109.153 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 28' ' ' LYS . 32.3 mt-30 -149.8 -65.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 108.78 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.31 56.57 1.19 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -53.95 142.89 23.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.943 -1.327 . . . . 0.0 108.704 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -47.21 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.5 p30 -100.31 121.25 41.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.37 -0.831 . . . . 0.0 109.592 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 59.9 ttt180 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 108.846 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.9 mp0 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -136.09 134.67 38.63 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.18 116.24 17.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.045 -1.034 . . . . 0.0 108.883 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.549 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -53.78 -35.52 61.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.5 -18.77 65.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.994 -1.066 . . . . 0.0 109.637 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.46 -14.1 36.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -68.8 150.59 97.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.239 -0.913 . . . . 0.0 109.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.25 -156.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 120.933 1.089 . . . . 0.0 109.652 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -96.88 -36.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.62 -36.45 78.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.76 47.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.034 -1.041 . . . . 0.0 109.549 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.549 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 3.6 mmtm -57.87 -60.71 3.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 109.019 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.57 -50.88 64.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.389 -0.82 . . . . 0.0 109.926 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.46 69.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 110.042 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.005 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.4 m95 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.28 165.48 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -114.14 152.37 45.8 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.76 -43.33 56.7 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.242 1.295 . . . . 0.0 110.471 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -59.56 -26.8 65.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.885 -179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -84.35 -25.68 28.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.051 -1.031 . . . . 0.0 109.449 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 12' ' ' ASN . 79.8 mt -82.39 -23.47 34.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.187 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.81 28.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.71 -0.619 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 10' ' ' LEU . 15.3 t-20 -147.39 -8.66 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.471 -1.393 . . . . 0.0 111.048 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.2 mt -78.7 147.51 71.19 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.538 -1.351 . . . . 0.0 108.329 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 -67.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.967 1.111 . . . . 0.0 111.0 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.36 -35.3 1.83 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.6 mt -95.35 150.62 37.83 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.186 -1.185 . . . . 0.0 108.865 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.53 -178.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 120.778 0.986 . . . . 0.0 109.996 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ALA . 4.4 mmmm -97.63 -17.46 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.241 -0.912 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -106.37 131.72 53.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.713 . . . . 0.0 109.413 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -53.27 -28.6 28.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.324 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.3 33.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.56 -35.33 66.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.63 -64.88 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.174 . . . . 0.0 109.398 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.5 mt -52.17 -41.61 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.09 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -60.17 -42.04 94.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.767 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.15 -24.34 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.076 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -56.26 -29.23 60.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.138 -0.976 . . . . 0.0 108.662 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -34.98 70.17 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -6.23 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.9 mt-30 -145.84 -70.49 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.378 -0.827 . . . . 0.0 108.87 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.47 55.11 1.11 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.0 m-90 -52.64 142.23 18.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.02 -1.282 . . . . 0.0 108.896 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -47.31 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.507 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.67 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -100.5 121.15 41.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.366 -0.834 . . . . 0.0 109.803 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.159 -0.963 . . . . 0.0 109.158 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.6 mm-40 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -135.35 128.82 32.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -75.73 117.15 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.024 . . . . 0.0 109.406 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' N ' HD21 ' A' ' 49' ' ' ASN . . . -54.78 -30.63 57.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.068 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.542 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 14.4 m120 -70.2 -19.93 63.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.91 -21.15 22.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.813 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.83 148.21 98.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.082 -1.011 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.36 -166.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.86 1.04 . . . . 0.0 109.78 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.4 -34.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.1 mp0 -58.77 -39.67 81.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.324 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.34 -40.26 21.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -57.59 -38.5 75.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.513 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.35 -56.89 6.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.01 -19.59 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.089 179.657 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.7 m95 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.96 153.74 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.347 -0.846 . . . . 0.0 109.904 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -102.46 152.69 38.39 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.743 . . . . 0.0 109.012 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.75 -45.24 41.9 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.164 1.243 . . . . 0.0 110.622 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -60.19 -25.86 65.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -84.24 -24.96 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.089 -1.007 . . . . 0.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -82.66 -19.1 38.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.168 -0.957 . . . . 0.0 109.227 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 32.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.642 -0.661 . . . . 0.0 111.038 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 10' ' ' LEU . 6.3 t-20 -145.9 -9.26 0.53 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.567 -1.333 . . . . 0.0 110.897 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.6 mt -78.68 147.32 70.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.569 -1.332 . . . . 0.0 108.127 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.93 -64.23 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.851 1.034 . . . . 0.0 110.484 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.95 -37.02 5.27 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.7 mt -93.8 149.58 37.27 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.105 -1.232 . . . . 0.0 109.1 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.0 174.75 0.19 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.826 1.017 . . . . 0.0 109.869 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -95.44 -1.74 50.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -0.883 . . . . 0.0 109.742 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -122.92 130.78 53.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -53.3 -28.97 30.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 0.0 109.616 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.67 65.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 -32.54 49.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' ALA . 56.9 t -65.97 -55.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -1.198 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.58 -45.43 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.061 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -60.57 -44.41 96.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 108.901 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.3 -19.13 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.07 -36.24 81.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.146 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.8 mtmt -70.48 -28.57 65.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.228 -0.92 . . . . 0.0 108.962 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -64.63 -1.45 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.825 . . . . 0.0 108.906 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.43 -62.76 0.2 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 108.82 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.68 50.86 2.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -49.28 146.77 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.244 . . . . 0.0 109.166 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.65 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.126 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.6 p30 -99.97 122.17 42.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.831 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.7 mt-10 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -135.51 126.27 27.33 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.486 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 49.3 t-20 -77.1 119.69 21.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 108.963 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.47 32.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 111.017 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.88 -20.42 62.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.114 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.668 ' N ' HD21 ' A' ' 51' ' ' ASN . 33.0 m -90.86 -20.41 22.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.067 -1.021 . . . . 0.0 110.003 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 89.3 mt -67.76 148.77 98.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.088 -1.008 . . . . 0.0 109.085 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.91 -157.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.845 1.03 . . . . 0.0 109.673 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -92.93 -40.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.42 -39.35 79.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.623 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.25 -42.86 22.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.433 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -60.29 -64.78 0.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.86 -44.95 49.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.7 -31.94 73.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.12 179.796 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 55.3 m95 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 t -138.45 164.17 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.312 -0.868 . . . . 0.0 109.958 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -110.73 152.81 43.73 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.5 -45.75 38.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 121.391 1.394 . . . . 0.0 110.655 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.45 -28.12 65.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -84.34 -24.96 29.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.732 -1.23 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 12' ' ' ASN . 56.2 mt -82.62 -20.5 36.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.263 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.18 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.619 -0.675 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 10' ' ' LEU . 36.4 m120 -146.11 -8.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.376 . . . . 0.0 110.656 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.13 147.32 69.25 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.0 107.954 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.7 -67.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.05 1.167 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.98 -34.12 2.92 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.7 mt -94.89 149.6 36.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.135 -1.215 . . . . 0.0 109.082 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.34 -179.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 120.882 1.055 . . . . 0.0 110.051 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -104.38 9.43 35.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.478 -0.763 . . . . 0.0 109.812 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -134.21 134.25 41.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.366 -0.834 . . . . 0.0 109.539 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -53.1 -31.43 41.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.883 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -51.47 64.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.423 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.83 -30.72 77.77 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.41 -54.52 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -1.204 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.57 -44.97 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.883 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.55 -41.48 94.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.079 -1.013 . . . . 0.0 108.935 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.78 -26.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 108.972 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.1 -33.32 51.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 30' ' ' GLN . 69.7 mttt -70.43 -28.12 64.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 0.0 109.055 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.58 -2.72 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.133 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.57 -60.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.67 45.63 3.13 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -48.69 135.84 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.065 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.56 99.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.056 -1.028 . . . . 0.0 109.189 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.6 p30 -100.43 123.22 44.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.0 109.638 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.033 179.573 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.4 mt-10 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -135.36 131.65 36.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.64 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -75.67 112.89 12.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.811 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.84 -26.28 23.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.44 -22.37 63.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.977 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 m -90.5 -10.4 43.77 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.082 -1.012 . . . . 0.0 110.072 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 54' ' ' PRO . 75.6 mt -67.32 149.97 98.13 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.066 -1.022 . . . . 0.0 108.828 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -57.18 -159.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.89 1.06 . . . . 0.0 109.581 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.62 -37.52 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.75 -37.27 81.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -0.819 . . . . 0.0 110.236 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.0 -32.18 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.727 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -55.47 -70.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 109.041 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.09 -42.38 18.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.42 74.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.097 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.206 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 44.3 m95 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.5 t -135.98 -139.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 m -163.03 152.99 13.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.317 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.02 -50.69 12.36 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.422 1.415 . . . . 0.0 110.874 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -57.46 -23.17 48.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 47.9 mt-10 -84.87 -25.0 28.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 109.671 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -83.13 -21.65 33.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.571 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.736 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.67 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -148.86 -7.23 0.38 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.399 -1.438 . . . . 0.0 111.072 -179.355 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.67 ' N ' HD21 ' A' ' 12' ' ' ASN . 19.1 mt -78.27 147.39 72.5 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.642 -1.286 . . . . 0.0 108.16 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -67.42 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 120.939 1.093 . . . . 0.0 110.862 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.11 -34.23 3.1 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -95.26 149.89 36.83 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.238 -1.154 . . . . 0.0 109.29 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.72 -177.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.936 1.09 . . . . 0.0 109.814 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -103.17 3.16 35.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.39 -0.819 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -129.12 131.07 47.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 t -52.38 -31.79 35.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.867 . . . . 0.0 109.346 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -33.79 59.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.49 -36.81 22.4 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.64 -60.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.5 mt -48.96 -40.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 108.733 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -62.55 -39.47 93.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.01 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.37 -10.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -60.04 -38.0 81.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.981 -1.075 . . . . 0.0 110.453 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.61 -27.33 61.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.794 -1.191 . . . . 0.0 109.261 -179.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -63.59 -4.41 2.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 109.044 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.5 mp0 -149.07 -60.89 0.23 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.19 59.86 1.15 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -65.0 133.72 52.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.979 -1.306 . . . . 0.0 108.927 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.12 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 3.8 p30 -103.68 121.53 43.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.436 -0.79 . . . . 0.0 109.45 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 35' ' ' ARG . 29.5 ttm-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 108.56 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 23.3 mm-40 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -135.14 129.01 33.18 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.373 -0.829 . . . . 0.0 109.407 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.536 HD22 HD21 ' A' ' 51' ' ' ASN . 22.9 t-20 -75.52 112.18 11.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.81 . . . . 0.0 109.301 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -31.3 61.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.797 . . . . 0.0 110.708 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.536 HD21 HD22 ' A' ' 49' ' ' ASN . 7.3 m-80 -68.13 -17.28 64.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.985 -1.072 . . . . 0.0 109.63 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.2 m -90.91 -16.04 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 79.3 mt -67.21 149.36 98.49 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.065 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.66 -157.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.894 1.062 . . . . 0.0 109.554 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.74 -39.87 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.86 -42.76 94.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.92 -11.66 59.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.842 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -75.59 -69.94 0.46 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.04 -41.41 16.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.075 -1.015 . . . . 0.0 109.104 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.28 79.68 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.303 -0.873 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.03 179.596 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.8 m95 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.469 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.5 t -132.24 -141.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.419 -0.801 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.469 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.1 m -162.81 153.58 14.3 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.126 -0.984 . . . . 0.0 109.454 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.26 -48.15 20.79 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.344 1.363 . . . . 0.0 110.624 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -58.82 -23.42 60.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 110.007 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.94 -29.62 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.5 mt -80.52 -24.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.269 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.14 29.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 110.92 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.6 m120 -145.69 -9.73 0.54 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.543 -1.348 . . . . 0.0 110.795 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.3 mt -78.78 147.48 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.601 -1.312 . . . . 0.0 108.061 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -65.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.006 1.137 . . . . 0.0 110.849 -179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.14 -37.37 4.4 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.3 150.16 37.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.22 -1.165 . . . . 0.0 109.134 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.12 171.04 0.41 Allowed 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.876 1.051 . . . . 0.0 109.786 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ALA . 51.1 mttm -91.5 -10.18 41.7 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.712 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -114.62 128.59 56.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.512 -0.743 . . . . 0.0 109.314 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -52.59 -28.97 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -33.72 56.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.239 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.16 -37.11 22.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.78 -59.96 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 109.392 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.01 -45.48 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.047 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.28 -42.82 99.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.3 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.39 -14.63 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.58 -31.2 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.21 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -27.83 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 108.576 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -63.92 -8.11 10.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.862 . . . . 0.0 109.245 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -150.18 -59.46 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.318 -0.864 . . . . 0.0 108.98 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.69 55.4 1.91 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -50.88 148.37 4.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.062 -1.258 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.68 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.63 114.43 28.11 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.314 -0.867 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.183 -0.948 . . . . 0.0 109.767 -179.98 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.597 0.713 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.5 130.71 35.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.484 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 28.9 t-20 -77.16 112.62 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 108.947 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.53 -22.95 23.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.369 -0.832 . . . . 0.0 111.029 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.67 HD21 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.788 -1.195 . . . . 0.0 109.843 -179.291 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.67 ' N ' HD21 ' A' ' 51' ' ' ASN . 5.1 m -92.47 -13.1 30.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.62 148.92 98.52 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.981 -1.074 . . . . 0.0 109.012 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -158.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.991 1.127 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.2 -37.37 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.378 -0.826 . . . . 0.0 109.363 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.01 -40.24 84.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.96 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.28 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -58.02 -69.65 0.17 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.104 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -43.38 15.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.789 . . . . 0.0 109.682 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.7 78.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 109.495 179.919 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.1 m95 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 6' ' ' SER . 95.1 t -138.33 165.28 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.341 -0.85 . . . . 0.0 110.198 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.44 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 m -104.52 153.76 38.91 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.458 -0.776 . . . . 0.0 109.348 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.02 -44.13 47.33 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.388 1.392 . . . . 0.0 110.83 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -23.22 45.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 109.814 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -84.56 -23.08 29.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 12' ' ' ASN . 96.6 mt -82.97 -22.49 33.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 0.0 109.094 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 32.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.762 -0.586 . . . . 0.0 111.336 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.4 t-20 -146.64 -9.04 0.48 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.519 -1.363 . . . . 0.0 110.775 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.1 mt -79.45 147.58 68.39 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.681 -1.262 . . . . 0.0 108.229 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.69 -61.83 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 120.871 1.047 . . . . 0.0 110.527 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.26 -38.87 6.79 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.9 mt -93.98 149.64 37.24 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 0.0 109.108 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.59 177.78 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.722 0.948 . . . . 0.0 109.712 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -98.47 9.06 44.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.258 -0.901 . . . . 0.0 109.63 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -134.17 130.52 37.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 0.0 109.323 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 p -53.13 -29.62 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.51 65.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.8 28.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.51 -59.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.266 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.4 mt -52.12 -43.03 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.078 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.97 -39.9 87.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -74.99 -27.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.05 -32.74 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.0 108.799 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -71.8 -33.4 68.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.131 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.15 -3.28 3.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.538 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.5 mt-30 -145.19 -63.42 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.0 108.935 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.4 51.84 1.8 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.538 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.4 m-90 -51.63 146.46 7.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.251 . . . . 0.0 109.076 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.49 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.064 . . . . 0.0 109.306 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.672 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -98.8 117.16 32.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.499 -0.751 . . . . 0.0 109.75 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.932 . . . . 0.0 108.604 179.178 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.756 0.789 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -135.81 136.72 40.9 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.704 HD21 ' H ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -77.54 114.78 16.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.082 -1.011 . . . . 0.0 109.334 -179.965 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.12 35.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 111.193 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 49' ' ' ASN . 5.6 m-20 -69.69 -17.94 63.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.895 -1.128 . . . . 0.0 110.089 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -91.83 -14.7 29.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.135 -0.978 . . . . 0.0 110.216 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt -66.89 148.17 98.9 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.056 . . . . 0.0 108.992 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -56.81 -161.86 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 121.01 1.14 . . . . 0.0 109.618 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 t -91.39 -38.81 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -59.37 -40.22 85.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.09 11.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.626 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -48.24 -50.9 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.775 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.81 -53.72 54.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.16 66.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 109.083 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 0.0 108.914 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 46.2 m95 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.4 t -135.24 -140.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.453 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.1 m -163.11 154.0 14.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 0.0 109.449 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.59 -50.56 12.97 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 121.345 1.363 . . . . 0.0 110.871 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -58.14 -24.33 58.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.123 -0.985 . . . . 0.0 110.131 -179.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -84.69 -28.46 26.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 12' ' ' ASN . 60.9 mt -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.28 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.15 30.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 10' ' ' LEU . 64.0 m-80 -145.71 -7.38 0.58 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.574 -1.329 . . . . 0.0 110.698 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.2 mt -79.19 147.81 69.93 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.669 -1.269 . . . . 0.0 108.04 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 120.839 1.026 . . . . 0.0 110.635 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.56 -36.39 4.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.6 mt -93.79 149.92 37.82 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.182 -1.187 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.8 171.13 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 120.763 0.975 . . . . 0.0 109.756 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.41 7.8 45.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.869 . . . . 0.0 109.779 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -133.62 129.63 37.19 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 p -53.0 -29.64 30.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 0.0 109.383 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.1 -35.83 62.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.7 -35.12 20.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.6 t -65.86 -53.17 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -1.135 . . . . 0.0 109.34 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -57.29 -48.47 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.11 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -60.02 -44.84 94.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -75.15 -18.36 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.96 -30.41 70.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 30' ' ' GLN . 41.4 mttp -71.51 -29.22 64.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -64.83 -3.21 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.7 mt-30 -149.81 -61.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.74 53.51 2.24 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -50.19 143.81 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.938 -1.33 . . . . 0.0 108.912 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.643 HE21 HD21 ' A' ' 49' ' ' ASN . 10.9 tt0 -46.97 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.156 -0.965 . . . . 0.0 109.527 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.3 p30 -106.14 117.17 33.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.522 -0.736 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 179.564 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 30.8 mt-10 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.64 126.49 27.5 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.166 -0.959 . . . . 0.0 109.891 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.643 HD21 HE21 ' A' ' 33' ' ' GLN . 50.5 t-20 -76.15 112.72 12.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 108.811 179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.08 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.992 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -71.2 -22.97 61.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.5 m -89.55 -11.78 41.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.082 -1.012 . . . . 0.0 110.272 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.6 mt -68.39 148.98 98.2 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.932 -1.105 . . . . 0.0 109.283 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.4 Cg_endo -58.02 -155.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.019 1.146 . . . . 0.0 109.643 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.11 -36.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.169 -0.957 . . . . 0.0 109.689 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.35 -38.16 82.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.698 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.95 47.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.574 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -59.92 -71.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 108.984 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.78 -42.3 11.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.444 -0.785 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.15 -35.48 80.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.264 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.2 -179.772 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.8 m95 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.61 145.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -96.76 152.29 38.38 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.09 -44.99 44.38 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.235 1.29 . . . . 0.0 110.297 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -60.57 -25.44 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 109.88 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -84.36 -27.07 27.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -81.97 -23.66 35.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 109.213 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 31.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.598 -0.688 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 10' ' ' LEU . 72.1 m-80 -144.83 -8.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.568 -1.333 . . . . 0.0 110.682 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.0 mt -78.93 147.61 70.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.689 -1.257 . . . . 0.0 108.04 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -64.93 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.888 1.058 . . . . 0.0 110.663 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.66 -36.99 4.89 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -93.76 149.84 37.72 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.132 -1.217 . . . . 0.0 109.156 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.77 175.11 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.956 1.104 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -98.84 7.18 46.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.32 -0.862 . . . . 0.0 109.658 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.31 130.71 41.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.468 -0.77 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -52.37 -30.75 30.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.42 62.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.35 -36.93 25.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.88 -55.83 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.03 -44.64 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.153 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.75 -43.02 98.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.067 . . . . 0.0 108.735 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.03 -22.11 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.66 -30.33 60.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 108.739 179.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -71.3 -30.68 66.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -65.37 -3.66 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.422 -0.799 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -151.29 -63.44 0.18 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.027 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.3 54.36 1.86 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.65 151.28 1.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.286 . . . . 0.0 109.378 179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.571 HE21 HD21 ' A' ' 49' ' ' ASN . 20.3 tt0 -54.8 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -96.69 114.6 26.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 35' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.416 0.627 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -135.45 131.66 36.46 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.571 HD21 HE21 ' A' ' 33' ' ' GLN . 43.7 t-20 -75.38 116.36 16.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.019 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.84 -24.72 24.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 52' ' ' SER . 49.8 p30 -70.76 -18.83 62.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.953 -1.092 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 19.4 m -92.5 -14.88 27.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.003 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.32 149.71 98.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.63 -155.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 121.035 1.157 . . . . 0.0 109.371 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 t -97.61 -37.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.152 -0.968 . . . . 0.0 109.329 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -61.04 -35.53 77.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.04 -47.0 15.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 0.0 109.803 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -53.73 -54.51 37.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.535 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.07 -51.37 53.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.182 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.93 -27.09 68.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.875 . . . . 0.0 109.203 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -135.55 160.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -106.27 153.78 40.16 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 109.377 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.85 -43.49 57.59 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 121.337 1.358 . . . . 0.0 110.559 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -58.23 -26.48 62.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 109.833 -179.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 42.8 mt-10 -84.57 -25.55 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.1 mt -82.8 -22.64 34.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 28.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.664 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.667 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -147.25 -5.7 0.5 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.477 -1.389 . . . . 0.0 110.901 -179.642 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.667 ' N ' HD21 ' A' ' 12' ' ' ASN . 33.2 mt -79.4 147.65 68.74 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.558 -1.339 . . . . 0.0 108.061 179.261 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.92 -62.31 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 120.966 1.111 . . . . 0.0 110.791 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.63 -40.74 6.63 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 47.4 mt -93.91 150.06 37.97 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.236 -1.155 . . . . 0.0 109.04 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -52.21 -178.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 120.844 1.029 . . . . 0.0 109.915 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -100.51 -7.23 24.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.301 -0.874 . . . . 0.0 109.661 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -116.42 128.11 55.21 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.186 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -52.22 -29.22 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.13 66.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.291 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.66 -35.88 34.92 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.01 -59.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 109.243 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.65 -44.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 0.0 109.107 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -61.16 -45.59 93.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.116 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.57 -22.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.286 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.79 -32.99 63.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 30' ' ' GLN . 23.7 mmtp -71.01 -29.02 64.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.052 179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -64.34 -0.6 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.2 mt-30 -150.86 -62.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.23 47.74 2.15 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.231 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -51.75 134.38 30.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.94 -1.329 . . . . 0.0 108.944 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.33 112.79 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.992 -1.068 . . . . 0.0 108.568 179.555 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 10.3 p30 -110.03 120.51 42.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.584 -0.697 . . . . 0.0 109.832 -179.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.112 179.464 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 40.4 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.4 132.76 35.93 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.426 -0.796 . . . . 0.0 109.334 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -77.45 120.18 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.92 -30.03 57.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.3 -0.875 . . . . 0.0 110.54 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -71.35 -18.71 62.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 35.9 m -89.74 -22.91 21.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.049 -1.032 . . . . 0.0 110.278 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.44 148.02 98.73 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.957 -1.09 . . . . 0.0 108.983 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.7 -164.44 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 120.899 1.066 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 t -89.28 -37.02 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.45 -39.43 79.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.567 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.76 -44.32 17.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.099 -1.0 . . . . 0.0 109.573 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.96 -42.33 72.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 109.829 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.91 -56.9 10.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.711 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.35 -19.96 65.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 -179.75 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.5 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.12 160.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.379 -0.826 . . . . 0.0 109.882 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -107.7 153.73 41.31 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.726 . . . . 0.0 109.362 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.92 -43.59 56.75 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.271 1.314 . . . . 0.0 110.503 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -57.72 -26.14 61.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.142 -0.974 . . . . 0.0 109.154 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.8 mt -82.91 -19.97 36.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.817 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.92 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.0 m120 -146.83 -7.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.544 -1.347 . . . . 0.0 110.907 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.22 147.71 69.6 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.603 -1.31 . . . . 0.0 108.215 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.72 -64.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.96 1.107 . . . . 0.0 110.511 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.88 -38.9 6.02 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' LEU . 57.8 mt -93.18 149.6 37.72 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.224 -1.163 . . . . 0.0 109.087 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.57 175.6 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.867 1.045 . . . . 0.0 109.88 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.6 -5.7 31.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -116.47 129.06 56.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 109.258 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -52.62 -29.49 26.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.56 -37.59 68.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.64 -35.41 36.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' ALA . 46.4 t -65.93 -50.11 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.419 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.65 -42.7 93.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.062 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -75.06 -24.29 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.243 179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.78 -31.39 66.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 0.0 108.737 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.05 -30.4 66.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -64.41 -0.98 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.231 179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.5 mt-30 -150.76 -63.23 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 108.768 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.33 49.7 2.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.9 m-90 -48.95 147.82 2.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.3 . . . . 0.0 109.01 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -47.54 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.997 . . . . 0.0 109.33 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.69 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.36 119.31 38.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.48 -0.763 . . . . 0.0 110.183 -179.359 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.234 -0.916 . . . . 0.0 108.962 179.274 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -136.46 126.51 26.09 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.26 -0.9 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.67 ' ND2' HD22 ' A' ' 51' ' ' ASN . 50.0 t-20 -76.31 120.46 21.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.06 -30.28 47.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 110.698 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.67 HD22 ' ND2' ' A' ' 49' ' ' ASN . 50.9 p30 -71.45 -19.22 62.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.93 -1.106 . . . . 0.0 110.106 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 70.3 m -90.05 -22.06 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.974 -179.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 80.0 mt -67.66 148.35 98.57 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 0.0 108.764 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.32 -158.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 120.879 1.052 . . . . 0.0 109.766 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.87 -37.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.09 -39.86 79.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.01 33.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.693 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -59.91 -39.11 84.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.01 18.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.179 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.02 -21.42 66.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.88 . . . . 0.0 109.045 179.757 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.3 m95 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.28 157.87 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.381 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -105.16 153.15 39.74 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.413 -0.804 . . . . 0.0 109.24 -179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.49 -42.88 62.22 Favored 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.24 1.294 . . . . 0.0 110.397 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -58.2 -27.0 63.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.603 -179.546 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -84.63 -24.47 29.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 109.119 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 12' ' ' ASN . 98.3 mt -82.42 -22.85 35.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.87 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.68 . . . . 0.0 111.394 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.4 m120 -148.34 -7.03 0.41 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.465 -1.397 . . . . 0.0 111.089 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -79.9 148.11 67.73 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.594 -1.316 . . . . 0.0 108.253 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.4 -67.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.039 1.159 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.67 2.36 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' LEU . 21.4 mt -95.19 150.61 37.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.21 -1.17 . . . . 0.0 109.015 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.9 -174.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.759 0.972 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -105.29 4.37 30.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.448 -0.782 . . . . 0.0 109.84 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 p -132.71 132.42 42.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.414 -0.804 . . . . 0.0 109.413 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -53.1 -30.83 38.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.324 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.31 61.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.275 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -36.84 15.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.92 -53.95 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -1.146 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.04 -43.25 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 108.929 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.46 -44.13 97.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 108.94 179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.38 -24.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.446 -0.784 . . . . 0.0 109.187 179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.46 -29.52 36.13 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.163 -0.961 . . . . 0.0 108.692 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 30' ' ' GLN . 7.4 mtpm? -72.14 -35.36 69.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -64.68 0.73 1.02 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.063 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 28' ' ' LYS . 32.2 mt-30 -151.94 -68.77 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 108.905 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.08 52.42 1.62 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -51.47 141.55 15.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.271 . . . . 0.0 109.115 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -50.51 91.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -97.83 118.47 34.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.331 -0.855 . . . . 0.0 109.303 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.667 179.86 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.3 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.97 127.63 28.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.669 ' ND2' HD22 ' A' ' 51' ' ' ASN . 46.9 t-20 -75.37 123.5 25.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.997 . . . . 0.0 109.296 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.12 63.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.828 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.669 HD22 ' ND2' ' A' ' 49' ' ' ASN . 42.2 p30 -69.83 -16.53 63.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.941 -1.1 . . . . 0.0 109.82 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 49.7 m -89.95 -23.88 21.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.63 148.31 98.59 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 108.948 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.83 -168.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.892 1.061 . . . . 0.0 109.676 179.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.0 -35.36 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 6.0 mp0 -59.28 -39.43 82.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.81 -29.03 32.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.61 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -63.79 -46.82 83.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.302 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.0 77.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 108.807 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.24 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.068 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 108.589 179.684 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.1 m95 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.4 t -136.05 -140.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.23 -0.919 . . . . 0.0 109.979 -179.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.452 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 4.9 m -162.83 153.0 13.65 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.46 -48.6 19.66 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.463 1.442 . . . . 0.0 110.959 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -57.25 -24.79 57.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -0.999 . . . . 0.0 109.968 -179.054 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.05 -26.06 27.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.185 -0.947 . . . . 0.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.2 mt -81.9 -21.59 37.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 30.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' LEU . 57.2 m-80 -146.69 -7.0 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.523 -1.361 . . . . 0.0 110.933 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.49 147.79 68.66 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.629 -1.295 . . . . 0.0 108.176 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -66.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.867 1.045 . . . . 0.0 110.707 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.36 -36.43 4.28 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.6 mt -93.68 149.95 37.95 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.173 -1.192 . . . . 0.0 109.18 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 172.77 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.821 1.014 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -94.36 6.6 48.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.735 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -131.86 129.66 40.68 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.506 -0.746 . . . . 0.0 109.309 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -52.71 -29.86 29.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.57 29.35 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.43 -58.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.8 mt -52.39 -44.52 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.937 . . . . 0.0 109.146 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.71 -44.35 96.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.982 . . . . 0.0 109.063 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.28 -24.04 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 109.215 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.28 -32.95 67.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 108.884 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -71.78 -33.52 68.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 108.966 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -65.15 -3.88 4.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.579 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 30.5 mt-30 -150.18 -67.58 0.2 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 108.779 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.88 59.04 1.01 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.579 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.5 m-90 -55.74 147.81 17.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.083 -1.245 . . . . 0.0 108.732 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.644 HE21 HD21 ' A' ' 49' ' ' ASN . 15.9 tt0 -49.24 90.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.148 -0.97 . . . . 0.0 109.537 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -102.98 121.2 42.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.876 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 35' ' ' ARG . 23.4 ttm-85 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 12.1 mm-40 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.05 128.42 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.452 -0.78 . . . . 0.0 109.596 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.644 HD21 HE21 ' A' ' 33' ' ' GLN . 57.3 t-20 -76.47 114.77 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.266 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.616 ' CB ' ' HZ3' ' A' ' 58' ' ' LYS . . . -54.7 -30.82 56.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.12 -19.67 63.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 m -89.18 -17.96 28.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 109.766 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.4 mt -67.71 149.2 98.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.046 -1.033 . . . . 0.0 109.032 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.66 -158.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.914 1.076 . . . . 0.0 110.031 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.11 -38.62 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -57.79 -41.45 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.52 -33.75 47.8 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.616 ' HZ3' ' CB ' ' A' ' 50' ' ' ALA . 1.2 tpmt? -56.98 -53.67 55.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.15 67.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.61 78.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.111 -0.993 . . . . 0.0 109.375 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.364 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -138.33 148.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 109.545 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.416 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.5 m -97.44 153.0 38.52 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 -179.663 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -51.81 -48.15 22.89 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.381 1.387 . . . . 0.0 110.869 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -58.74 -23.74 60.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.29 -179.194 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 24.0 mm-40 -85.03 -24.01 28.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.947 -1.096 . . . . 0.0 109.51 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -82.02 -23.18 36.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.134 -0.979 . . . . 0.0 108.8 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.623 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -146.89 -6.19 0.51 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.544 -1.347 . . . . 0.0 110.844 -179.466 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.623 ' N ' HD21 ' A' ' 12' ' ' ASN . 37.2 mt -78.9 147.3 70.1 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.558 -1.339 . . . . 0.0 108.02 179.241 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.96 -67.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.066 1.177 . . . . 0.0 110.756 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.71 -34.73 2.85 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.2 mt -94.57 149.94 37.3 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.152 -1.205 . . . . 0.0 109.031 -179.673 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.5 -176.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 120.921 1.081 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -102.57 -2.85 27.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.429 -0.794 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -119.65 126.15 50.46 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -52.27 -29.15 21.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.344 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.09 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.391 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.9 -36.16 37.21 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.78 -60.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -1.152 . . . . 0.0 109.36 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.0 mt -50.82 -42.42 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 108.97 179.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.41 -39.24 86.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.479 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -74.32 -28.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 108.976 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.57 -31.56 16.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 108.763 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 30' ' ' GLN . 56.5 mmtt -72.5 -39.63 67.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 0.0 109.008 179.412 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -64.99 1.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 28' ' ' LYS . 33.5 mt-30 -152.0 -70.43 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 108.975 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.44 51.18 1.6 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.3 m-90 -50.0 141.54 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.06 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.009 . . . . 0.0 109.117 179.784 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.3 p-10 -100.57 122.8 43.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.422 -0.799 . . . . 0.0 110.19 -179.313 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.347 -0.846 . . . . 0.0 109.343 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 56.5 mm-40 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -135.72 130.72 34.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -76.23 116.75 17.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.99 -30.57 59.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 -179.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -70.44 -19.35 62.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.99 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.4 m -89.65 -19.86 24.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 88.5 mt -67.59 149.05 98.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.103 -0.998 . . . . 0.0 108.859 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.69 -160.34 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.769 0.98 . . . . 0.0 109.661 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -92.03 -38.71 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.39 -39.33 83.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.724 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.86 -38.75 27.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.23 -59.73 4.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 109.373 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.43 -44.53 65.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.14 73.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.136 179.92 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.4 m95 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.05 153.08 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.79 -179.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.421 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.5 m -103.84 153.43 38.76 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.203 -179.749 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.95 -46.21 35.33 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.27 1.313 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -59.28 -23.92 62.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -84.87 -25.99 27.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 0.0 109.538 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' ASN . 62.9 mt -83.13 -21.29 33.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.892 . . . . 0.0 109.488 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.06 29.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.616 -0.677 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' LEU . 18.8 m-80 -148.03 -8.7 0.4 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.435 -1.416 . . . . 0.0 111.011 -179.411 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.7 mt -79.19 147.28 68.89 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.559 -1.338 . . . . 0.0 108.231 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -67.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.718 0 C-N-CA 121.087 1.191 . . . . 0.0 111.054 -179.182 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.91 -34.66 2.01 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.1 mt -95.37 150.06 37.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.197 -1.178 . . . . 0.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.34 179.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.875 1.05 . . . . 0.0 110.177 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.1 mmtt -96.56 -17.87 20.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.284 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -109.68 130.97 55.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.633 -0.667 . . . . 0.0 109.356 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -53.05 -29.31 29.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.16 -32.87 56.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.06 -36.0 29.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.96 -58.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.411 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.52 -46.05 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.052 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.61 -56.65 17.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 108.954 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.94 -15.09 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.449 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.1 -35.57 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.303 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 10.6 mptt -70.87 -28.71 64.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.129 179.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -64.2 -4.6 3.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.4 mp0 -149.22 -61.19 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.55 49.59 2.52 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.323 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -52.22 142.89 15.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.257 . . . . 0.0 109.385 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -57.03 96.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 108.961 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.9 p30 -99.45 123.81 44.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.369 -0.832 . . . . 0.0 109.944 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.61 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 12.3 mm-40 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -135.3 128.66 32.19 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.243 179.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -74.66 117.7 16.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.06 . . . . 0.0 109.169 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -26.73 60.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -68.57 -20.74 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.554 -179.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -91.24 -15.14 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.871 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.4 149.58 98.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 0.0 108.879 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.29 -157.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 120.954 1.103 . . . . 0.0 109.638 179.297 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.98 -37.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.72 -35.83 77.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 110.316 -179.389 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.91 -31.22 45.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -58.59 -68.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -45.7 17.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.397 -0.814 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.381 -0.824 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.321 -179.99 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 51.3 m95 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -134.63 150.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.378 -0.826 . . . . 0.0 109.58 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -98.34 153.01 38.22 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.434 -0.791 . . . . 0.0 109.488 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.68 -45.02 40.63 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.351 1.367 . . . . 0.0 110.582 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -58.19 -26.8 63.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.14 -24.93 30.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.696 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 12' ' ' ASN . 81.8 mt -81.87 -23.5 36.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 108.997 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.96 28.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 111.021 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.5 m-80 -147.42 -7.06 0.46 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.481 -1.387 . . . . 0.0 110.881 -179.377 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' LEU . 22.3 mt -79.16 147.42 69.31 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.648 -1.283 . . . . 0.0 108.181 179.412 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.77 -68.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.019 1.146 . . . . 0.0 110.796 -179.441 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.8 -34.56 1.91 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.1 mt -95.23 150.6 37.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.202 -1.175 . . . . 0.0 108.976 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.95 -179.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.762 0.975 . . . . 0.0 109.853 179.485 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 19.9 mmmt -98.73 -16.03 19.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.064 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -105.28 132.38 51.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.682 . . . . 0.0 109.305 -179.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.88 -28.56 37.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.83 -54.19 47.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.913 . . . . 0.0 109.749 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.62 -35.85 63.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.21 -65.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -1.21 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mt -51.27 -41.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.149 -179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -61.67 -42.7 99.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.07 -22.81 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.24 -29.16 31.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.0 108.842 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.3 mptp? -71.43 -32.51 68.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 108.872 179.59 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -64.64 -4.87 4.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.294 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -150.26 -67.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.08 54.14 1.31 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.9 m-90 -52.07 137.99 26.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.117 -1.225 . . . . 0.0 109.018 179.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -47.19 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.713 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -103.11 115.74 31.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.358 -0.838 . . . . 0.0 109.472 179.918 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 35' ' ' ARG . 4.2 ptt-85 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 179.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 7.5 mp0 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -136.36 128.96 30.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.193 -0.942 . . . . 0.0 109.796 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -76.09 114.34 14.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 108.984 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -26.36 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.465 -179.254 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -70.28 -21.1 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.3 m -90.0 -18.62 25.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.54 149.17 98.47 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.014 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.3 Cg_endo -57.8 -156.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 120.939 1.093 . . . . 0.0 109.42 179.228 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -98.21 -37.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.1 -35.52 77.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.05 -39.01 30.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.059 -1.026 . . . . 0.0 109.698 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.73 -59.17 5.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.971 . . . . 0.0 109.449 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.81 -45.42 50.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.917 -1.114 . . . . 0.0 109.16 179.688 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.34 -33.11 74.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 108.99 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.152 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.345 0.593 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -151.03 -67.73 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.0 tp 52.74 79.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.687 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -80.72 169.36 17.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 t -140.05 165.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -113.54 153.11 45.83 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -52.67 -46.77 31.14 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.303 1.335 . . . . 0.0 110.558 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -59.12 -25.92 64.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.931 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.46 -25.86 30.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.008 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 12' ' ' ASN . 89.7 mt -82.47 -23.5 34.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 108.898 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.3 m120 -145.49 -9.52 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.578 -1.326 . . . . 0.0 110.666 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.2 mt -79.18 147.4 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.667 -1.271 . . . . 0.0 108.098 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.53 -64.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.059 1.173 . . . . 0.0 110.802 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.84 4.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -94.92 149.79 36.83 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.114 -1.227 . . . . 0.0 109.018 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.41 175.81 0.17 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 120.905 1.07 . . . . 0.0 109.921 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -97.04 7.87 45.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 p -133.71 130.08 37.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.46 -0.775 . . . . 0.0 109.413 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -52.84 -29.83 30.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.63 63.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.16 -35.46 23.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.75 -53.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -1.189 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.78 -45.18 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 109.121 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.2 -41.73 93.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 0.0 108.951 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.96 -25.82 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 109.114 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.86 -31.71 40.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -71.11 -29.4 65.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.234 -0.916 . . . . 0.0 109.016 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -64.86 -7.13 10.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 109.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -150.72 -64.34 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 108.843 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.1 59.47 1.05 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -57.37 145.41 32.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.081 -1.247 . . . . 0.0 108.824 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -47.63 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -103.63 119.51 39.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.427 -0.796 . . . . 0.0 109.844 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -88.17 146.28 25.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.271 -0.893 . . . . 0.0 109.156 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -95.11 153.86 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -149.4 107.09 3.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.021 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.64 58.64 0.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.755 . . . . 0.0 109.917 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.0 -28.84 0.02 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.28 -1.57 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.865 -1.374 . . . . 0.0 110.406 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -170.68 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.929 -1.107 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.01 -153.45 9.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.59 4.7 67.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -173.61 95.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.63 -159.68 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.24 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -147.86 94.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.185 -0.947 . . . . 0.0 109.207 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.4 mt-10 -82.46 175.44 10.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 108.744 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -135.72 128.39 30.86 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.672 HD21 ' N ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -75.7 116.07 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 108.898 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.33 59.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.614 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.672 ' N ' HD21 ' A' ' 49' ' ' ASN . 5.1 m120 -69.4 -17.17 63.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.006 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.8 m -89.61 -20.27 23.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.0 109.782 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 54' ' ' PRO . 73.9 mt -67.92 149.27 98.28 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.121 -0.987 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -57.04 -157.89 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.845 1.03 . . . . 0.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 t -94.4 -36.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -58.08 -38.81 77.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.549 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.33 -36.4 29.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.36 -42.92 78.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.595 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.44 -58.06 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -23.31 67.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.749 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -63.4 -77.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.49 -13.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.36 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -69.08 -60.41 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 109.595 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 20.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.049 -1.032 . . . . 0.0 110.213 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.4 mm-40 -103.57 8.54 37.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.006 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . -50.6 135.71 28.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 66' ' ' GLY . 35.0 tt0 59.79 122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.485 -1.009 . . . . 0.0 109.998 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.64 ' CG2' ' H ' ' A' ' 69' ' ' GLU . 12.7 tt -160.06 -66.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 68' ' ' ILE . 26.3 mt-10 -159.66 161.34 34.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.436 -0.79 . . . . 0.0 109.041 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 p -88.5 -76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -158.24 145.21 17.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' TYR . 2.9 pp -172.03 152.8 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.89 15.33 0.1 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -90.11 9.26 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -1.204 . . . . 0.0 109.478 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 54.4 t80 39.73 26.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.798 -0.564 . . . . 0.0 110.448 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' TYR . 3.9 mp0 . . . . . 0 N--CA 1.492 1.663 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.293 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -151.14 109.94 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.193 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.6 tp -168.4 74.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.427 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 45.0 m95 -80.04 161.75 25.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.164 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 6' ' ' SER . 58.7 t -139.39 167.99 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.41 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 m -106.21 153.88 40.04 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.43 -0.794 . . . . 0.0 109.602 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.82 -49.72 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.481 1.454 . . . . 0.0 110.801 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.11 -23.85 22.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.564 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 43.1 mt-10 -84.18 -23.32 30.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.986 -1.071 . . . . 0.0 109.402 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.7 mt -83.65 -20.58 33.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.63 36.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.7 -0.625 . . . . 0.0 111.506 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 m120 -148.22 -11.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.343 -1.473 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -78.73 147.91 71.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.646 -1.284 . . . . 0.0 108.182 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.46 -60.71 0.28 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 120.823 1.015 . . . . 0.0 110.415 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.98 -39.57 9.07 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.4 mt -93.39 149.84 37.98 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.216 -1.167 . . . . 0.0 109.041 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.35 177.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.848 1.032 . . . . 0.0 109.97 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -101.56 8.41 41.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.429 -0.794 . . . . 0.0 109.552 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -130.09 132.96 46.36 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.525 -0.734 . . . . 0.0 109.351 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -52.82 -31.34 38.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.596 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.7 51.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -33.75 85.38 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.2 -65.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.169 . . . . 0.0 109.229 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -48.98 -41.11 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -61.66 -48.94 78.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 108.876 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.81 -36.45 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 108.959 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.33 -30.35 7.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.647 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' C ' ' H ' ' A' ' 30' ' ' GLN . 48.2 mtpt -73.77 -41.98 61.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.51 -0.744 . . . . 0.0 109.484 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -65.94 4.32 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.308 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.548 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 23.8 mt-30 -150.15 -75.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 105.35 50.39 0.92 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.548 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.6 m-90 -53.24 134.1 39.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.366 . . . . 0.0 108.463 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 105.01 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.96 -1.088 . . . . 0.0 109.513 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -104.17 124.36 48.97 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 110.282 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.2 123.22 31.23 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 109.38 20.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.837 -1.164 . . . . 0.0 110.148 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.99 163.66 18.75 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.81 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.743 -1.223 . . . . 0.0 109.32 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -84.07 -49.08 4.89 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t 56.99 -7.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.561 -0.964 . . . . 0.0 109.601 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.67 ' H ' ' C ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 169.35 -51.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -77.48 1.36 Allowed Glycine 0 N--CA 1.5 2.917 0 O-C-N 121.737 -0.602 . . . . 0.0 111.844 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.63 95.03 0.1 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' H ' ' HA2' ' A' ' 39' ' ' GLY . 29.0 mtmt 70.59 89.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.88 -0.776 . . . . 0.0 109.388 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.52 130.7 43.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.47 -0.769 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -90.81 148.46 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.035 -1.041 . . . . 0.0 108.981 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -132.98 169.38 16.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 46' ' ' ILE . 42.9 m-85 -135.47 135.38 40.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.53 112.31 12.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.123 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.87 19.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.307 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -72.11 -20.43 61.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.035 -1.041 . . . . 0.0 110.277 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.3 m -88.9 -16.65 31.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.081 -1.012 . . . . 0.0 110.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' PRO . 82.7 mt -67.73 148.13 98.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 108.962 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -56.69 -161.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.847 1.031 . . . . 0.0 109.686 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -91.2 -38.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.36 -41.15 84.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.47 -52.58 7.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.093 -1.004 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -46.69 -45.55 19.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.977 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -58.09 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.47 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.12 62.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.212 -0.93 . . . . 0.0 109.001 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' CD1' HE21 ' A' ' 65' ' ' GLN . 0.2 OUTLIER -64.4 -62.12 1.8 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 108.795 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.8 mt -46.74 -32.88 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.716 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.9 mt -64.95 -34.51 78.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 66' ' ' GLY . 21.4 mtp180 -69.89 -37.76 76.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.463 HE21 ' CD1' ' A' ' 61' ' ' LEU . 94.7 mm-40 -46.99 -13.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.911 -1.118 . . . . 0.0 109.926 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -59.67 105.89 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 66' ' ' GLY . 5.5 tm-20 45.9 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.912 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.99 -36.34 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.451 -0.781 . . . . 0.0 109.152 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -146.1 11.87 1.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 109.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.535 ' C ' ' H ' ' A' ' 72' ' ' LEU . 29.3 m 47.56 -109.33 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 t 58.76 0.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.018 -1.051 . . . . 0.0 109.713 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 70' ' ' THR . 34.6 mt -133.64 -125.38 0.17 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.812 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.55 4.39 89.22 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -88.45 12.55 14.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.249 . . . . 0.0 109.319 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 47.3 t80 49.01 29.8 2.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 75' ' ' PHE . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 3.6 ppp? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.576 ' N ' ' SD ' ' A' ' 1' ' ' MET . 31.0 tt0 -87.82 105.32 17.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 109.862 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.4 tp -149.27 85.79 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.905 . . . . 0.0 109.211 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 41.8 m95 -79.66 158.01 27.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 108.855 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.29 -137.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.418 -0.801 . . . . 0.0 109.349 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -166.12 152.31 8.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 109.508 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.39 -52.02 8.02 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.312 1.341 . . . . 0.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -58.54 -25.56 62.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.69 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 46.4 mm-40 -84.95 -30.34 24.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.077 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 12' ' ' ASN . 28.6 mt -80.69 -25.27 38.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.039 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 30.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 t-20 -145.1 -10.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.582 -1.324 . . . . 0.0 110.562 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' LEU . 21.2 mt -78.65 147.21 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.0 107.911 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.49 -64.39 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 120.978 1.119 . . . . 0.0 110.926 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.2 -37.47 4.52 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.6 mt -95.39 150.29 37.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.157 -1.202 . . . . 0.0 109.272 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.31 173.21 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 120.908 1.072 . . . . 0.0 110.027 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.36 8.47 43.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.296 -0.878 . . . . 0.0 109.69 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.02 131.92 41.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.487 -0.758 . . . . 0.0 109.375 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -53.02 -30.56 36.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -47.69 67.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.243 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.96 -36.36 86.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.5 -63.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -1.209 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.5 -42.46 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.968 . . . . 0.0 109.1 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.12 -44.79 96.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.016 . . . . 0.0 109.015 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.42 -26.34 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.91 -28.53 9.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.851 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.6 mptp? -72.92 -35.65 67.08 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.154 -0.966 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -65.37 -3.97 4.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -150.9 -68.96 0.18 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.89 54.55 1.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.88 143.75 12.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.942 -1.328 . . . . 0.0 109.006 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -50.01 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.001 . . . . 0.0 109.078 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.5 p30 -100.06 123.44 44.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.293 -0.88 . . . . 0.0 109.82 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -87.86 115.04 25.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -91.91 84.11 5.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 39' ' ' GLY . 5.9 tpt180 -90.37 96.8 10.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.51 35.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.932 . . . . 0.0 109.405 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 37' ' ' ARG . . . -92.89 -21.16 31.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 11.9 p -51.55 -44.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 75.8 tttt -174.08 -44.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.442 -0.786 . . . . 0.0 109.127 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.99 -7.72 0.26 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.14 11.28 30.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 52.49 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -1.084 . . . . 0.0 109.337 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.49 118.19 25.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.406 -0.809 . . . . 0.0 109.271 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.9 mt -88.37 97.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.331 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.37 169.48 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 108.861 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.43 130.02 34.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.389 -0.819 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.12 117.5 17.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.93 -28.29 66.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 110.053 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -70.02 -23.43 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -89.47 -10.63 45.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 54' ' ' PRO . 60.4 mt -66.52 153.64 92.73 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.094 -1.004 . . . . 0.0 108.527 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.5 Cg_exo -57.16 -147.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.206 -1.076 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.01 -37.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.933 -1.104 . . . . 0.0 109.457 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.83 -30.05 71.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 111.185 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 -41.42 37.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.669 -1.269 . . . . 0.0 110.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -56.7 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.122 . . . . 0.0 109.454 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.2 -48.73 23.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.284 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.89 -33.1 74.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.57 -34.01 77.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.294 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.3 mt -71.59 -27.48 63.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.251 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.42 -52.94 33.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 108.958 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -72.51 -43.96 62.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.207 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.06 142.99 36.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.76 -1.213 . . . . 0.0 109.597 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.14 -68.03 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -61.73 -24.63 66.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -1.149 . . . . 0.0 109.461 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' GLU . 19.5 mm -63.81 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 71' ' ' SER . 9.2 pt-20 37.74 36.27 0.09 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.224 0.535 . . . . 0.0 110.647 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.3 m 54.88 0.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.705 . . . . 0.0 110.606 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.4 t -148.52 159.66 43.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.803 -1.186 . . . . 0.0 109.814 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 1.9 mm? -66.7 119.37 11.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.7 -26.36 3.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -172.8 -77.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -1.062 . . . . 0.0 109.077 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 76' ' ' GLU . 40.6 p90 -142.73 -10.68 0.8 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 14.3 tt0 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.08 -1.012 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.348 0.594 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.38 131.36 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.9 tp -156.67 79.49 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -79.9 158.09 26.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.083 -1.01 . . . . 0.0 108.753 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.5 t -124.85 -138.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.509 -0.744 . . . . 0.0 109.203 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.41 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.5 m -167.04 152.55 7.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.905 -1.122 . . . . 0.0 109.609 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.35 -53.12 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.482 1.455 . . . . 0.0 110.615 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -56.47 -25.47 51.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 15.7 mm-40 -84.86 -28.06 26.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 12' ' ' ASN . 50.0 mt -81.96 -23.91 35.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.193 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.96 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.692 -0.63 . . . . 0.0 111.093 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.6 m120 -145.41 -7.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.521 -1.362 . . . . 0.0 110.745 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 17.6 mt -79.46 148.28 69.81 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.601 -1.312 . . . . 0.0 107.942 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.1 -64.12 0.12 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.889 1.059 . . . . 0.0 110.702 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.08 -38.3 4.72 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.9 mt -93.79 150.3 38.45 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.234 -1.156 . . . . 0.0 109.035 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.0 -178.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.804 1.002 . . . . 0.0 109.779 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.75 -7.78 27.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -117.3 129.81 56.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.655 -0.653 . . . . 0.0 109.284 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -53.24 -28.94 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.11 65.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.87 -35.23 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' ALA . 35.6 t -65.16 -56.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -1.157 . . . . 0.0 109.298 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.75 -43.56 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.2 -44.38 97.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.982 -1.074 . . . . 0.0 108.798 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.21 -19.09 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 109.125 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.61 -33.25 74.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 108.84 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' GLN . 21.8 mtmm -70.16 -27.61 64.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.265 -0.897 . . . . 0.0 108.761 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -64.79 -4.25 4.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.039 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LYS . 43.2 mt-30 -150.11 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.73 59.45 1.26 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.8 m-90 -56.38 147.84 20.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.037 -1.272 . . . . 0.0 108.796 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.503 HE21 HD21 ' A' ' 49' ' ' ASN . 15.7 tt0 -50.33 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p-10 -101.24 121.97 42.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -87.59 113.52 23.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.3 m -94.45 156.39 16.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -148.51 -54.63 0.19 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 109.376 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 37' ' ' ARG . . . 77.78 102.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.735 . . . . 0.0 109.295 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . 174.46 -34.67 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.02 -4.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' GLY . 75.8 tttt -172.95 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 51.76 1.32 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.03 28.37 0.81 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.7 mttm 55.49 96.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -1.04 . . . . 0.0 109.668 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.08 113.68 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.419 -0.801 . . . . 0.0 109.003 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -87.93 101.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.838 . . . . 0.0 109.913 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 29.5 mm-40 -84.52 171.57 12.4 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -135.45 127.29 29.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.503 HD21 HE21 ' A' ' 33' ' ' GLN . 48.8 t30 -77.69 116.36 18.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.067 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -56.39 -23.62 39.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.23 -25.17 63.26 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.081 -1.012 . . . . 0.0 109.544 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.7 m -91.86 -13.56 31.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.46 149.1 98.53 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.854 -1.154 . . . . 0.0 109.146 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.48 -155.95 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 120.973 1.115 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.7 -36.95 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.86 -39.05 83.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.31 -20.58 47.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 1.7 mmmm -75.2 -58.27 3.39 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.17 -0.956 . . . . 0.0 109.212 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.51 -44.06 55.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.102 . . . . 0.0 108.955 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.1 74.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.445 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.78 -54.76 38.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.9 mt -54.86 -27.2 40.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 108.779 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.66 -29.33 69.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 108.857 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 24.8 mtp180 -73.09 -61.03 1.96 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.6 -163.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.213 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.23 -44.43 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 69' ' ' GLU . 22.9 mt-10 -79.47 -11.68 59.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -1.143 . . . . 0.0 109.557 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm 52.61 7.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 67' ' ' GLU . 13.3 pt-20 -45.03 136.57 4.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.372 -0.83 . . . . 0.0 110.014 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.501 ' CG2' ' N ' ' A' ' 71' ' ' SER . 12.1 t -170.61 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 109.085 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 70' ' ' THR . 51.8 m -150.34 21.74 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.47 124.45 24.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 74' ' ' TYR . . . -69.51 -12.34 66.56 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 73' ' ' GLY . 78.0 m-85 -158.83 -82.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -160.83 23.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 0.0 109.309 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -88.72 166.74 13.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp -163.24 77.92 0.43 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.374 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -80.02 160.23 25.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.123 -0.986 . . . . 0.0 108.783 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 160.53 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.314 -0.866 . . . . 0.0 109.705 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -104.53 152.92 39.46 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.49 -43.83 55.17 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.421 1.414 . . . . 0.0 110.665 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -27.26 63.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 76.0 mm-40 -84.11 -22.66 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 109.317 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.5 mt -82.74 -23.17 34.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.288 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.95 29.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.154 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.62 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -148.3 -8.52 0.39 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.437 -1.414 . . . . 0.0 111.122 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.62 ' N ' HD21 ' A' ' 12' ' ' ASN . 29.1 mt -78.41 147.42 72.07 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.492 -1.38 . . . . 0.0 108.05 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.22 -66.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.989 1.126 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.04 -34.79 2.14 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.7 mt -95.17 150.47 37.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.275 -1.132 . . . . 0.0 108.86 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.08 -173.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.867 1.044 . . . . 0.0 110.071 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 27.7 mmtp -100.71 -17.58 16.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -109.57 130.14 55.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.55 -0.719 . . . . 0.0 109.391 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.35 -29.35 23.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.55 73.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.63 81.44 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.55 -64.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -1.173 . . . . 0.0 109.335 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.07 -39.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.117 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.79 -40.19 91.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 108.602 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.3 -27.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.07 -28.53 17.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.23 -0.919 . . . . 0.0 108.723 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.69 -32.96 68.4 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 -1.15 1.83 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.457 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.95 -65.43 0.19 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.96 49.6 1.74 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -51.52 136.71 25.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.038 -1.272 . . . . 0.0 109.006 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.528 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -48.79 110.89 0.4 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.006 -1.059 . . . . 0.0 108.582 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 10.1 p30 -105.09 122.13 45.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.424 -0.798 . . . . 0.0 109.624 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -87.59 96.59 10.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 109.151 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -92.69 154.56 18.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 109.074 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.443 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -150.06 -38.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.08 -1.013 . . . . 0.0 109.086 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 37' ' ' ARG . . . 75.79 63.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.622 -0.674 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.23 11.18 1.02 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.6 t -86.43 -78.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -1.147 . . . . 0.0 109.279 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.31 -59.0 1.78 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.48 -0.762 . . . . 0.0 109.22 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.79 61.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.71 42.85 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.2 mttm 58.04 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -1.144 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.87 112.91 21.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 mt -88.39 119.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.655 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -104.81 171.71 7.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -136.3 135.3 38.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -76.99 118.91 20.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.929 -1.107 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.45 59.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.379 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -69.58 -21.61 63.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.581 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 61.6 m -91.94 -15.14 28.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.21 150.28 97.79 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 109.321 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.4 151.37 75.03 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.033 1.156 . . . . 0.0 109.621 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.1 -38.7 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.3 -37.73 78.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.861 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.03 -35.41 37.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -60.89 -62.48 1.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.49 42.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.297 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.31 74.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -45.1 94.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 108.886 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.44 -20.35 62.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.78 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 tp -68.42 -53.98 20.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.389 -0.819 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 66' ' ' GLY . 6.6 ptm180 -71.65 -41.16 69.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.158 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.01 39.64 0.38 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.799 -1.188 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . -79.13 -137.71 1.43 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 1.4 pm0 -84.41 148.33 26.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.131 . . . . 0.0 109.562 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.7 mp -82.25 -28.07 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.059 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' THR . 13.3 pt-20 -162.55 37.67 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.454 ' O ' ' CB ' ' A' ' 71' ' ' SER . 92.8 m 54.07 168.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.587 -0.695 . . . . 0.0 109.692 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 70' ' ' THR . 1.2 m 166.99 -65.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.819 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.14 143.96 25.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 109.356 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.73 7.84 0.95 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' C ' ' H ' ' A' ' 76' ' ' GLU . 94.7 m-85 -96.64 32.98 1.92 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.575 -0.956 . . . . 0.0 109.436 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 64.2 t80 53.55 13.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 74' ' ' TYR . 3.0 tm-20 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.371 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' N ' ' SD ' ' A' ' 1' ' ' MET . 35.2 mt-10 -150.69 142.3 23.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.5 tp -160.74 74.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -79.99 167.43 20.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 108.665 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.25 155.53 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 109.712 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -104.99 152.17 39.58 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.06 -46.88 30.77 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.377 1.385 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -58.37 -24.36 59.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.206 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 18.0 mm-40 -84.25 -27.65 27.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.968 -1.082 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 12' ' ' ASN . 53.7 mt -83.0 -21.68 33.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 109.334 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.91 29.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.635 . . . . 0.0 111.133 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 10' ' ' LEU . 21.7 p30 -148.48 -6.81 0.4 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.511 -1.368 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.5 mt -79.46 147.36 67.9 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.567 -1.333 . . . . 0.0 108.181 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.55 -67.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.056 1.171 . . . . 0.0 110.978 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.07 -36.14 2.62 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.8 mt -94.68 150.51 38.09 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.252 -1.146 . . . . 0.0 108.926 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.78 -176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.836 1.024 . . . . 0.0 110.055 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 11' ' ' ALA . 22.5 mtpt -101.34 -15.04 17.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.344 -0.848 . . . . 0.0 109.919 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 p -113.74 131.29 56.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.73 . . . . 0.0 109.408 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -52.88 -29.29 27.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 109.251 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.71 65.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.69 -35.57 28.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.1 -56.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -1.147 . . . . 0.0 109.198 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.12 -43.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -61.14 -44.82 96.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 108.986 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.61 -25.47 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.429 -0.794 . . . . 0.0 109.059 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.4 -31.06 32.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.206 -0.934 . . . . 0.0 108.956 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -71.57 -28.83 64.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 109.057 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -64.73 -4.85 4.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 109.445 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.41 -58.15 0.18 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 108.879 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.8 51.62 2.26 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.4 m-90 -51.02 137.35 21.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.123 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -49.94 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.084 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -99.94 121.02 40.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.433 -0.792 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -88.87 120.73 30.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.858 . . . . 0.0 109.155 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.06 164.93 13.09 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.118 . . . . 0.0 109.021 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -152.0 -146.81 0.21 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.88 58.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.417 -0.802 . . . . 0.0 109.237 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -142.55 2.47 1.73 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' A' ' 42' ' ' GLY . 11.0 p -79.53 28.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.26 . . . . 0.0 108.546 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 39' ' ' GLY . 34.1 mtpt 59.67 2.37 0.35 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.069 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -99.07 -68.64 0.9 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.14 -5.33 0.9 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -178.83 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.124 -1.221 . . . . 0.0 109.445 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.49 117.32 28.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 17.1 tt -88.55 119.45 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.154 -0.966 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 44.6 mm-40 -100.81 172.81 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 109.502 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.23 129.96 34.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.228 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -75.34 117.32 17.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.93 -1.106 . . . . 0.0 109.489 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.33 59.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 110.437 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -69.51 -17.83 63.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -1.0 . . . . 0.0 109.576 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m -90.66 -22.33 21.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -67.11 148.39 98.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 109.031 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.4 Cg_endo -56.41 -161.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.851 1.034 . . . . 0.0 109.654 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.9 t -93.6 -33.82 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 109.375 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.2 mp0 -59.32 -39.31 82.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 109.515 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -82.19 -34.53 28.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.874 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -58.94 -39.66 82.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 -52.57 20.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.121 -0.987 . . . . 0.0 108.96 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.13 -19.48 65.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.415 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 64' ' ' ARG . 19.5 tp -63.44 -72.53 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 108.956 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.45 -29.0 22.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.094 -1.003 . . . . 0.0 108.604 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.76 -35.69 81.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.528 ' NE ' ' O ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -69.36 -46.25 67.44 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -46.41 110.07 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.57 15.55 0.22 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' GLU . 51.1 tt0 -153.96 -41.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -1.145 . . . . 0.0 109.369 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.1 mt 53.76 3.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.404 -0.81 . . . . 0.0 109.773 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' GLU . 23.1 tt0 60.29 44.9 11.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 p -82.81 -165.93 1.19 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.265 -0.897 . . . . 0.0 109.275 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -161.25 59.22 0.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.39 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.98 175.04 2.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.14 -7.79 0.56 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -97.31 30.77 2.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.372 -1.075 . . . . 0.0 109.389 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 51.57 40.01 26.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.335 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.383 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 1' ' ' MET . 9.4 tmm? . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' N ' ' SD ' ' A' ' 1' ' ' MET . 8.0 tp10 -151.1 139.23 20.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 109.353 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -160.89 92.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.327 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -79.68 171.8 14.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 0.0 108.848 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.1 164.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 0.0 109.416 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -113.86 152.58 45.75 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.13 -47.94 24.81 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 121.229 1.286 . . . . 0.0 110.251 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -60.74 -24.5 65.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.985 . . . . 0.0 110.108 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 43.2 mm-40 -84.35 -27.15 27.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.088 -1.008 . . . . 0.0 109.488 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -82.41 -22.49 35.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 10' ' ' LEU . 35.4 m120 -145.68 -9.37 0.55 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.577 -1.327 . . . . 0.0 110.805 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.22 147.66 69.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.638 -1.289 . . . . 0.0 108.039 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.29 -65.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 120.994 1.13 . . . . 0.0 110.838 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.57 -36.82 3.47 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.4 mt -94.69 150.27 37.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.213 -1.169 . . . . 0.0 108.939 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.01 175.31 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.953 1.102 . . . . 0.0 109.99 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -97.89 5.71 48.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 p -130.66 130.15 43.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.455 -0.778 . . . . 0.0 109.278 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 p -52.16 -30.99 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.433 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.57 70.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.33 -35.23 81.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 27' ' ' ALA . 61.4 t -65.32 -59.88 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.25 -43.26 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 108.933 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.49 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.978 -1.076 . . . . 0.0 108.82 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.17 -18.24 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.67 -33.28 73.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.949 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 30' ' ' GLN . 6.0 mtpm? -70.55 -29.11 65.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 108.677 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -65.1 -1.57 2.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.444 -0.785 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 28' ' ' LYS . 36.2 mt-30 -150.39 -63.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.19 55.27 1.29 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -54.87 137.65 44.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.026 -1.279 . . . . 0.0 108.962 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.59 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.376 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 4.3 p30 -99.65 121.36 41.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.296 -0.878 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.58 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -85.73 112.95 21.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.177 -0.952 . . . . 0.0 109.167 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 m -93.05 138.51 31.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 109.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.502 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -149.41 122.05 8.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 108.881 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.13 49.54 0.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.83 . . . . 0.0 109.965 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -91.72 -39.28 5.59 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 42' ' ' GLY . 3.1 t -61.32 -1.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 39' ' ' GLY . 19.4 ttpp 57.73 -5.21 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.57 -0.706 . . . . 0.0 110.533 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -67.32 -57.77 8.84 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.86 71.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mttm 58.24 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.66 -167.85 2.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -147.64 99.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.151 -0.968 . . . . 0.0 109.375 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 49.8 mm-40 -87.74 172.36 9.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 108.723 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.88 128.56 32.85 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.621 ' ND2' HD22 ' A' ' 51' ' ' ASN . 49.5 t-20 -75.68 114.17 13.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.899 -1.126 . . . . 0.0 109.092 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.32 -27.05 33.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 110.796 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.621 HD22 ' ND2' ' A' ' 49' ' ' ASN . 54.5 p30 -69.03 -17.53 63.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.895 -1.128 . . . . 0.0 110.052 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 13.5 m -90.58 -18.5 25.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.138 -0.976 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 92.1 mt -68.25 149.18 98.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.37 -156.38 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 120.918 1.079 . . . . 0.0 109.629 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.34 -36.47 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -59.35 -36.68 76.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.098 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.39 -34.41 41.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 109.572 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -55.79 -48.28 75.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.28 -57.29 11.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.64 -23.06 67.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.035 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.62 -77.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp -51.69 -14.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.11 -51.94 33.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.954 -1.092 . . . . 0.0 109.222 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 11.4 ptm180 -75.61 7.76 3.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -91.01 74.98 6.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.071 -1.018 . . . . 0.0 109.13 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.14 4.56 70.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' C ' ' H ' ' A' ' 69' ' ' GLU . 24.3 tt0 -72.28 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -1.184 . . . . 0.0 109.386 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 70' ' ' THR . 6.9 mt 56.12 0.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.968 -1.083 . . . . 0.0 109.583 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 67' ' ' GLU . 23.9 mt-10 55.56 6.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 109.377 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.548 ' HG1' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 44.3 -167.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.401 -0.812 . . . . 0.0 109.893 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.548 ' N ' ' HG1' ' A' ' 70' ' ' THR . 0.6 OUTLIER 76.19 -52.19 0.61 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 74' ' ' TYR . 9.2 mp 48.55 68.66 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -50.41 -13.23 0.7 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 72' ' ' LEU . 21.2 t80 60.15 1.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -1.096 . . . . 0.0 109.427 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 73' ' ' GLY . 74.5 m-85 -145.81 6.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.177 -0.952 . . . . 0.0 109.415 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.493 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.4 pm0 -89.56 57.64 4.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp -95.53 83.7 3.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.386 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -80.31 161.59 25.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.26 152.99 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -97.68 154.72 37.79 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.83 . . . . 0.0 109.579 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.51 -51.5 10.98 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.611 1.541 . . . . 0.0 112.138 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -57.81 -17.25 14.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.81 -1.181 . . . . 0.0 110.705 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.576 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 26.1 mp0 -87.14 -28.12 22.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.679 -1.263 . . . . 0.0 108.884 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 12' ' ' ASN . 48.7 mt -81.73 -22.35 37.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.855 . . . . 0.0 109.204 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 29.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.706 -0.621 . . . . 0.0 111.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.9 t-20 -146.7 -8.82 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.475 -1.39 . . . . 0.0 110.855 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.7 mt -78.94 147.82 70.94 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.551 -1.343 . . . . 0.0 108.006 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.67 -66.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 120.948 1.099 . . . . 0.0 110.923 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.81 -36.79 3.76 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.72 150.2 37.59 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.262 -1.14 . . . . 0.0 109.11 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.09 170.55 0.67 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 120.874 1.049 . . . . 0.0 110.063 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -94.17 2.89 55.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.868 . . . . 0.0 109.642 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -129.15 129.27 44.91 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.469 -0.769 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 p -52.21 -30.46 27.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.12 -35.72 59.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.234 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.46 -35.8 25.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.84 -58.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -1.134 . . . . 0.0 109.439 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -55.15 -47.07 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.187 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -61.26 -50.82 71.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.339 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -22.32 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.44 -0.787 . . . . 0.0 109.394 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.27 -30.69 18.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.102 -0.999 . . . . 0.0 109.054 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.1 mptt -71.17 -30.07 65.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.136 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -63.94 -4.14 3.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.5 mt-30 -149.96 -61.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 108.972 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.78 48.98 2.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.03 138.63 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -1.23 . . . . 0.0 109.334 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -49.93 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.854 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.8 p-10 -98.77 125.28 44.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -86.79 131.66 34.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 137.4 32.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.504 ' CD ' ' H ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -88.09 -144.87 0.14 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' H ' ' CD ' ' A' ' 37' ' ' ARG . . . -172.36 71.71 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.658 -1.277 . . . . 0.0 110.604 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 159.49 -73.78 0.21 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' C ' ' H ' ' A' ' 42' ' ' GLY . 7.3 p 33.17 30.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.548 0.69 . . . . 0.0 110.342 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 39' ' ' GLY . 6.0 pttt 71.62 -21.18 0.22 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -95.96 -72.44 1.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.27 -16.5 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.051 -1.264 . . . . 0.0 110.639 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -171.31 99.86 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.331 . . . . 0.0 109.235 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.0 -169.61 2.65 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.07 128.62 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.362 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.9 mp0 -109.59 174.01 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.25 131.7 36.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.325 -0.859 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.07 114.31 13.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 109.104 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.14 57.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 110.227 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -68.33 -18.13 64.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.997 . . . . 0.0 109.834 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -89.77 -19.33 24.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 98.4 mt -67.11 149.62 98.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 108.941 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.9 Cg_endo -56.06 -162.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.71 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.36 -37.29 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.198 -0.939 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -60.15 -37.13 79.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.281 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.99 -30.09 49.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.063 . . . . 0.0 109.644 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -59.86 -54.51 45.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 109.117 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.87 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.028 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.07 -30.03 69.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.926 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 2.0 tm? -64.82 -66.07 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 109.213 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 61' ' ' LEU . 2.0 pp -55.28 -21.19 13.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 109.224 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tp -65.68 -32.72 74.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 108.451 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 28.3 mtp180 -68.83 -37.74 79.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.573 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 64' ' ' ARG . 58.2 mm-40 -56.92 -107.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.38 66.85 2.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.2 mp0 57.72 137.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.974 -0.721 . . . . 0.0 110.23 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.38 -90.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -170.96 25.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.845 . . . . 0.0 109.296 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 72' ' ' LEU . 10.4 t -165.1 -150.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.236 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 m 51.96 -93.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 74' ' ' TYR . 18.6 mt -76.44 9.53 2.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.602 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.05 19.36 1.28 Allowed Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 72' ' ' LEU . 44.8 t80 -87.28 16.84 4.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -1.077 . . . . 0.0 109.446 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 50.2 34.77 9.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 109.763 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 5.4 ptp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.521 ' CD ' ' HE1' ' A' ' 4' ' ' TRP . 23.4 tp10 -150.47 59.04 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.08 82.03 1.92 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.396 -0.815 . . . . 0.0 109.995 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.521 ' HE1' ' CD ' ' A' ' 2' ' ' GLU . 47.5 m95 -80.34 171.34 15.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.825 -1.172 . . . . 0.0 108.227 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.97 -137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -169.33 151.33 4.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.06 -49.15 16.32 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.352 1.368 . . . . 0.0 110.677 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -59.4 -27.81 66.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.224 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.23 -26.57 28.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 12' ' ' ASN . 25.5 mt -82.91 -18.77 38.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.38 32.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 0.0 110.971 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.3 t-20 -146.15 -9.02 0.52 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.476 -1.39 . . . . 0.0 110.921 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.1 mt -78.56 147.55 71.76 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.358 . . . . 0.0 108.154 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.02 -65.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.996 1.13 . . . . 0.0 110.578 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.27 -37.06 4.44 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.3 mt -93.76 149.97 37.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.221 -1.164 . . . . 0.0 108.952 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.52 177.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 120.753 0.969 . . . . 0.0 109.779 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -99.08 -2.32 37.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -123.76 131.4 53.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.375 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -52.66 -30.32 31.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.17 53.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.69 -35.6 18.88 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.02 -45.85 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.71 -47.21 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.91 -41.82 96.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.05 -29.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.262 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.52 -29.27 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 108.748 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 30' ' ' GLN . 27.2 mtmt -71.9 -33.44 68.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.444 -0.785 . . . . 0.0 109.05 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -64.79 -1.74 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.2 mp0 -149.32 -68.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.358 -0.839 . . . . 0.0 108.765 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.0 55.88 1.35 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -51.3 152.08 2.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.253 . . . . 0.0 109.198 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -52.8 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.645 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -101.58 112.47 25.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.487 HH11 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -90.06 141.61 28.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.037 -1.039 . . . . 0.0 108.346 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.43 134.65 34.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.724 -1.235 . . . . 0.0 109.777 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -91.42 -147.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.69 49.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.085 -1.009 . . . . 0.0 109.973 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.76 70.95 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.401 HG21 ' H ' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -126.47 -92.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.992 . . . . 0.0 108.454 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' H ' HG21 ' A' ' 40' ' ' VAL . 63.2 mmtt -107.09 -64.66 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.21 -61.59 1.81 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.44 33.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -177.25 94.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 0.0 109.772 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.84 155.68 19.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.207 -0.933 . . . . 0.0 108.749 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' GLU . 14.0 tt -96.95 -41.96 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.28 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' ILE . 42.5 mt-10 55.26 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.849 0.833 . . . . 0.0 110.797 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -134.01 133.03 40.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.435 -0.791 . . . . 0.0 108.941 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.57 116.66 17.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 109.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 -27.51 55.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.365 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.9 -23.12 62.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.4 m -89.83 -12.87 37.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -0.965 . . . . 0.0 110.087 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.8 150.46 97.62 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.323 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 169.12 5.14 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.988 1.126 . . . . 0.0 109.424 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.23 -37.89 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.024 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.78 -39.15 80.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.11 -39.8 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.976 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.88 -57.86 11.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.607 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.87 58.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.083 -1.011 . . . . 0.0 109.33 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.26 -28.67 68.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -63.18 -49.76 72.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.386 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.5 -19.57 65.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.073 -1.017 . . . . 0.0 109.084 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -58.19 4.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.512 ' C ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -72.32 -41.26 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' HE ' ' A' ' 64' ' ' ARG . 22.9 mt-30 -63.25 -101.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.753 -1.217 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 58.37 174.96 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 66' ' ' GLY . 42.4 mt-10 52.91 102.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.36 -1.082 . . . . 0.0 109.637 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.24 -63.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.468 -0.77 . . . . 0.0 109.075 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 71' ' ' SER . 7.6 tp10 -69.84 116.2 9.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.682 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.0 m 54.73 0.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.425 -0.797 . . . . 0.0 110.222 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.574 ' H ' ' C ' ' A' ' 69' ' ' GLU . 34.4 t 47.42 31.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.939 -1.101 . . . . 0.0 109.65 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.5 mt 57.01 93.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.88 -20.47 79.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 38.1 t80 -165.39 26.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 52.2 t80 54.3 21.1 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 50.1 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.9 pm0 -89.86 -87.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.244 -0.91 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.4 tp 54.62 74.33 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 109.526 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.7 m95 -80.73 161.11 24.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 108.734 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.25 158.26 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.424 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.1 m -100.63 153.36 37.78 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.494 -0.754 . . . . 0.0 109.231 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.32 -40.04 87.75 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.114 1.209 . . . . 0.0 110.183 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -58.54 -27.24 64.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.63 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 34.3 mt-10 -83.57 -24.9 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 12' ' ' ASN . 91.5 mt -83.48 -23.93 31.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.99 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.625 -0.672 . . . . 0.0 111.21 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.704 HD22 HH12 ' A' ' 64' ' ' ARG . 1.3 p30 -149.42 -8.1 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.415 -1.428 . . . . 0.0 111.035 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.4 mt -78.75 147.89 71.72 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.618 -1.301 . . . . 0.0 108.118 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.97 -67.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.11 1.207 . . . . 0.0 110.989 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.16 2.19 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.35 150.36 37.47 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.29 -1.123 . . . . 0.0 108.882 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.44 -174.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 120.806 1.004 . . . . 0.0 110.021 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ALA . 65.2 mmtt -101.08 -16.56 17.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.324 -0.86 . . . . 0.0 109.558 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -110.65 131.2 55.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.478 -0.763 . . . . 0.0 109.478 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.88 -29.56 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.48 -39.62 70.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.43 56.37 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.59 -62.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mt -49.94 -40.62 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 108.673 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.36 -42.2 98.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.124 -0.985 . . . . 0.0 108.678 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -76.66 -20.45 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.499 -0.751 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.2 -39.59 60.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.08 -1.013 . . . . 0.0 110.188 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 30' ' ' GLN . 4.8 ptmt -70.91 -23.14 62.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 109.262 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.99 -4.49 2.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 108.731 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.27 -58.99 0.19 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.79 48.01 2.01 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -54.99 133.89 48.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.832 -1.393 . . . . 0.0 108.633 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.522 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -48.41 108.83 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.98 -1.075 . . . . 0.0 108.761 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.31 121.81 44.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.416 -0.802 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 35' ' ' ARG . 20.2 ttm-85 -88.96 139.36 30.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 109.447 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 107.48 19.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 108.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -89.15 91.9 8.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.2 -0.938 . . . . 0.0 109.117 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.69 52.68 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.853 . . . . 0.0 109.651 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 37' ' ' ARG . . . -158.2 64.3 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.13 -85.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -1.146 . . . . 0.0 109.16 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -96.97 -9.4 28.36 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.293 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 56.99 1.96 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.0 35.82 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mttp 51.04 89.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -1.159 . . . . 0.0 109.523 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.95 138.79 31.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.256 -0.903 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.1 tt -90.19 155.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.95 . . . . 0.0 109.637 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 68.4 mm-40 -139.98 175.35 9.66 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -136.3 134.24 37.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.414 -0.804 . . . . 0.0 109.31 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -75.87 114.18 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.138 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.54 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.305 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 1' ' ' MET . 1.7 m-80 -69.82 -20.77 63.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.915 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 27.8 m -90.58 -10.43 43.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.112 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 54' ' ' PRO . 76.1 mt -68.45 150.3 97.74 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.034 -1.041 . . . . 0.0 109.305 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -59.0 -155.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 120.968 1.112 . . . . 0.0 109.459 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.07 -36.62 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.48 -37.12 80.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.93 -25.49 40.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.363 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -62.02 -66.83 0.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.11 33.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.519 -0.738 . . . . 0.0 109.425 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.45 80.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.23 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.47 -24.21 67.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 108.695 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.87 -29.9 58.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.18 -36.39 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.704 HH12 HD22 ' A' ' 12' ' ' ASN . 20.1 mtp180 -72.52 -66.07 0.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -91.04 -128.5 0.09 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -0.782 . . . . 0.0 109.121 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.55 32.05 3.9 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.54 -9.38 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.173 . . . . 0.0 109.343 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 mm -82.72 -76.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.256 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -158.1 26.13 0.26 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.321 -0.862 . . . . 0.0 109.306 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 p -79.01 -64.37 1.2 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.132 -0.98 . . . . 0.0 109.529 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -160.74 81.73 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 74' ' ' TYR . 18.6 mt -72.13 -54.96 8.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 72.08 -17.69 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.529 ' H ' ' C ' ' A' ' 72' ' ' LEU . 83.9 m-85 52.61 9.28 0.11 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -1.075 . . . . 0.0 109.334 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' A' ' 73' ' ' GLY . 52.4 t80 -142.44 3.85 1.53 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 109.615 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 6.7 tm-20 -150.18 -23.36 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.091 -1.006 . . . . 0.0 109.175 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.9 tp -125.36 81.27 1.96 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.58 -0.7 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -79.72 171.97 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.023 . . . . 0.0 108.26 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.64 145.65 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.112 -0.993 . . . . 0.0 109.874 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -95.46 153.28 39.58 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.348 -0.845 . . . . 0.0 109.321 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.49 -42.48 65.31 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.233 1.288 . . . . 0.0 110.458 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -59.22 -24.41 63.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' CD ' HH12 ' A' ' 64' ' ' ARG . 12.5 mm-40 -84.24 -24.39 30.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -83.2 -24.35 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.99 29.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 111.345 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -147.32 -9.23 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.467 -1.396 . . . . 0.0 110.919 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' LEU . 40.1 mt -79.13 147.13 68.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.533 -1.354 . . . . 0.0 108.061 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -65.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.097 1.198 . . . . 0.0 110.739 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.63 -35.63 3.09 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.28 150.01 37.0 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.23 -1.159 . . . . 0.0 109.009 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.41 175.31 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 120.803 1.002 . . . . 0.0 109.787 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -97.16 6.59 48.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 109.749 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -133.6 130.74 38.78 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.521 -0.737 . . . . 0.0 109.205 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 p -52.57 -31.26 35.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.383 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.47 56.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.81 -38.39 20.05 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.14 -63.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.264 -1.139 . . . . 0.0 109.444 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.8 mt -47.87 -41.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.069 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.7 -48.35 81.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.184 -0.948 . . . . 0.0 108.703 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.57 -28.65 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.74 -31.02 10.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.15 -0.969 . . . . 0.0 108.927 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.5 mptt -72.7 -38.46 67.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 108.687 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' A' ' 29' ' ' LYS . 4.9 ttpm? -65.36 -3.6 4.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -150.32 -70.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 108.894 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.68 54.41 1.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.91 145.24 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.09 -1.241 . . . . 0.0 109.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -52.64 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.997 . . . . 0.0 109.056 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.8 p-10 -97.63 118.25 33.73 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -86.73 139.52 30.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.24 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -93.96 133.65 37.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 108.861 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 6.8 tpp180 -90.02 -65.37 1.02 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 109.18 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 37' ' ' ARG . . . 76.6 40.49 0.21 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 109.552 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.98 15.5 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.65 -37.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -1.219 . . . . 0.0 109.17 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -176.59 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.374 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.66 -111.85 1.36 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.31 17.6 0.21 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -179.73 96.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.18 -174.58 4.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.7 mm -139.91 75.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.4 168.72 15.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.121 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -133.58 132.43 40.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.384 -0.823 . . . . 0.0 109.534 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.706 HD22 HD22 ' A' ' 51' ' ' ASN . 51.7 t-20 -76.12 117.23 17.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.179 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.28 65.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.325 -0.86 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.706 HD22 HD22 ' A' ' 49' ' ' ASN . 43.1 p30 -67.44 -16.43 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.477 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 74.0 m -90.0 -16.53 29.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.1 mt -67.96 149.67 98.1 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.115 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.65 -156.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.903 1.069 . . . . 0.0 109.5 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.67 -36.76 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 109.78 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -60.24 -36.81 78.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.95 43.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 109.8 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -65.34 -65.68 0.64 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 108.744 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.56 19.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.517 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.37 80.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 tp -62.38 -52.18 64.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 108.795 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.29 -27.51 55.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.659 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.289 -0.882 . . . . 0.0 108.674 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.526 HH12 ' CD ' ' A' ' 9' ' ' GLU . 11.3 mtm180 -73.03 -69.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.0 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -46.24 160.63 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.605 -0.684 . . . . 0.0 109.908 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.15 -86.98 0.1 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.64 92.73 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 69' ' ' GLU . 17.6 mm -66.44 -40.7 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.41 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' ILE . 33.9 tt0 49.02 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 71' ' ' SER . 9.6 t -165.53 -45.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 73' ' ' GLY . 38.6 t -137.93 -71.52 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.03 -3.29 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 110.324 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 71' ' ' SER . . . -78.53 52.59 3.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -72.13 -11.17 60.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -1.118 . . . . 0.0 109.057 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 74' ' ' TYR . 3.8 p90 175.9 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 75' ' ' PHE . 6.6 pt-20 . . . . . 0 N--CA 1.503 2.209 0 CA-C-O 121.304 0.573 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.1 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 5.3 mp0 -89.3 124.49 34.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.9 tp -158.34 100.52 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -99.83 171.1 8.09 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 108.691 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.59 155.52 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.182 -0.949 . . . . 0.0 109.781 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -101.27 153.04 38.04 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 121.446 -0.784 . . . . 0.0 109.289 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.19 -43.39 59.45 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 121.371 1.38 . . . . 0.0 110.555 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -58.37 -27.24 64.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 0.0 109.78 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.463 ' OE1' ' CZ ' ' A' ' 64' ' ' ARG . 35.2 mm-40 -84.78 -24.74 28.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.17 -0.956 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.1 mt -83.53 -21.36 32.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.106 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -146.42 -4.18 0.61 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.501 -1.375 . . . . 0.0 110.642 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 12.0 mt -79.69 147.86 68.02 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.588 -1.32 . . . . 0.0 108.004 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.22 -64.52 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 120.882 1.054 . . . . 0.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.28 -35.94 7.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 30.0 mt -93.62 150.06 38.18 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.122 -1.222 . . . . 0.0 109.141 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.35 -175.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 120.876 1.051 . . . . 0.0 109.924 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -104.89 5.83 33.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.525 -0.734 . . . . 0.0 109.757 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 p -132.93 133.12 42.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -53.36 -30.62 40.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.57 62.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.82 -35.74 18.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.25 -49.72 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -65.09 -44.79 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -60.75 -41.96 96.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 108.92 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.82 -27.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.43 -0.794 . . . . 0.0 109.024 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.86 -29.31 19.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.6 -29.93 65.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.37 -0.831 . . . . 0.0 108.897 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.35 -4.13 3.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.48 -61.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.368 -0.833 . . . . 0.0 108.88 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.37 54.48 1.57 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.44 141.2 37.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.075 -1.25 . . . . 0.0 108.844 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -47.93 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.232 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.9 p30 -101.45 116.76 33.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.466 -0.772 . . . . 0.0 110.106 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.561 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -89.32 147.7 23.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 109.058 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -94.9 133.97 38.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.0 -1.063 . . . . 0.0 109.088 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 5.9 tpt180 -92.31 -55.81 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.2 79.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.446 -0.784 . . . . 0.0 109.407 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.94 -26.66 0.09 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.576 ' CG2' ' H ' ' A' ' 41' ' ' LYS . 26.9 m -73.31 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.223 -1.163 . . . . 0.0 109.86 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' H ' ' CG2' ' A' ' 40' ' ' VAL . 28.7 pttt -177.28 75.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.938 . . . . 0.0 109.586 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 44' ' ' LYS . . . 169.72 -5.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.39 -2.53 1.6 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 42' ' ' GLY . 46.3 tttp -174.63 89.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.999 . . . . 0.0 108.981 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.79 -163.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.172 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.58 89.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.234 -0.916 . . . . 0.0 109.002 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -76.49 169.13 18.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 108.849 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -135.16 134.87 40.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.834 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 17.6 t-20 -76.27 115.81 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 109.298 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.58 -34.16 64.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.374 -0.828 . . . . 0.0 110.61 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -69.98 -17.03 63.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.6 m -90.03 -15.46 31.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 109.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' PRO . 96.1 mt -67.96 148.96 98.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.0 Cg_exo -54.94 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.967 1.111 . . . . 0.0 109.833 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.5 -38.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -0.931 . . . . 0.0 109.928 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -58.17 -40.3 81.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.628 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.24 -38.54 42.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.124 -0.985 . . . . 0.0 109.228 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -49.03 -60.7 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.725 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.26 63.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.599 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -23.41 67.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 109.586 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.98 -63.89 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -44.93 -44.01 9.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 110.025 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.4 mt -66.3 -28.97 69.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 108.835 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -71.75 -44.77 63.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -43.07 154.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.46 100.22 0.22 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 69' ' ' GLU . 37.2 mt-10 -48.78 -35.75 15.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -1.197 . . . . 0.0 109.256 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.6 mt 54.73 -1.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.59 -0.694 . . . . 0.0 110.423 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' H ' ' C ' ' A' ' 67' ' ' GLU . 39.5 tt0 -92.43 -42.46 9.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.868 -1.145 . . . . 0.0 109.073 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 t -161.95 178.83 8.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 m 46.25 85.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.704 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.53 177.87 10.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.373 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.55 11.9 0.52 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 64.51 18.29 11.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.601 -0.94 . . . . 0.0 109.225 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 86.6 t80 -144.33 6.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 109.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 1.4 pm0 -151.14 47.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.3 tp -96.29 86.22 4.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.247 -0.908 . . . . 0.0 109.132 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -84.81 155.9 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.62 163.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.0 109.644 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -108.2 153.11 42.06 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.486 -0.759 . . . . 0.0 109.05 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.15 -44.55 48.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.239 1.293 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -57.68 -25.65 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 45.8 mt-10 -84.43 -24.18 29.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.128 -0.983 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.8 mt -82.96 -22.93 33.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.09 29.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.64 -0.663 . . . . 0.0 111.232 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' LEU . 10.0 t-20 -146.57 -7.47 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.513 -1.367 . . . . 0.0 110.892 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.4 mt -79.4 147.45 68.35 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 0.0 108.195 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.11 -63.97 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.962 1.108 . . . . 0.0 110.606 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.48 -38.22 5.2 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 26.2 mt -94.01 149.87 37.58 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.137 -1.214 . . . . 0.0 109.175 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.14 -178.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.875 1.05 . . . . 0.0 109.732 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -101.17 7.38 43.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -133.19 130.17 38.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.408 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -52.5 -30.64 31.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.354 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.75 -37.0 62.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.28 19.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.84 -58.78 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.275 -1.132 . . . . 0.0 109.171 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -52.4 -43.06 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -60.69 -41.76 95.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 108.933 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.96 -22.87 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.079 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.3 -29.81 66.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.192 -0.942 . . . . 0.0 108.497 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 30' ' ' GLN . 77.5 mttt -71.98 -32.79 67.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 109.065 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -65.03 2.92 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 108.888 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.1 mt-30 -150.85 -64.88 0.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.58 47.21 2.18 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -50.8 135.73 23.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.305 . . . . 0.0 108.961 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -48.27 112.21 0.55 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.008 -1.057 . . . . 0.0 108.617 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.666 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -107.51 119.55 39.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.502 -0.748 . . . . 0.0 109.832 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 20.7 ttm-85 -86.01 115.03 23.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.169 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.9 m -93.23 80.34 4.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' NE ' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -91.44 105.39 17.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.339 -0.85 . . . . 0.0 109.158 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' N ' ' NE ' ' A' ' 37' ' ' ARG . . . -75.2 59.96 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . -132.33 -35.31 0.33 Allowed Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 m -48.84 -12.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.054 -1.262 . . . . 0.0 109.831 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLY . 48.7 pttt -170.87 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 109.699 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.82 55.2 0.84 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.37 30.27 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp 51.02 77.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -1.127 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.07 138.95 30.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 109.254 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.43 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 6.1 tp -89.03 146.36 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 109.249 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 46' ' ' ILE . 8.5 mp0 -134.67 174.83 10.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.727 . . . . 0.0 109.149 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -136.4 134.61 37.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 0.0 109.237 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -76.89 119.85 21.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.904 -1.123 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.03 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.71 -19.13 64.35 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.012 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 44.4 m -92.0 -16.33 26.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 110.15 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.76 149.41 98.27 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 120.936 -1.103 . . . . 0.0 108.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.64 -166.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 120.864 1.043 . . . . 0.0 109.538 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.0 -35.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 109.263 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.4 mp0 -59.86 -39.47 85.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.407 -0.808 . . . . 0.0 109.515 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.6 14.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.625 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -50.34 -52.35 37.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.27 -51.96 64.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.48 67.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.453 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -64.84 -60.62 2.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 108.793 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.21 -34.01 5.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.696 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.38 -35.21 80.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 108.38 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 22.6 mtp180 -71.12 -58.92 3.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.188 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.82 -69.52 0.13 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.229 -0.92 . . . . 0.0 109.711 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.57 -78.31 1.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 6.9 pt-20 -166.04 109.01 0.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -1.148 . . . . 0.0 109.419 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm -134.91 -44.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.311 -0.868 . . . . 0.0 108.771 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 71' ' ' SER . 61.7 mm-40 -63.77 146.38 53.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.481 -0.762 . . . . 0.0 109.843 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 71' ' ' SER . 0.8 OUTLIER 57.24 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.823 -0.548 . . . . 0.0 110.807 179.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.577 ' N ' ' OG1' ' A' ' 70' ' ' THR . 11.1 t -50.19 87.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' THR . 68.0 mt -148.61 -164.77 2.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.896 . . . . 0.0 109.028 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 72.82 -14.21 2.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 72' ' ' LEU . 52.9 m-85 52.94 8.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -1.028 . . . . 0.0 109.08 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' H ' ' C ' ' A' ' 73' ' ' GLY . 65.8 t80 -154.56 14.67 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.417 -0.802 . . . . 0.0 109.401 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.54 68.61 8.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.146 -0.971 . . . . 0.0 109.224 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.25 84.48 5.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -79.79 167.09 21.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 108.729 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.71 -136.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.271 -0.893 . . . . 0.0 109.618 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -167.41 152.8 7.08 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.652 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.4 -51.89 8.97 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.596 1.531 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.8 42.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -0.999 . . . . 0.0 110.067 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -85.9 -25.97 25.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.034 -1.041 . . . . 0.0 109.251 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 12' ' ' ASN . 77.6 mt -82.6 -23.04 34.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 32.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.766 -0.584 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.4 t-20 -147.67 -10.97 0.4 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.43 -1.419 . . . . 0.0 111.142 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' LEU . 26.5 mt -78.89 147.35 70.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.574 -1.329 . . . . 0.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.75 -61.68 0.24 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.012 1.141 . . . . 0.0 110.758 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.09 -38.73 4.91 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' LEU . 12.1 mt -94.94 151.05 38.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.275 -1.132 . . . . 0.0 108.755 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.41 -174.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 120.747 0.965 . . . . 0.0 110.081 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -99.14 -15.67 18.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -111.09 132.31 54.37 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.599 -0.688 . . . . 0.0 109.451 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -53.23 -28.88 29.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -49.12 69.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.18 -34.18 89.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.38 -61.38 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -1.168 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.02 -43.01 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -60.19 -41.43 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.924 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.05 -25.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.46 -0.775 . . . . 0.0 108.991 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -54.32 -25.26 22.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.112 -0.993 . . . . 0.0 108.434 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -72.85 -32.76 65.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -65.19 -9.57 24.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.488 -0.757 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -150.07 -64.4 0.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.28 -0.887 . . . . 0.0 108.904 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.01 62.04 1.19 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -54.71 148.33 12.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -1.211 . . . . 0.0 109.02 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.01 98.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.2 p30 -108.4 117.75 34.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.99 121.01 28.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.542 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -93.22 125.95 38.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.98 -1.075 . . . . 0.0 108.949 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -90.92 -55.94 3.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' ARG . . . 77.44 29.24 0.55 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.493 -0.755 . . . . 0.0 109.207 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.43 12.08 70.3 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 42' ' ' GLY . 2.9 m -88.39 33.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -1.028 . . . . 0.0 108.953 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mttm 60.87 -0.89 0.27 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . 141.73 108.82 0.72 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' LYS . . . 165.59 -19.3 0.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' GLY . 22.6 mmtp 52.3 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -1.132 . . . . 0.0 109.073 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -173.95 4.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 108.922 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 mt -146.61 99.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.006 -1.059 . . . . 0.0 109.872 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.06 175.27 8.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.59 123.89 21.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.304 -0.872 . . . . 0.0 109.901 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.48 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 27.6 t-20 -74.06 114.73 12.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 108.532 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.22 22.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.805 . . . . 0.0 111.315 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.658 HD21 ' H ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -71.07 -21.87 62.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.684 -1.26 . . . . 0.0 110.52 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.658 ' H ' HD21 ' A' ' 51' ' ' ASN . 36.9 m -93.71 -8.27 41.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.905 -1.122 . . . . 0.0 110.552 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -68.97 149.51 97.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 0.0 109.724 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.26 140.77 84.94 Favored 'Trans proline' 0 C--O 1.21 -0.903 0 C-N-CA 121.173 1.249 . . . . 0.0 109.324 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -42.27 -41.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.432 -0.793 . . . . 0.0 111.02 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -55.81 -48.03 76.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.005 -1.06 . . . . 0.0 109.991 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.86 -43.09 25.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -46.02 -58.01 3.95 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.358 0.599 . . . . 0.0 109.415 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.01 61.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.9 64.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -65.67 -75.71 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.116 -0.99 . . . . 0.0 109.182 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.68 -13.6 1.75 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.78 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.19 -49.55 64.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.325 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -74.23 5.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.015 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -98.71 148.52 23.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.305 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 67' ' ' GLU . . . 160.81 75.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.1 pt-20 32.81 55.73 0.42 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.059 -0.671 . . . . 0.0 111.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.558 ' CD1' ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.92 -71.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.967 . . . . 0.0 108.574 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -110.96 40.53 2.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.608 -0.683 . . . . 0.0 109.498 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.0 m -79.97 -54.37 5.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.9 t -173.57 -89.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 109.43 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.9 mt 56.68 -142.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.6 1.28 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 72' ' ' LEU . 45.5 t80 -168.32 33.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.405 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 51.1 38.78 21.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.232 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' A' ' 1' ' ' MET . 1.7 tmt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -88.76 -168.31 2.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 109.377 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -165.29 76.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -80.28 158.61 26.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.8 t -131.77 162.84 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.429 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.3 m -103.78 153.44 38.73 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.2 -46.64 32.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 121.377 1.385 . . . . 0.0 110.924 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HZ1' ' CB ' ' A' ' 6' ' ' SER . 23.3 pttm -59.56 -21.8 60.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.111 -0.993 . . . . 0.0 110.656 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 39.6 mm-40 -85.14 -25.73 27.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.6 mt -82.94 -22.66 33.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.637 -0.664 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 10' ' ' LEU . 41.6 m-80 -147.03 -10.8 0.44 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.621 -1.299 . . . . 0.0 110.936 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 16' ' ' LEU . 31.6 mt -78.27 146.89 71.6 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.531 -1.356 . . . . 0.0 108.103 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -64.86 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.028 1.152 . . . . 0.0 110.937 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.12 -36.86 2.93 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.9 mt -96.02 150.46 37.3 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.249 -1.148 . . . . 0.0 108.972 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.34 176.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.864 1.043 . . . . 0.0 110.014 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -95.19 -13.09 25.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 109.61 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -106.15 130.83 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.662 . . . . 0.0 109.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.477 ' H ' ' HG ' ' A' ' 20' ' ' SER . 1.7 m -53.0 -29.3 28.46 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.89 -55.62 32.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.792 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -36.66 52.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.89 -65.61 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.077 -1.249 . . . . 0.0 109.64 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mt -48.83 -42.31 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.211 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.75 -49.15 77.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.849 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.34 -22.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.49 -34.37 24.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 109.405 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -28.1 64.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 108.648 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -64.35 -5.27 4.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.247 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -151.25 -60.74 0.18 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.331 -0.856 . . . . 0.0 108.809 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.4 47.15 2.22 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -52.16 135.51 31.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.935 -1.333 . . . . 0.0 109.03 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.522 ' NE2' ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -49.14 110.43 0.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.075 -1.016 . . . . 0.0 108.748 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.84 124.33 49.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -86.17 115.08 23.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.56 108.81 20.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.291 -0.88 . . . . 0.0 108.688 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.49 -30.4 14.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 51.03 90.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.82 -20.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.218 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.62 -42.09 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.027 -1.278 . . . . 0.0 109.666 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -157.09 -70.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.192 -0.943 . . . . 0.0 109.304 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.21 167.1 53.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' LYS . . . -72.65 -1.07 52.34 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 27.0 mtmm -157.93 92.89 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -1.074 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.04 110.08 19.26 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mt -82.93 100.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.072 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 21.3 mm-40 -87.26 175.99 7.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -136.1 133.72 37.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -76.54 117.58 18.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.961 -1.087 . . . . 0.0 108.991 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.93 61.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -21.3 62.93 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 34.4 m -90.98 -13.72 32.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.022 -1.049 . . . . 0.0 110.191 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.0 mt -67.39 149.07 98.58 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 108.986 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.3 Cg_exo -55.04 -165.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.982 1.121 . . . . 0.0 109.724 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.12 -37.61 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.35 -37.47 80.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.259 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.76 -31.62 40.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.703 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -60.93 -67.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.016 -1.052 . . . . 0.0 108.911 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.54 -42.81 16.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 109.568 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.41 84.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.51 -60.82 2.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 mt -49.53 -25.42 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 65' ' ' GLN . 9.1 tp -68.09 -56.4 8.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.491 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -75.54 28.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.838 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 63' ' ' LEU . 17.8 mt-30 -139.2 56.52 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.27 70.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -175.67 2.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -1.132 . . . . 0.0 109.484 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -85.38 -38.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' C ' ' H ' ' A' ' 71' ' ' SER . 55.9 mm-40 -143.46 33.72 1.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 108.926 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 m 55.62 4.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.37 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 69' ' ' GLU . 1.3 m 65.96 58.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.526 -0.734 . . . . 0.0 109.709 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.3 mt 55.83 169.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.746 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 175.44 -13.89 0.03 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 55.06 7.58 0.19 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.455 -1.027 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 73' ' ' GLY . 47.4 t80 -149.51 12.52 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.365 -0.835 . . . . 0.0 109.413 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mtp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -150.99 83.01 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 109.388 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.6 tp -97.34 91.42 5.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -86.99 165.85 15.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 108.863 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.05 162.42 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -110.56 152.64 43.52 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.52 -0.737 . . . . 0.0 109.049 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.62 -43.58 54.19 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.282 1.321 . . . . 0.0 110.606 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -59.65 -25.27 64.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 109.896 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -85.03 -24.68 28.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.5 mt -81.15 -24.6 37.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 109.003 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.669 -0.645 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' LEU . 14.2 m120 -146.18 -6.8 0.56 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.566 -1.333 . . . . 0.0 110.835 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -79.48 147.74 68.62 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.599 -1.313 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 120.908 1.072 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.46 -35.69 4.08 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 25.7 mt -93.9 149.28 36.73 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.135 -1.215 . . . . 0.0 109.117 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.64 178.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.882 1.055 . . . . 0.0 109.818 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -98.28 6.43 47.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.01 129.77 40.54 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.405 -0.81 . . . . 0.0 109.332 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -52.39 -30.58 29.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.419 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.44 66.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.94 -36.73 57.14 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.58 -64.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 109.394 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -49.78 -40.94 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.93 . . . . 0.0 109.095 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.93 -40.03 91.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 108.888 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.21 -27.82 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.92 -28.73 10.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 108.718 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.3 mptt -72.43 -39.78 67.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -65.48 -0.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.393 -0.817 . . . . 0.0 109.711 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 28' ' ' LYS . 35.4 mt-30 -151.82 -69.98 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 109.055 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.31 53.95 1.53 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.2 m-90 -51.02 147.71 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.227 . . . . 0.0 109.283 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -49.47 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 108.908 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -103.0 118.27 36.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -87.9 118.88 27.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.928 . . . . 0.0 109.891 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.2 m -93.52 123.53 36.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 108.832 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 19.9 tpt180 -90.04 -62.98 1.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' ARG . . . 76.82 87.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.54 -15.8 0.56 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.45 -71.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.046 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -100.14 -6.27 26.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.102 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.36 52.98 4.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.95 37.52 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 53.96 94.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 114.24 21.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.1 mm -86.47 113.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.661 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.27 174.06 6.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.462 -0.774 . . . . 0.0 109.057 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.17 126.9 29.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.452 -0.78 . . . . 0.0 109.47 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -75.33 113.97 13.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 0.0 109.033 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.8 -25.99 21.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.205 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.562 ' H ' HD21 ' A' ' 51' ' ' ASN . 1.4 m-80 -70.38 -22.97 62.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 0.0 109.792 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 m -90.45 -17.35 27.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.104 -0.998 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.18 148.71 98.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.955 -1.091 . . . . 0.0 109.014 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.58 -160.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.919 1.079 . . . . 0.0 109.693 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.74 -36.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.12 -39.09 81.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.308 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.03 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.7 -57.14 13.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.375 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.58 76.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.44 70.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 109.849 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.68 -32.63 73.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 mt -69.13 -45.14 70.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.04 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.09 -27.35 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -72.52 -54.22 9.85 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 64' ' ' ARG . 38.2 mt-30 -47.99 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.58 -117.52 0.63 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -68.7 94.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 109.369 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -82.07 -75.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 70' ' ' THR . 37.4 tt0 -172.72 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 96.8 m -166.82 -22.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.2 t -52.4 -35.3 51.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 74' ' ' TYR . 3.0 pp -171.83 -3.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.85 0.94 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 72' ' ' LEU . 46.2 t80 -82.2 23.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 109.502 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 53.43 18.15 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.478 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 180.0 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -89.22 148.86 23.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.913 . . . . 0.0 109.567 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.4 tp -151.57 75.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -0.929 . . . . 0.0 108.922 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.3 m95 -81.98 159.7 23.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.12 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.97 152.29 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 0.0 109.628 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.47 153.49 37.75 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.843 . . . . 0.0 109.543 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.92 -44.24 50.15 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.307 1.338 . . . . 0.0 110.497 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -58.73 -25.08 62.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 61.1 mm-40 -84.63 -24.98 28.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.018 . . . . 0.0 109.302 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.5 mt -80.97 -23.57 38.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.191 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.648 -0.658 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' LEU . 34.4 m120 -146.27 -9.1 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.544 -1.348 . . . . 0.0 110.827 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.8 mt -79.01 147.01 69.19 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.6 -1.312 . . . . 0.0 108.159 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.24 -64.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.019 1.146 . . . . 0.0 110.751 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.9 4.04 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.8 mt -94.46 149.95 37.4 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.163 -1.198 . . . . 0.0 109.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.22 176.27 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.837 1.025 . . . . 0.0 109.837 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -97.64 7.28 46.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.18 129.99 38.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.406 -0.809 . . . . 0.0 109.29 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -52.51 -30.56 30.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.33 -39.85 64.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.21 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.95 -36.71 40.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.0 t -66.22 -61.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -1.135 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -51.37 -44.14 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 108.952 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.23 -45.0 96.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 108.925 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.15 -16.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.37 -31.1 71.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 108.747 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 30' ' ' GLN . 22.5 mtmt -71.04 -28.42 64.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.28 -0.888 . . . . 0.0 108.822 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -64.89 -3.07 3.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.177 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' LYS . 43.0 mt-30 -150.2 -61.44 0.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 108.825 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.32 53.11 1.91 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -50.76 138.05 19.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.291 . . . . 0.0 109.148 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -48.64 99.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 5.5 p30 -99.82 123.14 43.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.898 . . . . 0.0 109.653 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 38.7 ttm180 -87.16 115.22 24.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.887 . . . . 0.0 109.226 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.5 m -93.25 84.47 4.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.227 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.404 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -91.45 121.81 33.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -0.9 . . . . 0.0 109.348 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.62 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.622 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -147.61 -40.51 0.04 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.6 m -52.43 -8.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.247 -1.149 . . . . 0.0 109.443 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 39' ' ' GLY . 37.9 ttpt -155.53 -32.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.539 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 47.35 2.31 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 173.24 61.74 0.05 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 43' ' ' GLY . 14.7 ptmt 32.9 80.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 122.082 -0.658 . . . . 0.0 110.83 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -153.27 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.812 . . . . 0.0 109.295 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.7 139.5 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.096 -1.002 . . . . 0.0 109.3 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 10.7 mp0 -132.81 175.99 8.86 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.11 133.56 37.41 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.339 -0.851 . . . . 0.0 109.439 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -76.6 117.9 18.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.018 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.31 61.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -69.94 -17.62 63.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.541 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.9 m -89.62 -21.31 22.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.59 148.41 98.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 108.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.83 -162.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 120.831 1.021 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.64 -38.36 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.21 -39.96 84.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.54 -48.35 11.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.39 -54.06 45.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.403 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.55 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.082 -1.011 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -29.02 69.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.53 -27.52 69.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -0.919 . . . . 0.0 109.248 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.63 -30.01 29.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.94 -47.83 70.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 109.653 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -71.87 -42.66 66.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.047 -1.033 . . . . 0.0 110.165 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -65.93 122.39 17.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 68' ' ' ILE . . . -175.83 172.28 45.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 58.11 3.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -1.115 . . . . 0.0 109.536 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.7 mt -74.26 -22.04 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 68' ' ' ILE . 8.7 pt-20 33.29 57.33 0.5 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.29 0.567 . . . . 0.0 111.013 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 p -74.54 -108.6 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -88.09 -28.93 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -85.95 177.43 7.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.2 -24.85 0.86 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 72' ' ' LEU . 34.7 t80 -85.69 13.29 7.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 109.473 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 53.58 26.71 5.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.473 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.05 135.64 33.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.489 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp -161.28 80.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -79.94 172.0 14.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.01 148.13 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.171 -0.956 . . . . 0.0 110.058 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.39 153.85 37.58 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.409 -0.807 . . . . 0.0 109.241 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.81 -41.33 75.41 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.219 1.28 . . . . 0.0 110.233 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -59.53 -27.02 65.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.35 -24.78 29.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.19 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.9 mt -82.33 -25.32 34.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.865 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 30.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.6 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.1 m120 -146.54 -6.44 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.575 -1.328 . . . . 0.0 110.8 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -79.41 148.47 70.36 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.609 -1.307 . . . . 0.0 108.16 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.75 -61.06 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 120.818 1.012 . . . . 0.0 110.239 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.42 -39.25 9.87 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LEU . 36.6 mt -93.0 149.56 37.77 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.129 -1.218 . . . . 0.0 108.987 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -53.85 -177.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.782 0.988 . . . . 0.0 109.677 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -100.93 -3.34 29.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -119.54 129.46 54.69 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.653 -0.654 . . . . 0.0 109.338 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -52.81 -29.24 26.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.68 71.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.27 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -35.74 75.83 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.37 -64.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -50.43 -41.27 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.939 . . . . 0.0 109.054 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.17 -43.41 95.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.018 . . . . 0.0 108.538 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.39 -21.38 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.763 . . . . 0.0 109.008 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.93 -31.95 73.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 108.595 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.9 mttm -71.45 -31.89 67.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 108.685 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -65.67 -0.29 2.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.468 -0.77 . . . . 0.0 109.153 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 28' ' ' LYS . 32.3 mt-30 -149.8 -65.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 108.78 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.31 56.57 1.19 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -53.95 142.89 23.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.943 -1.327 . . . . 0.0 108.704 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -47.21 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.5 p30 -100.31 121.25 41.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.37 -0.831 . . . . 0.0 109.592 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 59.9 ttt180 -87.05 111.72 21.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 108.846 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.54 86.6 5.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.957 . . . . 0.0 109.341 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -89.76 107.49 19.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.38 54.79 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.51 5.28 1.81 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -87.69 -79.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 109.176 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -88.05 -11.12 48.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.438 -0.789 . . . . 0.0 109.173 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.19 36.99 10.27 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.31 49.93 0.29 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 53.52 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -1.179 . . . . 0.0 109.136 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.18 132.47 41.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 108.949 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.419 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 12.3 mt -89.63 144.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.98 -1.075 . . . . 0.0 109.688 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.9 mp0 -135.72 172.18 13.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -136.09 134.67 38.63 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.18 116.24 17.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.045 -1.034 . . . . 0.0 108.883 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.549 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -53.78 -35.52 61.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.5 -18.77 65.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.994 -1.066 . . . . 0.0 109.637 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.46 -14.1 36.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -68.8 150.59 97.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.239 -0.913 . . . . 0.0 109.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.25 -156.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 120.933 1.089 . . . . 0.0 109.652 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -96.88 -36.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.62 -36.45 78.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.76 47.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.034 -1.041 . . . . 0.0 109.549 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.549 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 3.6 mmtm -57.87 -60.71 3.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 109.019 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.57 -50.88 64.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.389 -0.82 . . . . 0.0 109.926 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.46 69.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 110.042 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.52 -43.86 95.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.005 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.35 -47.09 79.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.083 -1.011 . . . . 0.0 109.275 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.26 -32.7 74.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.674 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -70.69 -36.17 73.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.601 -0.687 . . . . 0.0 109.674 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' ARG . 33.9 mt-30 -55.03 -168.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.943 -1.098 . . . . 0.0 109.73 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.74 4.49 69.8 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -160.02 90.06 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -1.152 . . . . 0.0 109.389 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.7 mp -85.04 -51.03 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 109.218 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 70' ' ' THR . 26.2 tt0 51.25 64.96 1.63 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 27.0 m -166.28 -32.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.332 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.2 p -171.72 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' CD1' ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -87.99 -104.33 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.245 -0.91 . . . . 0.0 109.133 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' H ' ' CD1' ' A' ' 72' ' ' LEU . . . 80.64 -7.47 58.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -83.19 -46.89 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -1.205 . . . . 0.0 109.349 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' GLU . 42.7 t80 -74.65 -23.61 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.282 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 75' ' ' PHE . 36.5 tt0 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.13 158.65 17.85 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.4 tp -167.35 78.69 0.19 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.238 -0.914 . . . . 0.0 109.223 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -79.74 167.65 20.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 108.826 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.28 165.48 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -114.14 152.37 45.8 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.76 -43.33 56.7 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.242 1.295 . . . . 0.0 110.471 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -59.56 -26.8 65.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.885 -179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' NH2' ' A' ' 64' ' ' ARG . 32.4 mm-40 -84.35 -25.68 28.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.051 -1.031 . . . . 0.0 109.449 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 12' ' ' ASN . 79.8 mt -82.39 -23.47 34.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.187 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.81 28.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.71 -0.619 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 10' ' ' LEU . 15.3 t-20 -147.39 -8.66 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.471 -1.393 . . . . 0.0 111.048 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.2 mt -78.7 147.51 71.19 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.538 -1.351 . . . . 0.0 108.329 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 -67.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.967 1.111 . . . . 0.0 111.0 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.36 -35.3 1.83 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.6 mt -95.35 150.62 37.83 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.186 -1.185 . . . . 0.0 108.865 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.53 -178.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 120.778 0.986 . . . . 0.0 109.996 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ALA . 4.4 mmmm -97.63 -17.46 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.241 -0.912 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -106.37 131.72 53.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.713 . . . . 0.0 109.413 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -53.27 -28.6 28.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.324 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.3 33.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.56 -35.33 66.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.63 -64.88 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.174 . . . . 0.0 109.398 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.5 mt -52.17 -41.61 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.09 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -60.17 -42.04 94.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.767 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.15 -24.34 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.076 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -56.26 -29.23 60.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.138 -0.976 . . . . 0.0 108.662 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -34.98 70.17 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -6.23 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.9 mt-30 -145.84 -70.49 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.378 -0.827 . . . . 0.0 108.87 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.47 55.11 1.11 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.0 m-90 -52.64 142.23 18.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.02 -1.282 . . . . 0.0 108.896 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -47.31 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.507 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.67 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -100.5 121.15 41.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.366 -0.834 . . . . 0.0 109.803 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -88.02 126.89 35.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.159 -0.963 . . . . 0.0 109.158 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.5 135.79 33.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' CZ ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.28 -38.17 12.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.16 47.3 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' CZ ' ' A' ' 37' ' ' ARG . . . 165.32 75.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.34 -33.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.153 . . . . 0.0 109.408 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -156.34 -70.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.95 -109.19 1.0 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.43 5.32 1.0 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -171.87 95.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -1.197 . . . . 0.0 109.34 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.35 111.61 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 108.765 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.1 mt -84.37 104.3 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.6 mm-40 -90.77 173.78 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -135.35 128.82 32.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -75.73 117.15 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.024 . . . . 0.0 109.406 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' N ' HD21 ' A' ' 49' ' ' ASN . . . -54.78 -30.63 57.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.068 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.542 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 14.4 m120 -70.2 -19.93 63.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.91 -21.15 22.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.813 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.83 148.21 98.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.082 -1.011 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.36 -166.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.86 1.04 . . . . 0.0 109.78 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.4 -34.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.1 mp0 -58.77 -39.67 81.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.324 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.34 -40.26 21.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -57.59 -38.5 75.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.513 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.35 -56.89 6.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.01 -19.59 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.9 -76.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.089 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -53.89 -14.96 1.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 tp -69.03 -48.99 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 109.114 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH2' ' OE1' ' A' ' 9' ' ' GLU . 11.1 ptm180 -74.16 4.86 5.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.917 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -95.43 33.85 1.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.82 -41.79 14.02 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.63 152.92 5.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -1.155 . . . . 0.0 109.351 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.0 mm -76.39 -73.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.927 . . . . 0.0 109.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.489 ' C ' ' HG1' ' A' ' 70' ' ' THR . 44.5 mt-10 -151.15 -49.48 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.489 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 46.9 m -166.34 -9.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.9 t -50.21 -45.35 53.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 74' ' ' TYR . 21.9 mt -77.73 102.52 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.195 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.83 22.24 2.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 72' ' ' LEU . 3.4 t80 69.97 73.4 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -1.079 . . . . 0.0 109.07 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 28.9 t80 60.2 26.47 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' N ' ' SD ' ' A' ' 1' ' ' MET . 36.4 tt0 -150.85 129.29 12.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.9 tp -160.02 84.38 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 109.326 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -81.72 167.04 19.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 108.911 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.96 153.74 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.347 -0.846 . . . . 0.0 109.904 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -102.46 152.69 38.39 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.743 . . . . 0.0 109.012 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.75 -45.24 41.9 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.164 1.243 . . . . 0.0 110.622 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -60.19 -25.86 65.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -84.24 -24.96 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.089 -1.007 . . . . 0.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -82.66 -19.1 38.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.168 -0.957 . . . . 0.0 109.227 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 32.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.642 -0.661 . . . . 0.0 111.038 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 10' ' ' LEU . 6.3 t-20 -145.9 -9.26 0.53 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.567 -1.333 . . . . 0.0 110.897 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.6 mt -78.68 147.32 70.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.569 -1.332 . . . . 0.0 108.127 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.93 -64.23 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.851 1.034 . . . . 0.0 110.484 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.95 -37.02 5.27 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.7 mt -93.8 149.58 37.27 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.105 -1.232 . . . . 0.0 109.1 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.0 174.75 0.19 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.826 1.017 . . . . 0.0 109.869 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -95.44 -1.74 50.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -0.883 . . . . 0.0 109.742 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -122.92 130.78 53.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -53.3 -28.97 30.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 0.0 109.616 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.67 65.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 -32.54 49.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' ALA . 56.9 t -65.97 -55.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -1.198 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.58 -45.43 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.061 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -60.57 -44.41 96.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 108.901 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.3 -19.13 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.07 -36.24 81.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.146 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.8 mtmt -70.48 -28.57 65.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.228 -0.92 . . . . 0.0 108.962 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -64.63 -1.45 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.825 . . . . 0.0 108.906 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.43 -62.76 0.2 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 108.82 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.68 50.86 2.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -49.28 146.77 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.244 . . . . 0.0 109.166 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.65 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.126 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.6 p30 -99.97 122.17 42.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -84.51 130.69 34.72 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.22 124.6 35.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 109.354 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -91.09 -173.89 3.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.48 57.12 0.11 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.334 -0.853 . . . . 0.0 109.259 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . 171.64 -39.44 0.17 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.9 m -49.3 -13.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.128 -1.219 . . . . 0.0 109.49 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 39' ' ' GLY . 30.9 tttm -160.06 -32.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.02 146.19 20.42 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.87 27.96 22.48 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' NZ ' ' CB ' ' A' ' 44' ' ' LYS . 5.4 ttpm? 53.94 94.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.126 . . . . 0.0 109.487 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.56 -161.16 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -0.815 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 tt -150.56 162.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.951 -1.093 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.7 mt-10 -148.12 170.6 17.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -135.51 126.27 27.33 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.486 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 49.3 t-20 -77.1 119.69 21.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 108.963 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.47 32.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 111.017 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.668 HD21 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.88 -20.42 62.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.114 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.668 ' N ' HD21 ' A' ' 51' ' ' ASN . 33.0 m -90.86 -20.41 22.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.067 -1.021 . . . . 0.0 110.003 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 89.3 mt -67.76 148.77 98.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.088 -1.008 . . . . 0.0 109.085 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.91 -157.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.845 1.03 . . . . 0.0 109.673 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -92.93 -40.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.42 -39.35 79.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.623 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.25 -42.86 22.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.433 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -60.29 -64.78 0.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.86 -44.95 49.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.7 -31.94 73.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.24 -28.74 69.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.12 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -72.53 -46.64 53.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.3 -37.21 83.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 109.352 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.566 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.17 -39.93 71.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.189 -0.944 . . . . 0.0 109.605 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -60.31 -0.98 0.28 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.731 -1.231 . . . . 0.0 109.419 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . -71.0 -77.99 0.46 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -79.73 101.2 8.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -1.17 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.39 -88.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -164.94 51.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.365 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 p -54.17 160.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.618 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -173.79 22.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.868 . . . . 0.0 109.295 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.67 95.12 5.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.29 10.02 62.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.98 -77.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.128 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -58.77 -40.78 84.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 0.0 109.393 179.888 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.517 ' N ' ' SD ' ' A' ' 1' ' ' MET . 21.9 pt-20 -151.07 179.77 7.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 109.323 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.7 tp -155.44 92.18 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.948 . . . . 0.0 109.419 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.51 ' HE1' ' CD ' ' A' ' 2' ' ' GLU . 55.3 m95 -85.1 164.93 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.015 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 t -138.45 164.17 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.312 -0.868 . . . . 0.0 109.958 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -110.73 152.81 43.73 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.5 -45.75 38.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 121.391 1.394 . . . . 0.0 110.655 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.45 -28.12 65.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -84.34 -24.96 29.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.732 -1.23 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 12' ' ' ASN . 56.2 mt -82.62 -20.5 36.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.263 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.18 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.619 -0.675 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 10' ' ' LEU . 36.4 m120 -146.11 -8.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.376 . . . . 0.0 110.656 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.13 147.32 69.25 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.0 107.954 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.7 -67.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.05 1.167 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.98 -34.12 2.92 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.7 mt -94.89 149.6 36.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.135 -1.215 . . . . 0.0 109.082 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.34 -179.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 120.882 1.055 . . . . 0.0 110.051 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -104.38 9.43 35.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.478 -0.763 . . . . 0.0 109.812 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -134.21 134.25 41.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.366 -0.834 . . . . 0.0 109.539 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -53.1 -31.43 41.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.883 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -51.47 64.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.423 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.83 -30.72 77.77 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.41 -54.52 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -1.204 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.57 -44.97 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.883 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.55 -41.48 94.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.079 -1.013 . . . . 0.0 108.935 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.78 -26.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 108.972 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.1 -33.32 51.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 30' ' ' GLN . 69.7 mttt -70.43 -28.12 64.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 0.0 109.055 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.58 -2.72 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.133 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.57 -60.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.67 45.63 3.13 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -48.69 135.84 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.065 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.56 99.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.056 -1.028 . . . . 0.0 109.189 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.6 p30 -100.43 123.22 44.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.0 109.638 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -87.31 123.74 32.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.033 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.64 153.74 18.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.009 . . . . 0.0 108.793 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -149.28 82.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.118 -0.989 . . . . 0.0 109.707 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.72 52.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.574 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.03 -8.52 0.55 Allowed Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -56.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.923 -1.339 . . . . 0.0 109.184 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -156.75 -69.23 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.43 165.55 22.78 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.12 -2.69 33.29 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.75 95.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -1.128 . . . . 0.0 109.589 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.76 115.81 24.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 108.81 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 tt -87.38 153.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.4 mt-10 -139.77 173.33 11.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -135.36 131.65 36.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.64 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -75.67 112.89 12.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.811 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.84 -26.28 23.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.44 -22.37 63.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.977 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 m -90.5 -10.4 43.77 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.082 -1.012 . . . . 0.0 110.072 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 54' ' ' PRO . 75.6 mt -67.32 149.97 98.13 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.066 -1.022 . . . . 0.0 108.828 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -57.18 -159.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.89 1.06 . . . . 0.0 109.581 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.62 -37.52 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.75 -37.27 81.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -0.819 . . . . 0.0 110.236 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.0 -32.18 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.727 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -55.47 -70.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 109.041 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.09 -42.38 18.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.42 74.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.097 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -66.06 -71.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.206 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -44.63 -21.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 110.034 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 61' ' ' LEU . 8.3 tp -69.49 -55.74 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.078 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -72.92 -43.81 61.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.022 -1.049 . . . . 0.0 110.815 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -81.47 164.14 22.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.653 -1.279 . . . . 0.0 109.756 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 67' ' ' GLU . . . 155.17 126.17 0.99 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 73.72 -65.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -1.136 . . . . 0.0 109.322 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' GLU . 6.7 mt 57.92 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.581 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.0 pt-20 32.91 57.8 0.44 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.599 -0.688 . . . . 0.0 111.503 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 72' ' ' LEU . 11.0 t -169.94 -177.95 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.002 -1.062 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t 53.25 8.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.55 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 70' ' ' THR . 25.8 mt -71.73 166.17 22.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 109.536 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.81 6.89 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' C ' ' H ' ' A' ' 76' ' ' GLU . 59.6 t80 -137.08 -31.3 0.83 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.643 -0.916 . . . . 0.0 109.403 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 76' ' ' GLU . 69.0 t80 -56.53 -6.83 0.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 74' ' ' TYR . 31.8 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.445 -0.784 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.66 123.64 33.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.7 tp -159.98 148.08 16.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.223 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 3' ' ' LEU . 44.3 m95 -141.15 165.74 26.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.393 -0.817 . . . . 0.0 108.808 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.5 t -135.98 -139.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 m -163.03 152.99 13.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.317 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.02 -50.69 12.36 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.422 1.415 . . . . 0.0 110.874 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -57.46 -23.17 48.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 47.9 mt-10 -84.87 -25.0 28.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 109.671 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -83.13 -21.65 33.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.571 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.736 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.67 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -148.86 -7.23 0.38 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.399 -1.438 . . . . 0.0 111.072 -179.355 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.67 ' N ' HD21 ' A' ' 12' ' ' ASN . 19.1 mt -78.27 147.39 72.5 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.642 -1.286 . . . . 0.0 108.16 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -67.42 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 120.939 1.093 . . . . 0.0 110.862 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.11 -34.23 3.1 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -95.26 149.89 36.83 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.238 -1.154 . . . . 0.0 109.29 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.72 -177.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.936 1.09 . . . . 0.0 109.814 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -103.17 3.16 35.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.39 -0.819 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -129.12 131.07 47.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 t -52.38 -31.79 35.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.867 . . . . 0.0 109.346 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -33.79 59.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.49 -36.81 22.4 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.64 -60.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.5 mt -48.96 -40.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 108.733 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -62.55 -39.47 93.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.01 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.37 -10.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -60.04 -38.0 81.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.981 -1.075 . . . . 0.0 110.453 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.61 -27.33 61.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.794 -1.191 . . . . 0.0 109.261 -179.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -63.59 -4.41 2.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 109.044 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.5 mp0 -149.07 -60.89 0.23 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.19 59.86 1.15 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -65.0 133.72 52.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.979 -1.306 . . . . 0.0 108.927 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.12 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 3.8 p30 -103.68 121.53 43.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.436 -0.79 . . . . 0.0 109.45 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 35' ' ' ARG . 29.5 ttm-85 -84.74 121.77 28.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 108.56 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.5 160.76 14.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -0.98 . . . . 0.0 109.521 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -147.78 179.12 7.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.74 75.41 0.28 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.01 -28.68 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -55.72 -16.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.235 -1.156 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -160.51 -73.26 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.313 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.86 72.57 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.48 30.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.6 mttt 56.47 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -1.166 . . . . 0.0 109.341 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.14 111.89 22.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.327 -0.858 . . . . 0.0 109.617 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.36 157.69 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 23.3 mm-40 -139.99 168.86 18.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -135.14 129.01 33.18 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.373 -0.829 . . . . 0.0 109.407 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.536 HD22 HD21 ' A' ' 51' ' ' ASN . 22.9 t-20 -75.52 112.18 11.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.81 . . . . 0.0 109.301 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -31.3 61.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.797 . . . . 0.0 110.708 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.536 HD21 HD22 ' A' ' 49' ' ' ASN . 7.3 m-80 -68.13 -17.28 64.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.985 -1.072 . . . . 0.0 109.63 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.2 m -90.91 -16.04 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 79.3 mt -67.21 149.36 98.49 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.065 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.66 -157.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.894 1.062 . . . . 0.0 109.554 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.74 -39.87 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.86 -42.76 94.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.92 -11.66 59.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.842 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -75.59 -69.94 0.46 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.04 -41.41 16.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.075 -1.015 . . . . 0.0 109.104 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.28 79.68 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.303 -0.873 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.97 -38.89 92.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.03 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.26 -38.03 73.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.953 . . . . 0.0 109.264 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.2 -32.65 74.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' NE ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -74.44 -62.61 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 108.927 179.522 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -61.68 140.38 58.19 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.18 -0.95 . . . . 0.0 109.531 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 166.35 -101.36 0.18 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -76.3 60.06 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.482 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.01 -44.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 109.613 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' OE1' ' OG1' ' A' ' 70' ' ' THR . 1.6 tm-20 -108.71 -31.02 7.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.431 -0.793 . . . . 0.0 109.428 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.4 m -161.94 -126.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.384 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 70' ' ' THR . 15.1 m -173.2 123.32 0.4 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.515 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -78.08 69.98 4.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.291 -0.88 . . . . 0.0 109.022 179.805 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 29.15 2.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 72' ' ' LEU . 69.0 m-85 -87.47 -79.05 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -1.169 . . . . 0.0 109.212 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 53.4 t80 -163.56 21.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 75' ' ' PHE . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' CB ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 36.5 tt0 -152.42 76.44 1.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 109.354 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -161.73 75.81 0.49 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.8 m95 -79.62 161.72 25.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 108.713 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.5 t -132.24 -141.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.419 -0.801 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.469 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.1 m -162.81 153.58 14.3 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.126 -0.984 . . . . 0.0 109.454 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.26 -48.15 20.79 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.344 1.363 . . . . 0.0 110.624 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -58.82 -23.42 60.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 110.007 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 44.4 mt-10 -84.94 -29.62 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.5 mt -80.52 -24.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.269 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.14 29.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 110.92 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.6 m120 -145.69 -9.73 0.54 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.543 -1.348 . . . . 0.0 110.795 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.3 mt -78.78 147.48 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.601 -1.312 . . . . 0.0 108.061 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -65.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.006 1.137 . . . . 0.0 110.849 -179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.14 -37.37 4.4 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.3 150.16 37.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.22 -1.165 . . . . 0.0 109.134 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.12 171.04 0.41 Allowed 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.876 1.051 . . . . 0.0 109.786 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ALA . 51.1 mttm -91.5 -10.18 41.7 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.712 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -114.62 128.59 56.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.512 -0.743 . . . . 0.0 109.314 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -52.59 -28.97 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -33.72 56.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.239 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.16 -37.11 22.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.78 -59.96 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 109.392 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.01 -45.48 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.047 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.28 -42.82 99.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.3 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.39 -14.63 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.58 -31.2 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.21 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -27.83 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 108.576 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -63.92 -8.11 10.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.862 . . . . 0.0 109.245 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -150.18 -59.46 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.318 -0.864 . . . . 0.0 108.98 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.69 55.4 1.91 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -50.88 148.37 4.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.062 -1.258 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.68 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.63 114.43 28.11 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.314 -0.867 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -88.83 108.97 19.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.183 -0.948 . . . . 0.0 109.767 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -93.89 147.95 22.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 108.872 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -148.72 -23.32 0.32 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 109.589 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.23 92.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.575 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -170.47 -32.35 0.02 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -56.38 -6.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -1.148 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 39' ' ' GLY . 46.3 tttp -158.49 -75.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.5 51.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.48 -83.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -179.49 102.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -1.055 . . . . 0.0 109.267 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.76 -152.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.181 -0.949 . . . . 0.0 109.239 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 47' ' ' GLU . 13.2 tt -150.73 -41.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.187 -0.946 . . . . 0.0 109.479 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 46' ' ' ILE . 80.2 mt-10 56.04 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.597 0.713 . . . . 0.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.5 130.71 35.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.484 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 28.9 t-20 -77.16 112.62 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 108.947 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.53 -22.95 23.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.369 -0.832 . . . . 0.0 111.029 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.67 HD21 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.788 -1.195 . . . . 0.0 109.843 -179.291 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.67 ' N ' HD21 ' A' ' 51' ' ' ASN . 5.1 m -92.47 -13.1 30.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.62 148.92 98.52 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.981 -1.074 . . . . 0.0 109.012 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -158.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.991 1.127 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.2 -37.37 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.378 -0.826 . . . . 0.0 109.363 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.01 -40.24 84.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.96 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.28 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -58.02 -69.65 0.17 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.104 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -43.38 15.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.789 . . . . 0.0 109.682 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.7 78.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.71 -25.74 68.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 109.495 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.76 -32.5 57.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.491 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.42 -52.89 34.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.835 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 9.5 ptm180 -72.12 -11.68 60.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -93.24 -112.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.644 -1.285 . . . . 0.0 109.236 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 50.6 83.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 66' ' ' GLY . 27.2 mt-10 53.77 106.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.977 . . . . 0.0 109.83 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 69' ' ' GLU . 10.2 tp -159.67 -46.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 109.318 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 43.6 mt-10 -45.75 169.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.688 . . . . 0.0 109.737 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -55.29 121.62 9.3 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 p -175.86 -26.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -81.68 108.02 14.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.132 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.19 2.47 56.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -171.74 -50.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.532 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 71.2 t80 -161.1 38.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.827 . . . . 0.0 109.291 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.309 -179.979 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -88.95 162.33 16.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.395 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 tp -160.69 77.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.1 m95 -79.95 158.08 26.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.286 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 6' ' ' SER . 95.1 t -138.33 165.28 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.341 -0.85 . . . . 0.0 110.198 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.44 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 m -104.52 153.76 38.91 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.458 -0.776 . . . . 0.0 109.348 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.02 -44.13 47.33 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.388 1.392 . . . . 0.0 110.83 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -23.22 45.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 109.814 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 25.6 mm-40 -84.56 -23.08 29.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 12' ' ' ASN . 96.6 mt -82.97 -22.49 33.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 0.0 109.094 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 32.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.762 -0.586 . . . . 0.0 111.336 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.4 t-20 -146.64 -9.04 0.48 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.519 -1.363 . . . . 0.0 110.775 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.1 mt -79.45 147.58 68.39 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.681 -1.262 . . . . 0.0 108.229 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.69 -61.83 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 120.871 1.047 . . . . 0.0 110.527 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.26 -38.87 6.79 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.9 mt -93.98 149.64 37.24 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 0.0 109.108 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.59 177.78 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.722 0.948 . . . . 0.0 109.712 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -98.47 9.06 44.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.258 -0.901 . . . . 0.0 109.63 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -134.17 130.52 37.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 0.0 109.323 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 p -53.13 -29.62 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.51 65.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.8 28.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.51 -59.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.266 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.4 mt -52.12 -43.03 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.078 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.97 -39.9 87.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -74.99 -27.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.05 -32.74 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.0 108.799 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -71.8 -33.4 68.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.131 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.15 -3.28 3.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.538 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.5 mt-30 -145.19 -63.42 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.0 108.935 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.4 51.84 1.8 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.538 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.4 m-90 -51.63 146.46 7.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.251 . . . . 0.0 109.076 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.49 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.064 . . . . 0.0 109.306 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.672 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -98.8 117.16 32.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.499 -0.751 . . . . 0.0 109.75 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -89.59 121.22 31.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.932 . . . . 0.0 108.604 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 m -90.17 74.33 7.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.763 -1.211 . . . . 0.0 109.696 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -91.01 113.88 26.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -0.851 . . . . 0.0 109.141 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.57 55.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.686 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.2 -2.47 7.06 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.29 -46.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -1.184 . . . . 0.0 109.393 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -168.92 -63.37 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 109.419 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.89 114.56 0.36 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.36 17.24 1.12 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 52.53 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.123 -1.222 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.0 156.99 20.21 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' GLU . 9.8 tt -91.19 -39.54 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.263 -0.898 . . . . 0.0 109.797 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 46' ' ' ILE . 78.2 mt-10 55.7 152.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.756 0.789 . . . . 0.0 110.655 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -135.81 136.72 40.9 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.704 HD21 ' H ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -77.54 114.78 16.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.082 -1.011 . . . . 0.0 109.334 -179.965 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.12 35.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 111.193 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 49' ' ' ASN . 5.6 m-20 -69.69 -17.94 63.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.895 -1.128 . . . . 0.0 110.089 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -91.83 -14.7 29.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.135 -0.978 . . . . 0.0 110.216 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt -66.89 148.17 98.9 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.056 . . . . 0.0 108.992 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -56.81 -161.86 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 121.01 1.14 . . . . 0.0 109.618 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 t -91.39 -38.81 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -59.37 -40.22 85.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.09 11.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.626 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -48.24 -50.9 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.775 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.81 -53.72 54.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.16 66.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 109.083 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.26 -66.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 0.0 108.914 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -49.54 -25.51 2.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.43 -0.794 . . . . 0.0 109.166 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.2 tp -66.82 -34.51 77.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 109.059 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 29.2 mtp180 -71.3 -50.91 27.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -45.33 117.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.933 . . . . 0.0 109.957 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.52 -65.65 0.14 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.57 129.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -1.067 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.3 mt -114.93 -80.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -96.34 99.36 11.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.138 -0.976 . . . . 0.0 109.156 179.964 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 51.2 p -49.43 120.46 4.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.938 . . . . 0.0 109.461 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 72' ' ' LEU . 2.4 t 177.58 -99.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 74' ' ' TYR . 7.1 mt 50.21 92.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 66.95 -7.37 1.63 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.58 ' H ' ' C ' ' A' ' 72' ' ' LEU . 97.9 m-85 54.67 4.74 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.632 -0.922 . . . . 0.0 109.573 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 73' ' ' GLY . 53.2 m-85 -95.33 -12.42 26.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 72' ' ' LEU . 14.8 mp0 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.34 141.72 28.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.496 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -168.56 83.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.662 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -79.87 165.5 22.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 108.564 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.4 t -135.24 -140.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.453 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 5.1 m -163.11 154.0 14.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 0.0 109.449 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.59 -50.56 12.97 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 121.345 1.363 . . . . 0.0 110.871 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -58.14 -24.33 58.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.123 -0.985 . . . . 0.0 110.131 -179.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -84.69 -28.46 26.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 12' ' ' ASN . 60.9 mt -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.28 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.15 30.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 10' ' ' LEU . 64.0 m-80 -145.71 -7.38 0.58 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.574 -1.329 . . . . 0.0 110.698 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.2 mt -79.19 147.81 69.93 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.669 -1.269 . . . . 0.0 108.04 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 120.839 1.026 . . . . 0.0 110.635 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.56 -36.39 4.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.6 mt -93.79 149.92 37.82 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.182 -1.187 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.8 171.13 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 120.763 0.975 . . . . 0.0 109.756 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.41 7.8 45.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.869 . . . . 0.0 109.779 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -133.62 129.63 37.19 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 p -53.0 -29.64 30.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 0.0 109.383 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.1 -35.83 62.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.7 -35.12 20.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.6 t -65.86 -53.17 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -1.135 . . . . 0.0 109.34 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -57.29 -48.47 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.11 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -60.02 -44.84 94.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -75.15 -18.36 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.96 -30.41 70.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 30' ' ' GLN . 41.4 mttp -71.51 -29.22 64.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -64.83 -3.21 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.7 mt-30 -149.81 -61.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.74 53.51 2.24 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -50.19 143.81 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.938 -1.33 . . . . 0.0 108.912 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.643 HE21 HD21 ' A' ' 49' ' ' ASN . 10.9 tt0 -46.97 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.156 -0.965 . . . . 0.0 109.527 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.3 p30 -106.14 117.17 33.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.522 -0.736 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -88.24 130.37 35.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.15 93.03 6.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.904 -1.123 . . . . 0.0 109.334 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.0 OUTLIER -89.08 99.68 12.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.303 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.67 54.56 0.79 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.95 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.53 51.99 0.28 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.144 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.64 -36.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -1.214 . . . . 0.0 109.283 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -143.33 -69.99 0.32 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.278 -0.889 . . . . 0.0 109.58 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.79 -121.63 4.11 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.95 11.25 5.65 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -179.5 74.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.79 31.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.1 tt -89.15 155.08 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.632 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 30.8 mt-10 -137.17 171.47 14.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.64 126.49 27.5 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.166 -0.959 . . . . 0.0 109.891 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.643 HD21 HE21 ' A' ' 33' ' ' GLN . 50.5 t-20 -76.15 112.72 12.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 108.811 179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.08 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.992 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -71.2 -22.97 61.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.5 m -89.55 -11.78 41.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.082 -1.012 . . . . 0.0 110.272 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.6 mt -68.39 148.98 98.2 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.932 -1.105 . . . . 0.0 109.283 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.4 Cg_endo -58.02 -155.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.019 1.146 . . . . 0.0 109.643 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.11 -36.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.169 -0.957 . . . . 0.0 109.689 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.35 -38.16 82.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.698 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.95 47.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.574 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -59.92 -71.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 108.984 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.78 -42.3 11.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.444 -0.785 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.15 -35.48 80.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.264 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.2 tp -65.96 -48.12 72.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.2 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -61.81 -38.67 88.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.117 -0.99 . . . . 0.0 110.484 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.2 mt -67.65 -50.4 58.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.396 -179.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -28.01 63.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.944 -1.097 . . . . 0.0 110.963 -178.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -83.55 -88.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.591 -1.318 . . . . 0.0 109.637 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.11 157.51 31.69 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.12 128.26 36.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -1.134 . . . . 0.0 109.652 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 70' ' ' THR . 4.5 pt -121.44 -35.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 57.28 2.92 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.425 -0.797 . . . . 0.0 109.771 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 42.88 -154.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 110.047 179.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.503 ' N ' ' OG1' ' A' ' 70' ' ' THR . 6.9 t 57.31 44.81 21.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.566 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.57 170.45 16.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 74' ' ' TYR . . . 155.71 -0.85 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CG ' ' O ' ' A' ' 73' ' ' GLY . 42.2 m-85 -156.65 19.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -1.101 . . . . 0.0 109.469 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 51.66 17.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.967 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 2.9 mp0 -89.03 138.93 30.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 109.457 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.0 tp -171.26 148.51 2.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.253 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -136.88 171.22 14.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.61 145.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -96.76 152.29 38.38 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.09 -44.99 44.38 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.235 1.29 . . . . 0.0 110.297 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -60.57 -25.44 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 109.88 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -84.36 -27.07 27.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -81.97 -23.66 35.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 109.213 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 31.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.598 -0.688 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 10' ' ' LEU . 72.1 m-80 -144.83 -8.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.568 -1.333 . . . . 0.0 110.682 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.0 mt -78.93 147.61 70.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.689 -1.257 . . . . 0.0 108.04 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -64.93 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.888 1.058 . . . . 0.0 110.663 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.66 -36.99 4.89 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -93.76 149.84 37.72 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.132 -1.217 . . . . 0.0 109.156 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.77 175.11 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.956 1.104 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -98.84 7.18 46.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.32 -0.862 . . . . 0.0 109.658 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.31 130.71 41.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.468 -0.77 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -52.37 -30.75 30.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.42 62.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.35 -36.93 25.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.88 -55.83 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.03 -44.64 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.153 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.75 -43.02 98.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.067 . . . . 0.0 108.735 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.03 -22.11 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.66 -30.33 60.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 108.739 179.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -71.3 -30.68 66.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -65.37 -3.66 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.422 -0.799 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -151.29 -63.44 0.18 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.027 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.3 54.36 1.86 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.65 151.28 1.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.286 . . . . 0.0 109.378 179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.571 HE21 HD21 ' A' ' 49' ' ' ASN . 20.3 tt0 -54.8 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -96.69 114.6 26.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.39 129.74 34.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.125 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.28 114.56 27.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.978 -1.076 . . . . 0.0 109.321 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -90.76 101.58 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 53.78 0.77 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.356 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.11 37.82 0.46 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.08 -87.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -1.108 . . . . 0.0 108.575 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -178.88 -28.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.57 -23.9 59.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 44' ' ' LYS . . . 102.02 90.35 2.11 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 34.2 tttp 81.6 101.74 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.68 -150.58 0.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 109.545 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' GLU . 17.1 mt -149.94 -61.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 46' ' ' ILE . 46.9 mt-10 56.04 154.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.416 0.627 . . . . 0.0 109.801 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -135.45 131.66 36.46 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.571 HD21 HE21 ' A' ' 33' ' ' GLN . 43.7 t-20 -75.38 116.36 16.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.019 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.84 -24.72 24.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 52' ' ' SER . 49.8 p30 -70.76 -18.83 62.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.953 -1.092 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 19.4 m -92.5 -14.88 27.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.003 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.32 149.71 98.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.63 -155.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 121.035 1.157 . . . . 0.0 109.371 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 t -97.61 -37.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.152 -0.968 . . . . 0.0 109.329 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -61.04 -35.53 77.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.04 -47.0 15.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 0.0 109.803 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -53.73 -54.51 37.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.535 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.07 -51.37 53.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.182 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.93 -27.09 68.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.875 . . . . 0.0 109.203 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -62.95 -59.22 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.619 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.88 -36.22 7.28 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.917 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.49 -31.29 71.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.117 -0.989 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.621 HH11 ' CB ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -72.17 -58.66 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.029 179.556 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -73.06 68.68 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.53 -73.3 1.17 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.84 5.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -1.111 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -75.73 -70.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.041 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' O ' ' OG1' ' A' ' 70' ' ' THR . 31.8 mp0 -64.45 77.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.253 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' ILE . 7.7 m -167.72 160.14 12.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' LEU . 4.7 t -83.6 17.32 2.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.5 mt 58.96 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.762 . . . . 0.0 109.855 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -70.26 11.99 1.95 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 72' ' ' LEU . 11.6 t80 69.06 -12.2 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.954 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' A' ' 73' ' ' GLY . 33.4 t80 -66.24 -22.31 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.005 179.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.297 -0.877 . . . . 0.0 109.323 179.954 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.236 0.541 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.89 -31.63 18.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.433 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 26.6 tp 52.78 75.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -80.13 164.4 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 108.483 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -135.55 160.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -178.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -106.27 153.78 40.16 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 109.377 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.85 -43.49 57.59 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 121.337 1.358 . . . . 0.0 110.559 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.483 ' HZ1' ' HZ3' ' A' ' 41' ' ' LYS . 50.7 pttt -58.23 -26.48 62.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 109.833 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 42.8 mt-10 -84.57 -25.55 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.1 mt -82.8 -22.64 34.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 28.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.664 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.667 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -147.25 -5.7 0.5 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.477 -1.389 . . . . 0.0 110.901 -179.642 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.667 ' N ' HD21 ' A' ' 12' ' ' ASN . 33.2 mt -79.4 147.65 68.74 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.558 -1.339 . . . . 0.0 108.061 179.261 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.92 -62.31 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 120.966 1.111 . . . . 0.0 110.791 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.63 -40.74 6.63 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 47.4 mt -93.91 150.06 37.97 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.236 -1.155 . . . . 0.0 109.04 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -52.21 -178.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 120.844 1.029 . . . . 0.0 109.915 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -100.51 -7.23 24.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.301 -0.874 . . . . 0.0 109.661 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -116.42 128.11 55.21 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.186 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -52.22 -29.22 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.13 66.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.291 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.66 -35.88 34.92 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.01 -59.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 109.243 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.65 -44.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 0.0 109.107 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -61.16 -45.59 93.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.116 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.57 -22.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.286 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.79 -32.99 63.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 30' ' ' GLN . 23.7 mmtp -71.01 -29.02 64.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.052 179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -64.34 -0.6 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.2 mt-30 -150.86 -62.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.23 47.74 2.15 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.231 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -51.75 134.38 30.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.94 -1.329 . . . . 0.0 108.944 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.33 112.79 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.992 -1.068 . . . . 0.0 108.568 179.555 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 10.3 p30 -110.03 120.51 42.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.584 -0.697 . . . . 0.0 109.832 -179.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -86.31 127.29 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.112 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.16 168.21 11.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 108.87 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -148.19 -156.89 0.76 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.17 83.19 0.11 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.88 34.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -86.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.237 . . . . 0.0 108.901 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HZ3' ' HZ1' ' A' ' 8' ' ' LYS . 38.7 mmtm -63.52 -29.89 71.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.61 -78.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.51 12.83 0.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -171.63 76.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -1.104 . . . . 0.0 109.373 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.23 139.48 30.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.4 tt -90.13 163.59 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 0.0 109.376 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 40.4 mt-10 -147.6 172.83 13.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.964 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.4 132.76 35.93 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.426 -0.796 . . . . 0.0 109.334 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -77.45 120.18 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.92 -30.03 57.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.3 -0.875 . . . . 0.0 110.54 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -71.35 -18.71 62.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 35.9 m -89.74 -22.91 21.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.049 -1.032 . . . . 0.0 110.278 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.44 148.02 98.73 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.957 -1.09 . . . . 0.0 108.983 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.7 -164.44 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 120.899 1.066 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 t -89.28 -37.02 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.45 -39.43 79.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.567 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.76 -44.32 17.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.099 -1.0 . . . . 0.0 109.573 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.96 -42.33 72.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 109.829 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.91 -56.9 10.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.711 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.35 -19.96 65.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 2.0 tm? -65.47 -66.0 0.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 61' ' ' LEU . 2.9 pp -64.22 -13.95 52.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.0 109.758 -178.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.12 -57.03 5.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.24 5.8 3.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.029 -1.045 . . . . 0.0 110.286 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -86.12 3.76 41.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 0.0 108.928 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 48.26 32.45 9.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' GLY . 39.9 tt0 48.35 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -1.185 . . . . 0.0 109.56 179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 69' ' ' GLU . 4.0 tp -76.9 -47.76 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 14.3 mm-40 45.45 -166.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 109.636 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -81.12 -32.16 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' LEU . 45.9 m -78.9 -174.67 4.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' SER . 13.7 mt 53.18 104.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.25 23.5 1.4 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -155.72 -84.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.171 . . . . 0.0 109.377 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 62.4 t80 -165.61 20.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.381 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.551 179.948 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 mtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.349 0.595 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 1.3 pp20? -150.77 146.63 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 tp -157.12 76.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -80.15 164.05 23.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.004 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.12 160.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.379 -0.826 . . . . 0.0 109.882 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -107.7 153.73 41.31 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.726 . . . . 0.0 109.362 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.92 -43.59 56.75 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.271 1.314 . . . . 0.0 110.503 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -57.72 -26.14 61.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' A' ' 64' ' ' ARG . 38.0 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.142 -0.974 . . . . 0.0 109.154 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.8 mt -82.91 -19.97 36.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.817 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.92 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.0 m120 -146.83 -7.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.544 -1.347 . . . . 0.0 110.907 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.22 147.71 69.6 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.603 -1.31 . . . . 0.0 108.215 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.72 -64.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.96 1.107 . . . . 0.0 110.511 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.88 -38.9 6.02 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' LEU . 57.8 mt -93.18 149.6 37.72 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.224 -1.163 . . . . 0.0 109.087 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.57 175.6 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.867 1.045 . . . . 0.0 109.88 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.6 -5.7 31.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -116.47 129.06 56.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 109.258 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -52.62 -29.49 26.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.56 -37.59 68.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.64 -35.41 36.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' ALA . 46.4 t -65.93 -50.11 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.419 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.65 -42.7 93.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.062 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -75.06 -24.29 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.243 179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.78 -31.39 66.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 0.0 108.737 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.05 -30.4 66.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -64.41 -0.98 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.231 179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.5 mt-30 -150.76 -63.23 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 108.768 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.33 49.7 2.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.9 m-90 -48.95 147.82 2.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.3 . . . . 0.0 109.01 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -47.54 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.997 . . . . 0.0 109.33 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.69 HD21 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.36 119.31 38.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.48 -0.763 . . . . 0.0 110.183 -179.359 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -87.15 124.31 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.234 -0.916 . . . . 0.0 108.962 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 150.35 20.78 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.974 -1.079 . . . . 0.0 108.995 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -150.17 100.43 2.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.19 53.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.814 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.49 13.08 0.68 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.74 -49.79 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.253 -1.145 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -158.73 -70.28 0.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.6 -108.67 0.05 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.17 8.46 1.07 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -172.15 79.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -1.099 . . . . 0.0 109.345 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.83 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.277 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 tt -89.88 155.51 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.692 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.93 174.68 10.31 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -136.46 126.51 26.09 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.26 -0.9 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.67 ' ND2' HD22 ' A' ' 51' ' ' ASN . 50.0 t-20 -76.31 120.46 21.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.06 -30.28 47.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 110.698 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.67 HD22 ' ND2' ' A' ' 49' ' ' ASN . 50.9 p30 -71.45 -19.22 62.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.93 -1.106 . . . . 0.0 110.106 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 70.3 m -90.05 -22.06 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.974 -179.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 80.0 mt -67.66 148.35 98.57 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 0.0 108.764 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.32 -158.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 120.879 1.052 . . . . 0.0 109.766 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.87 -37.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.09 -39.86 79.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.01 33.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.693 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -59.91 -39.11 84.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.01 18.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.179 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.02 -21.42 66.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.61 -57.78 9.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.88 . . . . 0.0 109.045 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -52.7 -42.77 65.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.36 -28.21 68.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.097 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 9' ' ' GLU . 0.8 OUTLIER -74.63 -61.19 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.012 179.693 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -50.7 162.16 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.421 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' H ' ' CD1' ' A' ' 68' ' ' ILE . . . -164.67 95.65 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 57.44 62.56 2.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -1.109 . . . . 0.0 110.501 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.513 ' CD1' ' H ' ' A' ' 66' ' ' GLY . 1.4 mp -100.59 -56.8 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -142.22 -26.32 0.64 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.277 -0.889 . . . . 0.0 109.121 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.7 m -73.57 -21.48 60.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.385 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m 53.23 36.45 22.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.59 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 1.5 pt? -71.21 -160.15 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 109.623 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.0 21.57 17.85 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -50.14 61.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.408 -1.054 . . . . 0.0 109.074 -179.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -85.71 -6.24 59.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.158 -0.964 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.995 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 2.3 mp0 -88.96 108.88 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.0 tp -158.65 81.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -82.72 162.65 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.377 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.28 157.87 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.381 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -105.16 153.15 39.74 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.413 -0.804 . . . . 0.0 109.24 -179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.49 -42.88 62.22 Favored 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.24 1.294 . . . . 0.0 110.397 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -58.2 -27.0 63.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.603 -179.546 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -84.63 -24.47 29.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 109.119 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 12' ' ' ASN . 98.3 mt -82.42 -22.85 35.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.87 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.68 . . . . 0.0 111.394 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.4 m120 -148.34 -7.03 0.41 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.465 -1.397 . . . . 0.0 111.089 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -79.9 148.11 67.73 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.594 -1.316 . . . . 0.0 108.253 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.4 -67.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.039 1.159 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.67 2.36 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' LEU . 21.4 mt -95.19 150.61 37.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.21 -1.17 . . . . 0.0 109.015 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.9 -174.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.759 0.972 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -105.29 4.37 30.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.448 -0.782 . . . . 0.0 109.84 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 p -132.71 132.42 42.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.414 -0.804 . . . . 0.0 109.413 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -53.1 -30.83 38.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.324 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.31 61.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.275 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -36.84 15.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.92 -53.95 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -1.146 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.04 -43.25 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 108.929 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.46 -44.13 97.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 108.94 179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.38 -24.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.446 -0.784 . . . . 0.0 109.187 179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.46 -29.52 36.13 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.163 -0.961 . . . . 0.0 108.692 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 30' ' ' GLN . 7.4 mtpm? -72.14 -35.36 69.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -64.68 0.73 1.02 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.063 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 28' ' ' LYS . 32.2 mt-30 -151.94 -68.77 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 108.905 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.08 52.42 1.62 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -51.47 141.55 15.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.271 . . . . 0.0 109.115 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -50.51 91.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -97.83 118.47 34.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.331 -0.855 . . . . 0.0 109.303 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.31 126.09 34.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.667 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.02 155.93 16.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 108.773 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 37' ' ' ARG . 14.0 ttm-85 -150.71 -111.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -0.796 . . . . 0.0 109.312 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -167.37 31.31 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -11.88 2.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' GLY . 6.3 m -91.08 38.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -1.07 . . . . 0.0 108.987 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp 65.28 -13.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.998 -0.439 . . . . 0.0 110.516 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . 150.81 82.83 0.04 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.437 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -170.69 -83.22 0.05 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' H ' ' CG2' ' A' ' 40' ' ' VAL . 6.7 ttpm? -178.27 93.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.698 -0.884 . . . . 0.0 109.088 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.25 120.94 32.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -84.96 156.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.3 mt-10 -147.34 170.75 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.97 127.63 28.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.669 ' ND2' HD22 ' A' ' 51' ' ' ASN . 46.9 t-20 -75.37 123.5 25.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.997 . . . . 0.0 109.296 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.12 63.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.828 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.669 HD22 ' ND2' ' A' ' 49' ' ' ASN . 42.2 p30 -69.83 -16.53 63.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.941 -1.1 . . . . 0.0 109.82 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 49.7 m -89.95 -23.88 21.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.63 148.31 98.59 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 108.948 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.83 -168.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.892 1.061 . . . . 0.0 109.676 179.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.0 -35.36 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 6.0 mp0 -59.28 -39.43 82.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.81 -29.03 32.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.61 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -63.79 -46.82 83.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.302 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.0 77.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 108.807 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.24 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.068 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -62.14 -35.77 79.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 108.589 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.73 -45.32 83.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.788 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.81 -26.84 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HG3' ' NH1' ' A' ' 64' ' ' ARG . 2.3 tpm_? -74.08 -63.34 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -63.12 -179.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 109.049 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.69 -57.71 0.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' C ' ' H ' ' A' ' 69' ' ' GLU . 48.2 mt-10 -56.97 -75.94 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -1.147 . . . . 0.0 109.438 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 35.9 mt 54.67 -2.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.735 . . . . 0.0 110.368 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' H ' ' C ' ' A' ' 67' ' ' GLU . 7.0 mp0 53.12 172.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.07 -1.019 . . . . 0.0 109.2 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' SER . 90.0 m 44.64 -95.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -0.957 . . . . 0.0 109.784 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.2 t 60.4 142.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.888 . . . . 0.0 110.0 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.645 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -81.81 177.99 8.57 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.246 -0.909 . . . . 0.0 109.17 179.883 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.9 21.23 1.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 72' ' ' LEU . 42.6 p90 -69.71 -12.45 61.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 109.076 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -173.11 -27.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.847 . . . . 0.0 109.387 179.967 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.35 0.595 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.76 134.62 33.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -0.94 . . . . 0.0 109.229 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.582 ' CD2' HE22 ' A' ' 65' ' ' GLN . 12.5 tp -161.03 78.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -79.6 166.73 21.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.086 -1.009 . . . . 0.0 108.381 179.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' CG1' ' H ' ' A' ' 6' ' ' SER . 2.4 t -136.05 -140.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.23 -0.919 . . . . 0.0 109.979 -179.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.452 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 4.9 m -162.83 153.0 13.65 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.46 -48.6 19.66 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.463 1.442 . . . . 0.0 110.959 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -57.25 -24.79 57.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -0.999 . . . . 0.0 109.968 -179.054 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 36.8 mt-10 -85.05 -26.06 27.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.185 -0.947 . . . . 0.0 109.417 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.2 mt -81.9 -21.59 37.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 30.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' LEU . 57.2 m-80 -146.69 -7.0 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.523 -1.361 . . . . 0.0 110.933 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.49 147.79 68.66 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.629 -1.295 . . . . 0.0 108.176 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -66.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.867 1.045 . . . . 0.0 110.707 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.36 -36.43 4.28 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.6 mt -93.68 149.95 37.95 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.173 -1.192 . . . . 0.0 109.18 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 172.77 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.821 1.014 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -94.36 6.6 48.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.735 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -131.86 129.66 40.68 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.506 -0.746 . . . . 0.0 109.309 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -52.71 -29.86 29.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.57 29.35 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.43 -58.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.8 mt -52.39 -44.52 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.937 . . . . 0.0 109.146 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.71 -44.35 96.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.982 . . . . 0.0 109.063 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.28 -24.04 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 109.215 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.28 -32.95 67.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 108.884 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -71.78 -33.52 68.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 108.966 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -65.15 -3.88 4.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.579 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 30.5 mt-30 -150.18 -67.58 0.2 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 108.779 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.88 59.04 1.01 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.579 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.5 m-90 -55.74 147.81 17.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.083 -1.245 . . . . 0.0 108.732 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.644 HE21 HD21 ' A' ' 49' ' ' ASN . 15.9 tt0 -49.24 90.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.148 -0.97 . . . . 0.0 109.537 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -102.98 121.2 42.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.876 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 35' ' ' ARG . 23.4 ttm-85 -86.7 117.5 25.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.42 112.07 23.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.05 . . . . 0.0 109.89 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -150.43 131.42 14.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -68.53 -107.49 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.36 -32.72 0.56 Allowed Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 178.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' H ' ' C ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -78.34 -75.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -1.12 . . . . 0.0 108.926 179.984 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -161.82 -34.23 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.43 174.74 44.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.65 -17.82 79.99 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 pttm -176.04 100.32 0.07 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -1.092 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.59 137.73 32.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.729 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 tt -91.4 123.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.263 -0.898 . . . . 0.0 109.703 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 12.1 mm-40 -101.89 170.57 8.05 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.05 128.42 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.452 -0.78 . . . . 0.0 109.596 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.644 HD21 HE21 ' A' ' 33' ' ' GLN . 57.3 t-20 -76.47 114.77 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.266 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.616 ' CB ' ' HZ3' ' A' ' 58' ' ' LYS . . . -54.7 -30.82 56.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.12 -19.67 63.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 m -89.18 -17.96 28.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 109.766 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.4 mt -67.71 149.2 98.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.046 -1.033 . . . . 0.0 109.032 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.66 -158.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.914 1.076 . . . . 0.0 110.031 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.11 -38.62 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -57.79 -41.45 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.52 -33.75 47.8 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.616 ' HZ3' ' CB ' ' A' ' 50' ' ' ALA . 1.2 tpmt? -56.98 -53.67 55.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.15 67.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.61 78.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.111 -0.993 . . . . 0.0 109.375 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -51.23 65.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -44.2 -31.24 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.449 -0.782 . . . . 0.0 109.569 -179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.96 -68.09 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.162 179.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 11.1 ptm180 -78.22 59.6 2.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.404 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.582 HE22 ' CD2' ' A' ' 3' ' ' LEU . 33.4 mm-40 -78.16 32.48 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.932 -1.105 . . . . 0.0 109.489 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . 47.02 -172.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -81.34 107.73 14.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.289 -1.124 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mt -71.0 -19.43 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -50.02 -29.2 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 p -62.67 -39.95 95.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t -68.15 -84.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.371 -0.831 . . . . 0.0 109.538 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 74' ' ' TYR . 1.7 pp -49.25 128.9 17.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -79.1 14.45 14.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.402 ' H ' ' C ' ' A' ' 72' ' ' LEU . 17.1 t80 65.96 -6.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.562 -0.963 . . . . 0.0 109.412 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 73' ' ' GLY . 41.3 t80 -75.35 -8.16 55.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.112 -0.993 . . . . 0.0 109.014 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 75' ' ' PHE . 24.2 mt-10 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.0 109.602 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 ttt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.01 158.49 18.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 109.337 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.8 tp -160.98 81.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -81.62 167.03 19.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.129 -0.982 . . . . 0.0 108.819 179.421 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -138.33 148.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 109.545 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.416 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.5 m -97.44 153.0 38.52 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 -179.663 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -51.81 -48.15 22.89 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.381 1.387 . . . . 0.0 110.869 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -58.74 -23.74 60.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.29 -179.194 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 24.0 mm-40 -85.03 -24.01 28.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.947 -1.096 . . . . 0.0 109.51 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -82.02 -23.18 36.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.134 -0.979 . . . . 0.0 108.8 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.623 HD21 ' N ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -146.89 -6.19 0.51 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.544 -1.347 . . . . 0.0 110.844 -179.466 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.623 ' N ' HD21 ' A' ' 12' ' ' ASN . 37.2 mt -78.9 147.3 70.1 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.558 -1.339 . . . . 0.0 108.02 179.241 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.96 -67.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.066 1.177 . . . . 0.0 110.756 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.71 -34.73 2.85 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.2 mt -94.57 149.94 37.3 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.152 -1.205 . . . . 0.0 109.031 -179.673 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.5 -176.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 120.921 1.081 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -102.57 -2.85 27.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.429 -0.794 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -119.65 126.15 50.46 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -52.27 -29.15 21.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.344 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.09 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.391 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.9 -36.16 37.21 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.78 -60.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -1.152 . . . . 0.0 109.36 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.0 mt -50.82 -42.42 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 108.97 179.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.41 -39.24 86.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.479 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -74.32 -28.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 108.976 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.57 -31.56 16.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 108.763 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 30' ' ' GLN . 56.5 mmtt -72.5 -39.63 67.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 0.0 109.008 179.412 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -64.99 1.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 28' ' ' LYS . 33.5 mt-30 -152.0 -70.43 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 108.975 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.44 51.18 1.6 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.3 m-90 -50.0 141.54 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.06 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.009 . . . . 0.0 109.117 179.784 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.3 p-10 -100.57 122.8 43.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.422 -0.799 . . . . 0.0 110.19 -179.313 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -90.71 123.2 34.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.347 -0.846 . . . . 0.0 109.343 179.31 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -93.21 116.2 28.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.888 -1.133 . . . . 0.0 109.24 179.712 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 21.9 ttm-85 -90.69 -68.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.57 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 37' ' ' ARG . . . 78.39 87.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.506 0.67 . . . . 0.0 109.304 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.79 -41.81 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 m -64.24 -33.23 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.274 -1.133 . . . . 0.0 109.373 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' C ' ' H ' ' A' ' 43' ' ' GLY . 71.7 tttt -132.88 -9.97 3.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.487 -0.758 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.67 -13.4 4.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 41' ' ' LYS . . . -83.4 25.61 4.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mttm 57.06 94.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -1.131 . . . . 0.0 109.451 -179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.71 122.37 31.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.68 121.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.251 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 56.5 mm-40 -100.65 174.21 6.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.264 -0.897 . . . . 0.0 109.307 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -135.72 130.72 34.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -76.23 116.75 17.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.99 -30.57 59.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 -179.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -70.44 -19.35 62.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.99 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.4 m -89.65 -19.86 24.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 88.5 mt -67.59 149.05 98.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.103 -0.998 . . . . 0.0 108.859 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.69 -160.34 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.769 0.98 . . . . 0.0 109.661 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -92.03 -38.71 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.39 -39.33 83.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.724 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.86 -38.75 27.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.23 -59.73 4.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 109.373 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.43 -44.53 65.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.14 73.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.93 -58.91 5.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.136 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.47 -24.85 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.375 -179.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 tp -69.51 -53.41 19.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.775 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.674 HH12 ' NE2' ' A' ' 65' ' ' GLN . 3.4 ptm180 -74.83 8.63 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.674 ' NE2' HH12 ' A' ' 64' ' ' ARG . 6.0 mm-40 -92.52 123.39 35.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.994 . . . . 0.0 109.221 179.554 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.77 41.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.65 35.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -1.156 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 HD11 ' H ' ' A' ' 68' ' ' ILE . 1.9 mp -66.94 -65.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.411 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 55.58 82.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 0.0 109.549 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.3 m -163.57 -94.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.461 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.3 m -83.82 -37.88 21.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 109.408 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.57 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.2 mt -70.36 -36.14 73.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.55 -6.88 1.12 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.57 ' H ' ' C ' ' A' ' 72' ' ' LEU . 9.9 t80 68.79 71.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.954 . . . . 0.0 109.11 -179.916 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' GLU . 21.5 t80 63.3 24.44 14.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.709 . . . . 0.0 109.437 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 75' ' ' PHE . 30.9 mt-10 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.65 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -145.96 80.41 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -92.22 78.65 5.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -79.95 171.0 15.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.053 . . . . 0.0 108.657 179.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.05 153.08 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.79 -179.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.421 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 5.5 m -103.84 153.43 38.76 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.203 -179.749 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.95 -46.21 35.33 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.27 1.313 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -59.28 -23.92 62.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -84.87 -25.99 27.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 0.0 109.538 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' ASN . 62.9 mt -83.13 -21.29 33.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.892 . . . . 0.0 109.488 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.06 29.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.616 -0.677 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' LEU . 18.8 m-80 -148.03 -8.7 0.4 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.435 -1.416 . . . . 0.0 111.011 -179.411 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.7 mt -79.19 147.28 68.89 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.559 -1.338 . . . . 0.0 108.231 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -67.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.718 0 C-N-CA 121.087 1.191 . . . . 0.0 111.054 -179.182 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.91 -34.66 2.01 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.1 mt -95.37 150.06 37.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.197 -1.178 . . . . 0.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.34 179.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.875 1.05 . . . . 0.0 110.177 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.1 mmtt -96.56 -17.87 20.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.284 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -109.68 130.97 55.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.633 -0.667 . . . . 0.0 109.356 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -53.05 -29.31 29.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.16 -32.87 56.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.06 -36.0 29.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.96 -58.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.411 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.52 -46.05 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.052 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.61 -56.65 17.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 108.954 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -57.94 -15.09 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.449 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.1 -35.57 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.303 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 10.6 mptt -70.87 -28.71 64.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.129 179.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -64.2 -4.6 3.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.4 mp0 -149.22 -61.19 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.55 49.59 2.52 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.323 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -52.22 142.89 15.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.257 . . . . 0.0 109.385 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -57.03 96.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 108.961 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.9 p30 -99.45 123.81 44.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.369 -0.832 . . . . 0.0 109.944 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -89.13 116.66 27.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -95.03 164.53 12.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.955 . . . . 0.0 108.868 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.74 -42.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.627 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.39 74.76 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.072 -1.018 . . . . 0.0 109.435 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.29 -44.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 41' ' ' LYS . 10.5 m -62.74 -45.73 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.313 -1.11 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 1.5 tmtp? -89.4 -73.55 0.51 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 52.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.99 -69.23 0.1 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -173.99 95.7 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -1.161 . . . . 0.0 109.362 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.41 104.74 16.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 109.024 179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 16.8 tt -87.83 121.53 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 109.508 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 12.3 mm-40 -101.83 171.2 7.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.432 -0.792 . . . . 0.0 109.191 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -135.3 128.66 32.19 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.243 179.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -74.66 117.7 16.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.06 . . . . 0.0 109.169 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -26.73 60.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -68.57 -20.74 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.554 -179.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -91.24 -15.14 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.871 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.4 149.58 98.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 0.0 108.879 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.29 -157.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 120.954 1.103 . . . . 0.0 109.638 179.297 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.98 -37.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.72 -35.83 77.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 110.316 -179.389 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.91 -31.22 45.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -58.59 -68.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -45.7 17.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.397 -0.814 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.381 -0.824 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.7 -33.71 76.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.321 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.89 -47.99 82.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 108.91 179.668 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 2.4 mm? -65.72 -28.61 69.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.114 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.54 ' HE ' ' C ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -70.65 -44.76 66.46 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -41.54 117.84 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.782 . . . . 0.0 110.432 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 -13.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -158.3 86.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -1.028 . . . . 0.0 108.937 179.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 mt -69.76 -24.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.839 -179.668 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' A' ' 70' ' ' THR . 34.9 mt-10 -147.74 -43.12 0.17 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.089 -1.007 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 31.6 m -166.31 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -171.74 -165.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -162.12 -178.69 6.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 179.91 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.85 11.14 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 72' ' ' LEU . 46.7 m-85 54.81 65.57 1.47 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.494 -1.003 . . . . 0.0 108.916 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.59 17.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.961 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.696 ' H1 ' HD22 ' A' ' 51' ' ' ASN . 62.0 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.19 -92.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.973 . . . . 0.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.5 tp 48.29 71.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.43 162.08 21.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 108.508 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -134.63 150.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.378 -0.826 . . . . 0.0 109.58 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -98.34 153.01 38.22 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.434 -0.791 . . . . 0.0 109.488 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.68 -45.02 40.63 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.351 1.367 . . . . 0.0 110.582 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -58.19 -26.8 63.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.525 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 45.4 mt-10 -84.14 -24.93 30.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.696 -179.729 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 12' ' ' ASN . 81.8 mt -81.87 -23.5 36.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 108.997 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.96 28.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 111.021 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.5 m-80 -147.42 -7.06 0.46 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.481 -1.387 . . . . 0.0 110.881 -179.377 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' LEU . 22.3 mt -79.16 147.42 69.31 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.648 -1.283 . . . . 0.0 108.181 179.412 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.77 -68.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.019 1.146 . . . . 0.0 110.796 -179.441 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.8 -34.56 1.91 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.1 mt -95.23 150.6 37.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.202 -1.175 . . . . 0.0 108.976 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.95 -179.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.762 0.975 . . . . 0.0 109.853 179.485 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 19.9 mmmt -98.73 -16.03 19.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.064 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -105.28 132.38 51.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.682 . . . . 0.0 109.305 -179.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.88 -28.56 37.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.83 -54.19 47.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.913 . . . . 0.0 109.749 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.62 -35.85 63.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.21 -65.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -1.21 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mt -51.27 -41.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.149 -179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -61.67 -42.7 99.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.07 -22.81 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.24 -29.16 31.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.0 108.842 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.3 mptp? -71.43 -32.51 68.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 108.872 179.59 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -64.64 -4.87 4.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.294 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -150.26 -67.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.08 54.14 1.31 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.9 m-90 -52.07 137.99 26.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.117 -1.225 . . . . 0.0 109.018 179.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -47.19 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.713 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -103.11 115.74 31.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.358 -0.838 . . . . 0.0 109.472 179.918 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 35' ' ' ARG . 4.2 ptt-85 -88.54 139.97 29.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.33 133.1 44.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.144 -0.973 . . . . 0.0 108.436 179.218 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -144.98 101.4 3.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.245 -0.909 . . . . 0.0 109.018 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' CB ' ' H ' ' A' ' 44' ' ' LYS . . . -75.17 51.35 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.81 . . . . 0.0 109.753 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.21 -19.84 6.15 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.77 -8.66 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -166.57 -30.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.818 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.27 46.46 2.01 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.31 33.14 0.59 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.612 ' H ' ' CB ' ' A' ' 38' ' ' ALA . 9.4 mtmp? 51.54 89.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -1.141 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.2 143.7 26.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 179.75 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.402 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 13.7 mt -86.96 145.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.025 . . . . 0.0 109.683 -179.796 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 7.5 mp0 -132.28 171.63 13.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -136.36 128.96 30.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.193 -0.942 . . . . 0.0 109.796 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -76.09 114.34 14.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 108.984 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -26.36 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.465 -179.254 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.696 HD22 ' H1 ' ' A' ' 1' ' ' MET . 22.0 m-20 -70.28 -21.1 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.3 m -90.0 -18.62 25.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.54 149.17 98.47 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.014 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.3 Cg_endo -57.8 -156.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 120.939 1.093 . . . . 0.0 109.42 179.228 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -98.21 -37.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.1 -35.52 77.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.05 -39.01 30.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.059 -1.026 . . . . 0.0 109.698 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.73 -59.17 5.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.971 . . . . 0.0 109.449 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.81 -45.42 50.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.917 -1.114 . . . . 0.0 109.16 179.688 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.34 -33.11 74.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 108.99 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.56 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.152 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 mt -47.68 -23.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 109.299 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -57.76 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 0.0 109.471 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 10.2 ptm180 -74.62 6.55 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.19 -0.944 . . . . 0.0 110.45 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 11.5 mm100 -83.26 63.0 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.348 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.24 36.44 1.11 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 65' ' ' GLN . 15.7 mt-10 -73.56 -1.93 20.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -1.134 . . . . 0.0 109.605 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CD1' ' H ' ' A' ' 68' ' ' ILE . 1.9 mp -50.46 -17.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.9 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 67' ' ' GLU . 51.2 mt-10 -58.59 161.57 4.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 0.0 109.355 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.445 ' O ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -55.05 118.3 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 70' ' ' THR . 3.6 m -179.62 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 pp -72.86 150.64 42.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.719 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -154.82 -0.14 0.16 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.17 15.61 0.55 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.533 -0.98 . . . . 0.0 109.315 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 43.8 t80 55.06 14.1 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.528 -179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.2 m95 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 6' ' ' SER . 18.6 t -140.05 165.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -113.54 153.11 45.83 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -52.67 -46.77 31.14 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.303 1.335 . . . . 0.0 110.558 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -59.12 -25.92 64.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.931 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.46 -25.86 30.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.008 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 89.7 mt -82.47 -23.5 34.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 108.898 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.3 m120 -145.49 -9.52 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.578 -1.326 . . . . 0.0 110.666 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.2 mt -79.18 147.4 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.667 -1.271 . . . . 0.0 108.098 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.53 -64.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.059 1.173 . . . . 0.0 110.802 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.84 4.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -94.92 149.79 36.83 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.114 -1.227 . . . . 0.0 109.018 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.41 175.81 0.17 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 120.905 1.07 . . . . 0.0 109.921 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -97.04 7.87 45.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 p -133.71 130.08 37.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.46 -0.775 . . . . 0.0 109.413 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -52.84 -29.83 30.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.63 63.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -81.16 -35.46 23.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.75 -53.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -1.189 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.78 -45.18 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 109.121 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.2 -41.73 93.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 0.0 108.951 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.9 t -74.96 -25.82 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 109.114 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.86 -31.71 40.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -71.11 -29.4 65.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.234 -0.916 . . . . 0.0 109.016 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -64.86 -7.13 10.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 109.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -150.72 -64.34 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 108.843 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.1 59.47 1.05 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -57.37 145.41 32.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.081 -1.247 . . . . 0.0 108.824 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -47.63 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p30 -103.63 119.51 39.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.427 -0.796 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.271 -0.893 . . . . 0.0 109.156 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.4 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -135.72 128.39 30.86 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -75.7 116.07 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 108.898 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.33 59.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.614 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -69.4 -17.17 63.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.006 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.8 m -89.61 -20.27 23.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.0 109.782 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 54' ' ' PRO . 73.9 mt -67.92 149.27 98.28 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.121 -0.987 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -57.04 -157.89 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.845 1.03 . . . . 0.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 t -94.4 -36.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -58.08 -38.81 77.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.549 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.33 -36.4 29.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.36 -42.92 78.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.595 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.44 -58.06 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -23.31 67.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.749 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 45.0 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 6' ' ' SER . 58.7 t -139.39 167.99 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -106.21 153.88 40.04 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.43 -0.794 . . . . 0.0 109.602 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.82 -49.72 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.481 1.454 . . . . 0.0 110.801 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.11 -23.85 22.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.564 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.18 -23.32 30.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.986 -1.071 . . . . 0.0 109.402 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.7 mt -83.65 -20.58 33.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.63 36.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.7 -0.625 . . . . 0.0 111.506 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 m120 -148.22 -11.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.343 -1.473 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -78.73 147.91 71.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.646 -1.284 . . . . 0.0 108.182 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.46 -60.71 0.28 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 120.823 1.015 . . . . 0.0 110.415 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.98 -39.57 9.07 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.4 mt -93.39 149.84 37.98 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.216 -1.167 . . . . 0.0 109.041 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.35 177.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.848 1.032 . . . . 0.0 109.97 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -101.56 8.41 41.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.429 -0.794 . . . . 0.0 109.552 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -130.09 132.96 46.36 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.525 -0.734 . . . . 0.0 109.351 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -52.82 -31.34 38.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.596 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.7 51.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -33.75 85.38 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.2 -65.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.169 . . . . 0.0 109.229 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -48.98 -41.11 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -61.66 -48.94 78.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 108.876 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.81 -36.45 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 108.959 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.33 -30.35 7.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.647 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 30' ' ' GLN . 48.2 mtpt -73.77 -41.98 61.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.51 -0.744 . . . . 0.0 109.484 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -65.94 4.32 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.308 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 28' ' ' LYS . 72.3 mt-30 -150.15 -75.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 105.35 50.39 0.92 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -53.24 134.1 39.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.366 . . . . 0.0 108.463 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 105.01 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.96 -1.088 . . . . 0.0 109.513 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -104.17 124.36 48.97 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 110.282 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.47 135.38 40.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.53 112.31 12.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.123 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.87 19.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.307 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -72.11 -20.43 61.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.035 -1.041 . . . . 0.0 110.277 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.3 m -88.9 -16.65 31.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.081 -1.012 . . . . 0.0 110.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' PRO . 82.7 mt -67.73 148.13 98.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 108.962 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -56.69 -161.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.847 1.031 . . . . 0.0 109.686 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -91.2 -38.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.36 -41.15 84.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.47 -52.58 7.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.093 -1.004 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -46.69 -45.55 19.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.977 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -58.09 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.47 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.12 62.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.212 -0.93 . . . . 0.0 109.001 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 108.795 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 41.8 m95 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -125.29 -137.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.418 -0.801 . . . . 0.0 109.349 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -166.12 152.31 8.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 109.508 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.39 -52.02 8.02 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.312 1.341 . . . . 0.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -58.54 -25.56 62.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.69 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -84.95 -30.34 24.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.077 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 12' ' ' ASN . 28.6 mt -80.69 -25.27 38.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.039 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 30.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 t-20 -145.1 -10.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.582 -1.324 . . . . 0.0 110.562 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' LEU . 21.2 mt -78.65 147.21 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.0 107.911 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.49 -64.39 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 120.978 1.119 . . . . 0.0 110.926 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.2 -37.47 4.52 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.6 mt -95.39 150.29 37.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.157 -1.202 . . . . 0.0 109.272 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.31 173.21 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 120.908 1.072 . . . . 0.0 110.027 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.36 8.47 43.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.296 -0.878 . . . . 0.0 109.69 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.02 131.92 41.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.487 -0.758 . . . . 0.0 109.375 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -53.02 -30.56 36.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -47.69 67.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.243 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -67.96 -36.36 86.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.5 -63.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -1.209 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.5 -42.46 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.968 . . . . 0.0 109.1 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.12 -44.79 96.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.016 . . . . 0.0 109.015 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 22' ' ' GLY . 41.5 t -69.42 -26.34 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.91 -28.53 9.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.851 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.6 mptp? -72.92 -35.65 67.08 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.154 -0.966 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -65.37 -3.97 4.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -150.9 -68.96 0.18 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.89 54.55 1.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.88 143.75 12.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.942 -1.328 . . . . 0.0 109.006 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -50.01 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.001 . . . . 0.0 109.078 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.5 p30 -100.06 123.44 44.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.293 -0.88 . . . . 0.0 109.82 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.43 130.02 34.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.389 -0.819 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.12 117.5 17.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -58.93 -28.29 66.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -23.43 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -89.47 -10.63 45.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 54' ' ' PRO . 60.4 mt -66.52 153.64 92.73 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.094 -1.004 . . . . 0.0 108.527 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.5 Cg_exo -57.16 -147.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.206 -1.076 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.01 -37.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.933 -1.104 . . . . 0.0 109.457 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.83 -30.05 71.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 111.185 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 -41.42 37.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.669 -1.269 . . . . 0.0 110.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.28 -56.7 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.122 . . . . 0.0 109.454 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.2 -48.73 23.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.284 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.89 -33.1 74.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.294 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -124.85 -138.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.509 -0.744 . . . . 0.0 109.203 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -167.04 152.55 7.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.905 -1.122 . . . . 0.0 109.609 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.35 -53.12 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.482 1.455 . . . . 0.0 110.615 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -56.47 -25.47 51.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.86 -28.06 26.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' ASN . 50.0 mt -81.96 -23.91 35.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.193 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.96 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.692 -0.63 . . . . 0.0 111.093 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.6 m120 -145.41 -7.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.521 -1.362 . . . . 0.0 110.745 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 17.6 mt -79.46 148.28 69.81 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.601 -1.312 . . . . 0.0 107.942 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.1 -64.12 0.12 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.889 1.059 . . . . 0.0 110.702 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.08 -38.3 4.72 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.9 mt -93.79 150.3 38.45 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.234 -1.156 . . . . 0.0 109.035 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.0 -178.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.804 1.002 . . . . 0.0 109.779 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.75 -7.78 27.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -117.3 129.81 56.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.655 -0.653 . . . . 0.0 109.284 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -53.24 -28.94 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.11 65.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.87 -35.23 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' ALA . 35.6 t -65.16 -56.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -1.157 . . . . 0.0 109.298 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.75 -43.56 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.2 -44.38 97.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.982 -1.074 . . . . 0.0 108.798 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.21 -19.09 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 109.125 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.61 -33.25 74.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 108.84 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -70.16 -27.61 64.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.265 -0.897 . . . . 0.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -64.79 -4.25 4.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.039 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -150.11 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.73 59.45 1.26 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.8 m-90 -56.38 147.84 20.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.037 -1.272 . . . . 0.0 108.796 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -50.33 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.608 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p30 -101.24 121.97 42.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 179.708 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 29.5 mm-40 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -135.45 127.29 29.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -77.69 116.36 18.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.067 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.39 -23.62 39.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.23 -25.17 63.26 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.081 -1.012 . . . . 0.0 109.544 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.7 m -91.86 -13.56 31.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.46 149.1 98.53 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.854 -1.154 . . . . 0.0 109.146 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.48 -155.95 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 120.973 1.115 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.7 -36.95 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.86 -39.05 83.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.31 -20.58 47.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -75.2 -58.27 3.39 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.17 -0.956 . . . . 0.0 109.212 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.51 -44.06 55.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.102 . . . . 0.0 108.955 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.1 74.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.445 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.8 m95 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 6' ' ' SER . 59.3 t -132.41 160.53 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.314 -0.866 . . . . 0.0 109.705 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -104.53 152.92 39.46 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.49 -43.83 55.17 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.421 1.414 . . . . 0.0 110.665 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -27.26 63.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.11 -22.66 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 109.317 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.5 mt -82.74 -23.17 34.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.288 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.95 29.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.154 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 52.0 p-10 -148.3 -8.52 0.39 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.437 -1.414 . . . . 0.0 111.122 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 29.1 mt -78.41 147.42 72.07 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.492 -1.38 . . . . 0.0 108.05 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.22 -66.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.989 1.126 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.04 -34.79 2.14 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.7 mt -95.17 150.47 37.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.275 -1.132 . . . . 0.0 108.86 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.08 -173.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.867 1.044 . . . . 0.0 110.071 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 27.7 mmtp -100.71 -17.58 16.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -109.57 130.14 55.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.55 -0.719 . . . . 0.0 109.391 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.35 -29.35 23.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.55 73.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.63 81.44 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.55 -64.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -1.173 . . . . 0.0 109.335 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.07 -39.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.117 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.79 -40.19 91.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 108.602 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.3 -27.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.07 -28.53 17.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.23 -0.919 . . . . 0.0 108.723 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -71.69 -32.96 68.4 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 -1.15 1.83 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.457 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -150.95 -65.43 0.19 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.96 49.6 1.74 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -51.52 136.71 25.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.038 -1.272 . . . . 0.0 109.006 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.584 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.79 110.89 0.4 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.006 -1.059 . . . . 0.0 108.582 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 34' ' ' ASN . 10.1 p30 -105.09 122.13 45.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.424 -0.798 . . . . 0.0 109.624 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 109.151 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -136.3 135.3 38.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -76.99 118.91 20.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.929 -1.107 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.45 59.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.379 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -69.58 -21.61 63.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.581 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 61.6 m -91.94 -15.14 28.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.21 150.28 97.79 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 109.321 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.4 151.37 75.03 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.033 1.156 . . . . 0.0 109.621 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.1 -38.7 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.3 -37.73 78.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.861 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.03 -35.41 37.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -60.89 -62.48 1.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.49 42.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.297 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.31 74.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 108.886 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.6 m95 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.25 155.53 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 109.712 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -104.99 152.17 39.58 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.06 -46.88 30.77 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.377 1.385 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -58.37 -24.36 59.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.206 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 18.0 mm-40 -84.25 -27.65 27.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.968 -1.082 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 53.7 mt -83.0 -21.68 33.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 109.334 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.91 29.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.635 . . . . 0.0 111.133 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 21.7 p30 -148.48 -6.81 0.4 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.511 -1.368 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.5 mt -79.46 147.36 67.9 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.567 -1.333 . . . . 0.0 108.181 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.55 -67.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.056 1.171 . . . . 0.0 110.978 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.07 -36.14 2.62 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.8 mt -94.68 150.51 38.09 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.252 -1.146 . . . . 0.0 108.926 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.78 -176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.836 1.024 . . . . 0.0 110.055 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 11' ' ' ALA . 22.5 mtpt -101.34 -15.04 17.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.344 -0.848 . . . . 0.0 109.919 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 p -113.74 131.29 56.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.73 . . . . 0.0 109.408 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -52.88 -29.29 27.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 109.251 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.71 65.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.69 -35.57 28.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.1 -56.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -1.147 . . . . 0.0 109.198 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.12 -43.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -61.14 -44.82 96.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 108.986 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.61 -25.47 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.429 -0.794 . . . . 0.0 109.059 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.4 -31.06 32.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.206 -0.934 . . . . 0.0 108.956 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -71.57 -28.83 64.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 109.057 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -64.73 -4.85 4.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 109.445 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.41 -58.15 0.18 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 108.879 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.8 51.62 2.26 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.4 m-90 -51.02 137.35 21.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.123 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -49.94 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.084 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -99.94 121.02 40.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.433 -0.792 . . . . 0.0 109.887 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.858 . . . . 0.0 109.155 179.302 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 44.6 mm-40 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.23 129.96 34.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.228 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -75.34 117.32 17.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.93 -1.106 . . . . 0.0 109.489 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.33 59.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 110.437 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -69.51 -17.83 63.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -1.0 . . . . 0.0 109.576 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m -90.66 -22.33 21.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -67.11 148.39 98.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 109.031 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.4 Cg_endo -56.41 -161.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.851 1.034 . . . . 0.0 109.654 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.9 t -93.6 -33.82 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 109.375 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp0 -59.32 -39.31 82.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 109.515 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -82.19 -34.53 28.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.874 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -58.94 -39.66 82.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 -52.57 20.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.121 -0.987 . . . . 0.0 108.96 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.13 -19.48 65.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.415 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' ALA . 19.5 tp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 108.956 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.8 m95 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.1 164.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 0.0 109.416 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -113.86 152.58 45.75 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.13 -47.94 24.81 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 121.229 1.286 . . . . 0.0 110.251 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -60.74 -24.5 65.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.985 . . . . 0.0 110.108 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -84.35 -27.15 27.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.088 -1.008 . . . . 0.0 109.488 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -82.41 -22.49 35.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 35.4 m120 -145.68 -9.37 0.55 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.577 -1.327 . . . . 0.0 110.805 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.22 147.66 69.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.638 -1.289 . . . . 0.0 108.039 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.29 -65.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 120.994 1.13 . . . . 0.0 110.838 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.57 -36.82 3.47 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.4 mt -94.69 150.27 37.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.213 -1.169 . . . . 0.0 108.939 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.01 175.31 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.953 1.102 . . . . 0.0 109.99 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -97.89 5.71 48.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 p -130.66 130.15 43.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.455 -0.778 . . . . 0.0 109.278 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 p -52.16 -30.99 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.433 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.57 70.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.33 -35.23 81.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 27' ' ' ALA . 61.4 t -65.32 -59.88 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.25 -43.26 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 108.933 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.49 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.978 -1.076 . . . . 0.0 108.82 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.17 -18.24 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.67 -33.28 73.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.949 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 30' ' ' GLN . 6.0 mtpm? -70.55 -29.11 65.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 108.677 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -65.1 -1.57 2.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.444 -0.785 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 28' ' ' LYS . 59.8 mt-30 -150.39 -63.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.19 55.27 1.29 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -54.87 137.65 44.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.026 -1.279 . . . . 0.0 108.962 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -49.59 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.376 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 4.3 p30 -99.65 121.36 41.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.296 -0.878 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.177 -0.952 . . . . 0.0 109.167 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 49.8 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.88 128.56 32.85 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.507 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -75.68 114.17 13.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.899 -1.126 . . . . 0.0 109.092 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' N ' HD21 ' A' ' 49' ' ' ASN . . . -54.32 -27.05 33.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 110.796 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 52' ' ' SER . 54.5 p30 -69.03 -17.53 63.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.895 -1.128 . . . . 0.0 110.052 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 13.5 m -90.58 -18.5 25.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.138 -0.976 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 92.1 mt -68.25 149.18 98.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.37 -156.38 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 120.918 1.079 . . . . 0.0 109.629 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.34 -36.47 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -59.35 -36.68 76.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.098 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.39 -34.41 41.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 109.572 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -55.79 -48.28 75.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.28 -57.29 11.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.64 -23.06 67.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.035 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.297 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.3 m95 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.26 152.99 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -97.68 154.72 37.79 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.83 . . . . 0.0 109.579 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.51 -51.5 10.98 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.611 1.541 . . . . 0.0 112.138 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -57.81 -17.25 14.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.81 -1.181 . . . . 0.0 110.705 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 26.1 mp0 -87.14 -28.12 22.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.679 -1.263 . . . . 0.0 108.884 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 48.7 mt -81.73 -22.35 37.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.855 . . . . 0.0 109.204 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 29.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.706 -0.621 . . . . 0.0 111.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.9 t-20 -146.7 -8.82 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.475 -1.39 . . . . 0.0 110.855 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.7 mt -78.94 147.82 70.94 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.551 -1.343 . . . . 0.0 108.006 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.67 -66.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 120.948 1.099 . . . . 0.0 110.923 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.81 -36.79 3.76 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.72 150.2 37.59 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.262 -1.14 . . . . 0.0 109.11 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.09 170.55 0.67 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 120.874 1.049 . . . . 0.0 110.063 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -94.17 2.89 55.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.868 . . . . 0.0 109.642 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -129.15 129.27 44.91 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.469 -0.769 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 p -52.21 -30.46 27.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.12 -35.72 59.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.234 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.46 -35.8 25.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.84 -58.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -1.134 . . . . 0.0 109.439 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 20.8 mt -55.15 -47.07 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.187 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -61.26 -50.82 71.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.339 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 58.6 t -65.91 -22.32 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.44 -0.787 . . . . 0.0 109.394 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.27 -30.69 18.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.102 -0.999 . . . . 0.0 109.054 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.1 mptt -71.17 -30.07 65.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.136 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -63.94 -4.14 3.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -149.96 -61.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 108.972 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.78 48.98 2.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.03 138.63 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -1.23 . . . . 0.0 109.334 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -49.93 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.854 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.8 p-10 -98.77 125.28 44.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.9 mp0 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.25 131.7 36.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.325 -0.859 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.07 114.31 13.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 109.104 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.14 57.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 110.227 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -68.33 -18.13 64.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.997 . . . . 0.0 109.834 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -89.77 -19.33 24.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 98.4 mt -67.11 149.62 98.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 108.941 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.9 Cg_endo -56.06 -162.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.71 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.36 -37.29 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.198 -0.939 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -60.15 -37.13 79.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.281 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.99 -30.09 49.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.063 . . . . 0.0 109.644 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -59.86 -54.51 45.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 109.117 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.87 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.028 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.07 -30.03 69.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.926 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.612 ' C ' HD13 ' A' ' 61' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 109.213 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 35' ' ' ARG . 47.5 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.97 -137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -169.33 151.33 4.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.372 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.06 -49.15 16.32 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.352 1.368 . . . . 0.0 110.677 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -59.4 -27.81 66.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.224 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.23 -26.57 28.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 25.5 mt -82.91 -18.77 38.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.38 32.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 0.0 110.971 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.3 t-20 -146.15 -9.02 0.52 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.476 -1.39 . . . . 0.0 110.921 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.1 mt -78.56 147.55 71.76 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.358 . . . . 0.0 108.154 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.02 -65.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.996 1.13 . . . . 0.0 110.578 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.27 -37.06 4.44 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.3 mt -93.76 149.97 37.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.221 -1.164 . . . . 0.0 108.952 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.52 177.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 120.753 0.969 . . . . 0.0 109.779 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -99.08 -2.32 37.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -123.76 131.4 53.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.375 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -52.66 -30.32 31.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.17 53.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.69 -35.6 18.88 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.02 -45.85 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.71 -47.21 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.91 -41.82 96.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HE22 ' A' ' 30' ' ' GLN . 62.1 t -75.05 -29.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.262 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.52 -29.27 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 108.748 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -71.9 -33.44 68.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.444 -0.785 . . . . 0.0 109.05 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 29' ' ' LYS . 15.1 mtpp -64.79 -1.74 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.57 HE22 HG12 ' A' ' 26' ' ' VAL . 2.2 mp0 -149.32 -68.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.358 -0.839 . . . . 0.0 108.765 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.0 55.88 1.35 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -51.3 152.08 2.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.253 . . . . 0.0 109.198 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -52.8 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.645 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -101.58 112.47 25.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.506 ' CB ' HH11 ' A' ' 35' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.037 -1.039 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.849 0.833 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -134.01 133.03 40.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.435 -0.791 . . . . 0.0 108.941 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -76.57 116.66 17.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 109.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 -27.51 55.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.365 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -70.9 -23.12 62.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.4 m -89.83 -12.87 37.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -0.965 . . . . 0.0 110.087 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.8 150.46 97.62 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.323 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 169.12 5.14 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.988 1.126 . . . . 0.0 109.424 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.23 -37.89 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.024 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.78 -39.15 80.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.11 -39.8 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.976 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.88 -57.86 11.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.607 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.87 58.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.083 -1.011 . . . . 0.0 109.33 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.26 -28.67 68.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.386 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.7 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 6' ' ' SER . 57.8 t -135.25 158.26 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -100.63 153.36 37.78 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.494 -0.754 . . . . 0.0 109.231 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.32 -40.04 87.75 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.114 1.209 . . . . 0.0 110.183 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -58.54 -27.24 64.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.63 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -83.57 -24.9 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 12' ' ' ASN . 91.5 mt -83.48 -23.93 31.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.99 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.625 -0.672 . . . . 0.0 111.21 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -149.42 -8.1 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.415 -1.428 . . . . 0.0 111.035 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.4 mt -78.75 147.89 71.72 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.618 -1.301 . . . . 0.0 108.118 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.97 -67.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.11 1.207 . . . . 0.0 110.989 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.16 2.19 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.35 150.36 37.47 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.29 -1.123 . . . . 0.0 108.882 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.44 -174.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 120.806 1.004 . . . . 0.0 110.021 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ALA . 65.2 mmtt -101.08 -16.56 17.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.324 -0.86 . . . . 0.0 109.558 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -110.65 131.2 55.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.478 -0.763 . . . . 0.0 109.478 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.88 -29.56 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.48 -39.62 70.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.43 56.37 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.59 -62.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mt -49.94 -40.62 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 108.673 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.36 -42.2 98.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.124 -0.985 . . . . 0.0 108.678 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -76.66 -20.45 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.499 -0.751 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.2 -39.59 60.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.08 -1.013 . . . . 0.0 110.188 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLN . 4.8 ptmt -70.91 -23.14 62.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 109.262 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.99 -4.49 2.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 108.731 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.27 -58.99 0.19 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.79 48.01 2.01 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -54.99 133.89 48.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.832 -1.393 . . . . 0.0 108.633 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.601 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.41 108.83 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.98 -1.075 . . . . 0.0 108.761 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.31 121.81 44.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.416 -0.802 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 35' ' ' ARG . 20.2 ttm-85 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 109.447 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 68.4 mm-40 . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -136.3 134.24 37.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.414 -0.804 . . . . 0.0 109.31 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -75.87 114.18 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.138 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.54 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.305 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -69.82 -20.77 63.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.915 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 27.8 m -90.58 -10.43 43.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.112 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 54' ' ' PRO . 76.1 mt -68.45 150.3 97.74 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.034 -1.041 . . . . 0.0 109.305 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -59.0 -155.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 120.968 1.112 . . . . 0.0 109.459 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.07 -36.62 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.48 -37.12 80.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.93 -25.49 40.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.363 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -62.02 -66.83 0.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.11 33.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.519 -0.738 . . . . 0.0 109.425 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.45 80.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.23 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--N 1.303 -1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 108.695 179.586 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 m95 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.64 145.65 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.112 -0.993 . . . . 0.0 109.874 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -95.46 153.28 39.58 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.348 -0.845 . . . . 0.0 109.321 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.49 -42.48 65.31 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.233 1.288 . . . . 0.0 110.458 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -59.22 -24.41 63.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 12.5 mm-40 -84.24 -24.39 30.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -83.2 -24.35 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.99 29.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 111.345 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -147.32 -9.23 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.467 -1.396 . . . . 0.0 110.919 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' LEU . 40.1 mt -79.13 147.13 68.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.533 -1.354 . . . . 0.0 108.061 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -65.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.097 1.198 . . . . 0.0 110.739 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.63 -35.63 3.09 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.28 150.01 37.0 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.23 -1.159 . . . . 0.0 109.009 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.41 175.31 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 120.803 1.002 . . . . 0.0 109.787 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -97.16 6.59 48.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 109.749 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -133.6 130.74 38.78 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.521 -0.737 . . . . 0.0 109.205 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 p -52.57 -31.26 35.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.383 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.47 56.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.81 -38.39 20.05 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.14 -63.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.264 -1.139 . . . . 0.0 109.444 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.8 mt -47.87 -41.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.069 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.7 -48.35 81.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.184 -0.948 . . . . 0.0 108.703 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' HZ1' ' A' ' 29' ' ' LYS . 45.9 t -61.57 -28.65 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.74 -31.02 10.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.15 -0.969 . . . . 0.0 108.927 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.5 mptt -72.7 -38.46 67.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 108.687 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' A' ' 29' ' ' LYS . 4.9 ttpm? -65.36 -3.6 4.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -150.32 -70.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 108.894 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.68 54.41 1.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.91 145.24 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.09 -1.241 . . . . 0.0 109.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -52.64 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.997 . . . . 0.0 109.056 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.8 p-10 -97.63 118.25 33.73 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.24 179.632 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -133.58 132.43 40.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.384 -0.823 . . . . 0.0 109.534 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 51' ' ' ASN . 51.7 t-20 -76.12 117.23 17.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.179 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.28 65.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.325 -0.86 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 49' ' ' ASN . 43.1 p30 -67.44 -16.43 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 74.0 m -90.0 -16.53 29.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.1 mt -67.96 149.67 98.1 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.115 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.65 -156.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.903 1.069 . . . . 0.0 109.5 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.67 -36.76 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 109.78 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -60.24 -36.81 78.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.95 43.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 109.8 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -65.34 -65.68 0.64 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 108.744 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.56 19.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.517 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.37 80.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 108.795 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.6 m95 . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 61' ' ' LEU . 12.2 t -140.59 155.52 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.182 -0.949 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -101.27 153.04 38.04 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 121.446 -0.784 . . . . 0.0 109.289 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.19 -43.39 59.45 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 121.371 1.38 . . . . 0.0 110.555 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -58.37 -27.24 64.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 0.0 109.78 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 35.2 mm-40 -84.78 -24.74 28.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.17 -0.956 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.1 mt -83.53 -21.36 32.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.106 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -146.42 -4.18 0.61 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.501 -1.375 . . . . 0.0 110.642 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 12.0 mt -79.69 147.86 68.02 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.588 -1.32 . . . . 0.0 108.004 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.22 -64.52 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 120.882 1.054 . . . . 0.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.28 -35.94 7.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 30.0 mt -93.62 150.06 38.18 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.122 -1.222 . . . . 0.0 109.141 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.35 -175.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 120.876 1.051 . . . . 0.0 109.924 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -104.89 5.83 33.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.525 -0.734 . . . . 0.0 109.757 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 p -132.93 133.12 42.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -53.36 -30.62 40.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.57 62.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.82 -35.74 18.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.25 -49.72 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -65.09 -44.79 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -60.75 -41.96 96.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 108.92 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.82 -27.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.43 -0.794 . . . . 0.0 109.024 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.86 -29.31 19.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.6 -29.93 65.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.37 -0.831 . . . . 0.0 108.897 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.35 -4.13 3.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.48 -61.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.368 -0.833 . . . . 0.0 108.88 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.37 54.48 1.57 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.44 141.2 37.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.075 -1.25 . . . . 0.0 108.844 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -47.93 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.232 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.9 p30 -101.45 116.76 33.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.466 -0.772 . . . . 0.0 110.106 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 109.058 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -135.16 134.87 40.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.834 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 17.6 t-20 -76.27 115.81 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 109.298 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.58 -34.16 64.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.374 -0.828 . . . . 0.0 110.61 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -69.98 -17.03 63.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.6 m -90.03 -15.46 31.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 109.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' PRO . 96.1 mt -67.96 148.96 98.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.0 Cg_exo -54.94 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.967 1.111 . . . . 0.0 109.833 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.5 -38.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -0.931 . . . . 0.0 109.928 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -58.17 -40.3 81.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.628 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.24 -38.54 42.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.124 -0.985 . . . . 0.0 109.228 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -49.03 -60.7 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.725 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.26 63.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.599 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -23.41 67.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 109.586 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.407 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.9 m95 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 61' ' ' LEU . 57.5 t -130.62 163.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.0 109.644 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.6 m -108.2 153.11 42.06 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.486 -0.759 . . . . 0.0 109.05 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.15 -44.55 48.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.239 1.293 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -57.68 -25.65 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.43 -24.18 29.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.128 -0.983 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.8 mt -82.96 -22.93 33.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.09 29.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.64 -0.663 . . . . 0.0 111.232 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 10.0 t-20 -146.57 -7.47 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.513 -1.367 . . . . 0.0 110.892 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.4 mt -79.4 147.45 68.35 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 0.0 108.195 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.11 -63.97 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.962 1.108 . . . . 0.0 110.606 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.48 -38.22 5.2 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 26.2 mt -94.01 149.87 37.58 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.137 -1.214 . . . . 0.0 109.175 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.14 -178.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.875 1.05 . . . . 0.0 109.732 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -101.17 7.38 43.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -133.19 130.17 38.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.408 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -52.5 -30.64 31.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.354 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.75 -37.0 62.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.28 19.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.84 -58.78 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.275 -1.132 . . . . 0.0 109.171 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -52.4 -43.06 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -60.69 -41.76 95.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 108.933 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.96 -22.87 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.079 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.3 -29.81 66.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.192 -0.942 . . . . 0.0 108.497 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' GLN . 77.5 mttt -71.98 -32.79 67.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 109.065 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -65.03 2.92 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 108.888 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.1 mt-30 -150.85 -64.88 0.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.58 47.21 2.18 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -50.8 135.73 23.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.305 . . . . 0.0 108.961 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.609 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.27 112.21 0.55 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.008 -1.057 . . . . 0.0 108.617 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -107.51 119.55 39.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.502 -0.748 . . . . 0.0 109.832 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 20.7 ttm-85 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.169 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.5 mp0 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -136.4 134.61 37.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 0.0 109.237 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -76.89 119.85 21.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.904 -1.123 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.03 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.71 -19.13 64.35 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.012 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 44.4 m -92.0 -16.33 26.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 110.15 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.76 149.41 98.27 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 120.936 -1.103 . . . . 0.0 108.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.64 -166.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 120.864 1.043 . . . . 0.0 109.538 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.0 -35.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 109.263 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 4.4 mp0 -59.86 -39.47 85.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.407 -0.808 . . . . 0.0 109.515 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.6 14.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.625 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -50.34 -52.35 37.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.27 -51.96 64.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.48 67.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.453 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 108.793 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.71 -136.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.271 -0.893 . . . . 0.0 109.618 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.512 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -167.41 152.8 7.08 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.652 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.4 -51.89 8.97 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.596 1.531 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.13 -22.8 42.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -0.999 . . . . 0.0 110.067 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -85.9 -25.97 25.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.034 -1.041 . . . . 0.0 109.251 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' ASN . 77.6 mt -82.6 -23.04 34.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LYS . . . -64.1 32.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.766 -0.584 . . . . 0.0 111.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.4 t-20 -147.67 -10.97 0.4 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.43 -1.419 . . . . 0.0 111.142 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' LEU . 26.5 mt -78.89 147.35 70.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.574 -1.329 . . . . 0.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.75 -61.68 0.24 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.012 1.141 . . . . 0.0 110.758 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.09 -38.73 4.91 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' LEU . 12.1 mt -94.94 151.05 38.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.275 -1.132 . . . . 0.0 108.755 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.41 -174.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 120.747 0.965 . . . . 0.0 110.081 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 28.8 mmtp -99.14 -15.67 18.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -111.09 132.31 54.37 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.599 -0.688 . . . . 0.0 109.451 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -53.23 -28.88 29.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -49.12 69.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.18 -34.18 89.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.38 -61.38 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -1.168 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.02 -43.01 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -60.19 -41.43 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.924 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.05 -25.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.46 -0.775 . . . . 0.0 108.991 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -54.32 -25.26 22.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.112 -0.993 . . . . 0.0 108.434 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -72.85 -32.76 65.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -65.19 -9.57 24.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.488 -0.757 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -150.07 -64.4 0.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.28 -0.887 . . . . 0.0 108.904 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.01 62.04 1.19 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -54.71 148.33 12.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -1.211 . . . . 0.0 109.02 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.01 98.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.2 p30 -108.4 117.75 34.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.542 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.59 123.89 21.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.304 -0.872 . . . . 0.0 109.901 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.06 114.73 12.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 108.532 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.22 22.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.805 . . . . 0.0 111.315 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 52' ' ' SER . 41.0 p-10 -71.07 -21.87 62.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.684 -1.26 . . . . 0.0 110.52 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.481 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 36.9 m -93.71 -8.27 41.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.905 -1.122 . . . . 0.0 110.552 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -68.97 149.51 97.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 0.0 109.724 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.26 140.77 84.94 Favored 'Trans proline' 0 C--O 1.21 -0.903 0 C-N-CA 121.173 1.249 . . . . 0.0 109.324 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' VAL . 17.5 t -42.27 -41.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.432 -0.793 . . . . 0.0 111.02 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -55.81 -48.03 76.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.005 -1.06 . . . . 0.0 109.991 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.86 -43.09 25.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -46.02 -58.01 3.95 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.358 0.599 . . . . 0.0 109.415 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.01 61.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.9 64.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.116 -0.99 . . . . 0.0 109.182 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 6' ' ' SER . 99.8 t -131.77 162.84 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -103.78 153.44 38.73 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.2 -46.64 32.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 121.377 1.385 . . . . 0.0 110.924 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -59.56 -21.8 60.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.111 -0.993 . . . . 0.0 110.656 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -85.14 -25.73 27.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.6 mt -82.94 -22.66 33.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.637 -0.664 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 10' ' ' LEU . 41.6 m-80 -147.03 -10.8 0.44 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.621 -1.299 . . . . 0.0 110.936 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 16' ' ' LEU . 31.6 mt -78.27 146.89 71.6 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.531 -1.356 . . . . 0.0 108.103 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -64.86 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.028 1.152 . . . . 0.0 110.937 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.12 -36.86 2.93 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.9 mt -96.02 150.46 37.3 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.249 -1.148 . . . . 0.0 108.972 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.34 176.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.864 1.043 . . . . 0.0 110.014 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -95.19 -13.09 25.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 109.61 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -106.15 130.83 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.662 . . . . 0.0 109.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -53.0 -29.3 28.46 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.89 -55.62 32.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.792 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -53.01 -36.66 52.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.89 -65.61 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.077 -1.249 . . . . 0.0 109.64 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 11.0 mt -48.83 -42.31 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.211 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.75 -49.15 77.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.849 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 22' ' ' GLY . 49.5 t -65.34 -22.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.49 -34.37 24.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 109.405 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -28.1 64.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 108.648 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -64.35 -5.27 4.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.247 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -151.25 -60.74 0.18 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.331 -0.856 . . . . 0.0 108.809 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.4 47.15 2.22 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -52.16 135.51 31.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.935 -1.333 . . . . 0.0 109.03 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.607 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -49.14 110.43 0.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.075 -1.016 . . . . 0.0 108.748 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 124.33 49.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.837 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -136.1 133.72 37.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -76.54 117.58 18.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.961 -1.087 . . . . 0.0 108.991 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.93 61.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -21.3 62.93 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 34.4 m -90.98 -13.72 32.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.022 -1.049 . . . . 0.0 110.191 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.0 mt -67.39 149.07 98.58 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 108.986 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.3 Cg_exo -55.04 -165.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.982 1.121 . . . . 0.0 109.724 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.12 -37.61 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.35 -37.47 80.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.259 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.76 -31.62 40.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.703 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -60.93 -67.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.016 -1.052 . . . . 0.0 108.911 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.54 -42.81 16.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 109.568 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.41 84.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 179.808 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.2 m95 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 6' ' ' SER . 48.0 t -139.05 162.42 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -110.56 152.64 43.52 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.52 -0.737 . . . . 0.0 109.049 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.62 -43.58 54.19 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.282 1.321 . . . . 0.0 110.606 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -59.65 -25.27 64.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 109.896 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -85.03 -24.68 28.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.5 mt -81.15 -24.6 37.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 109.003 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.669 -0.645 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 14.2 m120 -146.18 -6.8 0.56 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.566 -1.333 . . . . 0.0 110.835 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -79.48 147.74 68.62 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.599 -1.313 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 120.908 1.072 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.46 -35.69 4.08 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 25.7 mt -93.9 149.28 36.73 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.135 -1.215 . . . . 0.0 109.117 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.64 178.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.882 1.055 . . . . 0.0 109.818 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -98.28 6.43 47.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.01 129.77 40.54 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.405 -0.81 . . . . 0.0 109.332 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -52.39 -30.58 29.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.419 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.44 66.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -72.94 -36.73 57.14 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.58 -64.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 109.394 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -49.78 -40.94 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.93 . . . . 0.0 109.095 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.93 -40.03 91.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 108.888 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.8 t -74.21 -27.82 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.92 -28.73 10.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 108.718 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.3 mptt -72.43 -39.78 67.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -65.48 -0.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.393 -0.817 . . . . 0.0 109.711 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -151.82 -69.98 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 109.055 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.31 53.95 1.53 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.2 m-90 -51.02 147.71 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.227 . . . . 0.0 109.283 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -49.47 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 108.908 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 32' ' ' TRP . 10.9 p30 -103.0 118.27 36.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.928 . . . . 0.0 109.891 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.17 126.9 29.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.452 -0.78 . . . . 0.0 109.47 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -75.33 113.97 13.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 0.0 109.033 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.8 -25.99 21.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.205 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -70.38 -22.97 62.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 0.0 109.792 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 m -90.45 -17.35 27.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.104 -0.998 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.18 148.71 98.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.955 -1.091 . . . . 0.0 109.014 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.58 -160.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.919 1.079 . . . . 0.0 109.693 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.74 -36.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.12 -39.09 81.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.308 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.03 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.7 -57.14 13.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.375 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.58 76.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.44 70.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 109.849 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.3 m95 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.97 152.29 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 0.0 109.628 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.47 153.49 37.75 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.843 . . . . 0.0 109.543 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.92 -44.24 50.15 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.307 1.338 . . . . 0.0 110.497 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -58.73 -25.08 62.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -84.63 -24.98 28.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.018 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.5 mt -80.97 -23.57 38.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.191 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.648 -0.658 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' LEU . 34.4 m120 -146.27 -9.1 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.544 -1.348 . . . . 0.0 110.827 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.8 mt -79.01 147.01 69.19 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.6 -1.312 . . . . 0.0 108.159 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.24 -64.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.019 1.146 . . . . 0.0 110.751 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.9 4.04 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.8 mt -94.46 149.95 37.4 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.163 -1.198 . . . . 0.0 109.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.22 176.27 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.837 1.025 . . . . 0.0 109.837 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -97.64 7.28 46.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.18 129.99 38.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.406 -0.809 . . . . 0.0 109.29 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -52.51 -30.56 30.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.33 -39.85 64.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.21 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.95 -36.71 40.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.0 t -66.22 -61.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -1.135 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -51.37 -44.14 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 108.952 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.23 -45.0 96.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 108.925 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.15 -16.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.37 -31.1 71.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 108.747 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -71.04 -28.42 64.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.28 -0.888 . . . . 0.0 108.822 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -64.89 -3.07 3.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.177 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -150.2 -61.44 0.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 108.825 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.32 53.11 1.91 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -50.76 138.05 19.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.291 . . . . 0.0 109.148 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -48.64 99.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 5.5 p30 -99.82 123.14 43.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.898 . . . . 0.0 109.653 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 38.7 ttm180 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.887 . . . . 0.0 109.226 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 10.7 mp0 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.11 133.56 37.41 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.339 -0.851 . . . . 0.0 109.439 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -76.6 117.9 18.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.018 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.31 61.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -69.94 -17.62 63.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.541 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.9 m -89.62 -21.31 22.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.59 148.41 98.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 108.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.83 -162.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 120.831 1.021 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.64 -38.36 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.21 -39.96 84.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.54 -48.35 11.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.39 -54.06 45.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.403 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.55 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.082 -1.011 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -29.02 69.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.23 -0.919 . . . . 0.0 109.248 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.7 m95 . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.01 148.13 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.171 -0.956 . . . . 0.0 110.058 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.39 153.85 37.58 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.409 -0.807 . . . . 0.0 109.241 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.81 -41.33 75.41 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.219 1.28 . . . . 0.0 110.233 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -59.53 -27.02 65.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.35 -24.78 29.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.19 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.9 mt -82.33 -25.32 34.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.865 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 30.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.6 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.1 m120 -146.54 -6.44 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.575 -1.328 . . . . 0.0 110.8 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -79.41 148.47 70.36 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.609 -1.307 . . . . 0.0 108.16 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.75 -61.06 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 120.818 1.012 . . . . 0.0 110.239 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.42 -39.25 9.87 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LEU . 36.6 mt -93.0 149.56 37.77 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.129 -1.218 . . . . 0.0 108.987 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -53.85 -177.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.782 0.988 . . . . 0.0 109.677 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -100.93 -3.34 29.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -119.54 129.46 54.69 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.653 -0.654 . . . . 0.0 109.338 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -52.81 -29.24 26.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.68 71.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.27 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -35.74 75.83 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.37 -64.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -50.43 -41.27 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.939 . . . . 0.0 109.054 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.17 -43.41 95.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.018 . . . . 0.0 108.538 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.39 -21.38 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.763 . . . . 0.0 109.008 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.93 -31.95 73.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 108.595 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.9 mttm -71.45 -31.89 67.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 108.685 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -65.67 -0.29 2.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.468 -0.77 . . . . 0.0 109.153 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 28' ' ' LYS . 72.7 mt-30 -149.8 -65.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 108.78 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.31 56.57 1.19 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -53.95 142.89 23.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.943 -1.327 . . . . 0.0 108.704 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -47.21 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.5 p30 -100.31 121.25 41.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.37 -0.831 . . . . 0.0 109.592 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 59.9 ttt180 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 108.846 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.9 mp0 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -136.09 134.67 38.63 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.18 116.24 17.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.045 -1.034 . . . . 0.0 108.883 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -53.78 -35.52 61.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.5 -18.77 65.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.994 -1.066 . . . . 0.0 109.637 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.46 -14.1 36.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -68.8 150.59 97.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.239 -0.913 . . . . 0.0 109.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.25 -156.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 120.933 1.089 . . . . 0.0 109.652 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -96.88 -36.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.62 -36.45 78.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.76 47.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.034 -1.041 . . . . 0.0 109.549 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mmtm -57.87 -60.71 3.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 109.019 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.57 -50.88 64.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.389 -0.82 . . . . 0.0 109.926 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.46 69.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 110.042 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.005 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.4 m95 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 17.7 t -139.28 165.48 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -114.14 152.37 45.8 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.76 -43.33 56.7 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.242 1.295 . . . . 0.0 110.471 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -59.56 -26.8 65.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.885 -179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -84.35 -25.68 28.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.051 -1.031 . . . . 0.0 109.449 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 79.8 mt -82.39 -23.47 34.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.187 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.81 28.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.71 -0.619 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 15.3 t-20 -147.39 -8.66 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.471 -1.393 . . . . 0.0 111.048 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.2 mt -78.7 147.51 71.19 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.538 -1.351 . . . . 0.0 108.329 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 -67.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.967 1.111 . . . . 0.0 111.0 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.36 -35.3 1.83 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.6 mt -95.35 150.62 37.83 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.186 -1.185 . . . . 0.0 108.865 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.53 -178.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 120.778 0.986 . . . . 0.0 109.996 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ALA . 4.4 mmmm -97.63 -17.46 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.241 -0.912 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -106.37 131.72 53.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.713 . . . . 0.0 109.413 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -53.27 -28.6 28.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.324 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.3 33.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.56 -35.33 66.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.63 -64.88 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.174 . . . . 0.0 109.398 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.5 mt -52.17 -41.61 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.09 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -60.17 -42.04 94.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.767 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.15 -24.34 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.076 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -56.26 -29.23 60.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.138 -0.976 . . . . 0.0 108.662 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -71.66 -34.98 70.17 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -6.23 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.9 mt-30 -145.84 -70.49 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.378 -0.827 . . . . 0.0 108.87 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.47 55.11 1.11 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.0 m-90 -52.64 142.23 18.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.02 -1.282 . . . . 0.0 108.896 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -47.31 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.507 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.9 p30 -100.5 121.15 41.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.366 -0.834 . . . . 0.0 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.159 -0.963 . . . . 0.0 109.158 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.6 mm-40 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -135.35 128.82 32.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -75.73 117.15 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.024 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.78 -30.63 57.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.068 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -70.2 -19.93 63.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.91 -21.15 22.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.813 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.83 148.21 98.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.082 -1.011 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.36 -166.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.86 1.04 . . . . 0.0 109.78 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.4 -34.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 4.1 mp0 -58.77 -39.67 81.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.324 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.34 -40.26 21.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -57.59 -38.5 75.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.513 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.35 -56.89 6.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.01 -19.59 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.089 179.657 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.7 m95 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.96 153.74 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.347 -0.846 . . . . 0.0 109.904 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -102.46 152.69 38.39 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.743 . . . . 0.0 109.012 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.75 -45.24 41.9 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.164 1.243 . . . . 0.0 110.622 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -60.19 -25.86 65.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -84.24 -24.96 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.089 -1.007 . . . . 0.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -82.66 -19.1 38.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.168 -0.957 . . . . 0.0 109.227 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 32.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.642 -0.661 . . . . 0.0 111.038 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' LEU . 45.8 t30 -145.9 -9.26 0.53 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.567 -1.333 . . . . 0.0 110.897 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.6 mt -78.68 147.32 70.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.569 -1.332 . . . . 0.0 108.127 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.93 -64.23 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.851 1.034 . . . . 0.0 110.484 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.95 -37.02 5.27 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.7 mt -93.8 149.58 37.27 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.105 -1.232 . . . . 0.0 109.1 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.0 174.75 0.19 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.826 1.017 . . . . 0.0 109.869 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -95.44 -1.74 50.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -0.883 . . . . 0.0 109.742 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -122.92 130.78 53.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -53.3 -28.97 30.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 0.0 109.616 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.67 65.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 -32.54 49.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' ALA . 56.9 t -65.97 -55.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -1.198 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.58 -45.43 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.061 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -60.57 -44.41 96.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 108.901 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.3 -19.13 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.07 -36.24 81.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.146 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.8 mtmt -70.48 -28.57 65.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.228 -0.92 . . . . 0.0 108.962 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB2' ' HZ3' ' A' ' 29' ' ' LYS . 8.2 ttmm -64.63 -1.45 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.825 . . . . 0.0 108.906 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.43 -62.76 0.2 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 108.82 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.68 50.86 2.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -49.28 146.77 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.244 . . . . 0.0 109.166 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -51.65 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.126 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -99.97 122.17 42.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 -179.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.831 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.7 mt-10 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -135.51 126.27 27.33 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -77.1 119.69 21.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 108.963 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.47 32.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 111.017 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 52' ' ' SER . 34.7 p-10 -70.88 -20.42 62.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.114 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 33.0 m -90.86 -20.41 22.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.067 -1.021 . . . . 0.0 110.003 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 89.3 mt -67.76 148.77 98.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.088 -1.008 . . . . 0.0 109.085 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.91 -157.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.845 1.03 . . . . 0.0 109.673 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -92.93 -40.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.42 -39.35 79.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.623 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.25 -42.86 22.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.433 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -60.29 -64.78 0.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.86 -44.95 49.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.7 -31.94 73.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.12 179.796 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 55.3 m95 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 6' ' ' SER . 7.6 t -138.45 164.17 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.312 -0.868 . . . . 0.0 109.958 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -110.73 152.81 43.73 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.5 -45.75 38.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 121.391 1.394 . . . . 0.0 110.655 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.45 -28.12 65.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -84.34 -24.96 29.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.732 -1.23 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' ASN . 56.2 mt -82.62 -20.5 36.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.263 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.18 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.619 -0.675 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 10' ' ' LEU . 36.4 m120 -146.11 -8.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.376 . . . . 0.0 110.656 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.13 147.32 69.25 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.0 107.954 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.7 -67.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.05 1.167 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.98 -34.12 2.92 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.7 mt -94.89 149.6 36.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.135 -1.215 . . . . 0.0 109.082 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.34 -179.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 120.882 1.055 . . . . 0.0 110.051 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -104.38 9.43 35.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.478 -0.763 . . . . 0.0 109.812 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -134.21 134.25 41.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.366 -0.834 . . . . 0.0 109.539 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -53.1 -31.43 41.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.883 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -51.47 64.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.423 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -65.83 -30.72 77.77 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.41 -54.52 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -1.204 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.57 -44.97 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.883 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.55 -41.48 94.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.079 -1.013 . . . . 0.0 108.935 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.1 t -74.78 -26.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 108.972 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.1 -33.32 51.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -70.43 -28.12 64.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 0.0 109.055 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.58 -2.72 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.133 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -150.57 -60.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.67 45.63 3.13 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -48.69 135.84 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.065 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.56 99.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.056 -1.028 . . . . 0.0 109.189 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.6 p30 -100.43 123.22 44.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.0 109.638 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.033 179.573 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.4 mt-10 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -135.36 131.65 36.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.64 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -75.67 112.89 12.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.811 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.84 -26.28 23.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -69.44 -22.37 63.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.977 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 m -90.5 -10.4 43.77 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.082 -1.012 . . . . 0.0 110.072 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 54' ' ' PRO . 75.6 mt -67.32 149.97 98.13 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.066 -1.022 . . . . 0.0 108.828 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -57.18 -159.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.89 1.06 . . . . 0.0 109.581 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.62 -37.52 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.75 -37.27 81.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -0.819 . . . . 0.0 110.236 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.0 -32.18 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.727 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -55.47 -70.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 109.041 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.09 -42.38 18.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.42 74.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.097 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.206 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 44.3 m95 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -135.98 -139.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -163.03 152.99 13.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.317 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.02 -50.69 12.36 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.422 1.415 . . . . 0.0 110.874 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -57.46 -23.17 48.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -25.0 28.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 109.671 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -83.13 -21.65 33.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.571 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.736 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 10' ' ' LEU . 28.0 p30 -148.86 -7.23 0.38 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.399 -1.438 . . . . 0.0 111.072 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.1 mt -78.27 147.39 72.5 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.642 -1.286 . . . . 0.0 108.16 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -67.42 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 120.939 1.093 . . . . 0.0 110.862 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.11 -34.23 3.1 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -95.26 149.89 36.83 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.238 -1.154 . . . . 0.0 109.29 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.72 -177.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.936 1.09 . . . . 0.0 109.814 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -103.17 3.16 35.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.39 -0.819 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -129.12 131.07 47.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 t -52.38 -31.79 35.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.867 . . . . 0.0 109.346 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -33.79 59.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.49 -36.81 22.4 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.64 -60.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.5 mt -48.96 -40.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 108.733 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -62.55 -39.47 93.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.01 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.3 t -77.37 -10.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -60.04 -38.0 81.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.981 -1.075 . . . . 0.0 110.453 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.61 -27.33 61.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.794 -1.191 . . . . 0.0 109.261 -179.765 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 26.8 mmtm -63.59 -4.41 2.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 29' ' ' LYS . 24.5 mp0 -149.07 -60.89 0.23 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.19 59.86 1.15 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -65.0 133.72 52.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.979 -1.306 . . . . 0.0 108.927 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.12 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 3.8 p30 -103.68 121.53 43.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.436 -0.79 . . . . 0.0 109.45 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 35' ' ' ARG . 29.5 ttm-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 108.56 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 23.3 mm-40 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -135.14 129.01 33.18 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.373 -0.829 . . . . 0.0 109.407 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 22.9 t-20 -75.52 112.18 11.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.81 . . . . 0.0 109.301 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -31.3 61.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.797 . . . . 0.0 110.708 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 4.4 m120 -68.13 -17.28 64.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.985 -1.072 . . . . 0.0 109.63 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.2 m -90.91 -16.04 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 79.3 mt -67.21 149.36 98.49 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.065 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.66 -157.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.894 1.062 . . . . 0.0 109.554 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.74 -39.87 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.86 -42.76 94.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.92 -11.66 59.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.842 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -75.59 -69.94 0.46 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.04 -41.41 16.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.075 -1.015 . . . . 0.0 109.104 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.28 79.68 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.303 -0.873 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.03 179.596 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.8 m95 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -132.24 -141.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.419 -0.801 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.617 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -162.81 153.58 14.3 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.126 -0.984 . . . . 0.0 109.454 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.26 -48.15 20.79 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.344 1.363 . . . . 0.0 110.624 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -58.82 -23.42 60.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 110.007 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.94 -29.62 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.5 mt -80.52 -24.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.269 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.14 29.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 110.92 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.501 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.6 m120 -145.69 -9.73 0.54 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.543 -1.348 . . . . 0.0 110.795 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.3 mt -78.78 147.48 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.601 -1.312 . . . . 0.0 108.061 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -65.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.006 1.137 . . . . 0.0 110.849 -179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.14 -37.37 4.4 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.3 150.16 37.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.22 -1.165 . . . . 0.0 109.134 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.12 171.04 0.41 Allowed 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.876 1.051 . . . . 0.0 109.786 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ALA . 51.1 mttm -91.5 -10.18 41.7 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.712 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -114.62 128.59 56.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.512 -0.743 . . . . 0.0 109.314 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -52.59 -28.97 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -33.72 56.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.239 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.16 -37.11 22.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.78 -59.96 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 109.392 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.01 -45.48 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.047 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.28 -42.82 99.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.3 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.3 t -74.39 -14.63 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.58 -31.2 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.21 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' H ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -71.74 -27.83 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 108.576 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -63.92 -8.11 10.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.862 . . . . 0.0 109.245 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -150.18 -59.46 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.318 -0.864 . . . . 0.0 108.98 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.69 55.4 1.91 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -50.88 148.37 4.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.062 -1.258 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.68 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.63 114.43 28.11 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.314 -0.867 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.183 -0.948 . . . . 0.0 109.767 -179.98 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.597 0.713 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.5 130.71 35.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -77.16 112.62 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 108.947 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.53 -22.95 23.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.369 -0.832 . . . . 0.0 111.029 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 52' ' ' SER . 37.3 p-10 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.788 -1.195 . . . . 0.0 109.843 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.468 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 5.1 m -92.47 -13.1 30.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.62 148.92 98.52 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.981 -1.074 . . . . 0.0 109.012 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -158.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.991 1.127 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.2 -37.37 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.378 -0.826 . . . . 0.0 109.363 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.01 -40.24 84.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.96 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.28 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -58.02 -69.65 0.17 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.104 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -43.38 15.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.789 . . . . 0.0 109.682 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.7 78.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 109.495 179.919 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.1 m95 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 6' ' ' SER . 95.1 t -138.33 165.28 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.341 -0.85 . . . . 0.0 110.198 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -104.52 153.76 38.91 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.458 -0.776 . . . . 0.0 109.348 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.02 -44.13 47.33 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.388 1.392 . . . . 0.0 110.83 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -23.22 45.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 109.814 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -84.56 -23.08 29.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 12' ' ' ASN . 96.6 mt -82.97 -22.49 33.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 0.0 109.094 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 32.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.762 -0.586 . . . . 0.0 111.336 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.4 t-20 -146.64 -9.04 0.48 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.519 -1.363 . . . . 0.0 110.775 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.1 mt -79.45 147.58 68.39 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.681 -1.262 . . . . 0.0 108.229 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.69 -61.83 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 120.871 1.047 . . . . 0.0 110.527 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.26 -38.87 6.79 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.9 mt -93.98 149.64 37.24 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 0.0 109.108 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.59 177.78 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.722 0.948 . . . . 0.0 109.712 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -98.47 9.06 44.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.258 -0.901 . . . . 0.0 109.63 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -134.17 130.52 37.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 0.0 109.323 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 p -53.13 -29.62 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.51 65.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.8 28.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.51 -59.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.266 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.4 mt -52.12 -43.03 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.078 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.97 -39.9 87.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -74.99 -27.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.05 -32.74 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.0 108.799 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -71.8 -33.4 68.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.131 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.15 -3.28 3.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.538 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.5 mt-30 -145.19 -63.42 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.0 108.935 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.4 51.84 1.8 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.538 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.4 m-90 -51.63 146.46 7.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.251 . . . . 0.0 109.076 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.49 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.064 . . . . 0.0 109.306 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 34' ' ' ASN . 10.0 p30 -98.8 117.16 32.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.499 -0.751 . . . . 0.0 109.75 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.932 . . . . 0.0 108.604 179.178 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.756 0.789 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -135.81 136.72 40.9 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -77.54 114.78 16.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.082 -1.011 . . . . 0.0 109.334 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.12 35.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 111.193 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.69 -17.94 63.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.895 -1.128 . . . . 0.0 110.089 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -91.83 -14.7 29.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.135 -0.978 . . . . 0.0 110.216 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt -66.89 148.17 98.9 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.056 . . . . 0.0 108.992 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -56.81 -161.86 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 121.01 1.14 . . . . 0.0 109.618 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 t -91.39 -38.81 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -59.37 -40.22 85.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.09 11.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.626 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -48.24 -50.9 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.775 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.81 -53.72 54.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.16 66.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 109.083 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 0.0 108.914 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 46.2 m95 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -135.24 -140.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -163.11 154.0 14.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 0.0 109.449 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.59 -50.56 12.97 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 121.345 1.363 . . . . 0.0 110.871 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -58.14 -24.33 58.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.123 -0.985 . . . . 0.0 110.131 -179.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB2' HG12 ' A' ' 5' ' ' VAL . 37.4 mt-10 -84.69 -28.46 26.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 60.9 mt -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.28 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.15 30.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 64.0 m-80 -145.71 -7.38 0.58 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.574 -1.329 . . . . 0.0 110.698 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.2 mt -79.19 147.81 69.93 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.669 -1.269 . . . . 0.0 108.04 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 120.839 1.026 . . . . 0.0 110.635 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.56 -36.39 4.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.6 mt -93.79 149.92 37.82 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.182 -1.187 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.8 171.13 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 120.763 0.975 . . . . 0.0 109.756 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.41 7.8 45.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.869 . . . . 0.0 109.779 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -133.62 129.63 37.19 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 p -53.0 -29.64 30.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 0.0 109.383 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.1 -35.83 62.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.7 -35.12 20.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.6 t -65.86 -53.17 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -1.135 . . . . 0.0 109.34 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -57.29 -48.47 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.11 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -60.02 -44.84 94.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -75.15 -18.36 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.96 -30.41 70.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.51 -29.22 64.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -64.83 -3.21 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -149.81 -61.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.74 53.51 2.24 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -50.19 143.81 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.938 -1.33 . . . . 0.0 108.912 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -46.97 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.156 -0.965 . . . . 0.0 109.527 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -106.14 117.17 33.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.522 -0.736 . . . . 0.0 109.595 -179.855 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 179.564 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 30.8 mt-10 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.64 126.49 27.5 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.166 -0.959 . . . . 0.0 109.891 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -76.15 112.72 12.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 108.811 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.08 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.992 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -71.2 -22.97 61.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.5 m -89.55 -11.78 41.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.082 -1.012 . . . . 0.0 110.272 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.6 mt -68.39 148.98 98.2 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.932 -1.105 . . . . 0.0 109.283 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.4 Cg_endo -58.02 -155.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.019 1.146 . . . . 0.0 109.643 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.11 -36.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.169 -0.957 . . . . 0.0 109.689 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.35 -38.16 82.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.698 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.95 47.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.574 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -59.92 -71.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 108.984 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.78 -42.3 11.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.444 -0.785 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.15 -35.48 80.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.264 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.2 -179.772 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.8 m95 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.61 145.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -96.76 152.29 38.38 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.09 -44.99 44.38 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.235 1.29 . . . . 0.0 110.297 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -60.57 -25.44 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 109.88 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -84.36 -27.07 27.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -81.97 -23.66 35.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 109.213 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 31.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.598 -0.688 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 72.1 m-80 -144.83 -8.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.568 -1.333 . . . . 0.0 110.682 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.0 mt -78.93 147.61 70.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.689 -1.257 . . . . 0.0 108.04 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -64.93 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.888 1.058 . . . . 0.0 110.663 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.66 -36.99 4.89 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -93.76 149.84 37.72 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.132 -1.217 . . . . 0.0 109.156 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.77 175.11 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.956 1.104 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -98.84 7.18 46.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.32 -0.862 . . . . 0.0 109.658 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.31 130.71 41.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.468 -0.77 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -52.37 -30.75 30.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.42 62.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.35 -36.93 25.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.88 -55.83 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.03 -44.64 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.153 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.75 -43.02 98.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.067 . . . . 0.0 108.735 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 22' ' ' GLY . 53.6 t -75.03 -22.11 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.66 -30.33 60.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 108.739 179.679 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -71.3 -30.68 66.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -65.37 -3.66 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.422 -0.799 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -151.29 -63.44 0.18 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.027 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.3 54.36 1.86 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.65 151.28 1.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.286 . . . . 0.0 109.378 179.684 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -54.8 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -96.69 114.6 26.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.416 0.627 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -135.45 131.66 36.46 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -75.38 116.36 16.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.019 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.84 -24.72 24.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 52' ' ' SER . 49.8 p30 -70.76 -18.83 62.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.953 -1.092 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 19.4 m -92.5 -14.88 27.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.003 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.32 149.71 98.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.63 -155.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 121.035 1.157 . . . . 0.0 109.371 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 t -97.61 -37.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.152 -0.968 . . . . 0.0 109.329 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -61.04 -35.53 77.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.04 -47.0 15.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 0.0 109.803 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -53.73 -54.51 37.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.535 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.07 -51.37 53.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.182 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.93 -27.09 68.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.875 . . . . 0.0 109.203 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.412 ' CD1' ' C ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 52.1 t -135.55 160.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -178.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.0 m -106.27 153.78 40.16 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 109.377 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.85 -43.49 57.59 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 121.337 1.358 . . . . 0.0 110.559 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -58.23 -26.48 62.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 109.833 -179.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.57 -25.55 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.1 mt -82.8 -22.64 34.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 28.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.664 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.0 p30 -147.25 -5.7 0.5 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.477 -1.389 . . . . 0.0 110.901 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 33.2 mt -79.4 147.65 68.74 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.558 -1.339 . . . . 0.0 108.061 179.261 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.92 -62.31 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 120.966 1.111 . . . . 0.0 110.791 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.63 -40.74 6.63 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 47.4 mt -93.91 150.06 37.97 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.236 -1.155 . . . . 0.0 109.04 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -52.21 -178.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 120.844 1.029 . . . . 0.0 109.915 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -100.51 -7.23 24.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.301 -0.874 . . . . 0.0 109.661 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -116.42 128.11 55.21 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.186 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -52.22 -29.22 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.13 66.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.291 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.66 -35.88 34.92 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.01 -59.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 109.243 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.65 -44.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 0.0 109.107 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -61.16 -45.59 93.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.116 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.57 -22.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.286 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.79 -32.99 63.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 30' ' ' GLN . 23.7 mmtp -71.01 -29.02 64.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.052 179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -64.34 -0.6 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 28' ' ' LYS . 44.4 mt-30 -150.86 -62.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.23 47.74 2.15 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.231 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -51.75 134.38 30.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.94 -1.329 . . . . 0.0 108.944 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.61 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.33 112.79 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.992 -1.068 . . . . 0.0 108.568 179.555 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 10.3 p30 -110.03 120.51 42.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.584 -0.697 . . . . 0.0 109.832 -179.596 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.112 179.464 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 40.4 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.4 132.76 35.93 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.426 -0.796 . . . . 0.0 109.334 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -77.45 120.18 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.92 -30.03 57.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.3 -0.875 . . . . 0.0 110.54 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -71.35 -18.71 62.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 35.9 m -89.74 -22.91 21.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.049 -1.032 . . . . 0.0 110.278 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.44 148.02 98.73 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.957 -1.09 . . . . 0.0 108.983 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.7 -164.44 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 120.899 1.066 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 t -89.28 -37.02 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.45 -39.43 79.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.567 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.76 -44.32 17.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.099 -1.0 . . . . 0.0 109.573 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.96 -42.33 72.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 109.829 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.91 -56.9 10.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.711 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.35 -19.96 65.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 61' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.5 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 6' ' ' SER . 60.1 t -138.12 160.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.379 -0.826 . . . . 0.0 109.882 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -107.7 153.73 41.31 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.726 . . . . 0.0 109.362 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.92 -43.59 56.75 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.271 1.314 . . . . 0.0 110.503 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -57.72 -26.14 61.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.142 -0.974 . . . . 0.0 109.154 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.8 mt -82.91 -19.97 36.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.817 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.92 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.0 m120 -146.83 -7.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.544 -1.347 . . . . 0.0 110.907 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.22 147.71 69.6 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.603 -1.31 . . . . 0.0 108.215 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.72 -64.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.96 1.107 . . . . 0.0 110.511 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.88 -38.9 6.02 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' LEU . 57.8 mt -93.18 149.6 37.72 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.224 -1.163 . . . . 0.0 109.087 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.57 175.6 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.867 1.045 . . . . 0.0 109.88 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.6 -5.7 31.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -116.47 129.06 56.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 109.258 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -52.62 -29.49 26.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.56 -37.59 68.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -77.64 -35.41 36.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.93 -50.11 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.52 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.419 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.65 -42.7 93.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.062 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 73.3 t -75.06 -24.29 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.243 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.78 -31.39 66.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 0.0 108.737 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.05 -30.4 66.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -64.41 -0.98 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.231 179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.5 mt-30 -150.76 -63.23 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 108.768 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.33 49.7 2.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.9 m-90 -48.95 147.82 2.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.3 . . . . 0.0 109.01 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -47.54 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.997 . . . . 0.0 109.33 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' TRP . 11.0 p-10 -103.36 119.31 38.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.48 -0.763 . . . . 0.0 110.183 -179.359 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.234 -0.916 . . . . 0.0 108.962 179.274 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -136.46 126.51 26.09 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.26 -0.9 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 50.0 t-20 -76.31 120.46 21.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.06 -30.28 47.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 110.698 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 50.9 p30 -71.45 -19.22 62.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.93 -1.106 . . . . 0.0 110.106 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 70.3 m -90.05 -22.06 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.974 -179.57 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 80.0 mt -67.66 148.35 98.57 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 0.0 108.764 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.32 -158.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 120.879 1.052 . . . . 0.0 109.766 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.87 -37.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.09 -39.86 79.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.01 33.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.693 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -59.91 -39.11 84.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.01 18.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.179 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.02 -21.42 66.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.88 . . . . 0.0 109.045 179.757 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.3 m95 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 6' ' ' SER . 43.7 t -137.28 157.87 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.381 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -105.16 153.15 39.74 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.413 -0.804 . . . . 0.0 109.24 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.49 -42.88 62.22 Favored 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.24 1.294 . . . . 0.0 110.397 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -58.2 -27.0 63.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.603 -179.546 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -84.63 -24.47 29.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 109.119 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 12' ' ' ASN . 98.3 mt -82.42 -22.85 35.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.87 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.68 . . . . 0.0 111.394 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.4 m120 -148.34 -7.03 0.41 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.465 -1.397 . . . . 0.0 111.089 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -79.9 148.11 67.73 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.594 -1.316 . . . . 0.0 108.253 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.4 -67.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.039 1.159 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.67 2.36 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' LEU . 21.4 mt -95.19 150.61 37.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.21 -1.17 . . . . 0.0 109.015 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.9 -174.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.759 0.972 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -105.29 4.37 30.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.448 -0.782 . . . . 0.0 109.84 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 p -132.71 132.42 42.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.414 -0.804 . . . . 0.0 109.413 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -53.1 -30.83 38.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.324 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.31 61.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.275 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -36.84 15.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.92 -53.95 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -1.146 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.04 -43.25 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 108.929 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HE2' ' HZ1' ' A' ' 29' ' ' LYS . 91.5 t80 -61.46 -44.13 97.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.38 -24.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.446 -0.784 . . . . 0.0 109.187 179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.46 -29.52 36.13 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.163 -0.961 . . . . 0.0 108.692 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' GLN . 7.4 mtpm? -72.14 -35.36 69.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HZ1' ' HE2' ' A' ' 25' ' ' TYR . 1.8 mptm? -64.68 0.73 1.02 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' LYS . 64.3 mt-30 -151.94 -68.77 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 108.905 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.08 52.42 1.62 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -51.47 141.55 15.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.271 . . . . 0.0 109.115 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -50.51 91.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p30 -97.83 118.47 34.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.331 -0.855 . . . . 0.0 109.303 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.667 179.86 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.3 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.97 127.63 28.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 46.9 t-20 -75.37 123.5 25.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.997 . . . . 0.0 109.296 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.12 63.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.828 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 42.2 p30 -69.83 -16.53 63.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.941 -1.1 . . . . 0.0 109.82 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 49.7 m -89.95 -23.88 21.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.63 148.31 98.59 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 108.948 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.83 -168.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.892 1.061 . . . . 0.0 109.676 179.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.0 -35.36 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mp0 -59.28 -39.43 82.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.81 -29.03 32.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.61 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -63.79 -46.82 83.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.302 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.0 77.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 108.807 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.24 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.068 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 108.589 179.684 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.1 m95 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -136.05 -140.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.23 -0.919 . . . . 0.0 109.979 -179.09 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.608 ' H ' HG12 ' A' ' 5' ' ' VAL . 4.9 m -162.83 153.0 13.65 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.46 -48.6 19.66 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.463 1.442 . . . . 0.0 110.959 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -57.25 -24.79 57.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -0.999 . . . . 0.0 109.968 -179.054 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.05 -26.06 27.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.185 -0.947 . . . . 0.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.2 mt -81.9 -21.59 37.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 30.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 57.2 m-80 -146.69 -7.0 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.523 -1.361 . . . . 0.0 110.933 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.49 147.79 68.66 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.629 -1.295 . . . . 0.0 108.176 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -66.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.867 1.045 . . . . 0.0 110.707 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.36 -36.43 4.28 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.6 mt -93.68 149.95 37.95 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.173 -1.192 . . . . 0.0 109.18 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 172.77 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.821 1.014 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -94.36 6.6 48.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.735 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -131.86 129.66 40.68 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.506 -0.746 . . . . 0.0 109.309 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -52.71 -29.86 29.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.57 29.35 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.43 -58.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.8 mt -52.39 -44.52 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.937 . . . . 0.0 109.146 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.71 -44.35 96.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.982 . . . . 0.0 109.063 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.28 -24.04 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 109.215 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.28 -32.95 67.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 108.884 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -71.78 -33.52 68.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 108.966 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -65.15 -3.88 4.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -150.18 -67.58 0.2 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 108.779 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.88 59.04 1.01 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.545 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.74 147.81 17.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.083 -1.245 . . . . 0.0 108.732 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -49.24 90.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.148 -0.97 . . . . 0.0 109.537 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -102.98 121.2 42.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.876 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 35' ' ' ARG . 23.4 ttm-85 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 5' ' ' VAL . 12.1 mm-40 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.05 128.42 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.452 -0.78 . . . . 0.0 109.596 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.47 114.77 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.266 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.815 ' C ' ' HZ2' ' A' ' 58' ' ' LYS . . . -54.7 -30.82 56.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.12 -19.67 63.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 m -89.18 -17.96 28.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 109.766 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.4 mt -67.71 149.2 98.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.046 -1.033 . . . . 0.0 109.032 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.66 -158.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.914 1.076 . . . . 0.0 110.031 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.11 -38.62 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -57.79 -41.45 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.52 -33.75 47.8 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.815 ' HZ2' ' C ' ' A' ' 50' ' ' ALA . 1.2 tpmt? -56.98 -53.67 55.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.15 67.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.61 78.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.111 -0.993 . . . . 0.0 109.375 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.364 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -138.33 148.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 109.545 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -97.44 153.0 38.52 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -51.81 -48.15 22.89 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.381 1.387 . . . . 0.0 110.869 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -58.74 -23.74 60.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.29 -179.194 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -85.03 -24.01 28.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.947 -1.096 . . . . 0.0 109.51 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -82.02 -23.18 36.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.134 -0.979 . . . . 0.0 108.8 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.8 p30 -146.89 -6.19 0.51 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.544 -1.347 . . . . 0.0 110.844 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 16' ' ' LEU . 37.2 mt -78.9 147.3 70.1 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.558 -1.339 . . . . 0.0 108.02 179.241 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.96 -67.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.066 1.177 . . . . 0.0 110.756 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.71 -34.73 2.85 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.2 mt -94.57 149.94 37.3 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.152 -1.205 . . . . 0.0 109.031 -179.673 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.5 -176.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 120.921 1.081 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -102.57 -2.85 27.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.429 -0.794 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -119.65 126.15 50.46 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -52.27 -29.15 21.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.344 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.09 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.391 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -76.9 -36.16 37.21 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.78 -60.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -1.152 . . . . 0.0 109.36 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.0 mt -50.82 -42.42 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 108.97 179.812 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.41 -39.24 86.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.479 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' GLY . 55.9 t -74.32 -28.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 108.976 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.57 -31.56 16.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 108.763 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 30' ' ' GLN . 56.5 mmtt -72.5 -39.63 67.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 0.0 109.008 179.412 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -64.99 1.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 28' ' ' LYS . 55.9 mt-30 -152.0 -70.43 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 108.975 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.44 51.18 1.6 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.3 m-90 -50.0 141.54 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.06 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.009 . . . . 0.0 109.117 179.784 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.1 p30 -100.57 122.8 43.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.422 -0.799 . . . . 0.0 110.19 -179.313 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.347 -0.846 . . . . 0.0 109.343 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 56.5 mm-40 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -135.72 130.72 34.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -76.23 116.75 17.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.99 -30.57 59.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 -179.65 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -70.44 -19.35 62.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.99 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.4 m -89.65 -19.86 24.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 88.5 mt -67.59 149.05 98.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.103 -0.998 . . . . 0.0 108.859 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.69 -160.34 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.769 0.98 . . . . 0.0 109.661 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -92.03 -38.71 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.39 -39.33 83.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.724 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.86 -38.75 27.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.23 -59.73 4.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 109.373 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.43 -44.53 65.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.14 73.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.136 179.92 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.4 m95 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.05 153.08 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.79 -179.229 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -103.84 153.43 38.76 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.203 -179.749 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.95 -46.21 35.33 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.27 1.313 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -59.28 -23.92 62.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -84.87 -25.99 27.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 0.0 109.538 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 62.9 mt -83.13 -21.29 33.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.892 . . . . 0.0 109.488 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.06 29.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.616 -0.677 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.5 m120 -148.03 -8.7 0.4 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.435 -1.416 . . . . 0.0 111.011 -179.411 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.7 mt -79.19 147.28 68.89 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.559 -1.338 . . . . 0.0 108.231 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -67.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.718 0 C-N-CA 121.087 1.191 . . . . 0.0 111.054 -179.182 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.91 -34.66 2.01 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.1 mt -95.37 150.06 37.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.197 -1.178 . . . . 0.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.34 179.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.875 1.05 . . . . 0.0 110.177 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.1 mmtt -96.56 -17.87 20.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.284 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -109.68 130.97 55.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.633 -0.667 . . . . 0.0 109.356 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -53.05 -29.31 29.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.16 -32.87 56.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.06 -36.0 29.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.96 -58.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.411 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.6 mt -49.52 -46.05 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.052 179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.61 -56.65 17.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 108.954 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 22' ' ' GLY . 78.3 t -57.94 -15.09 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.449 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.1 -35.57 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.303 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 10.6 mptt -70.87 -28.71 64.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.129 179.804 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 16.8 tptm -64.2 -4.6 3.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 29' ' ' LYS . 24.3 mp0 -149.22 -61.19 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.55 49.59 2.52 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.323 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -52.22 142.89 15.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.257 . . . . 0.0 109.385 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -57.03 96.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 108.961 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -99.45 123.81 44.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.369 -0.832 . . . . 0.0 109.944 -179.423 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.61 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 12.3 mm-40 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -135.3 128.66 32.19 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.243 179.525 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -74.66 117.7 16.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.06 . . . . 0.0 109.169 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -26.73 60.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -68.57 -20.74 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.554 -179.395 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -91.24 -15.14 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.871 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.4 149.58 98.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 0.0 108.879 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.29 -157.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 120.954 1.103 . . . . 0.0 109.638 179.297 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.98 -37.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.72 -35.83 77.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 110.316 -179.389 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.91 -31.22 45.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -58.59 -68.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.613 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -45.7 17.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.397 -0.814 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.381 -0.824 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.321 -179.99 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 51.3 m95 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -134.63 150.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.378 -0.826 . . . . 0.0 109.58 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -98.34 153.01 38.22 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.434 -0.791 . . . . 0.0 109.488 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.68 -45.02 40.63 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.351 1.367 . . . . 0.0 110.582 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -58.19 -26.8 63.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.14 -24.93 30.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.696 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' ASN . 81.8 mt -81.87 -23.5 36.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 108.997 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.96 28.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 111.021 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.0 m120 -147.42 -7.06 0.46 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.481 -1.387 . . . . 0.0 110.881 -179.377 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' LEU . 22.3 mt -79.16 147.42 69.31 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.648 -1.283 . . . . 0.0 108.181 179.412 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.77 -68.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.019 1.146 . . . . 0.0 110.796 -179.441 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.8 -34.56 1.91 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.1 mt -95.23 150.6 37.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.202 -1.175 . . . . 0.0 108.976 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.95 -179.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.762 0.975 . . . . 0.0 109.853 179.485 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 19.9 mmmt -98.73 -16.03 19.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.064 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -105.28 132.38 51.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.682 . . . . 0.0 109.305 -179.851 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.88 -28.56 37.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.83 -54.19 47.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.913 . . . . 0.0 109.749 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.62 -35.85 63.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.707 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.21 -65.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -1.21 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mt -51.27 -41.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.149 -179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -61.67 -42.7 99.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.7 t -75.07 -22.81 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 0.0 109.297 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.24 -29.16 31.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.0 108.842 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.3 mptp? -71.43 -32.51 68.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 108.872 179.59 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -64.64 -4.87 4.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.294 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -150.26 -67.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.08 54.14 1.31 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.9 m-90 -52.07 137.99 26.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.117 -1.225 . . . . 0.0 109.018 179.474 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -47.19 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.713 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.8 p30 -103.11 115.74 31.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.358 -0.838 . . . . 0.0 109.472 179.918 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 35' ' ' ARG . 4.2 ptt-85 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 179.794 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 7.5 mp0 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -136.36 128.96 30.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.193 -0.942 . . . . 0.0 109.796 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -76.09 114.34 14.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 108.984 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -26.36 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.465 -179.254 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -70.28 -21.1 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.3 m -90.0 -18.62 25.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.54 149.17 98.47 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.014 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.3 Cg_endo -57.8 -156.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 120.939 1.093 . . . . 0.0 109.42 179.228 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -98.21 -37.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.1 -35.52 77.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.05 -39.01 30.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.059 -1.026 . . . . 0.0 109.698 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.73 -59.17 5.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.971 . . . . 0.0 109.449 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.81 -45.42 50.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.917 -1.114 . . . . 0.0 109.16 179.688 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.34 -33.11 74.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 108.99 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.152 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.345 0.593 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -151.03 -67.73 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.0 tp 52.74 79.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.687 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -80.72 169.36 17.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 6' ' ' SER . 18.6 t -140.05 165.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -113.54 153.11 45.83 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -52.67 -46.77 31.14 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.303 1.335 . . . . 0.0 110.558 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -59.12 -25.92 64.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.931 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.46 -25.86 30.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.008 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 89.7 mt -82.47 -23.5 34.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 108.898 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.3 m120 -145.49 -9.52 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.578 -1.326 . . . . 0.0 110.666 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.2 mt -79.18 147.4 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.667 -1.271 . . . . 0.0 108.098 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.53 -64.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.059 1.173 . . . . 0.0 110.802 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.84 4.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -94.92 149.79 36.83 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.114 -1.227 . . . . 0.0 109.018 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.41 175.81 0.17 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 120.905 1.07 . . . . 0.0 109.921 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -97.04 7.87 45.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 p -133.71 130.08 37.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.46 -0.775 . . . . 0.0 109.413 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -52.84 -29.83 30.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.63 63.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -81.16 -35.46 23.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.75 -53.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -1.189 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.78 -45.18 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 109.121 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.2 -41.73 93.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 0.0 108.951 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.9 t -74.96 -25.82 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 109.114 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.86 -31.71 40.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -71.11 -29.4 65.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.234 -0.916 . . . . 0.0 109.016 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -64.86 -7.13 10.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 109.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -150.72 -64.34 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 108.843 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.1 59.47 1.05 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -57.37 145.41 32.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.081 -1.247 . . . . 0.0 108.824 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -47.63 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p30 -103.63 119.51 39.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.427 -0.796 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -88.17 146.28 25.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.271 -0.893 . . . . 0.0 109.156 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -95.11 153.86 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -149.4 107.09 3.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.021 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.64 58.64 0.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.755 . . . . 0.0 109.917 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.0 -28.84 0.02 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.28 -1.57 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.865 -1.374 . . . . 0.0 110.406 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -170.68 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.929 -1.107 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.01 -153.45 9.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.59 4.7 67.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -173.61 95.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.63 -159.68 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.24 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -147.86 94.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.185 -0.947 . . . . 0.0 109.207 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.4 mt-10 -82.46 175.44 10.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 108.744 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -135.72 128.39 30.86 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -75.7 116.07 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 108.898 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.33 59.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.614 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -69.4 -17.17 63.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.006 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.8 m -89.61 -20.27 23.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.0 109.782 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 54' ' ' PRO . 73.9 mt -67.92 149.27 98.28 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.121 -0.987 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -57.04 -157.89 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.845 1.03 . . . . 0.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 t -94.4 -36.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -58.08 -38.81 77.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.549 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.33 -36.4 29.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.36 -42.92 78.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.595 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.44 -58.06 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -23.31 67.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.749 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -63.4 -77.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.49 -13.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.36 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -69.08 -60.41 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 109.595 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 20.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.049 -1.032 . . . . 0.0 110.213 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.4 mm-40 -103.57 8.54 37.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.006 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . -50.6 135.71 28.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 66' ' ' GLY . 35.0 tt0 59.79 122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.485 -1.009 . . . . 0.0 109.998 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.887 HG23 ' H ' ' A' ' 69' ' ' GLU . 12.7 tt -160.06 -66.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.887 ' H ' HG23 ' A' ' 68' ' ' ILE . 26.3 mt-10 -159.66 161.34 34.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.436 -0.79 . . . . 0.0 109.041 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 p -88.5 -76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -158.24 145.21 17.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' TYR . 2.9 pp -172.03 152.8 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.89 15.33 0.1 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -90.11 9.26 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -1.204 . . . . 0.0 109.478 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 54.4 t80 39.73 26.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.798 -0.564 . . . . 0.0 110.448 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' TYR . 3.9 mp0 . . . . . 0 N--CA 1.492 1.663 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.293 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -151.14 109.94 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.193 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.6 tp -168.4 74.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.427 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 45.0 m95 -80.04 161.75 25.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.164 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 6' ' ' SER . 58.7 t -139.39 167.99 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -106.21 153.88 40.04 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.43 -0.794 . . . . 0.0 109.602 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.82 -49.72 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.481 1.454 . . . . 0.0 110.801 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.11 -23.85 22.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.564 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 43.1 mt-10 -84.18 -23.32 30.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.986 -1.071 . . . . 0.0 109.402 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.7 mt -83.65 -20.58 33.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.63 36.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.7 -0.625 . . . . 0.0 111.506 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 m120 -148.22 -11.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.343 -1.473 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -78.73 147.91 71.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.646 -1.284 . . . . 0.0 108.182 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.46 -60.71 0.28 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 120.823 1.015 . . . . 0.0 110.415 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.98 -39.57 9.07 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.4 mt -93.39 149.84 37.98 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.216 -1.167 . . . . 0.0 109.041 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.35 177.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.848 1.032 . . . . 0.0 109.97 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -101.56 8.41 41.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.429 -0.794 . . . . 0.0 109.552 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -130.09 132.96 46.36 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.525 -0.734 . . . . 0.0 109.351 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -52.82 -31.34 38.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.596 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.7 51.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -33.75 85.38 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.2 -65.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.169 . . . . 0.0 109.229 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -48.98 -41.11 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -61.66 -48.94 78.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 108.876 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.81 -36.45 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 108.959 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.33 -30.35 7.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.647 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 30' ' ' GLN . 48.2 mtpt -73.77 -41.98 61.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.51 -0.744 . . . . 0.0 109.484 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -65.94 4.32 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.308 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 28' ' ' LYS . 72.3 mt-30 -150.15 -75.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 105.35 50.39 0.92 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -53.24 134.1 39.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.366 . . . . 0.0 108.463 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 105.01 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.96 -1.088 . . . . 0.0 109.513 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -104.17 124.36 48.97 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 110.282 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.2 123.22 31.23 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 109.38 20.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.837 -1.164 . . . . 0.0 110.148 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.99 163.66 18.75 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' ALA . . . -69.81 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.743 -1.223 . . . . 0.0 109.32 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -84.07 -49.08 4.89 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t 56.99 -7.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.561 -0.964 . . . . 0.0 109.601 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.652 ' H ' ' C ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 169.35 -51.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -77.48 1.36 Allowed Glycine 0 N--CA 1.5 2.917 0 O-C-N 121.737 -0.602 . . . . 0.0 111.844 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.63 95.03 0.1 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt 70.59 89.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.88 -0.776 . . . . 0.0 109.388 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -96.52 130.7 43.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.47 -0.769 . . . . 0.0 109.663 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -90.81 148.46 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.035 -1.041 . . . . 0.0 108.981 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -132.98 169.38 16.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 46' ' ' ILE . 42.9 m-85 -135.47 135.38 40.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.53 112.31 12.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.123 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.87 19.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.307 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -72.11 -20.43 61.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.035 -1.041 . . . . 0.0 110.277 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.3 m -88.9 -16.65 31.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.081 -1.012 . . . . 0.0 110.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' PRO . 82.7 mt -67.73 148.13 98.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 108.962 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -56.69 -161.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.847 1.031 . . . . 0.0 109.686 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -91.2 -38.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.36 -41.15 84.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.47 -52.58 7.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.093 -1.004 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -46.69 -45.55 19.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.977 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -58.09 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.47 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.12 62.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.212 -0.93 . . . . 0.0 109.001 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -64.4 -62.12 1.8 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 108.795 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 62' ' ' LEU . 22.8 mt -46.74 -32.88 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.716 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.9 mt -64.95 -34.51 78.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 66' ' ' GLY . 21.4 mtp180 -69.89 -37.76 76.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -46.99 -13.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.911 -1.118 . . . . 0.0 109.926 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -59.67 105.89 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 66' ' ' GLY . 5.5 tm-20 45.9 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.912 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.99 -36.34 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.451 -0.781 . . . . 0.0 109.152 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -146.1 11.87 1.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 109.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 72' ' ' LEU . 29.3 m 47.56 -109.33 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 t 58.76 0.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.018 -1.051 . . . . 0.0 109.713 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 70' ' ' THR . 34.6 mt -133.64 -125.38 0.17 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.812 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.55 4.39 89.22 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -88.45 12.55 14.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.249 . . . . 0.0 109.319 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 47.3 t80 49.01 29.8 2.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 75' ' ' PHE . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 3.6 ppp? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.576 ' N ' ' SD ' ' A' ' 1' ' ' MET . 31.0 tt0 -87.82 105.32 17.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 109.862 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.4 tp -149.27 85.79 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.905 . . . . 0.0 109.211 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 41.8 m95 -79.66 158.01 27.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 108.855 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -125.29 -137.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.418 -0.801 . . . . 0.0 109.349 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -166.12 152.31 8.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 109.508 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.39 -52.02 8.02 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.312 1.341 . . . . 0.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -58.54 -25.56 62.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.69 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 46.4 mm-40 -84.95 -30.34 24.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.077 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 12' ' ' ASN . 28.6 mt -80.69 -25.27 38.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.039 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 30.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 t-20 -145.1 -10.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.582 -1.324 . . . . 0.0 110.562 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' LEU . 21.2 mt -78.65 147.21 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.0 107.911 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.49 -64.39 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 120.978 1.119 . . . . 0.0 110.926 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.2 -37.47 4.52 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.6 mt -95.39 150.29 37.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.157 -1.202 . . . . 0.0 109.272 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.31 173.21 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 120.908 1.072 . . . . 0.0 110.027 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.36 8.47 43.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.296 -0.878 . . . . 0.0 109.69 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.02 131.92 41.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.487 -0.758 . . . . 0.0 109.375 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -53.02 -30.56 36.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -47.69 67.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.243 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -67.96 -36.36 86.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.5 -63.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -1.209 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.5 -42.46 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.968 . . . . 0.0 109.1 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.12 -44.79 96.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.016 . . . . 0.0 109.015 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 22' ' ' GLY . 41.5 t -69.42 -26.34 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.91 -28.53 9.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.851 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.6 mptp? -72.92 -35.65 67.08 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.154 -0.966 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -65.37 -3.97 4.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -150.9 -68.96 0.18 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.89 54.55 1.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.88 143.75 12.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.942 -1.328 . . . . 0.0 109.006 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -50.01 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.001 . . . . 0.0 109.078 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.5 p30 -100.06 123.44 44.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.293 -0.88 . . . . 0.0 109.82 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -87.86 115.04 25.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -91.91 84.11 5.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 39' ' ' GLY . 5.9 tpt180 -90.37 96.8 10.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.51 35.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.932 . . . . 0.0 109.405 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 37' ' ' ARG . . . -92.89 -21.16 31.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 41' ' ' LYS . 11.9 p -51.55 -44.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' N ' HG13 ' A' ' 40' ' ' VAL . 75.8 tttt -174.08 -44.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.442 -0.786 . . . . 0.0 109.127 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.99 -7.72 0.26 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.14 11.28 30.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 52.49 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -1.084 . . . . 0.0 109.337 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.49 118.19 25.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.406 -0.809 . . . . 0.0 109.271 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.9 mt -88.37 97.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.331 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.37 169.48 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 108.861 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.43 130.02 34.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.389 -0.819 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.12 117.5 17.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -58.93 -28.29 66.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -23.43 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -89.47 -10.63 45.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 54' ' ' PRO . 60.4 mt -66.52 153.64 92.73 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.094 -1.004 . . . . 0.0 108.527 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.5 Cg_exo -57.16 -147.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.206 -1.076 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.01 -37.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.933 -1.104 . . . . 0.0 109.457 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.83 -30.05 71.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 111.185 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 -41.42 37.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.669 -1.269 . . . . 0.0 110.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.28 -56.7 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.122 . . . . 0.0 109.454 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.2 -48.73 23.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.284 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.89 -33.1 74.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.57 -34.01 77.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.294 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.3 mt -71.59 -27.48 63.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.251 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.42 -52.94 33.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 108.958 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -72.51 -43.96 62.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.207 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.06 142.99 36.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.76 -1.213 . . . . 0.0 109.597 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.14 -68.03 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -61.73 -24.63 66.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -1.149 . . . . 0.0 109.461 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' GLU . 19.5 mm -63.81 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 71' ' ' SER . 9.2 pt-20 37.74 36.27 0.09 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.224 0.535 . . . . 0.0 110.647 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 70' ' ' THR . 63.3 m 54.88 0.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.705 . . . . 0.0 110.606 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.4 t -148.52 159.66 43.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.803 -1.186 . . . . 0.0 109.814 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 1.9 mm? -66.7 119.37 11.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.7 -26.36 3.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -172.8 -77.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -1.062 . . . . 0.0 109.077 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 76' ' ' GLU . 40.6 p90 -142.73 -10.68 0.8 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 14.3 tt0 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.08 -1.012 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.348 0.594 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.38 131.36 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.9 tp -156.67 79.49 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -79.9 158.09 26.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.083 -1.01 . . . . 0.0 108.753 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -124.85 -138.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.509 -0.744 . . . . 0.0 109.203 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -167.04 152.55 7.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.905 -1.122 . . . . 0.0 109.609 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.35 -53.12 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.482 1.455 . . . . 0.0 110.615 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -56.47 -25.47 51.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 15.7 mm-40 -84.86 -28.06 26.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' ASN . 50.0 mt -81.96 -23.91 35.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.193 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.96 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.692 -0.63 . . . . 0.0 111.093 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.6 m120 -145.41 -7.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.521 -1.362 . . . . 0.0 110.745 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 17.6 mt -79.46 148.28 69.81 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.601 -1.312 . . . . 0.0 107.942 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.1 -64.12 0.12 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.889 1.059 . . . . 0.0 110.702 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.08 -38.3 4.72 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.9 mt -93.79 150.3 38.45 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.234 -1.156 . . . . 0.0 109.035 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.0 -178.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.804 1.002 . . . . 0.0 109.779 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.75 -7.78 27.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -117.3 129.81 56.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.655 -0.653 . . . . 0.0 109.284 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -53.24 -28.94 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.11 65.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.87 -35.23 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' ALA . 35.6 t -65.16 -56.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -1.157 . . . . 0.0 109.298 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.75 -43.56 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.2 -44.38 97.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.982 -1.074 . . . . 0.0 108.798 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.21 -19.09 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 109.125 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.61 -33.25 74.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 108.84 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -70.16 -27.61 64.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.265 -0.897 . . . . 0.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -64.79 -4.25 4.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.039 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -150.11 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.73 59.45 1.26 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.8 m-90 -56.38 147.84 20.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.037 -1.272 . . . . 0.0 108.796 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -50.33 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.608 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p30 -101.24 121.97 42.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -87.59 113.52 23.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.3 m -94.45 156.39 16.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -148.51 -54.63 0.19 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 109.376 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 77.78 102.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.735 . . . . 0.0 109.295 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.46 -34.67 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.02 -4.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -172.95 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 51.76 1.32 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.03 28.37 0.81 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.7 mttm 55.49 96.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -1.04 . . . . 0.0 109.668 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.08 113.68 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.419 -0.801 . . . . 0.0 109.003 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -87.93 101.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.838 . . . . 0.0 109.913 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 29.5 mm-40 -84.52 171.57 12.4 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -135.45 127.29 29.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -77.69 116.36 18.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.067 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.39 -23.62 39.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.23 -25.17 63.26 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.081 -1.012 . . . . 0.0 109.544 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.7 m -91.86 -13.56 31.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.46 149.1 98.53 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.854 -1.154 . . . . 0.0 109.146 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.48 -155.95 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 120.973 1.115 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.7 -36.95 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.86 -39.05 83.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.31 -20.58 47.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -75.2 -58.27 3.39 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.17 -0.956 . . . . 0.0 109.212 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.51 -44.06 55.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.102 . . . . 0.0 108.955 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.1 74.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.445 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.78 -54.76 38.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.9 mt -54.86 -27.2 40.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 108.779 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.66 -29.33 69.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 108.857 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 24.8 mtp180 -73.09 -61.03 1.96 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.6 -163.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.213 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.23 -44.43 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 69' ' ' GLU . 22.9 mt-10 -79.47 -11.68 59.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -1.143 . . . . 0.0 109.557 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 68' ' ' ILE . 26.8 mm 52.61 7.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 67' ' ' GLU . 13.3 pt-20 -45.03 136.57 4.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.372 -0.83 . . . . 0.0 110.014 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 71' ' ' SER . 12.1 t -170.61 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 109.085 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 70' ' ' THR . 51.8 m -150.34 21.74 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.47 124.45 24.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 74' ' ' TYR . . . -69.51 -12.34 66.56 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 73' ' ' GLY . 78.0 m-85 -158.83 -82.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -160.83 23.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 0.0 109.309 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -88.72 166.74 13.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 39.1 tp -163.24 77.92 0.43 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.374 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -80.02 160.23 25.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.123 -0.986 . . . . 0.0 108.783 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 6' ' ' SER . 59.3 t -132.41 160.53 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.314 -0.866 . . . . 0.0 109.705 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -104.53 152.92 39.46 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.49 -43.83 55.17 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.421 1.414 . . . . 0.0 110.665 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -27.26 63.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.11 -22.66 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 109.317 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.5 mt -82.74 -23.17 34.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.288 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.95 29.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.154 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.902 HD22 HH11 ' A' ' 64' ' ' ARG . 52.0 p-10 -148.3 -8.52 0.39 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.437 -1.414 . . . . 0.0 111.122 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 29.1 mt -78.41 147.42 72.07 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.492 -1.38 . . . . 0.0 108.05 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.22 -66.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.989 1.126 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.04 -34.79 2.14 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.7 mt -95.17 150.47 37.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.275 -1.132 . . . . 0.0 108.86 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.08 -173.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.867 1.044 . . . . 0.0 110.071 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 27.7 mmtp -100.71 -17.58 16.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -109.57 130.14 55.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.55 -0.719 . . . . 0.0 109.391 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.35 -29.35 23.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.55 73.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.63 81.44 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.55 -64.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -1.173 . . . . 0.0 109.335 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.07 -39.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.117 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.79 -40.19 91.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 108.602 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.3 -27.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.07 -28.53 17.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.23 -0.919 . . . . 0.0 108.723 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -71.69 -32.96 68.4 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 -1.15 1.83 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.457 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -150.95 -65.43 0.19 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.96 49.6 1.74 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -51.52 136.71 25.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.038 -1.272 . . . . 0.0 109.006 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.584 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.79 110.89 0.4 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.006 -1.059 . . . . 0.0 108.582 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 10.1 p30 -105.09 122.13 45.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.424 -0.798 . . . . 0.0 109.624 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -87.59 96.59 10.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 109.151 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -92.69 154.56 18.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 109.074 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -150.06 -38.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.08 -1.013 . . . . 0.0 109.086 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 75.79 63.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.622 -0.674 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.23 11.18 1.02 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.6 t -86.43 -78.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -1.147 . . . . 0.0 109.279 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.31 -59.0 1.78 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.48 -0.762 . . . . 0.0 109.22 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.79 61.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.71 42.85 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 40.2 mttm 58.04 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -1.144 . . . . 0.0 109.577 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.87 112.91 21.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 mt -88.39 119.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.655 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -104.81 171.71 7.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -136.3 135.3 38.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -76.99 118.91 20.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.929 -1.107 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' LEU . . . -55.85 -29.45 59.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.379 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -69.58 -21.61 63.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.581 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 61.6 m -91.94 -15.14 28.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.21 150.28 97.79 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 109.321 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.4 151.37 75.03 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.033 1.156 . . . . 0.0 109.621 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.1 -38.7 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.3 -37.73 78.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.861 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.03 -35.41 37.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -60.89 -62.48 1.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.49 42.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.297 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.31 74.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -45.1 94.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 108.886 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.44 -20.35 62.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.78 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 tp -68.42 -53.98 20.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.389 -0.819 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.902 HH11 HD22 ' A' ' 12' ' ' ASN . 6.6 ptm180 -71.65 -41.16 69.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.158 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.01 39.64 0.38 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.799 -1.188 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.13 -137.71 1.43 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.634 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 1.4 pm0 -84.41 148.33 26.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.131 . . . . 0.0 109.562 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.7 mp -82.25 -28.07 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.059 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' THR . 13.3 pt-20 -162.55 37.67 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 71' ' ' SER . 92.8 m 54.07 168.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.587 -0.695 . . . . 0.0 109.692 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.614 ' N ' HG22 ' A' ' 70' ' ' THR . 1.2 m 166.99 -65.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.819 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.14 143.96 25.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 109.356 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.73 7.84 0.95 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' C ' ' N ' ' A' ' 76' ' ' GLU . 94.7 m-85 -96.64 32.98 1.92 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.575 -0.956 . . . . 0.0 109.436 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 64.2 t80 53.55 13.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 74' ' ' TYR . 3.0 tm-20 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.371 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' N ' ' SD ' ' A' ' 1' ' ' MET . 35.2 mt-10 -150.69 142.3 23.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.5 tp -160.74 74.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -79.99 167.43 20.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 108.665 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.25 155.53 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 109.712 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -104.99 152.17 39.58 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.06 -46.88 30.77 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.377 1.385 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -58.37 -24.36 59.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.206 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 18.0 mm-40 -84.25 -27.65 27.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.968 -1.082 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 53.7 mt -83.0 -21.68 33.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 109.334 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.91 29.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.635 . . . . 0.0 111.133 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 21.7 p30 -148.48 -6.81 0.4 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.511 -1.368 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.5 mt -79.46 147.36 67.9 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.567 -1.333 . . . . 0.0 108.181 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.55 -67.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.056 1.171 . . . . 0.0 110.978 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.07 -36.14 2.62 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.8 mt -94.68 150.51 38.09 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.252 -1.146 . . . . 0.0 108.926 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.78 -176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.836 1.024 . . . . 0.0 110.055 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 11' ' ' ALA . 22.5 mtpt -101.34 -15.04 17.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.344 -0.848 . . . . 0.0 109.919 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 p -113.74 131.29 56.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.73 . . . . 0.0 109.408 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -52.88 -29.29 27.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 109.251 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.71 65.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.69 -35.57 28.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.1 -56.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -1.147 . . . . 0.0 109.198 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.12 -43.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -61.14 -44.82 96.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 108.986 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.61 -25.47 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.429 -0.794 . . . . 0.0 109.059 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.4 -31.06 32.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.206 -0.934 . . . . 0.0 108.956 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -71.57 -28.83 64.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 109.057 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -64.73 -4.85 4.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 109.445 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.41 -58.15 0.18 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 108.879 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.8 51.62 2.26 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.4 m-90 -51.02 137.35 21.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.123 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -49.94 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.084 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -99.94 121.02 40.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.433 -0.792 . . . . 0.0 109.887 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -88.87 120.73 30.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.858 . . . . 0.0 109.155 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.06 164.93 13.09 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.118 . . . . 0.0 109.021 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -152.0 -146.81 0.21 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.88 58.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.417 -0.802 . . . . 0.0 109.237 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -142.55 2.47 1.73 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 42' ' ' GLY . 11.0 p -79.53 28.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.26 . . . . 0.0 108.546 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 39' ' ' GLY . 34.1 mtpt 59.67 2.37 0.35 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.069 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -99.07 -68.64 0.9 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.14 -5.33 0.9 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -178.83 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.124 -1.221 . . . . 0.0 109.445 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.49 117.32 28.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 46' ' ' ILE . 17.1 tt -88.55 119.45 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.154 -0.966 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 44.6 mm-40 -100.81 172.81 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 109.502 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.23 129.96 34.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.228 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -75.34 117.32 17.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.93 -1.106 . . . . 0.0 109.489 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.33 59.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 110.437 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -69.51 -17.83 63.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -1.0 . . . . 0.0 109.576 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m -90.66 -22.33 21.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -67.11 148.39 98.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 109.031 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.4 Cg_endo -56.41 -161.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.851 1.034 . . . . 0.0 109.654 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.9 t -93.6 -33.82 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 109.375 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.2 mp0 -59.32 -39.31 82.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 109.515 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -82.19 -34.53 28.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.874 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -58.94 -39.66 82.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 -52.57 20.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.121 -0.987 . . . . 0.0 108.96 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.13 -19.48 65.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.415 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 64' ' ' ARG . 19.5 tp -63.44 -72.53 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 108.956 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.45 -29.0 22.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.094 -1.003 . . . . 0.0 108.604 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 63' ' ' LEU . 1.7 tt -65.76 -35.69 81.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.528 ' O ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -69.36 -46.25 67.44 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -46.41 110.07 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.57 15.55 0.22 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 69' ' ' GLU . 51.1 tt0 -153.96 -41.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -1.145 . . . . 0.0 109.369 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 68' ' ' ILE . 29.1 mt 53.76 3.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.404 -0.81 . . . . 0.0 109.773 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 67' ' ' GLU . 23.1 tt0 60.29 44.9 11.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 p -82.81 -165.93 1.19 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.265 -0.897 . . . . 0.0 109.275 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -161.25 59.22 0.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.39 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.98 175.04 2.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.14 -7.79 0.56 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -97.31 30.77 2.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.372 -1.075 . . . . 0.0 109.389 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 51.57 40.01 26.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.335 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.383 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 1' ' ' MET . 9.4 tmm? . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' N ' ' SD ' ' A' ' 1' ' ' MET . 8.0 tp10 -151.1 139.23 20.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 109.353 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -160.89 92.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.327 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -79.68 171.8 14.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 0.0 108.848 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.1 164.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 0.0 109.416 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -113.86 152.58 45.75 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.13 -47.94 24.81 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 121.229 1.286 . . . . 0.0 110.251 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -60.74 -24.5 65.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.985 . . . . 0.0 110.108 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 64' ' ' ARG . 43.2 mm-40 -84.35 -27.15 27.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.088 -1.008 . . . . 0.0 109.488 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -82.41 -22.49 35.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 35.4 m120 -145.68 -9.37 0.55 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.577 -1.327 . . . . 0.0 110.805 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.22 147.66 69.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.638 -1.289 . . . . 0.0 108.039 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.29 -65.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 120.994 1.13 . . . . 0.0 110.838 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.57 -36.82 3.47 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.4 mt -94.69 150.27 37.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.213 -1.169 . . . . 0.0 108.939 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.01 175.31 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.953 1.102 . . . . 0.0 109.99 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -97.89 5.71 48.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 p -130.66 130.15 43.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.455 -0.778 . . . . 0.0 109.278 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 p -52.16 -30.99 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.433 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.57 70.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.33 -35.23 81.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 27' ' ' ALA . 61.4 t -65.32 -59.88 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.25 -43.26 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 108.933 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.49 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.978 -1.076 . . . . 0.0 108.82 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.17 -18.24 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.67 -33.28 73.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.949 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 30' ' ' GLN . 6.0 mtpm? -70.55 -29.11 65.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 108.677 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -65.1 -1.57 2.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.444 -0.785 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 28' ' ' LYS . 59.8 mt-30 -150.39 -63.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.19 55.27 1.29 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -54.87 137.65 44.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.026 -1.279 . . . . 0.0 108.962 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -49.59 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.376 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 4.3 p30 -99.65 121.36 41.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.296 -0.878 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -85.73 112.95 21.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.177 -0.952 . . . . 0.0 109.167 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 45' ' ' ALA . 39.9 m -93.05 138.51 31.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 109.173 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -149.41 122.05 8.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 108.881 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.13 49.54 0.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.83 . . . . 0.0 109.965 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -91.72 -39.28 5.59 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 42' ' ' GLY . 3.1 t -61.32 -1.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' GLY . 19.4 ttpp 57.73 -5.21 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.57 -0.706 . . . . 0.0 110.533 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -67.32 -57.77 8.84 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.86 71.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mttm 58.24 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 36' ' ' THR . . . -86.66 -167.85 2.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -147.64 99.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.151 -0.968 . . . . 0.0 109.375 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 49.8 mm-40 -87.74 172.36 9.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 108.723 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.88 128.56 32.85 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.507 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -75.68 114.17 13.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.899 -1.126 . . . . 0.0 109.092 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' N ' HD21 ' A' ' 49' ' ' ASN . . . -54.32 -27.05 33.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 110.796 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 52' ' ' SER . 54.5 p30 -69.03 -17.53 63.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.895 -1.128 . . . . 0.0 110.052 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 13.5 m -90.58 -18.5 25.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.138 -0.976 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 92.1 mt -68.25 149.18 98.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.37 -156.38 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 120.918 1.079 . . . . 0.0 109.629 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.34 -36.47 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -59.35 -36.68 76.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.098 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.39 -34.41 41.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 109.572 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -55.79 -48.28 75.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.28 -57.29 11.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.64 -23.06 67.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.035 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.62 -77.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp -51.69 -14.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.11 -51.94 33.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.954 -1.092 . . . . 0.0 109.222 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 9' ' ' GLU . 11.4 ptm180 -75.61 7.76 3.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -91.01 74.98 6.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.071 -1.018 . . . . 0.0 109.13 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.14 4.56 70.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 69' ' ' GLU . 24.3 tt0 -72.28 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -1.184 . . . . 0.0 109.386 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 70' ' ' THR . 6.9 mt 56.12 0.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.968 -1.083 . . . . 0.0 109.583 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' H ' ' C ' ' A' ' 67' ' ' GLU . 23.9 mt-10 55.56 6.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 109.377 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 44.3 -167.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.401 -0.812 . . . . 0.0 109.893 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 76.19 -52.19 0.61 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 72' ' ' LEU . 9.2 mp 48.55 68.66 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -50.41 -13.23 0.7 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' N ' ' C ' ' A' ' 72' ' ' LEU . 21.2 t80 60.15 1.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -1.096 . . . . 0.0 109.427 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 73' ' ' GLY . 74.5 m-85 -145.81 6.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.177 -0.952 . . . . 0.0 109.415 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.493 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.4 pm0 -89.56 57.64 4.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp -95.53 83.7 3.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.386 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -80.31 161.59 25.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.26 152.99 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -97.68 154.72 37.79 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.83 . . . . 0.0 109.579 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.51 -51.5 10.98 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.611 1.541 . . . . 0.0 112.138 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -57.81 -17.25 14.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.81 -1.181 . . . . 0.0 110.705 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.576 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 26.1 mp0 -87.14 -28.12 22.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.679 -1.263 . . . . 0.0 108.884 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 48.7 mt -81.73 -22.35 37.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.855 . . . . 0.0 109.204 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 29.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.706 -0.621 . . . . 0.0 111.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.9 t-20 -146.7 -8.82 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.475 -1.39 . . . . 0.0 110.855 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.7 mt -78.94 147.82 70.94 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.551 -1.343 . . . . 0.0 108.006 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.67 -66.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 120.948 1.099 . . . . 0.0 110.923 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.81 -36.79 3.76 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.72 150.2 37.59 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.262 -1.14 . . . . 0.0 109.11 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.09 170.55 0.67 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 120.874 1.049 . . . . 0.0 110.063 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -94.17 2.89 55.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.868 . . . . 0.0 109.642 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -129.15 129.27 44.91 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.469 -0.769 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 p -52.21 -30.46 27.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.12 -35.72 59.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.234 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.46 -35.8 25.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.84 -58.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -1.134 . . . . 0.0 109.439 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 20.8 mt -55.15 -47.07 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.187 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -61.26 -50.82 71.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.339 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 58.6 t -65.91 -22.32 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.44 -0.787 . . . . 0.0 109.394 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.27 -30.69 18.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.102 -0.999 . . . . 0.0 109.054 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.1 mptt -71.17 -30.07 65.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.136 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -63.94 -4.14 3.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -149.96 -61.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 108.972 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.78 48.98 2.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.03 138.63 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -1.23 . . . . 0.0 109.334 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -49.93 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.854 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.8 p-10 -98.77 125.28 44.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -86.79 131.66 34.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 137.4 32.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' CD ' ' H ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -88.09 -144.87 0.14 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' H ' ' CD ' ' A' ' 37' ' ' ARG . . . -172.36 71.71 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.658 -1.277 . . . . 0.0 110.604 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 159.49 -73.78 0.21 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.695 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.3 p 33.17 30.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.548 0.69 . . . . 0.0 110.342 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 39' ' ' GLY . 6.0 pttt 71.62 -21.18 0.22 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -95.96 -72.44 1.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.27 -16.5 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.051 -1.264 . . . . 0.0 110.639 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -171.31 99.86 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.331 . . . . 0.0 109.235 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.0 -169.61 2.65 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 46' ' ' ILE . 16.7 tt -150.07 128.62 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.9 mp0 -109.59 174.01 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.25 131.7 36.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.325 -0.859 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.07 114.31 13.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 109.104 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.14 57.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 110.227 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -68.33 -18.13 64.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.997 . . . . 0.0 109.834 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -89.77 -19.33 24.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 98.4 mt -67.11 149.62 98.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 108.941 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.9 Cg_endo -56.06 -162.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.71 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.36 -37.29 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.198 -0.939 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -60.15 -37.13 79.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.281 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.99 -30.09 49.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.063 . . . . 0.0 109.644 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -59.86 -54.51 45.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 109.117 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.87 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.028 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.07 -30.03 69.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.926 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 62' ' ' LEU . 2.0 tm? -64.82 -66.07 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 109.213 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 61' ' ' LEU . 2.0 pp -55.28 -21.19 13.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 109.224 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tp -65.68 -32.72 74.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 108.451 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 28.3 mtp180 -68.83 -37.74 79.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.573 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 64' ' ' ARG . 58.2 mm-40 -56.92 -107.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.38 66.85 2.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.2 mp0 57.72 137.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.974 -0.721 . . . . 0.0 110.23 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.38 -90.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -170.96 25.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.845 . . . . 0.0 109.296 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 72' ' ' LEU . 10.4 t -165.1 -150.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.236 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 m 51.96 -93.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 74' ' ' TYR . 18.6 mt -76.44 9.53 2.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.602 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.05 19.36 1.28 Allowed Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' H ' ' C ' ' A' ' 72' ' ' LEU . 44.8 t80 -87.28 16.84 4.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -1.077 . . . . 0.0 109.446 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 50.2 34.77 9.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 109.763 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' CD ' ' HE1' ' A' ' 4' ' ' TRP . 23.4 tp10 -150.47 59.04 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.08 82.03 1.92 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.396 -0.815 . . . . 0.0 109.995 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.561 ' HE1' ' CD ' ' A' ' 2' ' ' GLU . 47.5 m95 -80.34 171.34 15.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.825 -1.172 . . . . 0.0 108.227 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.97 -137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -169.33 151.33 4.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.372 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.06 -49.15 16.32 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.352 1.368 . . . . 0.0 110.677 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -59.4 -27.81 66.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.224 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.23 -26.57 28.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 25.5 mt -82.91 -18.77 38.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.38 32.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 0.0 110.971 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.3 t-20 -146.15 -9.02 0.52 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.476 -1.39 . . . . 0.0 110.921 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.1 mt -78.56 147.55 71.76 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.358 . . . . 0.0 108.154 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.02 -65.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.996 1.13 . . . . 0.0 110.578 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.27 -37.06 4.44 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.3 mt -93.76 149.97 37.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.221 -1.164 . . . . 0.0 108.952 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.52 177.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 120.753 0.969 . . . . 0.0 109.779 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -99.08 -2.32 37.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -123.76 131.4 53.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.375 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -52.66 -30.32 31.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.17 53.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.69 -35.6 18.88 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.02 -45.85 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.71 -47.21 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.91 -41.82 96.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HE22 ' A' ' 30' ' ' GLN . 62.1 t -75.05 -29.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.262 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.52 -29.27 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 108.748 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -71.9 -33.44 68.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.444 -0.785 . . . . 0.0 109.05 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 15.1 mtpp -64.79 -1.74 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.57 HE22 HG12 ' A' ' 26' ' ' VAL . 2.2 mp0 -149.32 -68.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.358 -0.839 . . . . 0.0 108.765 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.0 55.88 1.35 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -51.3 152.08 2.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.253 . . . . 0.0 109.198 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -52.8 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.645 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -101.58 112.47 25.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.506 ' CB ' HH11 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -90.06 141.61 28.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.037 -1.039 . . . . 0.0 108.346 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.43 134.65 34.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.724 -1.235 . . . . 0.0 109.777 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -91.42 -147.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.69 49.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.085 -1.009 . . . . 0.0 109.973 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.76 70.95 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -126.47 -92.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.992 . . . . 0.0 108.454 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' H ' HG23 ' A' ' 40' ' ' VAL . 63.2 mmtt -107.09 -64.66 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.21 -61.59 1.81 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.44 33.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -177.25 94.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 0.0 109.772 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -87.84 155.68 19.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.207 -0.933 . . . . 0.0 108.749 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 47' ' ' GLU . 14.0 tt -96.95 -41.96 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.28 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 46' ' ' ILE . 42.5 mt-10 55.26 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.849 0.833 . . . . 0.0 110.797 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -134.01 133.03 40.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.435 -0.791 . . . . 0.0 108.941 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -76.57 116.66 17.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 109.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 -27.51 55.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.365 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -70.9 -23.12 62.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.4 m -89.83 -12.87 37.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -0.965 . . . . 0.0 110.087 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.8 150.46 97.62 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.323 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 169.12 5.14 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.988 1.126 . . . . 0.0 109.424 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.23 -37.89 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.024 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.78 -39.15 80.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.11 -39.8 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.976 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.88 -57.86 11.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.607 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.87 58.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.083 -1.011 . . . . 0.0 109.33 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.26 -28.67 68.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -63.18 -49.76 72.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.386 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.5 -19.57 65.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.073 -1.017 . . . . 0.0 109.084 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -58.19 4.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -72.32 -41.26 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.515 ' N ' ' HE ' ' A' ' 64' ' ' ARG . 71.0 mt-30 -63.25 -101.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.753 -1.217 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 58.37 174.96 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 66' ' ' GLY . 42.4 mt-10 52.91 102.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.36 -1.082 . . . . 0.0 109.637 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.24 -63.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.468 -0.77 . . . . 0.0 109.075 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 71' ' ' SER . 7.6 tp10 -69.84 116.2 9.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.682 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 70' ' ' THR . 60.0 m 54.73 0.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.425 -0.797 . . . . 0.0 110.222 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 69' ' ' GLU . 34.4 t 47.42 31.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.939 -1.101 . . . . 0.0 109.65 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.5 mt 57.01 93.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.88 -20.47 79.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 38.1 t80 -165.39 26.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 52.2 t80 54.3 21.1 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 50.1 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.9 pm0 -89.86 -87.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.244 -0.91 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.4 tp 54.62 74.33 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 109.526 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 42.7 m95 -80.73 161.11 24.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 108.734 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 6' ' ' SER . 57.8 t -135.25 158.26 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -100.63 153.36 37.78 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.494 -0.754 . . . . 0.0 109.231 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.32 -40.04 87.75 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.114 1.209 . . . . 0.0 110.183 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -58.54 -27.24 64.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.63 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 34.3 mt-10 -83.57 -24.9 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 12' ' ' ASN . 91.5 mt -83.48 -23.93 31.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.99 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.625 -0.672 . . . . 0.0 111.21 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.734 HD21 HH12 ' A' ' 64' ' ' ARG . 1.3 p30 -149.42 -8.1 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.415 -1.428 . . . . 0.0 111.035 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.4 mt -78.75 147.89 71.72 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.618 -1.301 . . . . 0.0 108.118 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.97 -67.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.11 1.207 . . . . 0.0 110.989 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.16 2.19 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.35 150.36 37.47 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.29 -1.123 . . . . 0.0 108.882 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.44 -174.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 120.806 1.004 . . . . 0.0 110.021 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ALA . 65.2 mmtt -101.08 -16.56 17.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.324 -0.86 . . . . 0.0 109.558 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -110.65 131.2 55.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.478 -0.763 . . . . 0.0 109.478 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.88 -29.56 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.48 -39.62 70.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.43 56.37 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.59 -62.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mt -49.94 -40.62 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 108.673 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.36 -42.2 98.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.124 -0.985 . . . . 0.0 108.678 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -76.66 -20.45 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.499 -0.751 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.2 -39.59 60.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.08 -1.013 . . . . 0.0 110.188 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLN . 4.8 ptmt -70.91 -23.14 62.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 109.262 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.99 -4.49 2.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 108.731 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.27 -58.99 0.19 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.79 48.01 2.01 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -54.99 133.89 48.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.832 -1.393 . . . . 0.0 108.633 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.601 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.41 108.83 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.98 -1.075 . . . . 0.0 108.761 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.31 121.81 44.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.416 -0.802 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 35' ' ' ARG . 20.2 ttm-85 -88.96 139.36 30.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 109.447 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 107.48 19.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 108.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -89.15 91.9 8.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.2 -0.938 . . . . 0.0 109.117 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.69 52.68 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.853 . . . . 0.0 109.651 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 37' ' ' ARG . . . -158.2 64.3 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.13 -85.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -1.146 . . . . 0.0 109.16 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -96.97 -9.4 28.36 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.293 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 56.99 1.96 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.0 35.82 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mttp 51.04 89.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -1.159 . . . . 0.0 109.523 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.95 138.79 31.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.256 -0.903 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.1 tt -90.19 155.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.95 . . . . 0.0 109.637 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 68.4 mm-40 -139.98 175.35 9.66 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -136.3 134.24 37.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.414 -0.804 . . . . 0.0 109.31 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -75.87 114.18 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.138 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.54 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.305 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 1' ' ' MET . 1.7 m-80 -69.82 -20.77 63.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.915 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 27.8 m -90.58 -10.43 43.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.112 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 54' ' ' PRO . 76.1 mt -68.45 150.3 97.74 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.034 -1.041 . . . . 0.0 109.305 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -59.0 -155.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 120.968 1.112 . . . . 0.0 109.459 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.07 -36.62 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.48 -37.12 80.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.93 -25.49 40.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.363 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -62.02 -66.83 0.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.11 33.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.519 -0.738 . . . . 0.0 109.425 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.45 80.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.23 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.47 -24.21 67.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 108.695 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.87 -29.9 58.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.18 -36.39 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.734 HH12 HD21 ' A' ' 12' ' ' ASN . 20.1 mtp180 -72.52 -66.07 0.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -91.04 -128.5 0.09 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -0.782 . . . . 0.0 109.121 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.55 32.05 3.9 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.54 -9.38 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.173 . . . . 0.0 109.343 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 mm -82.72 -76.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.256 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -158.1 26.13 0.26 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.321 -0.862 . . . . 0.0 109.306 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 p -79.01 -64.37 1.2 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.132 -0.98 . . . . 0.0 109.529 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -160.74 81.73 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 74' ' ' TYR . 18.6 mt -72.13 -54.96 8.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 75' ' ' PHE . . . 72.08 -17.69 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 72' ' ' LEU . 83.9 m-85 52.61 9.28 0.11 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -1.075 . . . . 0.0 109.334 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' N ' ' C ' ' A' ' 73' ' ' GLY . 52.4 t80 -142.44 3.85 1.53 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 109.615 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 6.7 tm-20 -150.18 -23.36 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.091 -1.006 . . . . 0.0 109.175 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.9 tp -125.36 81.27 1.96 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.58 -0.7 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -79.72 171.97 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.023 . . . . 0.0 108.26 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.64 145.65 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.112 -0.993 . . . . 0.0 109.874 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -95.46 153.28 39.58 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.348 -0.845 . . . . 0.0 109.321 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.49 -42.48 65.31 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.233 1.288 . . . . 0.0 110.458 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -59.22 -24.41 63.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.545 ' CD ' HH12 ' A' ' 64' ' ' ARG . 12.5 mm-40 -84.24 -24.39 30.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -83.2 -24.35 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.99 29.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 111.345 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -147.32 -9.23 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.467 -1.396 . . . . 0.0 110.919 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' LEU . 40.1 mt -79.13 147.13 68.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.533 -1.354 . . . . 0.0 108.061 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -65.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.097 1.198 . . . . 0.0 110.739 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.63 -35.63 3.09 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.28 150.01 37.0 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.23 -1.159 . . . . 0.0 109.009 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.41 175.31 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 120.803 1.002 . . . . 0.0 109.787 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -97.16 6.59 48.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 109.749 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -133.6 130.74 38.78 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.521 -0.737 . . . . 0.0 109.205 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 p -52.57 -31.26 35.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.383 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.47 56.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.81 -38.39 20.05 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.14 -63.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.264 -1.139 . . . . 0.0 109.444 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.8 mt -47.87 -41.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.069 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.7 -48.35 81.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.184 -0.948 . . . . 0.0 108.703 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' HZ1' ' A' ' 29' ' ' LYS . 45.9 t -61.57 -28.65 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.74 -31.02 10.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.15 -0.969 . . . . 0.0 108.927 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.5 mptt -72.7 -38.46 67.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 108.687 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' CB ' ' NZ ' ' A' ' 29' ' ' LYS . 4.9 ttpm? -65.36 -3.6 4.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -150.32 -70.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 108.894 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.68 54.41 1.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.91 145.24 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.09 -1.241 . . . . 0.0 109.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -52.64 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.997 . . . . 0.0 109.056 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.8 p-10 -97.63 118.25 33.73 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -86.73 139.52 30.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.24 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -93.96 133.65 37.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 108.861 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 6.8 tpp180 -90.02 -65.37 1.02 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 109.18 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 76.6 40.49 0.21 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 109.552 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.98 15.5 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 40' ' ' VAL . 2.4 m -89.65 -37.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -1.219 . . . . 0.0 109.17 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -176.59 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.374 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.66 -111.85 1.36 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.31 17.6 0.21 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -179.73 96.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.18 -174.58 4.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.7 mm -139.91 75.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.4 168.72 15.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.121 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -133.58 132.43 40.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.384 -0.823 . . . . 0.0 109.534 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 51' ' ' ASN . 51.7 t-20 -76.12 117.23 17.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.179 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.28 65.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.325 -0.86 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 49' ' ' ASN . 43.1 p30 -67.44 -16.43 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 74.0 m -90.0 -16.53 29.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.1 mt -67.96 149.67 98.1 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.115 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.65 -156.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.903 1.069 . . . . 0.0 109.5 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.67 -36.76 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 109.78 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -60.24 -36.81 78.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.95 43.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 109.8 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -65.34 -65.68 0.64 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 108.744 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.56 19.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.517 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.37 80.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 tp -62.38 -52.18 64.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 108.795 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 62' ' ' LEU . 47.1 mt -56.29 -27.51 55.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.659 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.289 -0.882 . . . . 0.0 108.674 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.545 HH12 ' CD ' ' A' ' 9' ' ' GLU . 11.3 mtm180 -73.03 -69.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.0 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -46.24 160.63 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.605 -0.684 . . . . 0.0 109.908 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.15 -86.98 0.1 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.64 92.73 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 69' ' ' GLU . 17.6 mm -66.44 -40.7 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.41 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' ILE . 33.9 tt0 49.02 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 71' ' ' SER . 9.6 t -165.53 -45.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 70' ' ' THR . 38.6 t -137.93 -71.52 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.682 HD22 ' C ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.03 -3.29 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 110.324 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 71' ' ' SER . . . -78.53 52.59 3.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -72.13 -11.17 60.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -1.118 . . . . 0.0 109.057 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 74' ' ' TYR . 3.8 p90 175.9 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 75' ' ' PHE . 6.6 pt-20 . . . . . 0 N--CA 1.503 2.209 0 CA-C-O 121.304 0.573 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.1 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 5.3 mp0 -89.3 124.49 34.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.9 tp -158.34 100.52 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -99.83 171.1 8.09 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 108.691 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 61' ' ' LEU . 12.2 t -140.59 155.52 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.182 -0.949 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -101.27 153.04 38.04 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 121.446 -0.784 . . . . 0.0 109.289 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.19 -43.39 59.45 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 121.371 1.38 . . . . 0.0 110.555 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -58.37 -27.24 64.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 0.0 109.78 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.463 ' OE1' ' CZ ' ' A' ' 64' ' ' ARG . 35.2 mm-40 -84.78 -24.74 28.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.17 -0.956 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.1 mt -83.53 -21.36 32.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.106 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -146.42 -4.18 0.61 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.501 -1.375 . . . . 0.0 110.642 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 12.0 mt -79.69 147.86 68.02 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.588 -1.32 . . . . 0.0 108.004 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.22 -64.52 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 120.882 1.054 . . . . 0.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.28 -35.94 7.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 30.0 mt -93.62 150.06 38.18 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.122 -1.222 . . . . 0.0 109.141 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.35 -175.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 120.876 1.051 . . . . 0.0 109.924 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -104.89 5.83 33.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.525 -0.734 . . . . 0.0 109.757 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 p -132.93 133.12 42.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -53.36 -30.62 40.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.57 62.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.82 -35.74 18.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.25 -49.72 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -65.09 -44.79 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -60.75 -41.96 96.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 108.92 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.82 -27.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.43 -0.794 . . . . 0.0 109.024 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.86 -29.31 19.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.6 -29.93 65.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.37 -0.831 . . . . 0.0 108.897 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.35 -4.13 3.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.48 -61.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.368 -0.833 . . . . 0.0 108.88 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.37 54.48 1.57 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.44 141.2 37.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.075 -1.25 . . . . 0.0 108.844 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -47.93 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.232 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.9 p30 -101.45 116.76 33.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.466 -0.772 . . . . 0.0 110.106 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -89.32 147.7 23.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 109.058 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -94.9 133.97 38.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.0 -1.063 . . . . 0.0 109.088 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.413 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 5.9 tpt180 -92.31 -55.81 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.2 79.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.446 -0.784 . . . . 0.0 109.407 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.94 -26.66 0.09 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 41' ' ' LYS . 26.9 m -73.31 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.223 -1.163 . . . . 0.0 109.86 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.76 ' H ' HG23 ' A' ' 40' ' ' VAL . 28.7 pttt -177.28 75.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.938 . . . . 0.0 109.586 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 44' ' ' LYS . . . 169.72 -5.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.39 -2.53 1.6 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' GLY . 46.3 tttp -174.63 89.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.999 . . . . 0.0 108.981 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.79 -163.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.172 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.58 89.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.234 -0.916 . . . . 0.0 109.002 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -76.49 169.13 18.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 108.849 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -135.16 134.87 40.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.834 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 17.6 t-20 -76.27 115.81 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 109.298 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.58 -34.16 64.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.374 -0.828 . . . . 0.0 110.61 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -69.98 -17.03 63.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.6 m -90.03 -15.46 31.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 109.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' PRO . 96.1 mt -67.96 148.96 98.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.0 Cg_exo -54.94 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.967 1.111 . . . . 0.0 109.833 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.5 -38.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -0.931 . . . . 0.0 109.928 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -58.17 -40.3 81.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.628 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.24 -38.54 42.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.124 -0.985 . . . . 0.0 109.228 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -49.03 -60.7 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.725 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.26 63.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.599 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -23.41 67.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 109.586 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -65.98 -63.89 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -44.93 -44.01 9.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 110.025 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.4 mt -66.3 -28.97 69.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 108.835 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -71.75 -44.77 63.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 65' ' ' GLN . 17.3 mt-30 -43.07 154.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.46 100.22 0.22 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' GLU . 37.2 mt-10 -48.78 -35.75 15.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -1.197 . . . . 0.0 109.256 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 68' ' ' ILE . 26.6 mt 54.73 -1.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.59 -0.694 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' GLU . 39.5 tt0 -92.43 -42.46 9.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.868 -1.145 . . . . 0.0 109.073 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 t -161.95 178.83 8.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 m 46.25 85.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.704 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -156.53 177.87 10.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.373 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.55 11.9 0.52 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 64.51 18.29 11.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.601 -0.94 . . . . 0.0 109.225 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 86.6 t80 -144.33 6.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 109.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 1.4 pm0 -151.14 47.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.3 tp -96.29 86.22 4.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.247 -0.908 . . . . 0.0 109.132 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -84.81 155.9 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 61' ' ' LEU . 57.5 t -130.62 163.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.0 109.644 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.6 m -108.2 153.11 42.06 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.486 -0.759 . . . . 0.0 109.05 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.15 -44.55 48.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.239 1.293 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -57.68 -25.65 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 45.8 mt-10 -84.43 -24.18 29.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.128 -0.983 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.8 mt -82.96 -22.93 33.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.09 29.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.64 -0.663 . . . . 0.0 111.232 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 10.0 t-20 -146.57 -7.47 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.513 -1.367 . . . . 0.0 110.892 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.4 mt -79.4 147.45 68.35 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 0.0 108.195 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.11 -63.97 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.962 1.108 . . . . 0.0 110.606 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.48 -38.22 5.2 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 26.2 mt -94.01 149.87 37.58 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.137 -1.214 . . . . 0.0 109.175 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.14 -178.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.875 1.05 . . . . 0.0 109.732 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -101.17 7.38 43.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -133.19 130.17 38.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.408 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -52.5 -30.64 31.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.354 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.75 -37.0 62.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.28 19.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.84 -58.78 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.275 -1.132 . . . . 0.0 109.171 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -52.4 -43.06 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -60.69 -41.76 95.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 108.933 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.96 -22.87 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.079 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.3 -29.81 66.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.192 -0.942 . . . . 0.0 108.497 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' GLN . 77.5 mttt -71.98 -32.79 67.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 109.065 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -65.03 2.92 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 108.888 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.1 mt-30 -150.85 -64.88 0.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.58 47.21 2.18 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -50.8 135.73 23.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.305 . . . . 0.0 108.961 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.27 112.21 0.55 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.008 -1.057 . . . . 0.0 108.617 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.408 ' ND2' HD11 ' A' ' 46' ' ' ILE . 5.2 p30 -107.51 119.55 39.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.502 -0.748 . . . . 0.0 109.832 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 20.7 ttm-85 -86.01 115.03 23.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.169 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.9 m -93.23 80.34 4.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' NE ' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -91.44 105.39 17.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.339 -0.85 . . . . 0.0 109.158 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' N ' ' NE ' ' A' ' 37' ' ' ARG . . . -75.2 59.96 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . -132.33 -35.31 0.33 Allowed Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 m -48.84 -12.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.054 -1.262 . . . . 0.0 109.831 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLY . 48.7 pttt -170.87 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 109.699 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.82 55.2 0.84 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.37 30.27 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp 51.02 77.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -1.127 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.07 138.95 30.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 109.254 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.43 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 6.1 tp -89.03 146.36 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 109.249 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 46' ' ' ILE . 8.5 mp0 -134.67 174.83 10.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.727 . . . . 0.0 109.149 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -136.4 134.61 37.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 0.0 109.237 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -76.89 119.85 21.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.904 -1.123 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.03 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.71 -19.13 64.35 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.012 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 44.4 m -92.0 -16.33 26.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 110.15 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.76 149.41 98.27 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 120.936 -1.103 . . . . 0.0 108.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.64 -166.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 120.864 1.043 . . . . 0.0 109.538 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.0 -35.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 109.263 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.4 mp0 -59.86 -39.47 85.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.407 -0.808 . . . . 0.0 109.515 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.6 14.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.625 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -50.34 -52.35 37.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.27 -51.96 64.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.48 67.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.453 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -64.84 -60.62 2.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 108.793 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.21 -34.01 5.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.696 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.38 -35.21 80.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 108.38 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 22.6 mtp180 -71.12 -58.92 3.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.188 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.82 -69.52 0.13 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.229 -0.92 . . . . 0.0 109.711 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.57 -78.31 1.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 6.9 pt-20 -166.04 109.01 0.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -1.148 . . . . 0.0 109.419 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm -134.91 -44.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.311 -0.868 . . . . 0.0 108.771 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 71' ' ' SER . 61.7 mm-40 -63.77 146.38 53.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.481 -0.762 . . . . 0.0 109.843 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 71' ' ' SER . 0.8 OUTLIER 57.24 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.823 -0.548 . . . . 0.0 110.807 179.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.577 ' N ' ' OG1' ' A' ' 70' ' ' THR . 11.1 t -50.19 87.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' THR . 68.0 mt -148.61 -164.77 2.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.896 . . . . 0.0 109.028 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 72.82 -14.21 2.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 72' ' ' LEU . 52.9 m-85 52.94 8.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -1.028 . . . . 0.0 109.08 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.496 ' H ' ' C ' ' A' ' 73' ' ' GLY . 65.8 t80 -154.56 14.67 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.417 -0.802 . . . . 0.0 109.401 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HB2' ' HE1' ' A' ' 4' ' ' TRP . 5.2 pt-20 -88.54 68.61 8.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.146 -0.971 . . . . 0.0 109.224 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD21 HE22 ' A' ' 65' ' ' GLN . 13.0 tp -91.25 84.48 5.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.404 ' HE1' ' HB2' ' A' ' 2' ' ' GLU . 59.1 m95 -79.79 167.09 21.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 108.729 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.71 -136.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.271 -0.893 . . . . 0.0 109.618 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.512 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -167.41 152.8 7.08 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.652 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.4 -51.89 8.97 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.596 1.531 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD2' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.13 -22.8 42.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -0.999 . . . . 0.0 110.067 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -85.9 -25.97 25.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.034 -1.041 . . . . 0.0 109.251 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' ASN . 77.6 mt -82.6 -23.04 34.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LYS . . . -64.1 32.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.766 -0.584 . . . . 0.0 111.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.4 t-20 -147.67 -10.97 0.4 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.43 -1.419 . . . . 0.0 111.142 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' LEU . 26.5 mt -78.89 147.35 70.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.574 -1.329 . . . . 0.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.75 -61.68 0.24 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.012 1.141 . . . . 0.0 110.758 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.09 -38.73 4.91 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' LEU . 12.1 mt -94.94 151.05 38.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.275 -1.132 . . . . 0.0 108.755 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.41 -174.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 120.747 0.965 . . . . 0.0 110.081 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 28.8 mmtp -99.14 -15.67 18.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -111.09 132.31 54.37 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.599 -0.688 . . . . 0.0 109.451 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -53.23 -28.88 29.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -49.12 69.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.18 -34.18 89.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.38 -61.38 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -1.168 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.02 -43.01 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -60.19 -41.43 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.924 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.05 -25.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.46 -0.775 . . . . 0.0 108.991 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -54.32 -25.26 22.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.112 -0.993 . . . . 0.0 108.434 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -72.85 -32.76 65.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -65.19 -9.57 24.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.488 -0.757 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -150.07 -64.4 0.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.28 -0.887 . . . . 0.0 108.904 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.01 62.04 1.19 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -54.71 148.33 12.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -1.211 . . . . 0.0 109.02 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.01 98.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.2 p30 -108.4 117.75 34.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.99 121.01 28.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.542 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -93.22 125.95 38.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.98 -1.075 . . . . 0.0 108.949 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.658 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -90.92 -55.94 3.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 77.44 29.24 0.55 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.493 -0.755 . . . . 0.0 109.207 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.43 12.08 70.3 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 42' ' ' GLY . 2.9 m -88.39 33.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -1.028 . . . . 0.0 108.953 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mttm 60.87 -0.89 0.27 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . 141.73 108.82 0.72 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' LYS . . . 165.59 -19.3 0.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' GLY . 22.6 mmtp 52.3 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -1.132 . . . . 0.0 109.073 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -173.95 4.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 108.922 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 mt -146.61 99.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.006 -1.059 . . . . 0.0 109.872 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.06 175.27 8.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.59 123.89 21.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.304 -0.872 . . . . 0.0 109.901 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.06 114.73 12.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 108.532 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.22 22.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.805 . . . . 0.0 111.315 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 52' ' ' SER . 41.0 p-10 -71.07 -21.87 62.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.684 -1.26 . . . . 0.0 110.52 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.481 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 36.9 m -93.71 -8.27 41.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.905 -1.122 . . . . 0.0 110.552 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -68.97 149.51 97.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 0.0 109.724 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.26 140.77 84.94 Favored 'Trans proline' 0 C--O 1.21 -0.903 0 C-N-CA 121.173 1.249 . . . . 0.0 109.324 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' VAL . 17.5 t -42.27 -41.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.432 -0.793 . . . . 0.0 111.02 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -55.81 -48.03 76.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.005 -1.06 . . . . 0.0 109.991 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.86 -43.09 25.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -46.02 -58.01 3.95 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.358 0.599 . . . . 0.0 109.415 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.01 61.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.9 64.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -65.67 -75.71 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.116 -0.99 . . . . 0.0 109.182 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.68 -13.6 1.75 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.78 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.19 -49.55 64.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.325 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -74.23 5.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.015 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.4 HE22 HD21 ' A' ' 3' ' ' LEU . 77.4 mt-30 -98.71 148.52 23.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.305 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 67' ' ' GLU . . . 160.81 75.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.1 pt-20 32.81 55.73 0.42 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.059 -0.671 . . . . 0.0 111.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.92 -71.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.967 . . . . 0.0 108.574 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -110.96 40.53 2.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.608 -0.683 . . . . 0.0 109.498 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.0 m -79.97 -54.37 5.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.9 t -173.57 -89.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 109.43 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.9 mt 56.68 -142.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.6 1.28 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 45.5 t80 -168.32 33.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.405 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 51.1 38.78 21.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.232 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' SD ' ' A' ' 1' ' ' MET . 1.7 tmt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -88.76 -168.31 2.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 109.377 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -165.29 76.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -80.28 158.61 26.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 6' ' ' SER . 99.8 t -131.77 162.84 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -103.78 153.44 38.73 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.2 -46.64 32.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 121.377 1.385 . . . . 0.0 110.924 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -59.56 -21.8 60.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.111 -0.993 . . . . 0.0 110.656 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 39.6 mm-40 -85.14 -25.73 27.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.6 mt -82.94 -22.66 33.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.637 -0.664 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 10' ' ' LEU . 41.6 m-80 -147.03 -10.8 0.44 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.621 -1.299 . . . . 0.0 110.936 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 16' ' ' LEU . 31.6 mt -78.27 146.89 71.6 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.531 -1.356 . . . . 0.0 108.103 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -64.86 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.028 1.152 . . . . 0.0 110.937 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.12 -36.86 2.93 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.9 mt -96.02 150.46 37.3 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.249 -1.148 . . . . 0.0 108.972 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.34 176.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.864 1.043 . . . . 0.0 110.014 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -95.19 -13.09 25.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 109.61 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -106.15 130.83 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.662 . . . . 0.0 109.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -53.0 -29.3 28.46 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.89 -55.62 32.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.792 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -53.01 -36.66 52.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.89 -65.61 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.077 -1.249 . . . . 0.0 109.64 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 11.0 mt -48.83 -42.31 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.211 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.75 -49.15 77.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.849 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 22' ' ' GLY . 49.5 t -65.34 -22.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.49 -34.37 24.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 109.405 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -28.1 64.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 108.648 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -64.35 -5.27 4.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.247 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -151.25 -60.74 0.18 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.331 -0.856 . . . . 0.0 108.809 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.4 47.15 2.22 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -52.16 135.51 31.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.935 -1.333 . . . . 0.0 109.03 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -49.14 110.43 0.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.075 -1.016 . . . . 0.0 108.748 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 124.33 49.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -86.17 115.08 23.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.56 108.81 20.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.291 -0.88 . . . . 0.0 108.688 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.49 -30.4 14.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 51.03 90.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.82 -20.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.218 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 40' ' ' VAL . 2.2 m -75.62 -42.09 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.027 -1.278 . . . . 0.0 109.666 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -157.09 -70.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.192 -0.943 . . . . 0.0 109.304 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.21 167.1 53.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' LYS . . . -72.65 -1.07 52.34 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 27.0 mtmm -157.93 92.89 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -1.074 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.04 110.08 19.26 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mt -82.93 100.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.072 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -87.26 175.99 7.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -136.1 133.72 37.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -76.54 117.58 18.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.961 -1.087 . . . . 0.0 108.991 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.93 61.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -21.3 62.93 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 34.4 m -90.98 -13.72 32.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.022 -1.049 . . . . 0.0 110.191 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.0 mt -67.39 149.07 98.58 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 108.986 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.3 Cg_exo -55.04 -165.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.982 1.121 . . . . 0.0 109.724 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.12 -37.61 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.35 -37.47 80.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.259 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.76 -31.62 40.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.703 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -60.93 -67.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.016 -1.052 . . . . 0.0 108.911 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.54 -42.81 16.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 109.568 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.41 84.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.51 -60.82 2.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 mt -49.53 -25.42 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 65' ' ' GLN . 9.1 tp -68.09 -56.4 8.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.491 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -75.54 28.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.838 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 63' ' ' LEU . 80.2 mt-30 -139.2 56.52 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.27 70.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -175.67 2.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -1.132 . . . . 0.0 109.484 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -85.38 -38.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 71' ' ' SER . 55.9 mm-40 -143.46 33.72 1.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 108.926 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 70' ' ' THR . 39.5 m 55.62 4.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.37 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 69' ' ' GLU . 1.3 m 65.96 58.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.526 -0.734 . . . . 0.0 109.709 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.3 mt 55.83 169.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.746 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 175.44 -13.89 0.03 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 55.06 7.58 0.19 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.455 -1.027 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' H ' ' C ' ' A' ' 73' ' ' GLY . 47.4 t80 -149.51 12.52 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.365 -0.835 . . . . 0.0 109.413 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mtp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -150.99 83.01 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 109.388 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.6 tp -97.34 91.42 5.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -86.99 165.85 15.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 108.863 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 6' ' ' SER . 48.0 t -139.05 162.42 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -110.56 152.64 43.52 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.52 -0.737 . . . . 0.0 109.049 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.62 -43.58 54.19 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.282 1.321 . . . . 0.0 110.606 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -59.65 -25.27 64.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 109.896 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -85.03 -24.68 28.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.5 mt -81.15 -24.6 37.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 109.003 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.669 -0.645 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 14.2 m120 -146.18 -6.8 0.56 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.566 -1.333 . . . . 0.0 110.835 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -79.48 147.74 68.62 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.599 -1.313 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 120.908 1.072 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.46 -35.69 4.08 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 25.7 mt -93.9 149.28 36.73 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.135 -1.215 . . . . 0.0 109.117 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.64 178.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.882 1.055 . . . . 0.0 109.818 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -98.28 6.43 47.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.01 129.77 40.54 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.405 -0.81 . . . . 0.0 109.332 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -52.39 -30.58 29.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.419 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.44 66.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -72.94 -36.73 57.14 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.58 -64.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 109.394 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -49.78 -40.94 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.93 . . . . 0.0 109.095 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.93 -40.03 91.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 108.888 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.8 t -74.21 -27.82 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.92 -28.73 10.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 108.718 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.3 mptt -72.43 -39.78 67.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -65.48 -0.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.393 -0.817 . . . . 0.0 109.711 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -151.82 -69.98 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 109.055 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.31 53.95 1.53 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.2 m-90 -51.02 147.71 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.227 . . . . 0.0 109.283 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -49.47 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 108.908 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 32' ' ' TRP . 10.9 p30 -103.0 118.27 36.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -87.9 118.88 27.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.928 . . . . 0.0 109.891 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.2 m -93.52 123.53 36.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 108.832 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 19.9 tpt180 -90.04 -62.98 1.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 76.82 87.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.54 -15.8 0.56 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.45 -71.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.046 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -100.14 -6.27 26.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.102 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.36 52.98 4.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.95 37.52 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 53.96 94.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 114.24 21.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.1 mm -86.47 113.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.661 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.27 174.06 6.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.462 -0.774 . . . . 0.0 109.057 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.17 126.9 29.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.452 -0.78 . . . . 0.0 109.47 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -75.33 113.97 13.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 0.0 109.033 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.8 -25.99 21.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.205 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -70.38 -22.97 62.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 0.0 109.792 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 m -90.45 -17.35 27.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.104 -0.998 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.18 148.71 98.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.955 -1.091 . . . . 0.0 109.014 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.58 -160.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.919 1.079 . . . . 0.0 109.693 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.74 -36.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.12 -39.09 81.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.308 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.03 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.7 -57.14 13.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.375 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.58 76.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.44 70.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 109.849 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.68 -32.63 73.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 mt -69.13 -45.14 70.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.04 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.9 mp -66.09 -27.35 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -72.52 -54.22 9.85 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 64' ' ' ARG . 38.2 mt-30 -47.99 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.58 -117.52 0.63 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -68.7 94.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 109.369 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -82.07 -75.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -172.72 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -166.82 -22.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.329 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.2 t -52.4 -35.3 51.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 74' ' ' TYR . 3.0 pp -171.83 -3.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.85 0.94 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 46.2 t80 -82.2 23.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 109.502 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 53.43 18.15 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.478 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 180.0 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -89.22 148.86 23.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.913 . . . . 0.0 109.567 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 33.4 tp -151.57 75.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -0.929 . . . . 0.0 108.922 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.3 m95 -81.98 159.7 23.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.12 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.97 152.29 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 0.0 109.628 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.47 153.49 37.75 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.843 . . . . 0.0 109.543 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.92 -44.24 50.15 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.307 1.338 . . . . 0.0 110.497 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -58.73 -25.08 62.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 61.1 mm-40 -84.63 -24.98 28.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.018 . . . . 0.0 109.302 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.5 mt -80.97 -23.57 38.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.191 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.648 -0.658 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' LEU . 34.4 m120 -146.27 -9.1 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.544 -1.348 . . . . 0.0 110.827 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.8 mt -79.01 147.01 69.19 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.6 -1.312 . . . . 0.0 108.159 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.24 -64.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.019 1.146 . . . . 0.0 110.751 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.9 4.04 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.8 mt -94.46 149.95 37.4 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.163 -1.198 . . . . 0.0 109.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.22 176.27 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.837 1.025 . . . . 0.0 109.837 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -97.64 7.28 46.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.18 129.99 38.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.406 -0.809 . . . . 0.0 109.29 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -52.51 -30.56 30.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.33 -39.85 64.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.21 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.95 -36.71 40.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.0 t -66.22 -61.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -1.135 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -51.37 -44.14 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 108.952 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.23 -45.0 96.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 108.925 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.15 -16.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.37 -31.1 71.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 108.747 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -71.04 -28.42 64.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.28 -0.888 . . . . 0.0 108.822 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -64.89 -3.07 3.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.177 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -150.2 -61.44 0.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 108.825 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.32 53.11 1.91 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -50.76 138.05 19.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.291 . . . . 0.0 109.148 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -48.64 99.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 5.5 p30 -99.82 123.14 43.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.898 . . . . 0.0 109.653 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 38.7 ttm180 -87.16 115.22 24.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.887 . . . . 0.0 109.226 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 45' ' ' ALA . 22.5 m -93.25 84.47 4.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.227 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.41 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -91.45 121.81 33.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -0.9 . . . . 0.0 109.348 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.62 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.622 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -147.61 -40.51 0.04 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.6 m -52.43 -8.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.247 -1.149 . . . . 0.0 109.443 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 39' ' ' GLY . 37.9 ttpt -155.53 -32.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.539 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 47.35 2.31 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 173.24 61.74 0.05 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 43' ' ' GLY . 14.7 ptmt 32.9 80.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 122.082 -0.658 . . . . 0.0 110.83 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 36' ' ' THR . . . -87.27 -153.27 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.812 . . . . 0.0 109.295 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.7 139.5 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.096 -1.002 . . . . 0.0 109.3 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 10.7 mp0 -132.81 175.99 8.86 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.11 133.56 37.41 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.339 -0.851 . . . . 0.0 109.439 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -76.6 117.9 18.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.018 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 3' ' ' LEU . . . -55.1 -31.31 61.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -69.94 -17.62 63.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.541 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.9 m -89.62 -21.31 22.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.59 148.41 98.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 108.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.83 -162.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 120.831 1.021 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.64 -38.36 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.21 -39.96 84.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.54 -48.35 11.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.39 -54.06 45.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.403 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.55 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.082 -1.011 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -29.02 69.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.53 -27.52 69.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -0.919 . . . . 0.0 109.248 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.63 -30.01 29.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.94 -47.83 70.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 109.653 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -71.87 -42.66 66.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.047 -1.033 . . . . 0.0 110.165 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -65.93 122.39 17.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 68' ' ' ILE . . . -175.83 172.28 45.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 58.11 3.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -1.115 . . . . 0.0 109.536 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.7 mt -74.26 -22.04 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 68' ' ' ILE . 8.7 pt-20 33.29 57.33 0.5 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.29 0.567 . . . . 0.0 111.013 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 p -74.54 -108.6 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -88.09 -28.93 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -85.95 177.43 7.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.2 -24.85 0.86 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 72' ' ' LEU . 34.7 t80 -85.69 13.29 7.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 109.473 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 53.58 26.71 5.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.473 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.05 135.64 33.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.489 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp -161.28 80.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -79.94 172.0 14.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.01 148.13 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.171 -0.956 . . . . 0.0 110.058 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.39 153.85 37.58 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.409 -0.807 . . . . 0.0 109.241 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.81 -41.33 75.41 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.219 1.28 . . . . 0.0 110.233 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -59.53 -27.02 65.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.35 -24.78 29.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.19 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.9 mt -82.33 -25.32 34.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.865 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 30.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.6 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.1 m120 -146.54 -6.44 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.575 -1.328 . . . . 0.0 110.8 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -79.41 148.47 70.36 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.609 -1.307 . . . . 0.0 108.16 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.75 -61.06 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 120.818 1.012 . . . . 0.0 110.239 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.42 -39.25 9.87 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LEU . 36.6 mt -93.0 149.56 37.77 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.129 -1.218 . . . . 0.0 108.987 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -53.85 -177.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.782 0.988 . . . . 0.0 109.677 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -100.93 -3.34 29.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -119.54 129.46 54.69 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.653 -0.654 . . . . 0.0 109.338 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -52.81 -29.24 26.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.68 71.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.27 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -35.74 75.83 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.37 -64.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -50.43 -41.27 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.939 . . . . 0.0 109.054 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.17 -43.41 95.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.018 . . . . 0.0 108.538 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.39 -21.38 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.763 . . . . 0.0 109.008 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.93 -31.95 73.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 108.595 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.9 mttm -71.45 -31.89 67.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 108.685 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -65.67 -0.29 2.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.468 -0.77 . . . . 0.0 109.153 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 28' ' ' LYS . 72.7 mt-30 -149.8 -65.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 108.78 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.31 56.57 1.19 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -53.95 142.89 23.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.943 -1.327 . . . . 0.0 108.704 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -47.21 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.5 p30 -100.31 121.25 41.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.37 -0.831 . . . . 0.0 109.592 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 59.9 ttt180 -87.05 111.72 21.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 108.846 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.54 86.6 5.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.957 . . . . 0.0 109.341 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -89.76 107.49 19.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.38 54.79 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.51 5.28 1.81 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -87.69 -79.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 109.176 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -88.05 -11.12 48.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.438 -0.789 . . . . 0.0 109.173 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.19 36.99 10.27 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.31 49.93 0.29 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 53.52 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -1.179 . . . . 0.0 109.136 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.18 132.47 41.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 108.949 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.419 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 12.3 mt -89.63 144.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.98 -1.075 . . . . 0.0 109.688 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.9 mp0 -135.72 172.18 13.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -136.09 134.67 38.63 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.18 116.24 17.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.045 -1.034 . . . . 0.0 108.883 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -53.78 -35.52 61.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.5 -18.77 65.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.994 -1.066 . . . . 0.0 109.637 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.46 -14.1 36.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -68.8 150.59 97.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.239 -0.913 . . . . 0.0 109.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.25 -156.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 120.933 1.089 . . . . 0.0 109.652 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -96.88 -36.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.62 -36.45 78.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.76 47.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.034 -1.041 . . . . 0.0 109.549 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mmtm -57.87 -60.71 3.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 109.019 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.57 -50.88 64.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.389 -0.82 . . . . 0.0 109.926 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.46 69.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 110.042 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.52 -43.86 95.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.005 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.35 -47.09 79.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.083 -1.011 . . . . 0.0 109.275 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.7 mp -66.26 -32.7 74.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.674 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -70.69 -36.17 73.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.601 -0.687 . . . . 0.0 109.674 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' ARG . 33.9 mt-30 -55.03 -168.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.943 -1.098 . . . . 0.0 109.73 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.74 4.49 69.8 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -160.02 90.06 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -1.152 . . . . 0.0 109.389 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.7 mp -85.04 -51.03 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 109.218 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 70' ' ' THR . 26.2 tt0 51.25 64.96 1.63 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 27.0 m -166.28 -32.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.332 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.2 p -171.72 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.537 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -87.99 -104.33 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.245 -0.91 . . . . 0.0 109.133 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.537 ' H ' HD13 ' A' ' 72' ' ' LEU . . . 80.64 -7.47 58.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -83.19 -46.89 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -1.205 . . . . 0.0 109.349 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' GLU . 42.7 t80 -74.65 -23.61 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.282 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 75' ' ' PHE . 36.5 tt0 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.13 158.65 17.85 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.4 tp -167.35 78.69 0.19 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.238 -0.914 . . . . 0.0 109.223 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -79.74 167.65 20.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 108.826 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 17.7 t -139.28 165.48 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -114.14 152.37 45.8 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.76 -43.33 56.7 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.242 1.295 . . . . 0.0 110.471 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -59.56 -26.8 65.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.885 -179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' NH2' ' A' ' 64' ' ' ARG . 32.4 mm-40 -84.35 -25.68 28.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.051 -1.031 . . . . 0.0 109.449 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 79.8 mt -82.39 -23.47 34.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.187 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.81 28.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.71 -0.619 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 15.3 t-20 -147.39 -8.66 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.471 -1.393 . . . . 0.0 111.048 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.2 mt -78.7 147.51 71.19 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.538 -1.351 . . . . 0.0 108.329 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 -67.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.967 1.111 . . . . 0.0 111.0 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.36 -35.3 1.83 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.6 mt -95.35 150.62 37.83 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.186 -1.185 . . . . 0.0 108.865 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.53 -178.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 120.778 0.986 . . . . 0.0 109.996 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ALA . 4.4 mmmm -97.63 -17.46 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.241 -0.912 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -106.37 131.72 53.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.713 . . . . 0.0 109.413 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -53.27 -28.6 28.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.324 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.3 33.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.56 -35.33 66.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.63 -64.88 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.174 . . . . 0.0 109.398 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.5 mt -52.17 -41.61 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.09 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -60.17 -42.04 94.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.767 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.15 -24.34 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.076 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -56.26 -29.23 60.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.138 -0.976 . . . . 0.0 108.662 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -71.66 -34.98 70.17 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -6.23 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.9 mt-30 -145.84 -70.49 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.378 -0.827 . . . . 0.0 108.87 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.47 55.11 1.11 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.0 m-90 -52.64 142.23 18.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.02 -1.282 . . . . 0.0 108.896 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -47.31 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.507 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.9 p30 -100.5 121.15 41.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.366 -0.834 . . . . 0.0 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -88.02 126.89 35.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.159 -0.963 . . . . 0.0 109.158 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.5 135.79 33.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' CZ ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.28 -38.17 12.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.16 47.3 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' CZ ' ' A' ' 37' ' ' ARG . . . 165.32 75.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.34 -33.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.153 . . . . 0.0 109.408 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -156.34 -70.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.95 -109.19 1.0 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.43 5.32 1.0 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -171.87 95.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -1.197 . . . . 0.0 109.34 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.35 111.61 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 108.765 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.1 mt -84.37 104.3 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.6 mm-40 -90.77 173.78 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -135.35 128.82 32.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -75.73 117.15 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.024 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.78 -30.63 57.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.068 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -70.2 -19.93 63.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.91 -21.15 22.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.813 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.83 148.21 98.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.082 -1.011 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.36 -166.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.86 1.04 . . . . 0.0 109.78 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.4 -34.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.1 mp0 -58.77 -39.67 81.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.324 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.34 -40.26 21.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -57.59 -38.5 75.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.513 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.35 -56.89 6.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.01 -19.59 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.9 -76.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.089 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -53.89 -14.96 1.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 tp -69.03 -48.99 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 109.114 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH2' ' OE1' ' A' ' 9' ' ' GLU . 11.1 ptm180 -74.16 4.86 5.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.917 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -95.43 33.85 1.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.82 -41.79 14.02 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.63 152.92 5.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -1.155 . . . . 0.0 109.351 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.0 mm -76.39 -73.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.927 . . . . 0.0 109.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.15 -49.48 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.4 ' H ' ' H ' ' A' ' 71' ' ' SER . 46.9 m -166.34 -9.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' H ' ' H ' ' A' ' 70' ' ' THR . 42.9 t -50.21 -45.35 53.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 74' ' ' TYR . 21.9 mt -77.73 102.52 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.195 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.83 22.24 2.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' LEU . 3.4 t80 69.97 73.4 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -1.079 . . . . 0.0 109.07 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 28.9 t80 60.2 26.47 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' N ' ' SD ' ' A' ' 1' ' ' MET . 36.4 tt0 -150.85 129.29 12.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.9 tp -160.02 84.38 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 109.326 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -81.72 167.04 19.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 108.911 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.96 153.74 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.347 -0.846 . . . . 0.0 109.904 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -102.46 152.69 38.39 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.743 . . . . 0.0 109.012 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.75 -45.24 41.9 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.164 1.243 . . . . 0.0 110.622 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -60.19 -25.86 65.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -84.24 -24.96 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.089 -1.007 . . . . 0.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -82.66 -19.1 38.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.168 -0.957 . . . . 0.0 109.227 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 32.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.642 -0.661 . . . . 0.0 111.038 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' LEU . 45.8 t30 -145.9 -9.26 0.53 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.567 -1.333 . . . . 0.0 110.897 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.6 mt -78.68 147.32 70.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.569 -1.332 . . . . 0.0 108.127 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.93 -64.23 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.851 1.034 . . . . 0.0 110.484 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.95 -37.02 5.27 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.7 mt -93.8 149.58 37.27 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.105 -1.232 . . . . 0.0 109.1 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.0 174.75 0.19 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.826 1.017 . . . . 0.0 109.869 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -95.44 -1.74 50.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -0.883 . . . . 0.0 109.742 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -122.92 130.78 53.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -53.3 -28.97 30.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 0.0 109.616 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.67 65.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 -32.54 49.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' ALA . 56.9 t -65.97 -55.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -1.198 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.58 -45.43 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.061 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -60.57 -44.41 96.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 108.901 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.3 -19.13 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.07 -36.24 81.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.146 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.8 mtmt -70.48 -28.57 65.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.228 -0.92 . . . . 0.0 108.962 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 8.2 ttmm -64.63 -1.45 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.825 . . . . 0.0 108.906 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.43 -62.76 0.2 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 108.82 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.68 50.86 2.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -49.28 146.77 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.244 . . . . 0.0 109.166 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -51.65 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.126 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -99.97 122.17 42.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 -179.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -84.51 130.69 34.72 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.22 124.6 35.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 109.354 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -91.09 -173.89 3.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.48 57.12 0.11 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.334 -0.853 . . . . 0.0 109.259 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 171.64 -39.44 0.17 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.9 m -49.3 -13.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.128 -1.219 . . . . 0.0 109.49 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . 30.9 tttm -160.06 -32.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.02 146.19 20.42 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.87 27.96 22.48 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' CB ' ' NZ ' ' A' ' 44' ' ' LYS . 5.4 ttpm? 53.94 94.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.126 . . . . 0.0 109.487 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.56 -161.16 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -0.815 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 tt -150.56 162.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.951 -1.093 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.7 mt-10 -148.12 170.6 17.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -135.51 126.27 27.33 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -77.1 119.69 21.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 108.963 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.47 32.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 111.017 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 52' ' ' SER . 34.7 p-10 -70.88 -20.42 62.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.114 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 33.0 m -90.86 -20.41 22.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.067 -1.021 . . . . 0.0 110.003 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 89.3 mt -67.76 148.77 98.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.088 -1.008 . . . . 0.0 109.085 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.91 -157.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.845 1.03 . . . . 0.0 109.673 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -92.93 -40.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.42 -39.35 79.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.623 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.25 -42.86 22.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.433 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -60.29 -64.78 0.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.86 -44.95 49.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.7 -31.94 73.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.24 -28.74 69.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.12 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -72.53 -46.64 53.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 63' ' ' LEU . 10.4 mp -67.3 -37.21 83.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 109.352 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.17 -39.93 71.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.189 -0.944 . . . . 0.0 109.605 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -60.31 -0.98 0.28 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.731 -1.231 . . . . 0.0 109.419 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . -71.0 -77.99 0.46 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -79.73 101.2 8.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -1.17 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.39 -88.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -164.94 51.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.365 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 p -54.17 160.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.618 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -173.79 22.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.868 . . . . 0.0 109.295 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.67 95.12 5.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.29 10.02 62.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.98 -77.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.128 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -58.77 -40.78 84.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 0.0 109.393 179.888 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.554 ' CD ' ' HE1' ' A' ' 4' ' ' TRP . 21.9 pt-20 -151.07 179.77 7.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 109.323 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.7 tp -155.44 92.18 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.948 . . . . 0.0 109.419 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.554 ' HE1' ' CD ' ' A' ' 2' ' ' GLU . 55.3 m95 -85.1 164.93 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.015 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 6' ' ' SER . 7.6 t -138.45 164.17 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.312 -0.868 . . . . 0.0 109.958 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -110.73 152.81 43.73 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.5 -45.75 38.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 121.391 1.394 . . . . 0.0 110.655 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.45 -28.12 65.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -84.34 -24.96 29.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.732 -1.23 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' ASN . 56.2 mt -82.62 -20.5 36.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.263 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.18 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.619 -0.675 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 10' ' ' LEU . 36.4 m120 -146.11 -8.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.376 . . . . 0.0 110.656 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.13 147.32 69.25 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.0 107.954 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.7 -67.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.05 1.167 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.98 -34.12 2.92 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.7 mt -94.89 149.6 36.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.135 -1.215 . . . . 0.0 109.082 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.34 -179.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 120.882 1.055 . . . . 0.0 110.051 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -104.38 9.43 35.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.478 -0.763 . . . . 0.0 109.812 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -134.21 134.25 41.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.366 -0.834 . . . . 0.0 109.539 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -53.1 -31.43 41.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.883 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -51.47 64.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.423 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -65.83 -30.72 77.77 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.41 -54.52 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -1.204 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.57 -44.97 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.883 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.55 -41.48 94.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.079 -1.013 . . . . 0.0 108.935 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.1 t -74.78 -26.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 108.972 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.1 -33.32 51.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -70.43 -28.12 64.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 0.0 109.055 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.58 -2.72 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.133 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -150.57 -60.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.67 45.63 3.13 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -48.69 135.84 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.065 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.56 99.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.056 -1.028 . . . . 0.0 109.189 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.6 p30 -100.43 123.22 44.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.0 109.638 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -87.31 123.74 32.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.033 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.64 153.74 18.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.009 . . . . 0.0 108.793 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -149.28 82.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.118 -0.989 . . . . 0.0 109.707 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.72 52.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.574 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.03 -8.52 0.55 Allowed Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -56.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.923 -1.339 . . . . 0.0 109.184 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -156.75 -69.23 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.43 165.55 22.78 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.12 -2.69 33.29 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.75 95.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -1.128 . . . . 0.0 109.589 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.76 115.81 24.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 108.81 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 tt -87.38 153.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.4 mt-10 -139.77 173.33 11.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -135.36 131.65 36.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.64 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -75.67 112.89 12.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.811 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.84 -26.28 23.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -69.44 -22.37 63.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.977 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 m -90.5 -10.4 43.77 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.082 -1.012 . . . . 0.0 110.072 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 54' ' ' PRO . 75.6 mt -67.32 149.97 98.13 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.066 -1.022 . . . . 0.0 108.828 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -57.18 -159.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.89 1.06 . . . . 0.0 109.581 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.62 -37.52 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.75 -37.27 81.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -0.819 . . . . 0.0 110.236 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.0 -32.18 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.727 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -55.47 -70.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 109.041 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.09 -42.38 18.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.42 74.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.097 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -66.06 -71.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.206 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -44.63 -21.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 110.034 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 61' ' ' LEU . 8.3 tp -69.49 -55.74 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.078 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -72.92 -43.81 61.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.022 -1.049 . . . . 0.0 110.815 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -81.47 164.14 22.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.653 -1.279 . . . . 0.0 109.756 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 67' ' ' GLU . . . 155.17 126.17 0.99 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 73.72 -65.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -1.136 . . . . 0.0 109.322 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' GLU . 6.7 mt 57.92 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.0 pt-20 32.91 57.8 0.44 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.599 -0.688 . . . . 0.0 111.503 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 72' ' ' LEU . 11.0 t -169.94 -177.95 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.002 -1.062 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t 53.25 8.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.55 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 70' ' ' THR . 25.8 mt -71.73 166.17 22.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 109.536 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.81 6.89 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 76' ' ' GLU . 59.6 t80 -137.08 -31.3 0.83 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.643 -0.916 . . . . 0.0 109.403 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 76' ' ' GLU . 69.0 t80 -56.53 -6.83 0.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 74' ' ' TYR . 31.8 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.445 -0.784 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.66 123.64 33.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.7 tp -159.98 148.08 16.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.223 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 3' ' ' LEU . 44.3 m95 -141.15 165.74 26.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.393 -0.817 . . . . 0.0 108.808 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -135.98 -139.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -163.03 152.99 13.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.317 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.02 -50.69 12.36 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.422 1.415 . . . . 0.0 110.874 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -57.46 -23.17 48.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -25.0 28.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 109.671 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -83.13 -21.65 33.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.571 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.736 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.787 HD21 ' HE ' ' A' ' 64' ' ' ARG . 28.0 p30 -148.86 -7.23 0.38 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.399 -1.438 . . . . 0.0 111.072 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.1 mt -78.27 147.39 72.5 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.642 -1.286 . . . . 0.0 108.16 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -67.42 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 120.939 1.093 . . . . 0.0 110.862 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.11 -34.23 3.1 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -95.26 149.89 36.83 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.238 -1.154 . . . . 0.0 109.29 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.72 -177.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.936 1.09 . . . . 0.0 109.814 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -103.17 3.16 35.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.39 -0.819 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -129.12 131.07 47.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 t -52.38 -31.79 35.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.867 . . . . 0.0 109.346 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -33.79 59.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.49 -36.81 22.4 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.64 -60.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.5 mt -48.96 -40.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 108.733 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -62.55 -39.47 93.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.01 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.3 t -77.37 -10.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -60.04 -38.0 81.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.981 -1.075 . . . . 0.0 110.453 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.61 -27.33 61.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.794 -1.191 . . . . 0.0 109.261 -179.765 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 26.8 mmtm -63.59 -4.41 2.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 29' ' ' LYS . 24.5 mp0 -149.07 -60.89 0.23 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.19 59.86 1.15 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -65.0 133.72 52.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.979 -1.306 . . . . 0.0 108.927 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.12 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 3.8 p30 -103.68 121.53 43.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.436 -0.79 . . . . 0.0 109.45 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 35' ' ' ARG . 29.5 ttm-85 -84.74 121.77 28.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 108.56 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.5 160.76 14.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -0.98 . . . . 0.0 109.521 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.58 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -147.78 179.12 7.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.911 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.74 75.41 0.28 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.01 -28.68 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -55.72 -16.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.235 -1.156 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -160.51 -73.26 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.313 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.86 72.57 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.48 30.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.6 mttt 56.47 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -1.166 . . . . 0.0 109.341 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.14 111.89 22.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.327 -0.858 . . . . 0.0 109.617 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.36 157.69 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 23.3 mm-40 -139.99 168.86 18.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -135.14 129.01 33.18 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.373 -0.829 . . . . 0.0 109.407 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 22.9 t-20 -75.52 112.18 11.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.81 . . . . 0.0 109.301 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -31.3 61.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.797 . . . . 0.0 110.708 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 4.4 m120 -68.13 -17.28 64.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.985 -1.072 . . . . 0.0 109.63 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.2 m -90.91 -16.04 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 79.3 mt -67.21 149.36 98.49 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.065 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.66 -157.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.894 1.062 . . . . 0.0 109.554 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.74 -39.87 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.86 -42.76 94.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.92 -11.66 59.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.842 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -75.59 -69.94 0.46 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.04 -41.41 16.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.075 -1.015 . . . . 0.0 109.104 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.28 79.68 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.303 -0.873 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.97 -38.89 92.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.03 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.26 -38.03 73.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.953 . . . . 0.0 109.264 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.2 -32.65 74.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.787 ' HE ' HD21 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -74.44 -62.61 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 108.927 179.522 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -61.68 140.38 58.19 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.18 -0.95 . . . . 0.0 109.531 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 166.35 -101.36 0.18 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -76.3 60.06 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.482 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.01 -44.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 109.613 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' OE1' ' OG1' ' A' ' 70' ' ' THR . 1.6 tm-20 -108.71 -31.02 7.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.431 -0.793 . . . . 0.0 109.428 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 ' OG1' ' OE1' ' A' ' 69' ' ' GLU . 4.4 m -161.94 -126.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.384 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -173.2 123.32 0.4 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.997 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -78.08 69.98 4.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.291 -0.88 . . . . 0.0 109.022 179.805 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 29.15 2.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 72' ' ' LEU . 69.0 m-85 -87.47 -79.05 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -1.169 . . . . 0.0 109.212 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 53.4 t80 -163.56 21.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 75' ' ' PHE . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' CB ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 36.5 tt0 -152.42 76.44 1.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 109.354 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -161.73 75.81 0.49 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.8 m95 -79.62 161.72 25.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 108.713 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -132.24 -141.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.419 -0.801 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.617 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -162.81 153.58 14.3 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.126 -0.984 . . . . 0.0 109.454 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.26 -48.15 20.79 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.344 1.363 . . . . 0.0 110.624 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -58.82 -23.42 60.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 110.007 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 44.4 mt-10 -84.94 -29.62 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.5 mt -80.52 -24.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.269 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.14 29.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 110.92 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.501 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.6 m120 -145.69 -9.73 0.54 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.543 -1.348 . . . . 0.0 110.795 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.3 mt -78.78 147.48 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.601 -1.312 . . . . 0.0 108.061 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -65.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.006 1.137 . . . . 0.0 110.849 -179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.14 -37.37 4.4 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.3 150.16 37.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.22 -1.165 . . . . 0.0 109.134 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.12 171.04 0.41 Allowed 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.876 1.051 . . . . 0.0 109.786 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ALA . 51.1 mttm -91.5 -10.18 41.7 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.712 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -114.62 128.59 56.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.512 -0.743 . . . . 0.0 109.314 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -52.59 -28.97 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -33.72 56.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.239 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.16 -37.11 22.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.78 -59.96 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 109.392 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.01 -45.48 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.047 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.28 -42.82 99.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.3 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.3 t -74.39 -14.63 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.58 -31.2 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.21 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' H ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -71.74 -27.83 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 108.576 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -63.92 -8.11 10.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.862 . . . . 0.0 109.245 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -150.18 -59.46 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.318 -0.864 . . . . 0.0 108.98 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.69 55.4 1.91 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -50.88 148.37 4.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.062 -1.258 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.68 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.63 114.43 28.11 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.314 -0.867 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -88.83 108.97 19.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.183 -0.948 . . . . 0.0 109.767 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 45' ' ' ALA . 52.7 m -93.89 147.95 22.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 108.872 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 4.4 tmt_? -148.72 -23.32 0.32 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 109.589 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 64.23 92.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -170.47 -32.35 0.02 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -56.38 -6.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -1.148 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 39' ' ' GLY . 46.3 tttp -158.49 -75.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.5 51.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.48 -83.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -179.49 102.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -1.055 . . . . 0.0 109.267 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 36' ' ' THR . . . -84.76 -152.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.181 -0.949 . . . . 0.0 109.239 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 47' ' ' GLU . 13.2 tt -150.73 -41.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.187 -0.946 . . . . 0.0 109.479 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 46' ' ' ILE . 80.2 mt-10 56.04 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.597 0.713 . . . . 0.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.5 130.71 35.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -77.16 112.62 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 108.947 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.53 -22.95 23.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.369 -0.832 . . . . 0.0 111.029 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 52' ' ' SER . 37.3 p-10 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.788 -1.195 . . . . 0.0 109.843 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.468 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 5.1 m -92.47 -13.1 30.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.62 148.92 98.52 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.981 -1.074 . . . . 0.0 109.012 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -158.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.991 1.127 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.2 -37.37 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.378 -0.826 . . . . 0.0 109.363 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.01 -40.24 84.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.96 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.28 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -58.02 -69.65 0.17 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.104 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -43.38 15.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.789 . . . . 0.0 109.682 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.7 78.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.71 -25.74 68.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 109.495 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.76 -32.5 57.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.491 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.42 -52.89 34.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.835 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 9.5 ptm180 -72.12 -11.68 60.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -93.24 -112.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.644 -1.285 . . . . 0.0 109.236 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 50.6 83.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 66' ' ' GLY . 27.2 mt-10 53.77 106.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.977 . . . . 0.0 109.83 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 69' ' ' GLU . 10.2 tp -159.67 -46.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 109.318 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' N ' HG23 ' A' ' 68' ' ' ILE . 43.6 mt-10 -45.75 169.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.688 . . . . 0.0 109.737 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -55.29 121.62 9.3 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 p -175.86 -26.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.581 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -81.68 108.02 14.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.132 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.19 2.47 56.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -171.74 -50.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.532 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 71.2 t80 -161.1 38.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.827 . . . . 0.0 109.291 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.309 -179.979 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -88.95 162.33 16.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.395 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 tp -160.69 77.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.1 m95 -79.95 158.08 26.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.286 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 6' ' ' SER . 95.1 t -138.33 165.28 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.341 -0.85 . . . . 0.0 110.198 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -104.52 153.76 38.91 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.458 -0.776 . . . . 0.0 109.348 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.02 -44.13 47.33 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.388 1.392 . . . . 0.0 110.83 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -23.22 45.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 109.814 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 25.6 mm-40 -84.56 -23.08 29.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 12' ' ' ASN . 96.6 mt -82.97 -22.49 33.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 0.0 109.094 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 32.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.762 -0.586 . . . . 0.0 111.336 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.4 t-20 -146.64 -9.04 0.48 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.519 -1.363 . . . . 0.0 110.775 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.1 mt -79.45 147.58 68.39 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.681 -1.262 . . . . 0.0 108.229 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.69 -61.83 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 120.871 1.047 . . . . 0.0 110.527 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.26 -38.87 6.79 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.9 mt -93.98 149.64 37.24 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 0.0 109.108 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.59 177.78 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.722 0.948 . . . . 0.0 109.712 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -98.47 9.06 44.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.258 -0.901 . . . . 0.0 109.63 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -134.17 130.52 37.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 0.0 109.323 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 p -53.13 -29.62 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.51 65.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.8 28.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.51 -59.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.266 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.4 mt -52.12 -43.03 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.078 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.97 -39.9 87.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -74.99 -27.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.05 -32.74 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.0 108.799 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -71.8 -33.4 68.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.131 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.15 -3.28 3.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.538 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.5 mt-30 -145.19 -63.42 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.0 108.935 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.4 51.84 1.8 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.538 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.4 m-90 -51.63 146.46 7.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.251 . . . . 0.0 109.076 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.49 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.064 . . . . 0.0 109.306 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 34' ' ' ASN . 10.0 p30 -98.8 117.16 32.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.499 -0.751 . . . . 0.0 109.75 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -89.59 121.22 31.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.932 . . . . 0.0 108.604 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 m -90.17 74.33 7.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.763 -1.211 . . . . 0.0 109.696 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -91.01 113.88 26.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -0.851 . . . . 0.0 109.141 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.57 55.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.686 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.2 -2.47 7.06 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.29 -46.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -1.184 . . . . 0.0 109.393 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -168.92 -63.37 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 109.419 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.89 114.56 0.36 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.36 17.24 1.12 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HZ2' ' HB3' ' A' ' 44' ' ' LYS . 13.9 mtpp 52.53 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.123 -1.222 . . . . 0.0 109.422 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.0 156.99 20.21 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' GLU . 9.8 tt -91.19 -39.54 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.263 -0.898 . . . . 0.0 109.797 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 46' ' ' ILE . 78.2 mt-10 55.7 152.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.756 0.789 . . . . 0.0 110.655 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -135.81 136.72 40.9 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -77.54 114.78 16.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.082 -1.011 . . . . 0.0 109.334 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.12 35.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 111.193 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -69.69 -17.94 63.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.895 -1.128 . . . . 0.0 110.089 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -91.83 -14.7 29.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.135 -0.978 . . . . 0.0 110.216 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt -66.89 148.17 98.9 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.056 . . . . 0.0 108.992 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -56.81 -161.86 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 121.01 1.14 . . . . 0.0 109.618 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 t -91.39 -38.81 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -59.37 -40.22 85.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.09 11.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.626 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -48.24 -50.9 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.775 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.81 -53.72 54.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.16 66.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 109.083 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.26 -66.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 0.0 108.914 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -49.54 -25.51 2.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.43 -0.794 . . . . 0.0 109.166 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.2 tp -66.82 -34.51 77.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 109.059 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 29.2 mtp180 -71.3 -50.91 27.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -45.33 117.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.933 . . . . 0.0 109.957 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.52 -65.65 0.14 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.57 129.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -1.067 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.3 mt -114.93 -80.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -96.34 99.36 11.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.138 -0.976 . . . . 0.0 109.156 179.964 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 51.2 p -49.43 120.46 4.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.938 . . . . 0.0 109.461 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 72' ' ' LEU . 2.4 t 177.58 -99.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 74' ' ' TYR . 7.1 mt 50.21 92.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 66.95 -7.37 1.63 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.548 ' H ' ' C ' ' A' ' 72' ' ' LEU . 97.9 m-85 54.67 4.74 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.632 -0.922 . . . . 0.0 109.573 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 73' ' ' GLY . 53.2 m-85 -95.33 -12.42 26.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 72' ' ' LEU . 14.8 mp0 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.34 141.72 28.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.496 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -168.56 83.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.662 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -79.87 165.5 22.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 108.564 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -135.24 -140.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -163.11 154.0 14.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 0.0 109.449 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.59 -50.56 12.97 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 121.345 1.363 . . . . 0.0 110.871 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -58.14 -24.33 58.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.123 -0.985 . . . . 0.0 110.131 -179.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB2' HG12 ' A' ' 5' ' ' VAL . 37.4 mt-10 -84.69 -28.46 26.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 60.9 mt -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.28 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.15 30.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 64.0 m-80 -145.71 -7.38 0.58 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.574 -1.329 . . . . 0.0 110.698 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.2 mt -79.19 147.81 69.93 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.669 -1.269 . . . . 0.0 108.04 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 120.839 1.026 . . . . 0.0 110.635 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.56 -36.39 4.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.6 mt -93.79 149.92 37.82 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.182 -1.187 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.8 171.13 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 120.763 0.975 . . . . 0.0 109.756 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.41 7.8 45.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.869 . . . . 0.0 109.779 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -133.62 129.63 37.19 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 p -53.0 -29.64 30.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 0.0 109.383 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.1 -35.83 62.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.7 -35.12 20.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.6 t -65.86 -53.17 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -1.135 . . . . 0.0 109.34 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -57.29 -48.47 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.11 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -60.02 -44.84 94.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -75.15 -18.36 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.96 -30.41 70.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.51 -29.22 64.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -64.83 -3.21 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -149.81 -61.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.74 53.51 2.24 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -50.19 143.81 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.938 -1.33 . . . . 0.0 108.912 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -46.97 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.156 -0.965 . . . . 0.0 109.527 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -106.14 117.17 33.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.522 -0.736 . . . . 0.0 109.595 -179.855 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -88.24 130.37 35.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.15 93.03 6.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.904 -1.123 . . . . 0.0 109.334 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.0 OUTLIER -89.08 99.68 12.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.303 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 43' ' ' GLY . . . -75.67 54.56 0.79 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.95 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' H ' ' HD2' ' A' ' 37' ' ' ARG . . . -164.53 51.99 0.28 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.64 -36.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -1.214 . . . . 0.0 109.283 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -143.33 -69.99 0.32 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.278 -0.889 . . . . 0.0 109.58 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.79 -121.63 4.11 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HB1' ' A' ' 38' ' ' ALA . . . -130.95 11.25 5.65 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -179.5 74.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.79 31.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.1 tt -89.15 155.08 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.632 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 30.8 mt-10 -137.17 171.47 14.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.64 126.49 27.5 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.166 -0.959 . . . . 0.0 109.891 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -76.15 112.72 12.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 108.811 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.08 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.992 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -71.2 -22.97 61.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.5 m -89.55 -11.78 41.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.082 -1.012 . . . . 0.0 110.272 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.6 mt -68.39 148.98 98.2 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.932 -1.105 . . . . 0.0 109.283 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.4 Cg_endo -58.02 -155.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.019 1.146 . . . . 0.0 109.643 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.11 -36.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.169 -0.957 . . . . 0.0 109.689 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.35 -38.16 82.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.698 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.95 47.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.574 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -59.92 -71.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 108.984 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.78 -42.3 11.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.444 -0.785 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.15 -35.48 80.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.264 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.2 tp -65.96 -48.12 72.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.2 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -61.81 -38.67 88.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.117 -0.99 . . . . 0.0 110.484 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.2 mt -67.65 -50.4 58.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.396 -179.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -28.01 63.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.944 -1.097 . . . . 0.0 110.963 -178.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -83.55 -88.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.591 -1.318 . . . . 0.0 109.637 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.11 157.51 31.69 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.12 128.26 36.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -1.134 . . . . 0.0 109.652 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 70' ' ' THR . 4.5 pt -121.44 -35.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 57.28 2.92 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.425 -0.797 . . . . 0.0 109.771 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 42.88 -154.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 110.047 179.536 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.503 ' N ' ' OG1' ' A' ' 70' ' ' THR . 6.9 t 57.31 44.81 21.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.566 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.57 170.45 16.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 74' ' ' TYR . . . 155.71 -0.85 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CG ' ' O ' ' A' ' 73' ' ' GLY . 42.2 m-85 -156.65 19.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -1.101 . . . . 0.0 109.469 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 51.66 17.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.967 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 2.9 mp0 -89.03 138.93 30.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 109.457 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.0 tp -171.26 148.51 2.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.253 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -136.88 171.22 14.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.61 145.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -96.76 152.29 38.38 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.09 -44.99 44.38 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.235 1.29 . . . . 0.0 110.297 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -60.57 -25.44 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 109.88 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -84.36 -27.07 27.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -81.97 -23.66 35.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 109.213 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 31.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.598 -0.688 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 72.1 m-80 -144.83 -8.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.568 -1.333 . . . . 0.0 110.682 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.0 mt -78.93 147.61 70.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.689 -1.257 . . . . 0.0 108.04 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -64.93 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.888 1.058 . . . . 0.0 110.663 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.66 -36.99 4.89 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -93.76 149.84 37.72 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.132 -1.217 . . . . 0.0 109.156 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.77 175.11 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.956 1.104 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -98.84 7.18 46.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.32 -0.862 . . . . 0.0 109.658 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.31 130.71 41.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.468 -0.77 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -52.37 -30.75 30.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.42 62.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.35 -36.93 25.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.88 -55.83 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.03 -44.64 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.153 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.75 -43.02 98.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.067 . . . . 0.0 108.735 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 22' ' ' GLY . 53.6 t -75.03 -22.11 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.66 -30.33 60.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 108.739 179.679 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -71.3 -30.68 66.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -65.37 -3.66 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.422 -0.799 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -151.29 -63.44 0.18 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.027 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.3 54.36 1.86 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.65 151.28 1.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.286 . . . . 0.0 109.378 179.684 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -54.8 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -96.69 114.6 26.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HG2' HH11 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.39 129.74 34.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.125 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -91.28 114.56 27.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.978 -1.076 . . . . 0.0 109.321 -179.342 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -90.76 101.58 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 53.78 0.77 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.356 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.11 37.82 0.46 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.08 -87.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -1.108 . . . . 0.0 108.575 179.762 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' H ' HG23 ' A' ' 40' ' ' VAL . 15.4 ptmt -178.88 -28.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.57 -23.9 59.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 44' ' ' LYS . . . 102.02 90.35 2.11 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 34.2 tttp 81.6 101.74 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 36' ' ' THR . . . -86.68 -150.58 0.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 109.545 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' GLU . 17.1 mt -149.94 -61.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 46' ' ' ILE . 46.9 mt-10 56.04 154.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.416 0.627 . . . . 0.0 109.801 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -135.45 131.66 36.46 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -75.38 116.36 16.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.019 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.84 -24.72 24.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 52' ' ' SER . 49.8 p30 -70.76 -18.83 62.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.953 -1.092 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 19.4 m -92.5 -14.88 27.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.003 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.32 149.71 98.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.63 -155.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 121.035 1.157 . . . . 0.0 109.371 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 t -97.61 -37.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.152 -0.968 . . . . 0.0 109.329 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -61.04 -35.53 77.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.04 -47.0 15.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 0.0 109.803 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -53.73 -54.51 37.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.535 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.07 -51.37 53.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.182 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.93 -27.09 68.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.875 . . . . 0.0 109.203 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -62.95 -59.22 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.619 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.88 -36.22 7.28 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.917 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.49 -31.29 71.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.117 -0.989 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.641 ' CB ' HH11 ' A' ' 64' ' ' ARG . 0.0 OUTLIER -72.17 -58.66 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.029 179.556 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -73.06 68.68 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.53 -73.3 1.17 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.84 5.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -1.111 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.7 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -75.73 -70.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.041 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 31.8 mp0 -64.45 77.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.253 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' ILE . 7.7 m -167.72 160.14 12.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' LEU . 4.7 t -83.6 17.32 2.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.5 mt 58.96 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.762 . . . . 0.0 109.855 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -70.26 11.99 1.95 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 72' ' ' LEU . 11.6 t80 69.06 -12.2 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.954 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 73' ' ' GLY . 33.4 t80 -66.24 -22.31 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.005 179.596 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.297 -0.877 . . . . 0.0 109.323 179.954 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.236 0.541 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.89 -31.63 18.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.433 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 26.6 tp 52.78 75.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -80.13 164.4 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 108.483 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 52.1 t -135.55 160.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -178.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.0 m -106.27 153.78 40.16 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 109.377 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.85 -43.49 57.59 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 121.337 1.358 . . . . 0.0 110.559 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -58.23 -26.48 62.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 109.833 -179.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.57 -25.55 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.1 mt -82.8 -22.64 34.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 28.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.664 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.0 p30 -147.25 -5.7 0.5 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.477 -1.389 . . . . 0.0 110.901 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 33.2 mt -79.4 147.65 68.74 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.558 -1.339 . . . . 0.0 108.061 179.261 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.92 -62.31 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 120.966 1.111 . . . . 0.0 110.791 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.63 -40.74 6.63 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 47.4 mt -93.91 150.06 37.97 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.236 -1.155 . . . . 0.0 109.04 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -52.21 -178.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 120.844 1.029 . . . . 0.0 109.915 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -100.51 -7.23 24.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.301 -0.874 . . . . 0.0 109.661 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -116.42 128.11 55.21 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.186 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -52.22 -29.22 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.13 66.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.291 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.66 -35.88 34.92 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.01 -59.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 109.243 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.65 -44.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 0.0 109.107 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -61.16 -45.59 93.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.116 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.57 -22.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.286 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.79 -32.99 63.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 30' ' ' GLN . 23.7 mmtp -71.01 -29.02 64.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.052 179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -64.34 -0.6 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 28' ' ' LYS . 44.4 mt-30 -150.86 -62.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.23 47.74 2.15 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.231 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -51.75 134.38 30.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.94 -1.329 . . . . 0.0 108.944 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.33 112.79 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.992 -1.068 . . . . 0.0 108.568 179.555 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 10.3 p30 -110.03 120.51 42.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.584 -0.697 . . . . 0.0 109.832 -179.596 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -86.31 127.29 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.112 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.16 168.21 11.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 108.87 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -148.19 -156.89 0.76 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.43 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.17 83.19 0.11 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.88 34.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.82 -86.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.237 . . . . 0.0 108.901 -179.936 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' H ' HG23 ' A' ' 40' ' ' VAL . 38.7 mmtm -63.52 -29.89 71.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.61 -78.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.51 12.83 0.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -171.63 76.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -1.104 . . . . 0.0 109.373 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.23 139.48 30.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.4 tt -90.13 163.59 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 0.0 109.376 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 40.4 mt-10 -147.6 172.83 13.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.964 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.4 132.76 35.93 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.426 -0.796 . . . . 0.0 109.334 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -77.45 120.18 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.92 -30.03 57.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.3 -0.875 . . . . 0.0 110.54 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -71.35 -18.71 62.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 35.9 m -89.74 -22.91 21.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.049 -1.032 . . . . 0.0 110.278 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.44 148.02 98.73 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.957 -1.09 . . . . 0.0 108.983 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.7 -164.44 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 120.899 1.066 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 t -89.28 -37.02 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.45 -39.43 79.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.567 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.76 -44.32 17.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.099 -1.0 . . . . 0.0 109.573 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.96 -42.33 72.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 109.829 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.91 -56.9 10.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.711 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.35 -19.96 65.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 62' ' ' LEU . 2.0 tm? -65.47 -66.0 0.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 61' ' ' LEU . 2.9 pp -64.22 -13.95 52.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.0 109.758 -178.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 63' ' ' LEU . 3.7 tt -69.12 -57.03 5.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.24 5.8 3.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.029 -1.045 . . . . 0.0 110.286 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -86.12 3.76 41.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 0.0 108.928 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 48.26 32.45 9.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' GLY . 39.9 tt0 48.35 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -1.185 . . . . 0.0 109.56 179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 69' ' ' GLU . 4.0 tp -76.9 -47.76 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 68' ' ' ILE . 14.3 mm-40 45.45 -166.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 109.636 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -81.12 -32.16 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' LEU . 45.9 m -78.9 -174.67 4.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' SER . 13.7 mt 53.18 104.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.25 23.5 1.4 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -155.72 -84.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.171 . . . . 0.0 109.377 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 62.4 t80 -165.61 20.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.381 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.551 179.948 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 mtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.349 0.595 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 1.3 pp20? -150.77 146.63 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 tp -157.12 76.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -80.15 164.05 23.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.004 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 6' ' ' SER . 60.1 t -138.12 160.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.379 -0.826 . . . . 0.0 109.882 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -107.7 153.73 41.31 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.726 . . . . 0.0 109.362 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.92 -43.59 56.75 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.271 1.314 . . . . 0.0 110.503 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -57.72 -26.14 61.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' A' ' 64' ' ' ARG . 38.0 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.142 -0.974 . . . . 0.0 109.154 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.8 mt -82.91 -19.97 36.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.817 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.92 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.0 m120 -146.83 -7.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.544 -1.347 . . . . 0.0 110.907 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.22 147.71 69.6 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.603 -1.31 . . . . 0.0 108.215 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.72 -64.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.96 1.107 . . . . 0.0 110.511 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.88 -38.9 6.02 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' LEU . 57.8 mt -93.18 149.6 37.72 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.224 -1.163 . . . . 0.0 109.087 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.57 175.6 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.867 1.045 . . . . 0.0 109.88 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.6 -5.7 31.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -116.47 129.06 56.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 109.258 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -52.62 -29.49 26.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.56 -37.59 68.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -77.64 -35.41 36.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.93 -50.11 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.52 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.419 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.65 -42.7 93.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.062 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 73.3 t -75.06 -24.29 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.243 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.78 -31.39 66.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 0.0 108.737 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.05 -30.4 66.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -64.41 -0.98 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.231 179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.5 mt-30 -150.76 -63.23 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 108.768 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.33 49.7 2.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.9 m-90 -48.95 147.82 2.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.3 . . . . 0.0 109.01 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -47.54 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.997 . . . . 0.0 109.33 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' TRP . 11.0 p-10 -103.36 119.31 38.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.48 -0.763 . . . . 0.0 110.183 -179.359 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -87.15 124.31 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.234 -0.916 . . . . 0.0 108.962 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 150.35 20.78 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.974 -1.079 . . . . 0.0 108.995 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -150.17 100.43 2.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.19 53.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.814 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.49 13.08 0.68 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.74 -49.79 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.253 -1.145 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -158.73 -70.28 0.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.6 -108.67 0.05 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.17 8.46 1.07 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -172.15 79.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -1.099 . . . . 0.0 109.345 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.83 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.277 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 tt -89.88 155.51 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.692 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.93 174.68 10.31 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -136.46 126.51 26.09 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.26 -0.9 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 50.0 t-20 -76.31 120.46 21.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.06 -30.28 47.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 110.698 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 50.9 p30 -71.45 -19.22 62.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.93 -1.106 . . . . 0.0 110.106 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 70.3 m -90.05 -22.06 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.974 -179.57 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 80.0 mt -67.66 148.35 98.57 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 0.0 108.764 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.32 -158.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 120.879 1.052 . . . . 0.0 109.766 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.87 -37.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.09 -39.86 79.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.01 33.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.693 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -59.91 -39.11 84.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.01 18.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.179 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.02 -21.42 66.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.61 -57.78 9.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.88 . . . . 0.0 109.045 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -52.7 -42.77 65.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.36 -28.21 68.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.097 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 9' ' ' GLU . 0.8 OUTLIER -74.63 -61.19 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.012 179.693 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -50.7 162.16 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.421 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.685 ' H ' HD13 ' A' ' 68' ' ' ILE . . . -164.67 95.65 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' C ' HD12 ' A' ' 68' ' ' ILE . 28.1 tt0 57.44 62.56 2.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -1.109 . . . . 0.0 110.501 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.685 HD13 ' H ' ' A' ' 66' ' ' GLY . 1.4 mp -100.59 -56.8 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -142.22 -26.32 0.64 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.277 -0.889 . . . . 0.0 109.121 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.7 m -73.57 -21.48 60.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.385 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m 53.23 36.45 22.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.59 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 72' ' ' LEU . 1.5 pt? -71.21 -160.15 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 109.623 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.0 21.57 17.85 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -50.14 61.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.408 -1.054 . . . . 0.0 109.074 -179.899 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -85.71 -6.24 59.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.158 -0.964 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.995 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.426 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 2.3 mp0 -88.96 108.88 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.0 tp -158.65 81.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -82.72 162.65 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.377 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 6' ' ' SER . 43.7 t -137.28 157.87 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.381 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -105.16 153.15 39.74 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.413 -0.804 . . . . 0.0 109.24 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.49 -42.88 62.22 Favored 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.24 1.294 . . . . 0.0 110.397 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -58.2 -27.0 63.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.603 -179.546 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -84.63 -24.47 29.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 109.119 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 12' ' ' ASN . 98.3 mt -82.42 -22.85 35.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.87 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.68 . . . . 0.0 111.394 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.4 m120 -148.34 -7.03 0.41 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.465 -1.397 . . . . 0.0 111.089 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -79.9 148.11 67.73 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.594 -1.316 . . . . 0.0 108.253 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.4 -67.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.039 1.159 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.67 2.36 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' LEU . 21.4 mt -95.19 150.61 37.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.21 -1.17 . . . . 0.0 109.015 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.9 -174.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.759 0.972 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -105.29 4.37 30.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.448 -0.782 . . . . 0.0 109.84 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 p -132.71 132.42 42.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.414 -0.804 . . . . 0.0 109.413 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -53.1 -30.83 38.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.324 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.31 61.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.275 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -36.84 15.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.92 -53.95 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -1.146 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.04 -43.25 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 108.929 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HE2' ' HZ1' ' A' ' 29' ' ' LYS . 91.5 t80 -61.46 -44.13 97.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.38 -24.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.446 -0.784 . . . . 0.0 109.187 179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.46 -29.52 36.13 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.163 -0.961 . . . . 0.0 108.692 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' GLN . 7.4 mtpm? -72.14 -35.36 69.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HZ1' ' HE2' ' A' ' 25' ' ' TYR . 1.8 mptm? -64.68 0.73 1.02 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' LYS . 64.3 mt-30 -151.94 -68.77 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 108.905 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.08 52.42 1.62 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -51.47 141.55 15.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.271 . . . . 0.0 109.115 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -50.51 91.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p30 -97.83 118.47 34.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.331 -0.855 . . . . 0.0 109.303 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.31 126.09 34.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.667 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.02 155.93 16.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 108.773 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 37' ' ' ARG . 14.0 ttm-85 -150.71 -111.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -0.796 . . . . 0.0 109.312 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 40' ' ' VAL . . . -167.37 31.31 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -11.88 2.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG21 ' H ' ' A' ' 44' ' ' LYS . 6.3 m -91.08 38.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -1.07 . . . . 0.0 108.987 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp 65.28 -13.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.998 -0.439 . . . . 0.0 110.516 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . 150.81 82.83 0.04 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.437 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -170.69 -83.22 0.05 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' H ' HG21 ' A' ' 40' ' ' VAL . 6.7 ttpm? -178.27 93.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.698 -0.884 . . . . 0.0 109.088 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.25 120.94 32.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -84.96 156.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.3 mt-10 -147.34 170.75 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.97 127.63 28.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 46.9 t-20 -75.37 123.5 25.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.997 . . . . 0.0 109.296 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.12 63.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.828 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 42.2 p30 -69.83 -16.53 63.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.941 -1.1 . . . . 0.0 109.82 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 49.7 m -89.95 -23.88 21.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.63 148.31 98.59 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 108.948 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.83 -168.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.892 1.061 . . . . 0.0 109.676 179.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.0 -35.36 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 6.0 mp0 -59.28 -39.43 82.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.81 -29.03 32.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.61 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -63.79 -46.82 83.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.302 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.0 77.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 108.807 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.24 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.068 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -62.14 -35.77 79.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 108.589 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.73 -45.32 83.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.788 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 63' ' ' LEU . 10.4 mp -65.81 -26.84 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' HG3' ' NH1' ' A' ' 64' ' ' ARG . 2.3 tpm_? -74.08 -63.34 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -63.12 -179.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 109.049 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.69 -57.71 0.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 69' ' ' GLU . 48.2 mt-10 -56.97 -75.94 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -1.147 . . . . 0.0 109.438 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 68' ' ' ILE . 35.9 mt 54.67 -2.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.735 . . . . 0.0 110.368 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 67' ' ' GLU . 7.0 mp0 53.12 172.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.07 -1.019 . . . . 0.0 109.2 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' SER . 90.0 m 44.64 -95.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -0.957 . . . . 0.0 109.784 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.2 t 60.4 142.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.888 . . . . 0.0 110.0 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.994 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -81.81 177.99 8.57 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.246 -0.909 . . . . 0.0 109.17 179.883 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.9 21.23 1.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 72' ' ' LEU . 42.6 p90 -69.71 -12.45 61.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 109.076 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -173.11 -27.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.847 . . . . 0.0 109.387 179.967 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.35 0.595 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.76 134.62 33.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -0.94 . . . . 0.0 109.229 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.481 ' CD2' HE22 ' A' ' 65' ' ' GLN . 12.5 tp -161.03 78.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -79.6 166.73 21.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.086 -1.009 . . . . 0.0 108.381 179.191 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -136.05 -140.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.23 -0.919 . . . . 0.0 109.979 -179.09 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.608 ' H ' HG12 ' A' ' 5' ' ' VAL . 4.9 m -162.83 153.0 13.65 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.46 -48.6 19.66 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.463 1.442 . . . . 0.0 110.959 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -57.25 -24.79 57.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -0.999 . . . . 0.0 109.968 -179.054 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 36.8 mt-10 -85.05 -26.06 27.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.185 -0.947 . . . . 0.0 109.417 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.2 mt -81.9 -21.59 37.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 30.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 28.1 m120 -146.69 -7.0 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.523 -1.361 . . . . 0.0 110.933 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.49 147.79 68.66 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.629 -1.295 . . . . 0.0 108.176 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -66.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.867 1.045 . . . . 0.0 110.707 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.36 -36.43 4.28 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.6 mt -93.68 149.95 37.95 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.173 -1.192 . . . . 0.0 109.18 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 172.77 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.821 1.014 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -94.36 6.6 48.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.735 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -131.86 129.66 40.68 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.506 -0.746 . . . . 0.0 109.309 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -52.71 -29.86 29.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.57 29.35 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.43 -58.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.8 mt -52.39 -44.52 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.937 . . . . 0.0 109.146 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.71 -44.35 96.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.982 . . . . 0.0 109.063 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.28 -24.04 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 109.215 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.28 -32.95 67.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 108.884 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -71.78 -33.52 68.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 108.966 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -65.15 -3.88 4.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -150.18 -67.58 0.2 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 108.779 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.88 59.04 1.01 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.545 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.74 147.81 17.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.083 -1.245 . . . . 0.0 108.732 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -49.24 90.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.148 -0.97 . . . . 0.0 109.537 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -102.98 121.2 42.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.876 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 35' ' ' ARG . 23.4 ttm-85 -86.7 117.5 25.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.42 112.07 23.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.05 . . . . 0.0 109.89 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -150.43 131.42 14.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.05 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -68.53 -107.49 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.274 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.36 -32.72 0.56 Allowed Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 178.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -78.34 -75.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -1.12 . . . . 0.0 108.926 179.984 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' H ' HG23 ' A' ' 40' ' ' VAL . 34.0 ttmt -161.82 -34.23 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.43 174.74 44.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.65 -17.82 79.99 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 pttm -176.04 100.32 0.07 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -1.092 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.59 137.73 32.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.729 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 46' ' ' ILE . 16.7 tt -91.4 123.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.263 -0.898 . . . . 0.0 109.703 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 5' ' ' VAL . 12.1 mm-40 -101.89 170.57 8.05 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.05 128.42 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.452 -0.78 . . . . 0.0 109.596 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.47 114.77 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.266 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.815 ' C ' ' HZ2' ' A' ' 58' ' ' LYS . . . -54.7 -30.82 56.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.12 -19.67 63.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 m -89.18 -17.96 28.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 109.766 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.4 mt -67.71 149.2 98.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.046 -1.033 . . . . 0.0 109.032 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.66 -158.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.914 1.076 . . . . 0.0 110.031 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.11 -38.62 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -57.79 -41.45 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.52 -33.75 47.8 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.815 ' HZ2' ' C ' ' A' ' 50' ' ' ALA . 1.2 tpmt? -56.98 -53.67 55.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.15 67.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.61 78.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.111 -0.993 . . . . 0.0 109.375 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -51.23 65.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -44.2 -31.24 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.449 -0.782 . . . . 0.0 109.569 -179.457 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.96 -68.09 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.162 179.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 11.1 ptm180 -78.22 59.6 2.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.404 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.481 HE22 ' CD2' ' A' ' 3' ' ' LEU . 4.7 mm100 -78.16 32.48 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.932 -1.105 . . . . 0.0 109.489 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . 47.02 -172.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -81.34 107.73 14.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.289 -1.124 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mt -71.0 -19.43 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -50.02 -29.2 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 p -62.67 -39.95 95.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t -68.15 -84.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.371 -0.831 . . . . 0.0 109.538 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -49.25 128.9 17.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -79.1 14.45 14.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 t80 65.96 -6.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.562 -0.963 . . . . 0.0 109.412 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 73' ' ' GLY . 41.3 t80 -75.35 -8.16 55.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.112 -0.993 . . . . 0.0 109.014 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 75' ' ' PHE . 24.2 mt-10 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.0 109.602 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 ttt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.01 158.49 18.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 109.337 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.8 tp -160.98 81.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -81.62 167.03 19.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.129 -0.982 . . . . 0.0 108.819 179.421 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -138.33 148.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 109.545 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -97.44 153.0 38.52 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -51.81 -48.15 22.89 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.381 1.387 . . . . 0.0 110.869 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -58.74 -23.74 60.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.29 -179.194 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -85.03 -24.01 28.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.947 -1.096 . . . . 0.0 109.51 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -82.02 -23.18 36.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.134 -0.979 . . . . 0.0 108.8 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.8 p30 -146.89 -6.19 0.51 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.544 -1.347 . . . . 0.0 110.844 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 16' ' ' LEU . 37.2 mt -78.9 147.3 70.1 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.558 -1.339 . . . . 0.0 108.02 179.241 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.96 -67.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.066 1.177 . . . . 0.0 110.756 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.71 -34.73 2.85 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.2 mt -94.57 149.94 37.3 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.152 -1.205 . . . . 0.0 109.031 -179.673 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.5 -176.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 120.921 1.081 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -102.57 -2.85 27.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.429 -0.794 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -119.65 126.15 50.46 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -52.27 -29.15 21.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.344 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.09 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.391 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -76.9 -36.16 37.21 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.78 -60.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -1.152 . . . . 0.0 109.36 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.0 mt -50.82 -42.42 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 108.97 179.812 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.41 -39.24 86.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.479 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' GLY . 55.9 t -74.32 -28.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 108.976 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.57 -31.56 16.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 108.763 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 30' ' ' GLN . 56.5 mmtt -72.5 -39.63 67.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 0.0 109.008 179.412 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -64.99 1.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 28' ' ' LYS . 55.9 mt-30 -152.0 -70.43 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 108.975 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.44 51.18 1.6 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.3 m-90 -50.0 141.54 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.06 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.009 . . . . 0.0 109.117 179.784 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.1 p30 -100.57 122.8 43.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.422 -0.799 . . . . 0.0 110.19 -179.313 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -90.71 123.2 34.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.347 -0.846 . . . . 0.0 109.343 179.31 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -93.21 116.2 28.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.888 -1.133 . . . . 0.0 109.24 179.712 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.64 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 21.9 ttm-85 -90.69 -68.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.57 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 78.39 87.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.506 0.67 . . . . 0.0 109.304 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.79 -41.81 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 m -64.24 -33.23 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.274 -1.133 . . . . 0.0 109.373 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 43' ' ' GLY . 71.7 tttt -132.88 -9.97 3.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.487 -0.758 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.67 -13.4 4.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 41' ' ' LYS . . . -83.4 25.61 4.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 34.8 mttm 57.06 94.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -1.131 . . . . 0.0 109.451 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.71 122.37 31.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 46' ' ' ILE . 20.2 tt -88.68 121.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.251 -179.896 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 56.5 mm-40 -100.65 174.21 6.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.264 -0.897 . . . . 0.0 109.307 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -135.72 130.72 34.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -76.23 116.75 17.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.99 -30.57 59.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 -179.65 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -70.44 -19.35 62.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.99 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.4 m -89.65 -19.86 24.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 88.5 mt -67.59 149.05 98.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.103 -0.998 . . . . 0.0 108.859 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.69 -160.34 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.769 0.98 . . . . 0.0 109.661 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -92.03 -38.71 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.39 -39.33 83.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.724 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.86 -38.75 27.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.23 -59.73 4.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 109.373 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.43 -44.53 65.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.14 73.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.93 -58.91 5.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.136 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.47 -24.85 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.375 -179.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 tp -69.51 -53.41 19.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.775 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.83 8.63 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -179.513 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -92.52 123.39 35.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.994 . . . . 0.0 109.221 179.554 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.77 41.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.65 35.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -1.156 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.663 ' H ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -66.94 -65.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.411 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 55.58 82.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 0.0 109.549 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.3 m -163.57 -94.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.461 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.3 m -83.82 -37.88 21.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 109.408 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.2 mt -70.36 -36.14 73.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.55 -6.88 1.12 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.657 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 72' ' ' LEU . 9.9 t80 68.79 71.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.954 . . . . 0.0 109.11 -179.916 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' GLU . 21.5 t80 63.3 24.44 14.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.709 . . . . 0.0 109.437 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 75' ' ' PHE . 30.9 mt-10 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.65 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -145.96 80.41 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -92.22 78.65 5.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -79.95 171.0 15.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.053 . . . . 0.0 108.657 179.191 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.05 153.08 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.79 -179.229 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -103.84 153.43 38.76 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.203 -179.749 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.95 -46.21 35.33 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.27 1.313 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -59.28 -23.92 62.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB3' HH11 ' A' ' 64' ' ' ARG . 74.3 mm-40 -84.87 -25.99 27.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 62.9 mt -83.13 -21.29 33.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.892 . . . . 0.0 109.488 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.06 29.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.616 -0.677 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.5 m120 -148.03 -8.7 0.4 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.435 -1.416 . . . . 0.0 111.011 -179.411 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.7 mt -79.19 147.28 68.89 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.559 -1.338 . . . . 0.0 108.231 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -67.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.718 0 C-N-CA 121.087 1.191 . . . . 0.0 111.054 -179.182 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.91 -34.66 2.01 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.1 mt -95.37 150.06 37.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.197 -1.178 . . . . 0.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.34 179.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.875 1.05 . . . . 0.0 110.177 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.1 mmtt -96.56 -17.87 20.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.284 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -109.68 130.97 55.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.633 -0.667 . . . . 0.0 109.356 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -53.05 -29.31 29.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.16 -32.87 56.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.06 -36.0 29.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.96 -58.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.411 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.6 mt -49.52 -46.05 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.052 179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.61 -56.65 17.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 108.954 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 22' ' ' GLY . 78.3 t -57.94 -15.09 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.449 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.1 -35.57 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.303 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 10.6 mptt -70.87 -28.71 64.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.129 179.804 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 16.8 tptm -64.2 -4.6 3.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 29' ' ' LYS . 24.3 mp0 -149.22 -61.19 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.55 49.59 2.52 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.323 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -52.22 142.89 15.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.257 . . . . 0.0 109.385 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -57.03 96.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 108.961 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -99.45 123.81 44.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.369 -0.832 . . . . 0.0 109.944 -179.423 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -89.13 116.66 27.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -95.03 164.53 12.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.955 . . . . 0.0 108.868 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.74 -42.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.627 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.39 74.76 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.072 -1.018 . . . . 0.0 109.435 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.29 -44.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 41' ' ' LYS . 10.5 m -62.74 -45.73 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.313 -1.11 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 40' ' ' VAL . 1.5 tmtp? -89.4 -73.55 0.51 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 52.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.888 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.99 -69.23 0.1 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -173.99 95.7 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -1.161 . . . . 0.0 109.362 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.41 104.74 16.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 109.024 179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 46' ' ' ILE . 16.8 tt -87.83 121.53 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 109.508 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 12.3 mm-40 -101.83 171.2 7.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.432 -0.792 . . . . 0.0 109.191 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -135.3 128.66 32.19 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.243 179.525 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -74.66 117.7 16.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.06 . . . . 0.0 109.169 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -26.73 60.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -68.57 -20.74 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.554 -179.395 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -91.24 -15.14 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.871 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.4 149.58 98.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 0.0 108.879 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.29 -157.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 120.954 1.103 . . . . 0.0 109.638 179.297 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.98 -37.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.72 -35.83 77.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 110.316 -179.389 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.91 -31.22 45.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -58.59 -68.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -45.7 17.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.397 -0.814 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.381 -0.824 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.7 -33.71 76.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.321 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.89 -47.99 82.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 108.91 179.668 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 2.4 mm? -65.72 -28.61 69.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.114 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HE ' ' C ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -70.65 -44.76 66.46 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -41.54 117.84 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.782 . . . . 0.0 110.432 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' H ' ' H ' ' A' ' 67' ' ' GLU . . . -160.8 -13.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.721 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' H ' ' H ' ' A' ' 66' ' ' GLY . 47.1 tt0 -158.3 86.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -1.028 . . . . 0.0 108.937 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 mt -69.76 -24.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.839 -179.668 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' A' ' 70' ' ' THR . 34.9 mt-10 -147.74 -43.12 0.17 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.089 -1.007 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 31.6 m -166.31 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -171.74 -165.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -162.12 -178.69 6.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 179.91 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.85 11.14 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 72' ' ' LEU . 46.7 m-85 54.81 65.57 1.47 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.494 -1.003 . . . . 0.0 108.916 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.59 17.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.961 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.19 -92.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.973 . . . . 0.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.5 tp 48.29 71.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.43 162.08 21.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 108.508 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -134.63 150.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.378 -0.826 . . . . 0.0 109.58 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -98.34 153.01 38.22 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.434 -0.791 . . . . 0.0 109.488 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.68 -45.02 40.63 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.351 1.367 . . . . 0.0 110.582 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -58.19 -26.8 63.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.525 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 45.4 mt-10 -84.14 -24.93 30.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.696 -179.729 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' ASN . 81.8 mt -81.87 -23.5 36.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 108.997 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.96 28.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 111.021 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.0 m120 -147.42 -7.06 0.46 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.481 -1.387 . . . . 0.0 110.881 -179.377 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' LEU . 22.3 mt -79.16 147.42 69.31 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.648 -1.283 . . . . 0.0 108.181 179.412 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.77 -68.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.019 1.146 . . . . 0.0 110.796 -179.441 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.8 -34.56 1.91 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.1 mt -95.23 150.6 37.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.202 -1.175 . . . . 0.0 108.976 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.95 -179.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.762 0.975 . . . . 0.0 109.853 179.485 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 19.9 mmmt -98.73 -16.03 19.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.064 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -105.28 132.38 51.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.682 . . . . 0.0 109.305 -179.851 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.88 -28.56 37.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.83 -54.19 47.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.913 . . . . 0.0 109.749 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.62 -35.85 63.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.707 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.21 -65.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -1.21 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mt -51.27 -41.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.149 -179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -61.67 -42.7 99.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.7 t -75.07 -22.81 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 0.0 109.297 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.24 -29.16 31.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.0 108.842 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.3 mptp? -71.43 -32.51 68.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 108.872 179.59 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -64.64 -4.87 4.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.294 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -150.26 -67.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.08 54.14 1.31 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.9 m-90 -52.07 137.99 26.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.117 -1.225 . . . . 0.0 109.018 179.474 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -47.19 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.713 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.8 p30 -103.11 115.74 31.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.358 -0.838 . . . . 0.0 109.472 179.918 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 35' ' ' ARG . 4.2 ptt-85 -88.54 139.97 29.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.33 133.1 44.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.144 -0.973 . . . . 0.0 108.436 179.218 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -144.98 101.4 3.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.245 -0.909 . . . . 0.0 109.018 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.681 ' HB2' ' H ' ' A' ' 44' ' ' LYS . . . -75.17 51.35 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.81 . . . . 0.0 109.753 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.21 -19.84 6.15 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.2 p -80.77 -8.66 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 109.657 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 9.8 ptmm? -166.57 -30.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.818 -179.897 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.27 46.46 2.01 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.31 33.14 0.59 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.681 ' H ' ' HB2' ' A' ' 38' ' ' ALA . 9.4 mtmp? 51.54 89.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -1.141 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.2 143.7 26.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 179.75 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.402 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 13.7 mt -86.96 145.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.025 . . . . 0.0 109.683 -179.796 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 7.5 mp0 -132.28 171.63 13.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -136.36 128.96 30.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.193 -0.942 . . . . 0.0 109.796 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -76.09 114.34 14.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 108.984 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -26.36 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.465 -179.254 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 51' ' ' ASN . 2.0 m120 -70.28 -21.1 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.3 m -90.0 -18.62 25.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.54 149.17 98.47 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.014 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.3 Cg_endo -57.8 -156.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 120.939 1.093 . . . . 0.0 109.42 179.228 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -98.21 -37.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.1 -35.52 77.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.05 -39.01 30.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.059 -1.026 . . . . 0.0 109.698 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.73 -59.17 5.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.971 . . . . 0.0 109.449 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.81 -45.42 50.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.917 -1.114 . . . . 0.0 109.16 179.688 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.34 -33.11 74.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 108.99 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.56 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.152 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 mt -47.68 -23.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 109.299 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -70.1 -57.76 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 0.0 109.471 179.971 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 10.2 ptm180 -74.62 6.55 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.19 -0.944 . . . . 0.0 110.45 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 11.5 mm100 -83.26 63.0 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.348 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.24 36.44 1.11 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 65' ' ' GLN . 15.7 mt-10 -73.56 -1.93 20.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -1.134 . . . . 0.0 109.605 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -50.46 -17.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.9 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 67' ' ' GLU . 51.2 mt-10 -58.59 161.57 4.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 0.0 109.355 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -55.05 118.3 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -179.62 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 pp -72.86 150.64 42.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.719 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -154.82 -0.14 0.16 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.17 15.61 0.55 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.533 -0.98 . . . . 0.0 109.315 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 43.8 t80 55.06 14.1 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.528 -179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.2 m95 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 6' ' ' SER . 18.6 t -140.05 165.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -113.54 153.11 45.83 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -52.67 -46.77 31.14 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.303 1.335 . . . . 0.0 110.558 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -59.12 -25.92 64.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.931 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.46 -25.86 30.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.008 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 89.7 mt -82.47 -23.5 34.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 108.898 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.3 m120 -145.49 -9.52 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.578 -1.326 . . . . 0.0 110.666 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.2 mt -79.18 147.4 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.667 -1.271 . . . . 0.0 108.098 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.53 -64.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.059 1.173 . . . . 0.0 110.802 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.84 4.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -94.92 149.79 36.83 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.114 -1.227 . . . . 0.0 109.018 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.41 175.81 0.17 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 120.905 1.07 . . . . 0.0 109.921 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -97.04 7.87 45.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 p -133.71 130.08 37.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.46 -0.775 . . . . 0.0 109.413 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -52.84 -29.83 30.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.63 63.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -81.16 -35.46 23.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.75 -53.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -1.189 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.78 -45.18 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 109.121 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.2 -41.73 93.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 0.0 108.951 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.9 t -74.96 -25.82 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 109.114 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.86 -31.71 40.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -71.11 -29.4 65.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.234 -0.916 . . . . 0.0 109.016 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -64.86 -7.13 10.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 109.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -150.72 -64.34 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 108.843 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.1 59.47 1.05 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -57.37 145.41 32.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.081 -1.247 . . . . 0.0 108.824 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -47.63 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -103.63 119.51 39.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.427 -0.796 . . . . 0.0 109.844 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.271 -0.893 . . . . 0.0 109.156 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.4 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -135.72 128.39 30.86 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -75.7 116.07 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 108.898 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.33 59.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.614 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.727 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 5.1 m120 -69.4 -17.17 63.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.006 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.8 m -89.61 -20.27 23.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.0 109.782 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 54' ' ' PRO . 73.9 mt -67.92 149.27 98.28 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.121 -0.987 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -57.04 -157.89 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.845 1.03 . . . . 0.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 t -94.4 -36.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -58.08 -38.81 77.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.549 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.33 -36.4 29.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.36 -42.92 78.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.595 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.44 -58.06 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -23.31 67.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.749 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 45.0 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 6' ' ' SER . 58.7 t -139.39 167.99 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -106.21 153.88 40.04 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.43 -0.794 . . . . 0.0 109.602 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.82 -49.72 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.481 1.454 . . . . 0.0 110.801 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.11 -23.85 22.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.564 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.18 -23.32 30.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.986 -1.071 . . . . 0.0 109.402 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.7 mt -83.65 -20.58 33.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.63 36.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.7 -0.625 . . . . 0.0 111.506 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 m120 -148.22 -11.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.343 -1.473 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -78.73 147.91 71.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.646 -1.284 . . . . 0.0 108.182 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.46 -60.71 0.28 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 120.823 1.015 . . . . 0.0 110.415 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.98 -39.57 9.07 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.4 mt -93.39 149.84 37.98 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.216 -1.167 . . . . 0.0 109.041 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.35 177.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.848 1.032 . . . . 0.0 109.97 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -101.56 8.41 41.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.429 -0.794 . . . . 0.0 109.552 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -130.09 132.96 46.36 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.525 -0.734 . . . . 0.0 109.351 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -52.82 -31.34 38.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.596 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.7 51.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -33.75 85.38 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.2 -65.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.169 . . . . 0.0 109.229 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -48.98 -41.11 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -61.66 -48.94 78.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 108.876 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.81 -36.45 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 108.959 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.33 -30.35 7.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.647 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 30' ' ' GLN . 48.2 mtpt -73.77 -41.98 61.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.51 -0.744 . . . . 0.0 109.484 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -65.94 4.32 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.308 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.558 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 23.8 mt-30 -150.15 -75.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 105.35 50.39 0.92 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.558 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.6 m-90 -53.24 134.1 39.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.366 . . . . 0.0 108.463 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 105.01 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.96 -1.088 . . . . 0.0 109.513 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -104.17 124.36 48.97 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 110.282 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.47 135.38 40.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.53 112.31 12.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.123 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.87 19.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.307 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -72.11 -20.43 61.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.035 -1.041 . . . . 0.0 110.277 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.3 m -88.9 -16.65 31.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.081 -1.012 . . . . 0.0 110.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' PRO . 82.7 mt -67.73 148.13 98.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 108.962 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -56.69 -161.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.847 1.031 . . . . 0.0 109.686 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -91.2 -38.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.36 -41.15 84.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.47 -52.58 7.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.093 -1.004 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -46.69 -45.55 19.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.977 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -58.09 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.47 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.12 62.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.212 -0.93 . . . . 0.0 109.001 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 108.795 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 41.8 m95 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -125.29 -137.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.418 -0.801 . . . . 0.0 109.349 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -166.12 152.31 8.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 109.508 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.39 -52.02 8.02 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.312 1.341 . . . . 0.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -58.54 -25.56 62.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.69 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -84.95 -30.34 24.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.077 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 12' ' ' ASN . 28.6 mt -80.69 -25.27 38.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.039 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 30.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 t-20 -145.1 -10.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.582 -1.324 . . . . 0.0 110.562 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' LEU . 21.2 mt -78.65 147.21 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.0 107.911 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.49 -64.39 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 120.978 1.119 . . . . 0.0 110.926 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.2 -37.47 4.52 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.6 mt -95.39 150.29 37.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.157 -1.202 . . . . 0.0 109.272 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.31 173.21 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 120.908 1.072 . . . . 0.0 110.027 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.36 8.47 43.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.296 -0.878 . . . . 0.0 109.69 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.02 131.92 41.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.487 -0.758 . . . . 0.0 109.375 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -53.02 -30.56 36.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -47.69 67.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.243 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -67.96 -36.36 86.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.5 -63.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -1.209 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.5 -42.46 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.968 . . . . 0.0 109.1 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.12 -44.79 96.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.016 . . . . 0.0 109.015 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 22' ' ' GLY . 41.5 t -69.42 -26.34 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.91 -28.53 9.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.851 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.6 mptp? -72.92 -35.65 67.08 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.154 -0.966 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -65.37 -3.97 4.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -150.9 -68.96 0.18 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.89 54.55 1.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.88 143.75 12.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.942 -1.328 . . . . 0.0 109.006 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -50.01 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.001 . . . . 0.0 109.078 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.5 p30 -100.06 123.44 44.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.293 -0.88 . . . . 0.0 109.82 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.43 130.02 34.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.389 -0.819 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.12 117.5 17.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -58.93 -28.29 66.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -70.02 -23.43 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -89.47 -10.63 45.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 54' ' ' PRO . 60.4 mt -66.52 153.64 92.73 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.094 -1.004 . . . . 0.0 108.527 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.5 Cg_exo -57.16 -147.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.206 -1.076 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.01 -37.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.933 -1.104 . . . . 0.0 109.457 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.83 -30.05 71.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 111.185 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 -41.42 37.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.669 -1.269 . . . . 0.0 110.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.28 -56.7 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.122 . . . . 0.0 109.454 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.2 -48.73 23.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.284 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.89 -33.1 74.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.294 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -124.85 -138.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.509 -0.744 . . . . 0.0 109.203 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -167.04 152.55 7.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.905 -1.122 . . . . 0.0 109.609 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.35 -53.12 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.482 1.455 . . . . 0.0 110.615 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -56.47 -25.47 51.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.86 -28.06 26.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' ASN . 50.0 mt -81.96 -23.91 35.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.193 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.96 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.692 -0.63 . . . . 0.0 111.093 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.6 m120 -145.41 -7.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.521 -1.362 . . . . 0.0 110.745 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 17.6 mt -79.46 148.28 69.81 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.601 -1.312 . . . . 0.0 107.942 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.1 -64.12 0.12 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.889 1.059 . . . . 0.0 110.702 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.08 -38.3 4.72 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.9 mt -93.79 150.3 38.45 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.234 -1.156 . . . . 0.0 109.035 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.0 -178.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.804 1.002 . . . . 0.0 109.779 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.75 -7.78 27.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -117.3 129.81 56.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.655 -0.653 . . . . 0.0 109.284 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -53.24 -28.94 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.11 65.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.87 -35.23 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' ALA . 35.6 t -65.16 -56.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -1.157 . . . . 0.0 109.298 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.75 -43.56 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.2 -44.38 97.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.982 -1.074 . . . . 0.0 108.798 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.21 -19.09 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 109.125 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.61 -33.25 74.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 108.84 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -70.16 -27.61 64.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.265 -0.897 . . . . 0.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -64.79 -4.25 4.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.039 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -150.11 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.73 59.45 1.26 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.8 m-90 -56.38 147.84 20.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.037 -1.272 . . . . 0.0 108.796 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.543 HE21 HD22 ' A' ' 49' ' ' ASN . 15.7 tt0 -50.33 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p-10 -101.24 121.97 42.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 179.708 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 29.5 mm-40 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -135.45 127.29 29.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.543 HD22 HE21 ' A' ' 33' ' ' GLN . 48.8 t30 -77.69 116.36 18.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.067 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.39 -23.62 39.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.23 -25.17 63.26 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.081 -1.012 . . . . 0.0 109.544 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.7 m -91.86 -13.56 31.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.46 149.1 98.53 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.854 -1.154 . . . . 0.0 109.146 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.48 -155.95 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 120.973 1.115 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.7 -36.95 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.86 -39.05 83.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.31 -20.58 47.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -75.2 -58.27 3.39 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.17 -0.956 . . . . 0.0 109.212 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.51 -44.06 55.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.102 . . . . 0.0 108.955 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.1 74.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.445 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.8 m95 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 6' ' ' SER . 59.3 t -132.41 160.53 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.314 -0.866 . . . . 0.0 109.705 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -104.53 152.92 39.46 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.49 -43.83 55.17 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.421 1.414 . . . . 0.0 110.665 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -27.26 63.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 76.0 mm-40 -84.11 -22.66 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 109.317 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.5 mt -82.74 -23.17 34.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.288 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.95 29.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.154 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.646 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -148.3 -8.52 0.39 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.437 -1.414 . . . . 0.0 111.122 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.646 ' N ' HD22 ' A' ' 12' ' ' ASN . 29.1 mt -78.41 147.42 72.07 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.492 -1.38 . . . . 0.0 108.05 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.22 -66.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.989 1.126 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.04 -34.79 2.14 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.7 mt -95.17 150.47 37.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.275 -1.132 . . . . 0.0 108.86 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.08 -173.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.867 1.044 . . . . 0.0 110.071 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 27.7 mmtp -100.71 -17.58 16.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -109.57 130.14 55.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.55 -0.719 . . . . 0.0 109.391 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.35 -29.35 23.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.55 73.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.63 81.44 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.55 -64.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -1.173 . . . . 0.0 109.335 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.07 -39.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.117 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.79 -40.19 91.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 108.602 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.3 -27.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.07 -28.53 17.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.23 -0.919 . . . . 0.0 108.723 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -71.69 -32.96 68.4 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 -1.15 1.83 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.457 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -150.95 -65.43 0.19 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.96 49.6 1.74 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -51.52 136.71 25.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.038 -1.272 . . . . 0.0 109.006 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.584 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.79 110.89 0.4 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.006 -1.059 . . . . 0.0 108.582 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 34' ' ' ASN . 10.1 p30 -105.09 122.13 45.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.424 -0.798 . . . . 0.0 109.624 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 109.151 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -136.3 135.3 38.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -76.99 118.91 20.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.929 -1.107 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.45 59.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.379 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -69.58 -21.61 63.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.581 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 61.6 m -91.94 -15.14 28.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.21 150.28 97.79 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 109.321 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.4 151.37 75.03 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.033 1.156 . . . . 0.0 109.621 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.1 -38.7 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.3 -37.73 78.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.861 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.03 -35.41 37.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -60.89 -62.48 1.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.49 42.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.297 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.31 74.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 108.886 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.6 m95 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.25 155.53 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 109.712 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -104.99 152.17 39.58 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.06 -46.88 30.77 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.377 1.385 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -58.37 -24.36 59.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.206 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 18.0 mm-40 -84.25 -27.65 27.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.968 -1.082 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 53.7 mt -83.0 -21.68 33.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 109.334 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.91 29.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.635 . . . . 0.0 111.133 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 21.7 p30 -148.48 -6.81 0.4 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.511 -1.368 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.5 mt -79.46 147.36 67.9 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.567 -1.333 . . . . 0.0 108.181 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.55 -67.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.056 1.171 . . . . 0.0 110.978 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.07 -36.14 2.62 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.8 mt -94.68 150.51 38.09 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.252 -1.146 . . . . 0.0 108.926 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.78 -176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.836 1.024 . . . . 0.0 110.055 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 11' ' ' ALA . 22.5 mtpt -101.34 -15.04 17.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.344 -0.848 . . . . 0.0 109.919 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 p -113.74 131.29 56.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.73 . . . . 0.0 109.408 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -52.88 -29.29 27.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 109.251 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.71 65.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.69 -35.57 28.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.1 -56.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -1.147 . . . . 0.0 109.198 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.12 -43.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -61.14 -44.82 96.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 108.986 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.61 -25.47 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.429 -0.794 . . . . 0.0 109.059 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.4 -31.06 32.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.206 -0.934 . . . . 0.0 108.956 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -71.57 -28.83 64.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 109.057 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -64.73 -4.85 4.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 109.445 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.41 -58.15 0.18 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 108.879 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.8 51.62 2.26 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.4 m-90 -51.02 137.35 21.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.123 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -49.94 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.084 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -99.94 121.02 40.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.433 -0.792 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.858 . . . . 0.0 109.155 179.302 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 44.6 mm-40 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.23 129.96 34.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.228 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -75.34 117.32 17.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.93 -1.106 . . . . 0.0 109.489 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.33 59.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 110.437 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -69.51 -17.83 63.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -1.0 . . . . 0.0 109.576 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m -90.66 -22.33 21.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -67.11 148.39 98.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 109.031 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.4 Cg_endo -56.41 -161.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.851 1.034 . . . . 0.0 109.654 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.9 t -93.6 -33.82 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 109.375 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.2 mp0 -59.32 -39.31 82.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 109.515 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -82.19 -34.53 28.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.874 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -58.94 -39.66 82.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 -52.57 20.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.121 -0.987 . . . . 0.0 108.96 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.13 -19.48 65.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.415 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' ALA . 19.5 tp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 108.956 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.8 m95 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.1 164.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 0.0 109.416 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -113.86 152.58 45.75 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.13 -47.94 24.81 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 121.229 1.286 . . . . 0.0 110.251 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -60.74 -24.5 65.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.985 . . . . 0.0 110.108 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -84.35 -27.15 27.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.088 -1.008 . . . . 0.0 109.488 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -82.41 -22.49 35.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 35.4 m120 -145.68 -9.37 0.55 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.577 -1.327 . . . . 0.0 110.805 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.22 147.66 69.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.638 -1.289 . . . . 0.0 108.039 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.29 -65.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 120.994 1.13 . . . . 0.0 110.838 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.57 -36.82 3.47 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.4 mt -94.69 150.27 37.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.213 -1.169 . . . . 0.0 108.939 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.01 175.31 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.953 1.102 . . . . 0.0 109.99 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -97.89 5.71 48.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 p -130.66 130.15 43.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.455 -0.778 . . . . 0.0 109.278 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 p -52.16 -30.99 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.433 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.57 70.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.33 -35.23 81.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 27' ' ' ALA . 61.4 t -65.32 -59.88 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.25 -43.26 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 108.933 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.49 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.978 -1.076 . . . . 0.0 108.82 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.17 -18.24 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.67 -33.28 73.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.949 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 30' ' ' GLN . 6.0 mtpm? -70.55 -29.11 65.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 108.677 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -65.1 -1.57 2.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.444 -0.785 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 28' ' ' LYS . 36.2 mt-30 -150.39 -63.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.19 55.27 1.29 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -54.87 137.65 44.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.026 -1.279 . . . . 0.0 108.962 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.59 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.376 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 4.3 p30 -99.65 121.36 41.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.296 -0.878 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.177 -0.952 . . . . 0.0 109.167 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 49.8 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.88 128.56 32.85 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.64 ' ND2' HD21 ' A' ' 51' ' ' ASN . 49.5 t-20 -75.68 114.17 13.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.899 -1.126 . . . . 0.0 109.092 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.32 -27.05 33.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 110.796 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.64 HD21 ' ND2' ' A' ' 49' ' ' ASN . 54.5 p30 -69.03 -17.53 63.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.895 -1.128 . . . . 0.0 110.052 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 13.5 m -90.58 -18.5 25.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.138 -0.976 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 92.1 mt -68.25 149.18 98.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.37 -156.38 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 120.918 1.079 . . . . 0.0 109.629 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.34 -36.47 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -59.35 -36.68 76.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.098 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.39 -34.41 41.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 109.572 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -55.79 -48.28 75.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.28 -57.29 11.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.64 -23.06 67.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.035 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.297 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.3 m95 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.26 152.99 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -97.68 154.72 37.79 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.83 . . . . 0.0 109.579 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.51 -51.5 10.98 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.611 1.541 . . . . 0.0 112.138 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -57.81 -17.25 14.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.81 -1.181 . . . . 0.0 110.705 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 26.1 mp0 -87.14 -28.12 22.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.679 -1.263 . . . . 0.0 108.884 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 48.7 mt -81.73 -22.35 37.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.855 . . . . 0.0 109.204 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 29.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.706 -0.621 . . . . 0.0 111.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.9 t-20 -146.7 -8.82 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.475 -1.39 . . . . 0.0 110.855 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.7 mt -78.94 147.82 70.94 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.551 -1.343 . . . . 0.0 108.006 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.67 -66.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 120.948 1.099 . . . . 0.0 110.923 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.81 -36.79 3.76 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.72 150.2 37.59 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.262 -1.14 . . . . 0.0 109.11 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.09 170.55 0.67 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 120.874 1.049 . . . . 0.0 110.063 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -94.17 2.89 55.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.868 . . . . 0.0 109.642 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -129.15 129.27 44.91 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.469 -0.769 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 p -52.21 -30.46 27.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.12 -35.72 59.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.234 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.46 -35.8 25.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.84 -58.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -1.134 . . . . 0.0 109.439 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 20.8 mt -55.15 -47.07 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.187 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -61.26 -50.82 71.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.339 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 58.6 t -65.91 -22.32 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.44 -0.787 . . . . 0.0 109.394 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.27 -30.69 18.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.102 -0.999 . . . . 0.0 109.054 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.1 mptt -71.17 -30.07 65.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.136 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -63.94 -4.14 3.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -149.96 -61.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 108.972 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.78 48.98 2.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.03 138.63 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -1.23 . . . . 0.0 109.334 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -49.93 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.854 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.8 p-10 -98.77 125.28 44.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.9 mp0 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.25 131.7 36.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.325 -0.859 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.07 114.31 13.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 109.104 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.14 57.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 110.227 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -68.33 -18.13 64.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.997 . . . . 0.0 109.834 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -89.77 -19.33 24.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 98.4 mt -67.11 149.62 98.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 108.941 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.9 Cg_endo -56.06 -162.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.71 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.36 -37.29 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.198 -0.939 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -60.15 -37.13 79.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.281 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.99 -30.09 49.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.063 . . . . 0.0 109.644 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -59.86 -54.51 45.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 109.117 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.87 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.028 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.07 -30.03 69.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.926 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.612 ' C ' HD13 ' A' ' 61' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 109.213 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 35' ' ' ARG . 47.5 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.97 -137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -169.33 151.33 4.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.372 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.06 -49.15 16.32 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.352 1.368 . . . . 0.0 110.677 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -59.4 -27.81 66.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.224 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.23 -26.57 28.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 25.5 mt -82.91 -18.77 38.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.38 32.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 0.0 110.971 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.3 t-20 -146.15 -9.02 0.52 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.476 -1.39 . . . . 0.0 110.921 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.1 mt -78.56 147.55 71.76 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.358 . . . . 0.0 108.154 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.02 -65.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.996 1.13 . . . . 0.0 110.578 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.27 -37.06 4.44 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.3 mt -93.76 149.97 37.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.221 -1.164 . . . . 0.0 108.952 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.52 177.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 120.753 0.969 . . . . 0.0 109.779 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -99.08 -2.32 37.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -123.76 131.4 53.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.375 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -52.66 -30.32 31.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.17 53.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.69 -35.6 18.88 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.02 -45.85 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.71 -47.21 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.91 -41.82 96.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HE22 ' A' ' 30' ' ' GLN . 62.1 t -75.05 -29.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.262 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.52 -29.27 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 108.748 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -71.9 -33.44 68.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.444 -0.785 . . . . 0.0 109.05 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 29' ' ' LYS . 15.1 mtpp -64.79 -1.74 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.57 HE22 HG12 ' A' ' 26' ' ' VAL . 2.2 mp0 -149.32 -68.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.358 -0.839 . . . . 0.0 108.765 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.0 55.88 1.35 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -51.3 152.08 2.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.253 . . . . 0.0 109.198 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -52.8 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.645 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -101.58 112.47 25.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.506 HH11 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.037 -1.039 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.849 0.833 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -134.01 133.03 40.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.435 -0.791 . . . . 0.0 108.941 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.57 116.66 17.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 109.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 -27.51 55.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.365 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 4.7 m-80 -70.9 -23.12 62.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.4 m -89.83 -12.87 37.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -0.965 . . . . 0.0 110.087 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.8 150.46 97.62 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.323 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 169.12 5.14 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.988 1.126 . . . . 0.0 109.424 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.23 -37.89 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.024 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.78 -39.15 80.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.11 -39.8 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.976 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.88 -57.86 11.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.607 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.87 58.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.083 -1.011 . . . . 0.0 109.33 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.26 -28.67 68.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.386 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 42.7 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 6' ' ' SER . 57.8 t -135.25 158.26 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -100.63 153.36 37.78 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.494 -0.754 . . . . 0.0 109.231 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.32 -40.04 87.75 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.114 1.209 . . . . 0.0 110.183 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -58.54 -27.24 64.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.63 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 34.3 mt-10 -83.57 -24.9 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 12' ' ' ASN . 91.5 mt -83.48 -23.93 31.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.99 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.625 -0.672 . . . . 0.0 111.21 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 10' ' ' LEU . 1.3 p30 -149.42 -8.1 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.415 -1.428 . . . . 0.0 111.035 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.4 mt -78.75 147.89 71.72 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.618 -1.301 . . . . 0.0 108.118 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.97 -67.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.11 1.207 . . . . 0.0 110.989 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.16 2.19 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.35 150.36 37.47 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.29 -1.123 . . . . 0.0 108.882 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.44 -174.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 120.806 1.004 . . . . 0.0 110.021 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ALA . 65.2 mmtt -101.08 -16.56 17.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.324 -0.86 . . . . 0.0 109.558 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -110.65 131.2 55.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.478 -0.763 . . . . 0.0 109.478 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.88 -29.56 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.48 -39.62 70.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.43 56.37 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.59 -62.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mt -49.94 -40.62 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 108.673 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.36 -42.2 98.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.124 -0.985 . . . . 0.0 108.678 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -76.66 -20.45 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.499 -0.751 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.2 -39.59 60.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.08 -1.013 . . . . 0.0 110.188 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLN . 4.8 ptmt -70.91 -23.14 62.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 109.262 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.99 -4.49 2.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 108.731 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.27 -58.99 0.19 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.79 48.01 2.01 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -54.99 133.89 48.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.832 -1.393 . . . . 0.0 108.633 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.601 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.41 108.83 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.98 -1.075 . . . . 0.0 108.761 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.31 121.81 44.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.416 -0.802 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 35' ' ' ARG . 20.2 ttm-85 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 109.447 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 68.4 mm-40 . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -136.3 134.24 37.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.414 -0.804 . . . . 0.0 109.31 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -75.87 114.18 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.138 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.54 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.305 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.481 HD22 ' H ' ' A' ' 51' ' ' ASN . 1.7 m-80 -69.82 -20.77 63.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.915 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 27.8 m -90.58 -10.43 43.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.112 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 54' ' ' PRO . 76.1 mt -68.45 150.3 97.74 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.034 -1.041 . . . . 0.0 109.305 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -59.0 -155.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 120.968 1.112 . . . . 0.0 109.459 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.07 -36.62 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.48 -37.12 80.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.93 -25.49 40.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.363 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -62.02 -66.83 0.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.11 33.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.519 -0.738 . . . . 0.0 109.425 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.45 80.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.23 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--N 1.303 -1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 108.695 179.586 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 m95 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.64 145.65 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.112 -0.993 . . . . 0.0 109.874 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -95.46 153.28 39.58 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.348 -0.845 . . . . 0.0 109.321 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.49 -42.48 65.31 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.233 1.288 . . . . 0.0 110.458 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -59.22 -24.41 63.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 12.5 mm-40 -84.24 -24.39 30.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -83.2 -24.35 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.99 29.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 111.345 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -147.32 -9.23 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.467 -1.396 . . . . 0.0 110.919 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' LEU . 40.1 mt -79.13 147.13 68.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.533 -1.354 . . . . 0.0 108.061 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -65.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.097 1.198 . . . . 0.0 110.739 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.63 -35.63 3.09 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.28 150.01 37.0 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.23 -1.159 . . . . 0.0 109.009 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.41 175.31 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 120.803 1.002 . . . . 0.0 109.787 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -97.16 6.59 48.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 109.749 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -133.6 130.74 38.78 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.521 -0.737 . . . . 0.0 109.205 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 p -52.57 -31.26 35.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.383 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.47 56.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.81 -38.39 20.05 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.14 -63.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.264 -1.139 . . . . 0.0 109.444 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.8 mt -47.87 -41.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.069 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.7 -48.35 81.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.184 -0.948 . . . . 0.0 108.703 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' HZ1' ' A' ' 29' ' ' LYS . 45.9 t -61.57 -28.65 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.74 -31.02 10.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.15 -0.969 . . . . 0.0 108.927 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.5 mptt -72.7 -38.46 67.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 108.687 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' CB ' ' NZ ' ' A' ' 29' ' ' LYS . 4.9 ttpm? -65.36 -3.6 4.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -150.32 -70.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 108.894 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.68 54.41 1.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.91 145.24 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.09 -1.241 . . . . 0.0 109.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -52.64 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.997 . . . . 0.0 109.056 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.8 p-10 -97.63 118.25 33.73 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.24 179.632 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -133.58 132.43 40.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.384 -0.823 . . . . 0.0 109.534 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 51' ' ' ASN . 51.7 t-20 -76.12 117.23 17.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.179 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.28 65.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.325 -0.86 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 49' ' ' ASN . 43.1 p30 -67.44 -16.43 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 74.0 m -90.0 -16.53 29.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.1 mt -67.96 149.67 98.1 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.115 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.65 -156.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.903 1.069 . . . . 0.0 109.5 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.67 -36.76 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 109.78 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -60.24 -36.81 78.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.95 43.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 109.8 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -65.34 -65.68 0.64 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 108.744 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.56 19.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.517 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.37 80.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 108.795 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.6 m95 . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 61' ' ' LEU . 12.2 t -140.59 155.52 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.182 -0.949 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -101.27 153.04 38.04 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 121.446 -0.784 . . . . 0.0 109.289 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.19 -43.39 59.45 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 121.371 1.38 . . . . 0.0 110.555 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -58.37 -27.24 64.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 0.0 109.78 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 35.2 mm-40 -84.78 -24.74 28.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.17 -0.956 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.1 mt -83.53 -21.36 32.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.106 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -146.42 -4.18 0.61 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.501 -1.375 . . . . 0.0 110.642 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 12.0 mt -79.69 147.86 68.02 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.588 -1.32 . . . . 0.0 108.004 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.22 -64.52 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 120.882 1.054 . . . . 0.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.28 -35.94 7.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 30.0 mt -93.62 150.06 38.18 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.122 -1.222 . . . . 0.0 109.141 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.35 -175.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 120.876 1.051 . . . . 0.0 109.924 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -104.89 5.83 33.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.525 -0.734 . . . . 0.0 109.757 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 p -132.93 133.12 42.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -53.36 -30.62 40.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.57 62.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.82 -35.74 18.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.25 -49.72 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -65.09 -44.79 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -60.75 -41.96 96.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 108.92 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.82 -27.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.43 -0.794 . . . . 0.0 109.024 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.86 -29.31 19.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.6 -29.93 65.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.37 -0.831 . . . . 0.0 108.897 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.35 -4.13 3.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.48 -61.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.368 -0.833 . . . . 0.0 108.88 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.37 54.48 1.57 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.44 141.2 37.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.075 -1.25 . . . . 0.0 108.844 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -47.93 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.232 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.9 p30 -101.45 116.76 33.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.466 -0.772 . . . . 0.0 110.106 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 109.058 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -135.16 134.87 40.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.834 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 17.6 t-20 -76.27 115.81 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 109.298 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.58 -34.16 64.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.374 -0.828 . . . . 0.0 110.61 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -69.98 -17.03 63.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.6 m -90.03 -15.46 31.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 109.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' PRO . 96.1 mt -67.96 148.96 98.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.0 Cg_exo -54.94 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.967 1.111 . . . . 0.0 109.833 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.5 -38.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -0.931 . . . . 0.0 109.928 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -58.17 -40.3 81.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.628 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.24 -38.54 42.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.124 -0.985 . . . . 0.0 109.228 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -49.03 -60.7 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.725 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.26 63.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.599 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -23.41 67.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 109.586 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.407 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.9 m95 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 61' ' ' LEU . 57.5 t -130.62 163.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.0 109.644 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.6 m -108.2 153.11 42.06 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.486 -0.759 . . . . 0.0 109.05 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.15 -44.55 48.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.239 1.293 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -57.68 -25.65 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.43 -24.18 29.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.128 -0.983 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.8 mt -82.96 -22.93 33.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.09 29.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.64 -0.663 . . . . 0.0 111.232 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 10.0 t-20 -146.57 -7.47 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.513 -1.367 . . . . 0.0 110.892 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.4 mt -79.4 147.45 68.35 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 0.0 108.195 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.11 -63.97 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.962 1.108 . . . . 0.0 110.606 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.48 -38.22 5.2 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 26.2 mt -94.01 149.87 37.58 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.137 -1.214 . . . . 0.0 109.175 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.14 -178.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.875 1.05 . . . . 0.0 109.732 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -101.17 7.38 43.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -133.19 130.17 38.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.408 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -52.5 -30.64 31.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.354 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.75 -37.0 62.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.28 19.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.84 -58.78 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.275 -1.132 . . . . 0.0 109.171 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -52.4 -43.06 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -60.69 -41.76 95.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 108.933 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.96 -22.87 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.079 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.3 -29.81 66.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.192 -0.942 . . . . 0.0 108.497 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' GLN . 77.5 mttt -71.98 -32.79 67.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 109.065 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -65.03 2.92 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 108.888 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.1 mt-30 -150.85 -64.88 0.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.58 47.21 2.18 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -50.8 135.73 23.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.305 . . . . 0.0 108.961 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.27 112.21 0.55 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.008 -1.057 . . . . 0.0 108.617 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -107.51 119.55 39.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.502 -0.748 . . . . 0.0 109.832 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 20.7 ttm-85 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.169 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.5 mp0 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -136.4 134.61 37.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 0.0 109.237 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -76.89 119.85 21.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.904 -1.123 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.03 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.71 -19.13 64.35 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.012 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 44.4 m -92.0 -16.33 26.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 110.15 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.76 149.41 98.27 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 120.936 -1.103 . . . . 0.0 108.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.64 -166.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 120.864 1.043 . . . . 0.0 109.538 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.0 -35.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 109.263 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.4 mp0 -59.86 -39.47 85.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.407 -0.808 . . . . 0.0 109.515 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.6 14.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.625 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -50.34 -52.35 37.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.27 -51.96 64.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.48 67.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.453 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 108.793 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.71 -136.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.271 -0.893 . . . . 0.0 109.618 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.512 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -167.41 152.8 7.08 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.652 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.4 -51.89 8.97 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.596 1.531 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD2' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.13 -22.8 42.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -0.999 . . . . 0.0 110.067 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -85.9 -25.97 25.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.034 -1.041 . . . . 0.0 109.251 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' ASN . 77.6 mt -82.6 -23.04 34.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LYS . . . -64.1 32.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.766 -0.584 . . . . 0.0 111.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.4 t-20 -147.67 -10.97 0.4 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.43 -1.419 . . . . 0.0 111.142 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' LEU . 26.5 mt -78.89 147.35 70.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.574 -1.329 . . . . 0.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.75 -61.68 0.24 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.012 1.141 . . . . 0.0 110.758 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.09 -38.73 4.91 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' LEU . 12.1 mt -94.94 151.05 38.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.275 -1.132 . . . . 0.0 108.755 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.41 -174.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 120.747 0.965 . . . . 0.0 110.081 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 28.8 mmtp -99.14 -15.67 18.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -111.09 132.31 54.37 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.599 -0.688 . . . . 0.0 109.451 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -53.23 -28.88 29.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -49.12 69.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.18 -34.18 89.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.38 -61.38 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -1.168 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.02 -43.01 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -60.19 -41.43 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.924 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.05 -25.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.46 -0.775 . . . . 0.0 108.991 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -54.32 -25.26 22.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.112 -0.993 . . . . 0.0 108.434 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -72.85 -32.76 65.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -65.19 -9.57 24.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.488 -0.757 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -150.07 -64.4 0.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.28 -0.887 . . . . 0.0 108.904 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.01 62.04 1.19 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -54.71 148.33 12.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -1.211 . . . . 0.0 109.02 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.01 98.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.2 p30 -108.4 117.75 34.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.542 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.59 123.89 21.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.304 -0.872 . . . . 0.0 109.901 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.48 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 27.6 t-20 -74.06 114.73 12.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 108.532 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.22 22.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.805 . . . . 0.0 111.315 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -71.07 -21.87 62.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.684 -1.26 . . . . 0.0 110.52 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.677 ' N ' HD22 ' A' ' 51' ' ' ASN . 36.9 m -93.71 -8.27 41.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.905 -1.122 . . . . 0.0 110.552 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -68.97 149.51 97.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 0.0 109.724 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.26 140.77 84.94 Favored 'Trans proline' 0 C--O 1.21 -0.903 0 C-N-CA 121.173 1.249 . . . . 0.0 109.324 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' VAL . 17.5 t -42.27 -41.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.432 -0.793 . . . . 0.0 111.02 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -55.81 -48.03 76.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.005 -1.06 . . . . 0.0 109.991 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.86 -43.09 25.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -46.02 -58.01 3.95 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.358 0.599 . . . . 0.0 109.415 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.01 61.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.9 64.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.116 -0.99 . . . . 0.0 109.182 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 6' ' ' SER . 99.8 t -131.77 162.84 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -103.78 153.44 38.73 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.2 -46.64 32.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 121.377 1.385 . . . . 0.0 110.924 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -59.56 -21.8 60.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.111 -0.993 . . . . 0.0 110.656 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -85.14 -25.73 27.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.6 mt -82.94 -22.66 33.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.637 -0.664 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 10' ' ' LEU . 41.6 m-80 -147.03 -10.8 0.44 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.621 -1.299 . . . . 0.0 110.936 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 16' ' ' LEU . 31.6 mt -78.27 146.89 71.6 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.531 -1.356 . . . . 0.0 108.103 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -64.86 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.028 1.152 . . . . 0.0 110.937 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.12 -36.86 2.93 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.9 mt -96.02 150.46 37.3 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.249 -1.148 . . . . 0.0 108.972 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.34 176.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.864 1.043 . . . . 0.0 110.014 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -95.19 -13.09 25.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 109.61 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -106.15 130.83 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.662 . . . . 0.0 109.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -53.0 -29.3 28.46 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.89 -55.62 32.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.792 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -53.01 -36.66 52.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.89 -65.61 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.077 -1.249 . . . . 0.0 109.64 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 11.0 mt -48.83 -42.31 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.211 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.75 -49.15 77.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.849 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 22' ' ' GLY . 49.5 t -65.34 -22.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.49 -34.37 24.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 109.405 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -28.1 64.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 108.648 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -64.35 -5.27 4.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.247 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -151.25 -60.74 0.18 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.331 -0.856 . . . . 0.0 108.809 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.4 47.15 2.22 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -52.16 135.51 31.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.935 -1.333 . . . . 0.0 109.03 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -49.14 110.43 0.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.075 -1.016 . . . . 0.0 108.748 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 1.2 p30 -105.84 124.33 49.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.837 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -136.1 133.72 37.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -76.54 117.58 18.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.961 -1.087 . . . . 0.0 108.991 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.93 61.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -21.3 62.93 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 34.4 m -90.98 -13.72 32.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.022 -1.049 . . . . 0.0 110.191 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.0 mt -67.39 149.07 98.58 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 108.986 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.3 Cg_exo -55.04 -165.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.982 1.121 . . . . 0.0 109.724 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.12 -37.61 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.35 -37.47 80.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.259 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.76 -31.62 40.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.703 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -60.93 -67.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.016 -1.052 . . . . 0.0 108.911 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.54 -42.81 16.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 109.568 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.41 84.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 179.808 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.2 m95 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 6' ' ' SER . 48.0 t -139.05 162.42 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -110.56 152.64 43.52 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.52 -0.737 . . . . 0.0 109.049 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.62 -43.58 54.19 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.282 1.321 . . . . 0.0 110.606 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -59.65 -25.27 64.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 109.896 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -85.03 -24.68 28.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.5 mt -81.15 -24.6 37.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 109.003 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.669 -0.645 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 14.2 m120 -146.18 -6.8 0.56 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.566 -1.333 . . . . 0.0 110.835 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -79.48 147.74 68.62 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.599 -1.313 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 120.908 1.072 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.46 -35.69 4.08 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 25.7 mt -93.9 149.28 36.73 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.135 -1.215 . . . . 0.0 109.117 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.64 178.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.882 1.055 . . . . 0.0 109.818 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -98.28 6.43 47.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.01 129.77 40.54 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.405 -0.81 . . . . 0.0 109.332 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -52.39 -30.58 29.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.419 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.44 66.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -72.94 -36.73 57.14 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.58 -64.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 109.394 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -49.78 -40.94 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.93 . . . . 0.0 109.095 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.93 -40.03 91.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 108.888 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.8 t -74.21 -27.82 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.92 -28.73 10.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 108.718 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.3 mptt -72.43 -39.78 67.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -65.48 -0.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.393 -0.817 . . . . 0.0 109.711 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -151.82 -69.98 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 109.055 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.31 53.95 1.53 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.2 m-90 -51.02 147.71 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.227 . . . . 0.0 109.283 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -49.47 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 108.908 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.756 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -103.0 118.27 36.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.928 . . . . 0.0 109.891 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.17 126.9 29.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.452 -0.78 . . . . 0.0 109.47 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -75.33 113.97 13.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 0.0 109.033 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.8 -25.99 21.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.205 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 51' ' ' ASN . 1.4 m-80 -70.38 -22.97 62.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 0.0 109.792 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 m -90.45 -17.35 27.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.104 -0.998 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.18 148.71 98.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.955 -1.091 . . . . 0.0 109.014 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.58 -160.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.919 1.079 . . . . 0.0 109.693 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.74 -36.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.12 -39.09 81.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.308 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.03 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.7 -57.14 13.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.375 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.58 76.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.44 70.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 109.849 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.3 m95 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.97 152.29 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 0.0 109.628 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.47 153.49 37.75 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.843 . . . . 0.0 109.543 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.92 -44.24 50.15 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.307 1.338 . . . . 0.0 110.497 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -58.73 -25.08 62.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -84.63 -24.98 28.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.018 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.5 mt -80.97 -23.57 38.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.191 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.648 -0.658 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' LEU . 34.4 m120 -146.27 -9.1 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.544 -1.348 . . . . 0.0 110.827 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.8 mt -79.01 147.01 69.19 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.6 -1.312 . . . . 0.0 108.159 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.24 -64.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.019 1.146 . . . . 0.0 110.751 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.9 4.04 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.8 mt -94.46 149.95 37.4 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.163 -1.198 . . . . 0.0 109.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.22 176.27 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.837 1.025 . . . . 0.0 109.837 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -97.64 7.28 46.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.18 129.99 38.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.406 -0.809 . . . . 0.0 109.29 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -52.51 -30.56 30.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.33 -39.85 64.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.21 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.95 -36.71 40.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.0 t -66.22 -61.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -1.135 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -51.37 -44.14 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 108.952 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.23 -45.0 96.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 108.925 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.15 -16.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.37 -31.1 71.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 108.747 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -71.04 -28.42 64.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.28 -0.888 . . . . 0.0 108.822 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -64.89 -3.07 3.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.177 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -150.2 -61.44 0.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 108.825 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.32 53.11 1.91 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -50.76 138.05 19.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.291 . . . . 0.0 109.148 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -48.64 99.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 5.5 p30 -99.82 123.14 43.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.898 . . . . 0.0 109.653 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 38.7 ttm180 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.887 . . . . 0.0 109.226 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 10.7 mp0 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.11 133.56 37.41 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.339 -0.851 . . . . 0.0 109.439 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -76.6 117.9 18.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.018 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.31 61.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -69.94 -17.62 63.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.541 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.9 m -89.62 -21.31 22.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.59 148.41 98.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 108.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.83 -162.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 120.831 1.021 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.64 -38.36 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.21 -39.96 84.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.54 -48.35 11.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.39 -54.06 45.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.403 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.55 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.082 -1.011 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -29.02 69.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.23 -0.919 . . . . 0.0 109.248 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.7 m95 . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.01 148.13 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.171 -0.956 . . . . 0.0 110.058 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.39 153.85 37.58 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.409 -0.807 . . . . 0.0 109.241 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.81 -41.33 75.41 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.219 1.28 . . . . 0.0 110.233 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -59.53 -27.02 65.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.35 -24.78 29.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.19 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.9 mt -82.33 -25.32 34.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.865 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 30.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.6 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.1 m120 -146.54 -6.44 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.575 -1.328 . . . . 0.0 110.8 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -79.41 148.47 70.36 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.609 -1.307 . . . . 0.0 108.16 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.75 -61.06 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 120.818 1.012 . . . . 0.0 110.239 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.42 -39.25 9.87 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LEU . 36.6 mt -93.0 149.56 37.77 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.129 -1.218 . . . . 0.0 108.987 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -53.85 -177.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.782 0.988 . . . . 0.0 109.677 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -100.93 -3.34 29.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -119.54 129.46 54.69 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.653 -0.654 . . . . 0.0 109.338 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -52.81 -29.24 26.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.68 71.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.27 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -35.74 75.83 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.37 -64.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -50.43 -41.27 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.939 . . . . 0.0 109.054 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.17 -43.41 95.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.018 . . . . 0.0 108.538 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.39 -21.38 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.763 . . . . 0.0 109.008 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.93 -31.95 73.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 108.595 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.9 mttm -71.45 -31.89 67.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 108.685 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -65.67 -0.29 2.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.468 -0.77 . . . . 0.0 109.153 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 32.3 mt-30 -149.8 -65.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 108.78 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.31 56.57 1.19 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -53.95 142.89 23.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.943 -1.327 . . . . 0.0 108.704 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -47.21 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.5 p30 -100.31 121.25 41.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.37 -0.831 . . . . 0.0 109.592 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 59.9 ttt180 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 108.846 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.9 mp0 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -136.09 134.67 38.63 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.18 116.24 17.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.045 -1.034 . . . . 0.0 108.883 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -53.78 -35.52 61.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.5 -18.77 65.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.994 -1.066 . . . . 0.0 109.637 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.46 -14.1 36.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -68.8 150.59 97.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.239 -0.913 . . . . 0.0 109.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.25 -156.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 120.933 1.089 . . . . 0.0 109.652 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -96.88 -36.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.62 -36.45 78.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.76 47.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.034 -1.041 . . . . 0.0 109.549 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mmtm -57.87 -60.71 3.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 109.019 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.57 -50.88 64.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.389 -0.82 . . . . 0.0 109.926 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.46 69.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 110.042 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.005 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.4 m95 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 17.7 t -139.28 165.48 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -114.14 152.37 45.8 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.76 -43.33 56.7 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.242 1.295 . . . . 0.0 110.471 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -59.56 -26.8 65.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.885 -179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -84.35 -25.68 28.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.051 -1.031 . . . . 0.0 109.449 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 79.8 mt -82.39 -23.47 34.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.187 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.81 28.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.71 -0.619 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 15.3 t-20 -147.39 -8.66 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.471 -1.393 . . . . 0.0 111.048 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.2 mt -78.7 147.51 71.19 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.538 -1.351 . . . . 0.0 108.329 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 -67.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.967 1.111 . . . . 0.0 111.0 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.36 -35.3 1.83 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.6 mt -95.35 150.62 37.83 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.186 -1.185 . . . . 0.0 108.865 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.53 -178.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 120.778 0.986 . . . . 0.0 109.996 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ALA . 4.4 mmmm -97.63 -17.46 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.241 -0.912 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -106.37 131.72 53.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.713 . . . . 0.0 109.413 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -53.27 -28.6 28.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.324 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.3 33.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.56 -35.33 66.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.63 -64.88 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.174 . . . . 0.0 109.398 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.5 mt -52.17 -41.61 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.09 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -60.17 -42.04 94.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.767 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.15 -24.34 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.076 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -56.26 -29.23 60.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.138 -0.976 . . . . 0.0 108.662 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -71.66 -34.98 70.17 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -6.23 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.9 mt-30 -145.84 -70.49 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.378 -0.827 . . . . 0.0 108.87 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.47 55.11 1.11 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.0 m-90 -52.64 142.23 18.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.02 -1.282 . . . . 0.0 108.896 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -47.31 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.507 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.762 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -100.5 121.15 41.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.366 -0.834 . . . . 0.0 109.803 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.159 -0.963 . . . . 0.0 109.158 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.6 mm-40 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -135.35 128.82 32.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -75.73 117.15 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.024 . . . . 0.0 109.406 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' HD22 ' A' ' 49' ' ' ASN . . . -54.78 -30.63 57.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.068 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 14.4 m120 -70.2 -19.93 63.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.91 -21.15 22.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.813 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.83 148.21 98.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.082 -1.011 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.36 -166.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.86 1.04 . . . . 0.0 109.78 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.4 -34.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.1 mp0 -58.77 -39.67 81.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.324 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.34 -40.26 21.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -57.59 -38.5 75.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.513 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.35 -56.89 6.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.01 -19.59 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.089 179.657 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.7 m95 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.96 153.74 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.347 -0.846 . . . . 0.0 109.904 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -102.46 152.69 38.39 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.743 . . . . 0.0 109.012 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.75 -45.24 41.9 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.164 1.243 . . . . 0.0 110.622 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -60.19 -25.86 65.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -84.24 -24.96 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.089 -1.007 . . . . 0.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -82.66 -19.1 38.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.168 -0.957 . . . . 0.0 109.227 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 32.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.642 -0.661 . . . . 0.0 111.038 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' LEU . 6.3 t-20 -145.9 -9.26 0.53 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.567 -1.333 . . . . 0.0 110.897 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.6 mt -78.68 147.32 70.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.569 -1.332 . . . . 0.0 108.127 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.93 -64.23 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.851 1.034 . . . . 0.0 110.484 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.95 -37.02 5.27 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.7 mt -93.8 149.58 37.27 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.105 -1.232 . . . . 0.0 109.1 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.0 174.75 0.19 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.826 1.017 . . . . 0.0 109.869 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -95.44 -1.74 50.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -0.883 . . . . 0.0 109.742 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -122.92 130.78 53.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -53.3 -28.97 30.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 0.0 109.616 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.67 65.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 -32.54 49.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' ALA . 56.9 t -65.97 -55.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -1.198 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.58 -45.43 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.061 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -60.57 -44.41 96.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 108.901 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.3 -19.13 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.07 -36.24 81.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.146 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.8 mtmt -70.48 -28.57 65.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.228 -0.92 . . . . 0.0 108.962 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB2' ' HZ3' ' A' ' 29' ' ' LYS . 8.2 ttmm -64.63 -1.45 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.825 . . . . 0.0 108.906 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.43 -62.76 0.2 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 108.82 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.68 50.86 2.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -49.28 146.77 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.244 . . . . 0.0 109.166 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.65 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.126 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.6 p30 -99.97 122.17 42.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.831 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.7 mt-10 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -135.51 126.27 27.33 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.486 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 49.3 t-20 -77.1 119.69 21.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 108.963 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.47 32.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 111.017 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.88 -20.42 62.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.114 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.684 ' N ' HD22 ' A' ' 51' ' ' ASN . 33.0 m -90.86 -20.41 22.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.067 -1.021 . . . . 0.0 110.003 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 89.3 mt -67.76 148.77 98.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.088 -1.008 . . . . 0.0 109.085 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.91 -157.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.845 1.03 . . . . 0.0 109.673 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -92.93 -40.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.42 -39.35 79.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.623 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.25 -42.86 22.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.433 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -60.29 -64.78 0.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.86 -44.95 49.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.7 -31.94 73.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.12 179.796 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 55.3 m95 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 6' ' ' SER . 7.6 t -138.45 164.17 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.312 -0.868 . . . . 0.0 109.958 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -110.73 152.81 43.73 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.5 -45.75 38.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 121.391 1.394 . . . . 0.0 110.655 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.45 -28.12 65.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -84.34 -24.96 29.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.732 -1.23 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' ASN . 56.2 mt -82.62 -20.5 36.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.263 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.18 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.619 -0.675 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 10' ' ' LEU . 36.4 m120 -146.11 -8.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.376 . . . . 0.0 110.656 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.13 147.32 69.25 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.0 107.954 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.7 -67.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.05 1.167 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.98 -34.12 2.92 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.7 mt -94.89 149.6 36.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.135 -1.215 . . . . 0.0 109.082 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.34 -179.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 120.882 1.055 . . . . 0.0 110.051 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -104.38 9.43 35.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.478 -0.763 . . . . 0.0 109.812 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -134.21 134.25 41.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.366 -0.834 . . . . 0.0 109.539 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -53.1 -31.43 41.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.883 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -51.47 64.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.423 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -65.83 -30.72 77.77 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.41 -54.52 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -1.204 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.57 -44.97 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.883 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.55 -41.48 94.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.079 -1.013 . . . . 0.0 108.935 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.1 t -74.78 -26.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 108.972 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.1 -33.32 51.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -70.43 -28.12 64.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 0.0 109.055 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.58 -2.72 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.133 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -150.57 -60.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.67 45.63 3.13 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -48.69 135.84 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.065 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.56 99.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.056 -1.028 . . . . 0.0 109.189 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.6 p30 -100.43 123.22 44.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.0 109.638 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.033 179.573 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.4 mt-10 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -135.36 131.65 36.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.64 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -75.67 112.89 12.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.811 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.84 -26.28 23.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.435 HD22 ' H ' ' A' ' 51' ' ' ASN . 2.2 m-80 -69.44 -22.37 63.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.977 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 m -90.5 -10.4 43.77 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.082 -1.012 . . . . 0.0 110.072 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 54' ' ' PRO . 75.6 mt -67.32 149.97 98.13 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.066 -1.022 . . . . 0.0 108.828 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -57.18 -159.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.89 1.06 . . . . 0.0 109.581 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.62 -37.52 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.75 -37.27 81.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -0.819 . . . . 0.0 110.236 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.0 -32.18 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.727 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -55.47 -70.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 109.041 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.09 -42.38 18.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.42 74.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.097 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.206 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 44.3 m95 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -135.98 -139.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -163.03 152.99 13.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.317 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.02 -50.69 12.36 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.422 1.415 . . . . 0.0 110.874 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -57.46 -23.17 48.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 47.9 mt-10 -84.87 -25.0 28.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 109.671 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -83.13 -21.65 33.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.571 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.736 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.706 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -148.86 -7.23 0.38 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.399 -1.438 . . . . 0.0 111.072 -179.355 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.706 ' N ' HD22 ' A' ' 12' ' ' ASN . 19.1 mt -78.27 147.39 72.5 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.642 -1.286 . . . . 0.0 108.16 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -67.42 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 120.939 1.093 . . . . 0.0 110.862 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.11 -34.23 3.1 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -95.26 149.89 36.83 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.238 -1.154 . . . . 0.0 109.29 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.72 -177.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.936 1.09 . . . . 0.0 109.814 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -103.17 3.16 35.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.39 -0.819 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -129.12 131.07 47.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 t -52.38 -31.79 35.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.867 . . . . 0.0 109.346 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -33.79 59.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.49 -36.81 22.4 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.64 -60.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.5 mt -48.96 -40.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 108.733 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -62.55 -39.47 93.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.01 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.3 t -77.37 -10.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -60.04 -38.0 81.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.981 -1.075 . . . . 0.0 110.453 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.61 -27.33 61.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.794 -1.191 . . . . 0.0 109.261 -179.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -63.59 -4.41 2.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 109.044 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.405 HE22 ' CG1' ' A' ' 26' ' ' VAL . 2.5 mp0 -149.07 -60.89 0.23 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.19 59.86 1.15 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -65.0 133.72 52.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.979 -1.306 . . . . 0.0 108.927 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.12 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 3.8 p30 -103.68 121.53 43.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.436 -0.79 . . . . 0.0 109.45 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 35' ' ' ARG . 29.5 ttm-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 108.56 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 23.3 mm-40 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -135.14 129.01 33.18 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.373 -0.829 . . . . 0.0 109.407 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.589 HD21 HD22 ' A' ' 51' ' ' ASN . 22.9 t-20 -75.52 112.18 11.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.81 . . . . 0.0 109.301 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -31.3 61.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.797 . . . . 0.0 110.708 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.589 HD22 HD21 ' A' ' 49' ' ' ASN . 7.3 m-80 -68.13 -17.28 64.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.985 -1.072 . . . . 0.0 109.63 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.2 m -90.91 -16.04 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 79.3 mt -67.21 149.36 98.49 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.065 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.66 -157.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.894 1.062 . . . . 0.0 109.554 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.74 -39.87 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.86 -42.76 94.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.92 -11.66 59.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.842 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -75.59 -69.94 0.46 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.04 -41.41 16.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.075 -1.015 . . . . 0.0 109.104 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.28 79.68 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.303 -0.873 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.03 179.596 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.8 m95 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -132.24 -141.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.419 -0.801 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.617 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -162.81 153.58 14.3 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.126 -0.984 . . . . 0.0 109.454 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.26 -48.15 20.79 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.344 1.363 . . . . 0.0 110.624 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -58.82 -23.42 60.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 110.007 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.94 -29.62 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.5 mt -80.52 -24.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.269 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.14 29.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 110.92 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.501 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.6 m120 -145.69 -9.73 0.54 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.543 -1.348 . . . . 0.0 110.795 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.3 mt -78.78 147.48 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.601 -1.312 . . . . 0.0 108.061 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -65.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.006 1.137 . . . . 0.0 110.849 -179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.14 -37.37 4.4 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.3 150.16 37.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.22 -1.165 . . . . 0.0 109.134 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.12 171.04 0.41 Allowed 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.876 1.051 . . . . 0.0 109.786 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ALA . 51.1 mttm -91.5 -10.18 41.7 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.712 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -114.62 128.59 56.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.512 -0.743 . . . . 0.0 109.314 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -52.59 -28.97 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -33.72 56.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.239 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.16 -37.11 22.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.78 -59.96 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 109.392 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.01 -45.48 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.047 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.28 -42.82 99.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.3 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.3 t -74.39 -14.63 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.58 -31.2 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.21 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -71.74 -27.83 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 108.576 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -63.92 -8.11 10.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.862 . . . . 0.0 109.245 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -150.18 -59.46 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.318 -0.864 . . . . 0.0 108.98 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.69 55.4 1.91 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -50.88 148.37 4.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.062 -1.258 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.68 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.63 114.43 28.11 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.314 -0.867 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.183 -0.948 . . . . 0.0 109.767 -179.98 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.597 0.713 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.5 130.71 35.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.484 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 28.9 t-20 -77.16 112.62 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 108.947 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.53 -22.95 23.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.369 -0.832 . . . . 0.0 111.029 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.788 -1.195 . . . . 0.0 109.843 -179.291 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.7 ' N ' HD22 ' A' ' 51' ' ' ASN . 5.1 m -92.47 -13.1 30.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.62 148.92 98.52 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.981 -1.074 . . . . 0.0 109.012 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -158.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.991 1.127 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.2 -37.37 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.378 -0.826 . . . . 0.0 109.363 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.01 -40.24 84.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.96 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.28 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -58.02 -69.65 0.17 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.104 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -43.38 15.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.789 . . . . 0.0 109.682 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.7 78.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 109.495 179.919 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.1 m95 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 6' ' ' SER . 95.1 t -138.33 165.28 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.341 -0.85 . . . . 0.0 110.198 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -104.52 153.76 38.91 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.458 -0.776 . . . . 0.0 109.348 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.02 -44.13 47.33 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.388 1.392 . . . . 0.0 110.83 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -23.22 45.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 109.814 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -84.56 -23.08 29.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 12' ' ' ASN . 96.6 mt -82.97 -22.49 33.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 0.0 109.094 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 32.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.762 -0.586 . . . . 0.0 111.336 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.4 t-20 -146.64 -9.04 0.48 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.519 -1.363 . . . . 0.0 110.775 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.1 mt -79.45 147.58 68.39 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.681 -1.262 . . . . 0.0 108.229 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.69 -61.83 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 120.871 1.047 . . . . 0.0 110.527 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.26 -38.87 6.79 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.9 mt -93.98 149.64 37.24 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 0.0 109.108 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.59 177.78 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.722 0.948 . . . . 0.0 109.712 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -98.47 9.06 44.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.258 -0.901 . . . . 0.0 109.63 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -134.17 130.52 37.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 0.0 109.323 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 p -53.13 -29.62 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.51 65.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.8 28.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.51 -59.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.266 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.4 mt -52.12 -43.03 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.078 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.97 -39.9 87.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -74.99 -27.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.05 -32.74 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.0 108.799 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -71.8 -33.4 68.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.131 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.15 -3.28 3.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.538 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.5 mt-30 -145.19 -63.42 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.0 108.935 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.4 51.84 1.8 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.538 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.4 m-90 -51.63 146.46 7.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.251 . . . . 0.0 109.076 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.49 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.064 . . . . 0.0 109.306 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.759 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -98.8 117.16 32.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.499 -0.751 . . . . 0.0 109.75 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.932 . . . . 0.0 108.604 179.178 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.756 0.789 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -135.81 136.72 40.9 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.799 HD22 ' H ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -77.54 114.78 16.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.082 -1.011 . . . . 0.0 109.334 -179.965 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.12 35.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 111.193 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.799 ' H ' HD22 ' A' ' 49' ' ' ASN . 5.6 m-20 -69.69 -17.94 63.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.895 -1.128 . . . . 0.0 110.089 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -91.83 -14.7 29.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.135 -0.978 . . . . 0.0 110.216 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt -66.89 148.17 98.9 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.056 . . . . 0.0 108.992 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -56.81 -161.86 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 121.01 1.14 . . . . 0.0 109.618 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 t -91.39 -38.81 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -59.37 -40.22 85.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.09 11.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.626 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -48.24 -50.9 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.775 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.81 -53.72 54.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.16 66.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 109.083 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 0.0 108.914 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 46.2 m95 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -135.24 -140.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -163.11 154.0 14.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 0.0 109.449 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.59 -50.56 12.97 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 121.345 1.363 . . . . 0.0 110.871 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -58.14 -24.33 58.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.123 -0.985 . . . . 0.0 110.131 -179.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB2' HG12 ' A' ' 5' ' ' VAL . 37.4 mt-10 -84.69 -28.46 26.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 60.9 mt -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.28 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.15 30.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 64.0 m-80 -145.71 -7.38 0.58 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.574 -1.329 . . . . 0.0 110.698 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.2 mt -79.19 147.81 69.93 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.669 -1.269 . . . . 0.0 108.04 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 120.839 1.026 . . . . 0.0 110.635 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.56 -36.39 4.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.6 mt -93.79 149.92 37.82 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.182 -1.187 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.8 171.13 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 120.763 0.975 . . . . 0.0 109.756 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.41 7.8 45.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.869 . . . . 0.0 109.779 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -133.62 129.63 37.19 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 p -53.0 -29.64 30.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 0.0 109.383 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.1 -35.83 62.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.7 -35.12 20.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.6 t -65.86 -53.17 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -1.135 . . . . 0.0 109.34 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -57.29 -48.47 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.11 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -60.02 -44.84 94.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -75.15 -18.36 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.96 -30.41 70.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.51 -29.22 64.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -64.83 -3.21 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -149.81 -61.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.74 53.51 2.24 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -50.19 143.81 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.938 -1.33 . . . . 0.0 108.912 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.711 HE21 HD22 ' A' ' 49' ' ' ASN . 10.9 tt0 -46.97 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.156 -0.965 . . . . 0.0 109.527 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.3 p30 -106.14 117.17 33.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.522 -0.736 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 179.564 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 30.8 mt-10 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.64 126.49 27.5 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.166 -0.959 . . . . 0.0 109.891 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.711 HD22 HE21 ' A' ' 33' ' ' GLN . 50.5 t-20 -76.15 112.72 12.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 108.811 179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.08 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.992 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -71.2 -22.97 61.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.5 m -89.55 -11.78 41.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.082 -1.012 . . . . 0.0 110.272 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.6 mt -68.39 148.98 98.2 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.932 -1.105 . . . . 0.0 109.283 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.4 Cg_endo -58.02 -155.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.019 1.146 . . . . 0.0 109.643 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.11 -36.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.169 -0.957 . . . . 0.0 109.689 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.35 -38.16 82.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.698 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.95 47.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.574 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -59.92 -71.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 108.984 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.78 -42.3 11.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.444 -0.785 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.15 -35.48 80.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.264 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.2 -179.772 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.8 m95 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.61 145.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -96.76 152.29 38.38 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.09 -44.99 44.38 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.235 1.29 . . . . 0.0 110.297 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -60.57 -25.44 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 109.88 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -84.36 -27.07 27.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -81.97 -23.66 35.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 109.213 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 31.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.598 -0.688 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 72.1 m-80 -144.83 -8.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.568 -1.333 . . . . 0.0 110.682 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.0 mt -78.93 147.61 70.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.689 -1.257 . . . . 0.0 108.04 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -64.93 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.888 1.058 . . . . 0.0 110.663 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.66 -36.99 4.89 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -93.76 149.84 37.72 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.132 -1.217 . . . . 0.0 109.156 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.77 175.11 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.956 1.104 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -98.84 7.18 46.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.32 -0.862 . . . . 0.0 109.658 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.31 130.71 41.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.468 -0.77 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -52.37 -30.75 30.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.42 62.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.35 -36.93 25.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.88 -55.83 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.03 -44.64 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.153 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.75 -43.02 98.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.067 . . . . 0.0 108.735 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 22' ' ' GLY . 53.6 t -75.03 -22.11 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.66 -30.33 60.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 108.739 179.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -71.3 -30.68 66.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -65.37 -3.66 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.422 -0.799 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -151.29 -63.44 0.18 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.027 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.3 54.36 1.86 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.65 151.28 1.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.286 . . . . 0.0 109.378 179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.614 HE21 HD22 ' A' ' 49' ' ' ASN . 20.3 tt0 -54.8 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -96.69 114.6 26.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HG2' HH11 ' A' ' 35' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.416 0.627 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -135.45 131.66 36.46 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.614 HD22 HE21 ' A' ' 33' ' ' GLN . 43.7 t-20 -75.38 116.36 16.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.019 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.84 -24.72 24.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 52' ' ' SER . 49.8 p30 -70.76 -18.83 62.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.953 -1.092 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 19.4 m -92.5 -14.88 27.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.003 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.32 149.71 98.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.63 -155.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 121.035 1.157 . . . . 0.0 109.371 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 t -97.61 -37.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.152 -0.968 . . . . 0.0 109.329 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -61.04 -35.53 77.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.04 -47.0 15.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 0.0 109.803 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -53.73 -54.51 37.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.535 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.07 -51.37 53.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.182 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.93 -27.09 68.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.875 . . . . 0.0 109.203 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 52.1 t -135.55 160.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -178.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.0 m -106.27 153.78 40.16 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 109.377 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.85 -43.49 57.59 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 121.337 1.358 . . . . 0.0 110.559 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -58.23 -26.48 62.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 109.833 -179.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 42.8 mt-10 -84.57 -25.55 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.1 mt -82.8 -22.64 34.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 28.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.664 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.702 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -147.25 -5.7 0.5 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.477 -1.389 . . . . 0.0 110.901 -179.642 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.702 ' N ' HD22 ' A' ' 12' ' ' ASN . 33.2 mt -79.4 147.65 68.74 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.558 -1.339 . . . . 0.0 108.061 179.261 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.92 -62.31 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 120.966 1.111 . . . . 0.0 110.791 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.63 -40.74 6.63 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 47.4 mt -93.91 150.06 37.97 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.236 -1.155 . . . . 0.0 109.04 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -52.21 -178.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 120.844 1.029 . . . . 0.0 109.915 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -100.51 -7.23 24.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.301 -0.874 . . . . 0.0 109.661 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -116.42 128.11 55.21 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.186 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -52.22 -29.22 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.13 66.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.291 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.66 -35.88 34.92 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.01 -59.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 109.243 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.65 -44.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 0.0 109.107 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -61.16 -45.59 93.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.116 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.57 -22.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.286 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.79 -32.99 63.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 30' ' ' GLN . 23.7 mmtp -71.01 -29.02 64.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.052 179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -64.34 -0.6 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.2 mt-30 -150.86 -62.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.23 47.74 2.15 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.231 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -51.75 134.38 30.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.94 -1.329 . . . . 0.0 108.944 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.33 112.79 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.992 -1.068 . . . . 0.0 108.568 179.555 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 10.3 p30 -110.03 120.51 42.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.584 -0.697 . . . . 0.0 109.832 -179.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.112 179.464 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 40.4 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.4 132.76 35.93 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.426 -0.796 . . . . 0.0 109.334 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -77.45 120.18 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.92 -30.03 57.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.3 -0.875 . . . . 0.0 110.54 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -71.35 -18.71 62.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 35.9 m -89.74 -22.91 21.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.049 -1.032 . . . . 0.0 110.278 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.44 148.02 98.73 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.957 -1.09 . . . . 0.0 108.983 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.7 -164.44 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 120.899 1.066 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 t -89.28 -37.02 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.45 -39.43 79.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.567 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.76 -44.32 17.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.099 -1.0 . . . . 0.0 109.573 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.96 -42.33 72.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 109.829 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.91 -56.9 10.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.711 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.35 -19.96 65.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 61' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.5 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 6' ' ' SER . 60.1 t -138.12 160.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.379 -0.826 . . . . 0.0 109.882 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -107.7 153.73 41.31 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.726 . . . . 0.0 109.362 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.92 -43.59 56.75 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.271 1.314 . . . . 0.0 110.503 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -57.72 -26.14 61.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.142 -0.974 . . . . 0.0 109.154 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.8 mt -82.91 -19.97 36.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.817 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.92 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.0 m120 -146.83 -7.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.544 -1.347 . . . . 0.0 110.907 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.22 147.71 69.6 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.603 -1.31 . . . . 0.0 108.215 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.72 -64.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.96 1.107 . . . . 0.0 110.511 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.88 -38.9 6.02 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' LEU . 57.8 mt -93.18 149.6 37.72 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.224 -1.163 . . . . 0.0 109.087 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.57 175.6 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.867 1.045 . . . . 0.0 109.88 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.6 -5.7 31.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -116.47 129.06 56.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 109.258 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -52.62 -29.49 26.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.56 -37.59 68.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -77.64 -35.41 36.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.93 -50.11 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.52 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.419 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.65 -42.7 93.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.062 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 73.3 t -75.06 -24.29 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.243 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.78 -31.39 66.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 0.0 108.737 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.05 -30.4 66.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -64.41 -0.98 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.231 179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.5 mt-30 -150.76 -63.23 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 108.768 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.33 49.7 2.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.9 m-90 -48.95 147.82 2.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.3 . . . . 0.0 109.01 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -47.54 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.997 . . . . 0.0 109.33 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.747 ' ND2' ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.36 119.31 38.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.48 -0.763 . . . . 0.0 110.183 -179.359 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.234 -0.916 . . . . 0.0 108.962 179.274 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -136.46 126.51 26.09 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.26 -0.9 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 50.0 t-20 -76.31 120.46 21.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.06 -30.28 47.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 110.698 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 50.9 p30 -71.45 -19.22 62.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.93 -1.106 . . . . 0.0 110.106 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 70.3 m -90.05 -22.06 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.974 -179.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 80.0 mt -67.66 148.35 98.57 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 0.0 108.764 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.32 -158.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 120.879 1.052 . . . . 0.0 109.766 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.87 -37.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.09 -39.86 79.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.01 33.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.693 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -59.91 -39.11 84.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.01 18.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.179 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.02 -21.42 66.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.88 . . . . 0.0 109.045 179.757 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.3 m95 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 6' ' ' SER . 43.7 t -137.28 157.87 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.381 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -105.16 153.15 39.74 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.413 -0.804 . . . . 0.0 109.24 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.49 -42.88 62.22 Favored 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.24 1.294 . . . . 0.0 110.397 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -58.2 -27.0 63.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.603 -179.546 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -84.63 -24.47 29.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 109.119 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 12' ' ' ASN . 98.3 mt -82.42 -22.85 35.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.87 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.68 . . . . 0.0 111.394 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.4 m120 -148.34 -7.03 0.41 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.465 -1.397 . . . . 0.0 111.089 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -79.9 148.11 67.73 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.594 -1.316 . . . . 0.0 108.253 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.4 -67.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.039 1.159 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.67 2.36 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' LEU . 21.4 mt -95.19 150.61 37.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.21 -1.17 . . . . 0.0 109.015 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.9 -174.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.759 0.972 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -105.29 4.37 30.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.448 -0.782 . . . . 0.0 109.84 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 p -132.71 132.42 42.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.414 -0.804 . . . . 0.0 109.413 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -53.1 -30.83 38.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.324 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.31 61.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.275 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -36.84 15.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.92 -53.95 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -1.146 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.04 -43.25 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 108.929 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HE2' ' HZ1' ' A' ' 29' ' ' LYS . 91.5 t80 -61.46 -44.13 97.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.38 -24.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.446 -0.784 . . . . 0.0 109.187 179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.46 -29.52 36.13 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.163 -0.961 . . . . 0.0 108.692 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' GLN . 7.4 mtpm? -72.14 -35.36 69.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HZ1' ' HE2' ' A' ' 25' ' ' TYR . 1.8 mptm? -64.68 0.73 1.02 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' LYS . 32.2 mt-30 -151.94 -68.77 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 108.905 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.08 52.42 1.62 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -51.47 141.55 15.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.271 . . . . 0.0 109.115 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -50.51 91.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -97.83 118.47 34.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.331 -0.855 . . . . 0.0 109.303 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.667 179.86 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.3 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.97 127.63 28.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 46.9 t-20 -75.37 123.5 25.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.997 . . . . 0.0 109.296 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.12 63.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.828 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 42.2 p30 -69.83 -16.53 63.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.941 -1.1 . . . . 0.0 109.82 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 49.7 m -89.95 -23.88 21.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.63 148.31 98.59 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 108.948 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.83 -168.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.892 1.061 . . . . 0.0 109.676 179.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.0 -35.36 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 6.0 mp0 -59.28 -39.43 82.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.81 -29.03 32.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.61 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -63.79 -46.82 83.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.302 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.0 77.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 108.807 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.24 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.068 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 108.589 179.684 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.1 m95 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -136.05 -140.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.23 -0.919 . . . . 0.0 109.979 -179.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.608 ' H ' HG12 ' A' ' 5' ' ' VAL . 4.9 m -162.83 153.0 13.65 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.46 -48.6 19.66 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.463 1.442 . . . . 0.0 110.959 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -57.25 -24.79 57.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -0.999 . . . . 0.0 109.968 -179.054 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.05 -26.06 27.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.185 -0.947 . . . . 0.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.2 mt -81.9 -21.59 37.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 30.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 57.2 m-80 -146.69 -7.0 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.523 -1.361 . . . . 0.0 110.933 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.49 147.79 68.66 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.629 -1.295 . . . . 0.0 108.176 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -66.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.867 1.045 . . . . 0.0 110.707 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.36 -36.43 4.28 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.6 mt -93.68 149.95 37.95 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.173 -1.192 . . . . 0.0 109.18 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 172.77 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.821 1.014 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -94.36 6.6 48.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.735 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -131.86 129.66 40.68 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.506 -0.746 . . . . 0.0 109.309 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -52.71 -29.86 29.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.57 29.35 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.43 -58.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.8 mt -52.39 -44.52 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.937 . . . . 0.0 109.146 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.71 -44.35 96.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.982 . . . . 0.0 109.063 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.28 -24.04 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 109.215 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.28 -32.95 67.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 108.884 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -71.78 -33.52 68.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 108.966 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -65.15 -3.88 4.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.601 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 30.5 mt-30 -150.18 -67.58 0.2 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 108.779 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.88 59.04 1.01 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.601 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.5 m-90 -55.74 147.81 17.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.083 -1.245 . . . . 0.0 108.732 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.697 HE21 HD22 ' A' ' 49' ' ' ASN . 15.9 tt0 -49.24 90.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.148 -0.97 . . . . 0.0 109.537 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -102.98 121.2 42.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.876 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 35' ' ' ARG . 23.4 ttm-85 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 5' ' ' VAL . 12.1 mm-40 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.05 128.42 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.452 -0.78 . . . . 0.0 109.596 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.697 HD22 HE21 ' A' ' 33' ' ' GLN . 57.3 t-20 -76.47 114.77 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.266 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.815 ' C ' ' HZ2' ' A' ' 58' ' ' LYS . . . -54.7 -30.82 56.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.12 -19.67 63.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 m -89.18 -17.96 28.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 109.766 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.4 mt -67.71 149.2 98.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.046 -1.033 . . . . 0.0 109.032 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.66 -158.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.914 1.076 . . . . 0.0 110.031 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.11 -38.62 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -57.79 -41.45 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.52 -33.75 47.8 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.815 ' HZ2' ' C ' ' A' ' 50' ' ' ALA . 1.2 tpmt? -56.98 -53.67 55.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.15 67.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.61 78.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.111 -0.993 . . . . 0.0 109.375 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.364 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -138.33 148.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 109.545 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -97.44 153.0 38.52 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -51.81 -48.15 22.89 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.381 1.387 . . . . 0.0 110.869 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -58.74 -23.74 60.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.29 -179.194 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 24.0 mm-40 -85.03 -24.01 28.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.947 -1.096 . . . . 0.0 109.51 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -82.02 -23.18 36.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.134 -0.979 . . . . 0.0 108.8 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -146.89 -6.19 0.51 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.544 -1.347 . . . . 0.0 110.844 -179.466 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.66 ' N ' HD22 ' A' ' 12' ' ' ASN . 37.2 mt -78.9 147.3 70.1 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.558 -1.339 . . . . 0.0 108.02 179.241 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.96 -67.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.066 1.177 . . . . 0.0 110.756 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.71 -34.73 2.85 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.2 mt -94.57 149.94 37.3 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.152 -1.205 . . . . 0.0 109.031 -179.673 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.5 -176.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 120.921 1.081 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -102.57 -2.85 27.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.429 -0.794 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -119.65 126.15 50.46 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -52.27 -29.15 21.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.344 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.09 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.391 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -76.9 -36.16 37.21 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.78 -60.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -1.152 . . . . 0.0 109.36 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.0 mt -50.82 -42.42 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 108.97 179.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.41 -39.24 86.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.479 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' GLY . 55.9 t -74.32 -28.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 108.976 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.57 -31.56 16.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 108.763 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 30' ' ' GLN . 56.5 mmtt -72.5 -39.63 67.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 0.0 109.008 179.412 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -64.99 1.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 28' ' ' LYS . 33.5 mt-30 -152.0 -70.43 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 108.975 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.44 51.18 1.6 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.3 m-90 -50.0 141.54 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.06 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.009 . . . . 0.0 109.117 179.784 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.3 p-10 -100.57 122.8 43.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.422 -0.799 . . . . 0.0 110.19 -179.313 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.347 -0.846 . . . . 0.0 109.343 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 56.5 mm-40 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -135.72 130.72 34.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -76.23 116.75 17.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.99 -30.57 59.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 -179.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -70.44 -19.35 62.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.99 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.4 m -89.65 -19.86 24.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 88.5 mt -67.59 149.05 98.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.103 -0.998 . . . . 0.0 108.859 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.69 -160.34 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.769 0.98 . . . . 0.0 109.661 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -92.03 -38.71 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.39 -39.33 83.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.724 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.86 -38.75 27.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.23 -59.73 4.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 109.373 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.43 -44.53 65.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.14 73.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.136 179.92 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.4 m95 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.05 153.08 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.79 -179.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -103.84 153.43 38.76 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.203 -179.749 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.95 -46.21 35.33 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.27 1.313 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -59.28 -23.92 62.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -84.87 -25.99 27.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 0.0 109.538 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 62.9 mt -83.13 -21.29 33.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.892 . . . . 0.0 109.488 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.06 29.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.616 -0.677 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 18.8 m-80 -148.03 -8.7 0.4 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.435 -1.416 . . . . 0.0 111.011 -179.411 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.7 mt -79.19 147.28 68.89 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.559 -1.338 . . . . 0.0 108.231 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -67.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.718 0 C-N-CA 121.087 1.191 . . . . 0.0 111.054 -179.182 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.91 -34.66 2.01 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.1 mt -95.37 150.06 37.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.197 -1.178 . . . . 0.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.34 179.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.875 1.05 . . . . 0.0 110.177 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.1 mmtt -96.56 -17.87 20.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.284 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -109.68 130.97 55.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.633 -0.667 . . . . 0.0 109.356 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -53.05 -29.31 29.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.16 -32.87 56.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.06 -36.0 29.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.96 -58.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.411 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.6 mt -49.52 -46.05 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.052 179.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.61 -56.65 17.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 108.954 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.51 HG12 HE22 ' A' ' 30' ' ' GLN . 78.3 t -57.94 -15.09 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.449 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.1 -35.57 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.303 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 10.6 mptt -70.87 -28.71 64.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.129 179.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -64.2 -4.6 3.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.51 HE22 HG12 ' A' ' 26' ' ' VAL . 2.4 mp0 -149.22 -61.19 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.55 49.59 2.52 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.323 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -52.22 142.89 15.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.257 . . . . 0.0 109.385 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -57.03 96.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 108.961 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.9 p30 -99.45 123.81 44.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.369 -0.832 . . . . 0.0 109.944 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.61 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 12.3 mm-40 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -135.3 128.66 32.19 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.243 179.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -74.66 117.7 16.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.06 . . . . 0.0 109.169 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -26.73 60.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -68.57 -20.74 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.554 -179.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -91.24 -15.14 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.871 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.4 149.58 98.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 0.0 108.879 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.29 -157.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 120.954 1.103 . . . . 0.0 109.638 179.297 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.98 -37.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.72 -35.83 77.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 110.316 -179.389 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.91 -31.22 45.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -58.59 -68.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -45.7 17.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.397 -0.814 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.381 -0.824 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.321 -179.99 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 51.3 m95 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -134.63 150.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.378 -0.826 . . . . 0.0 109.58 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -98.34 153.01 38.22 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.434 -0.791 . . . . 0.0 109.488 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.68 -45.02 40.63 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.351 1.367 . . . . 0.0 110.582 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -58.19 -26.8 63.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.14 -24.93 30.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.696 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' ASN . 81.8 mt -81.87 -23.5 36.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 108.997 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.96 28.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 111.021 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.5 m-80 -147.42 -7.06 0.46 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.481 -1.387 . . . . 0.0 110.881 -179.377 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' LEU . 22.3 mt -79.16 147.42 69.31 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.648 -1.283 . . . . 0.0 108.181 179.412 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.77 -68.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.019 1.146 . . . . 0.0 110.796 -179.441 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.8 -34.56 1.91 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.1 mt -95.23 150.6 37.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.202 -1.175 . . . . 0.0 108.976 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.95 -179.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.762 0.975 . . . . 0.0 109.853 179.485 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 19.9 mmmt -98.73 -16.03 19.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.064 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -105.28 132.38 51.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.682 . . . . 0.0 109.305 -179.851 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.88 -28.56 37.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.83 -54.19 47.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.913 . . . . 0.0 109.749 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.62 -35.85 63.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.707 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.21 -65.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -1.21 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mt -51.27 -41.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.149 -179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -61.67 -42.7 99.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.7 t -75.07 -22.81 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 0.0 109.297 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.24 -29.16 31.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.0 108.842 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.3 mptp? -71.43 -32.51 68.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 108.872 179.59 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -64.64 -4.87 4.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.294 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -150.26 -67.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.08 54.14 1.31 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.9 m-90 -52.07 137.99 26.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.117 -1.225 . . . . 0.0 109.018 179.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -47.19 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.713 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -103.11 115.74 31.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.358 -0.838 . . . . 0.0 109.472 179.918 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 35' ' ' ARG . 4.2 ptt-85 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 179.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 7.5 mp0 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -136.36 128.96 30.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.193 -0.942 . . . . 0.0 109.796 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -76.09 114.34 14.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 108.984 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -26.36 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.465 -179.254 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -70.28 -21.1 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.3 m -90.0 -18.62 25.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.54 149.17 98.47 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.014 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.3 Cg_endo -57.8 -156.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 120.939 1.093 . . . . 0.0 109.42 179.228 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -98.21 -37.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.1 -35.52 77.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.05 -39.01 30.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.059 -1.026 . . . . 0.0 109.698 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.73 -59.17 5.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.971 . . . . 0.0 109.449 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.81 -45.42 50.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.917 -1.114 . . . . 0.0 109.16 179.688 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.34 -33.11 74.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 108.99 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.152 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.345 0.593 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -151.03 -67.73 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.0 tp 52.74 79.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.687 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -80.72 169.36 17.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 6' ' ' SER . 18.6 t -140.05 165.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -113.54 153.11 45.83 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -52.67 -46.77 31.14 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.303 1.335 . . . . 0.0 110.558 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -59.12 -25.92 64.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.931 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.46 -25.86 30.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.008 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 89.7 mt -82.47 -23.5 34.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 108.898 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 111.128 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.3 m120 -145.49 -9.52 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.578 -1.326 . . . . 0.0 110.666 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.2 mt -79.18 147.4 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.667 -1.271 . . . . 0.0 108.098 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.53 -64.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.059 1.173 . . . . 0.0 110.802 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.84 4.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -94.92 149.79 36.83 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.114 -1.227 . . . . 0.0 109.018 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.41 175.81 0.17 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 120.905 1.07 . . . . 0.0 109.921 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -97.04 7.87 45.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 p -133.71 130.08 37.64 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.46 -0.775 . . . . 0.0 109.413 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -52.84 -29.83 30.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.63 63.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -81.16 -35.46 23.82 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.75 -53.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -1.189 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.78 -45.18 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -0.936 . . . . 0.0 109.121 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -60.2 -41.73 93.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 0.0 108.951 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.9 t -74.96 -25.82 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 109.114 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.86 -31.71 40.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -71.11 -29.4 65.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.234 -0.916 . . . . 0.0 109.016 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -64.86 -7.13 10.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 109.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -150.72 -64.34 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 108.843 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.1 59.47 1.05 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -57.37 145.41 32.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.081 -1.247 . . . . 0.0 108.824 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -47.63 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -103.63 119.51 39.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.427 -0.796 . . . . 0.0 109.844 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -88.17 146.28 25.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.271 -0.893 . . . . 0.0 109.156 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -95.11 153.86 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -149.4 107.09 3.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.243 -0.911 . . . . 0.0 109.021 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.64 58.64 0.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.755 . . . . 0.0 109.917 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.0 -28.84 0.02 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.28 -1.57 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.865 -1.374 . . . . 0.0 110.406 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -170.68 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.929 -1.107 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.01 -153.45 9.21 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.59 4.7 67.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -173.61 95.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.63 -159.68 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.24 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 mt -147.86 94.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.185 -0.947 . . . . 0.0 109.207 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.4 mt-10 -82.46 175.44 10.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 108.744 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -135.72 128.39 30.86 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -75.7 116.07 16.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 108.898 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.33 59.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.614 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.727 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 5.1 m120 -69.4 -17.17 63.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.006 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.8 m -89.61 -20.27 23.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.0 109.782 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 54' ' ' PRO . 73.9 mt -67.92 149.27 98.28 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.121 -0.987 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -57.04 -157.89 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.845 1.03 . . . . 0.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.7 t -94.4 -36.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -58.08 -38.81 77.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.549 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.33 -36.4 29.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.36 -42.92 78.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.595 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.44 -58.06 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.13 -23.31 67.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.749 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -63.4 -77.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.49 -13.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.36 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -69.08 -60.41 2.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 109.595 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 20.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.049 -1.032 . . . . 0.0 110.213 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.4 mm-40 -103.57 8.54 37.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 109.006 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . -50.6 135.71 28.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 66' ' ' GLY . 35.0 tt0 59.79 122.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.485 -1.009 . . . . 0.0 109.998 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.887 HG23 ' H ' ' A' ' 69' ' ' GLU . 12.7 tt -160.06 -66.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.887 ' H ' HG23 ' A' ' 68' ' ' ILE . 26.3 mt-10 -159.66 161.34 34.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.436 -0.79 . . . . 0.0 109.041 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 p -88.5 -76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -158.24 145.21 17.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' TYR . 2.9 pp -172.03 152.8 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.89 15.33 0.1 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -90.11 9.26 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.154 -1.204 . . . . 0.0 109.478 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 54.4 t80 39.73 26.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.798 -0.564 . . . . 0.0 110.448 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' TYR . 3.9 mp0 . . . . . 0 N--CA 1.492 1.663 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.293 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -151.14 109.94 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.193 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.6 tp -168.4 74.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.427 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 45.0 m95 -80.04 161.75 25.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.164 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 6' ' ' SER . 58.7 t -139.39 167.99 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -106.21 153.88 40.04 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.43 -0.794 . . . . 0.0 109.602 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.82 -49.72 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.481 1.454 . . . . 0.0 110.801 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.11 -23.85 22.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.564 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 43.1 mt-10 -84.18 -23.32 30.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.986 -1.071 . . . . 0.0 109.402 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.7 mt -83.65 -20.58 33.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.63 36.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.7 -0.625 . . . . 0.0 111.506 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 m120 -148.22 -11.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.343 -1.473 . . . . 0.0 110.874 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -78.73 147.91 71.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.646 -1.284 . . . . 0.0 108.182 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.46 -60.71 0.28 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 120.823 1.015 . . . . 0.0 110.415 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.98 -39.57 9.07 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.4 mt -93.39 149.84 37.98 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.216 -1.167 . . . . 0.0 109.041 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.35 177.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.848 1.032 . . . . 0.0 109.97 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -101.56 8.41 41.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.429 -0.794 . . . . 0.0 109.552 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -130.09 132.96 46.36 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.525 -0.734 . . . . 0.0 109.351 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -52.82 -31.34 38.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.596 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.7 51.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -33.75 85.38 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.2 -65.42 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.169 . . . . 0.0 109.229 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -48.98 -41.11 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -61.66 -48.94 78.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 108.876 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.81 -36.45 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 108.959 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.33 -30.35 7.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.647 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 30' ' ' GLN . 48.2 mtpt -73.77 -41.98 61.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.51 -0.744 . . . . 0.0 109.484 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -65.94 4.32 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.308 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.558 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 23.8 mt-30 -150.15 -75.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 105.35 50.39 0.92 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.558 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.6 m-90 -53.24 134.1 39.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.366 . . . . 0.0 108.463 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 105.01 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.96 -1.088 . . . . 0.0 109.513 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -104.17 124.36 48.97 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 110.282 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.2 123.22 31.23 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 109.38 20.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.837 -1.164 . . . . 0.0 110.148 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.99 163.66 18.75 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' ALA . . . -69.81 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.743 -1.223 . . . . 0.0 109.32 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -84.07 -49.08 4.89 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.9 t 56.99 -7.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.561 -0.964 . . . . 0.0 109.601 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.652 ' H ' ' C ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 169.35 -51.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -77.48 1.36 Allowed Glycine 0 N--CA 1.5 2.917 0 O-C-N 121.737 -0.602 . . . . 0.0 111.844 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.63 95.03 0.1 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt 70.59 89.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.88 -0.776 . . . . 0.0 109.388 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -96.52 130.7 43.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.47 -0.769 . . . . 0.0 109.663 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -90.81 148.46 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.035 -1.041 . . . . 0.0 108.981 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -132.98 169.38 16.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 46' ' ' ILE . 42.9 m-85 -135.47 135.38 40.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -76.53 112.31 12.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.123 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.65 -23.87 19.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.307 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -72.11 -20.43 61.64 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.035 -1.041 . . . . 0.0 110.277 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.3 m -88.9 -16.65 31.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.081 -1.012 . . . . 0.0 110.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 54' ' ' PRO . 82.7 mt -67.73 148.13 98.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 108.962 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -56.69 -161.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.847 1.031 . . . . 0.0 109.686 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -91.2 -38.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.36 -41.15 84.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 109.625 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.47 -52.58 7.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.093 -1.004 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -46.69 -45.55 19.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.977 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -58.09 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.47 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.33 -20.12 62.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.212 -0.93 . . . . 0.0 109.001 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' CD1' HE21 ' A' ' 65' ' ' GLN . 0.2 OUTLIER -64.4 -62.12 1.8 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 108.795 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 62' ' ' LEU . 22.8 mt -46.74 -32.88 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.716 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.9 mt -64.95 -34.51 78.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 66' ' ' GLY . 21.4 mtp180 -69.89 -37.76 76.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.498 HE21 ' CD1' ' A' ' 61' ' ' LEU . 94.7 mm-40 -46.99 -13.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.911 -1.118 . . . . 0.0 109.926 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -59.67 105.89 0.84 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 66' ' ' GLY . 5.5 tm-20 45.9 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.912 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.99 -36.34 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.451 -0.781 . . . . 0.0 109.152 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -146.1 11.87 1.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 109.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 72' ' ' LEU . 29.3 m 47.56 -109.33 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 t 58.76 0.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.018 -1.051 . . . . 0.0 109.713 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 70' ' ' THR . 34.6 mt -133.64 -125.38 0.17 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.812 . . . . 0.0 109.022 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.55 4.39 89.22 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -88.45 12.55 14.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.249 . . . . 0.0 109.319 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 47.3 t80 49.01 29.8 2.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 75' ' ' PHE . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 3.6 ppp? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.576 ' N ' ' SD ' ' A' ' 1' ' ' MET . 31.0 tt0 -87.82 105.32 17.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 109.862 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.4 tp -149.27 85.79 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.905 . . . . 0.0 109.211 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 41.8 m95 -79.66 158.01 27.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 108.855 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -125.29 -137.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.418 -0.801 . . . . 0.0 109.349 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -166.12 152.31 8.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 109.508 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.39 -52.02 8.02 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.312 1.341 . . . . 0.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -58.54 -25.56 62.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.69 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 46.4 mm-40 -84.95 -30.34 24.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.077 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 12' ' ' ASN . 28.6 mt -80.69 -25.27 38.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.039 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 30.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 10' ' ' LEU . 20.8 t-20 -145.1 -10.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.582 -1.324 . . . . 0.0 110.562 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' LEU . 21.2 mt -78.65 147.21 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.681 -1.262 . . . . 0.0 107.911 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.49 -64.39 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 120.978 1.119 . . . . 0.0 110.926 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.2 -37.47 4.52 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.6 mt -95.39 150.29 37.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.157 -1.202 . . . . 0.0 109.272 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.31 173.21 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 120.908 1.072 . . . . 0.0 110.027 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.36 8.47 43.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.296 -0.878 . . . . 0.0 109.69 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.02 131.92 41.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.487 -0.758 . . . . 0.0 109.375 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -53.02 -30.56 36.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -47.69 67.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.243 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -67.96 -36.36 86.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.5 -63.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -1.209 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.5 -42.46 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.968 . . . . 0.0 109.1 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.12 -44.79 96.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.016 . . . . 0.0 109.015 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 22' ' ' GLY . 41.5 t -69.42 -26.34 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.91 -28.53 9.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.851 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.6 mptp? -72.92 -35.65 67.08 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.154 -0.966 . . . . 0.0 108.94 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -65.37 -3.97 4.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -150.9 -68.96 0.18 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.89 54.55 1.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.88 143.75 12.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.942 -1.328 . . . . 0.0 109.006 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -50.01 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.001 . . . . 0.0 109.078 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.5 p30 -100.06 123.44 44.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.293 -0.88 . . . . 0.0 109.82 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -87.86 115.04 25.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -91.91 84.11 5.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 39' ' ' GLY . 5.9 tpt180 -90.37 96.8 10.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.51 35.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.932 . . . . 0.0 109.405 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 37' ' ' ARG . . . -92.89 -21.16 31.52 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 41' ' ' LYS . 11.9 p -51.55 -44.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' N ' HG13 ' A' ' 40' ' ' VAL . 75.8 tttt -174.08 -44.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.442 -0.786 . . . . 0.0 109.127 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.99 -7.72 0.26 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.14 11.28 30.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm 52.49 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -1.084 . . . . 0.0 109.337 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.49 118.19 25.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.406 -0.809 . . . . 0.0 109.271 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.9 mt -88.37 97.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.331 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -79.37 169.48 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 108.861 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.43 130.02 34.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.389 -0.819 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.12 117.5 17.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -58.93 -28.29 66.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 110.053 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -70.02 -23.43 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 m -89.47 -10.63 45.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 54' ' ' PRO . 60.4 mt -66.52 153.64 92.73 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.094 -1.004 . . . . 0.0 108.527 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.5 Cg_exo -57.16 -147.17 0.0 OUTLIER 'Trans proline' 0 C--O 1.206 -1.076 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.01 -37.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.933 -1.104 . . . . 0.0 109.457 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.83 -30.05 71.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 111.185 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 -41.42 37.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.669 -1.269 . . . . 0.0 110.484 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.28 -56.7 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.122 . . . . 0.0 109.454 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.2 -48.73 23.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.284 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.89 -33.1 74.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.57 -34.01 77.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.294 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.3 mt -71.59 -27.48 63.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.251 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.42 -52.94 33.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 108.958 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -72.51 -43.96 62.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.207 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.06 142.99 36.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.76 -1.213 . . . . 0.0 109.597 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.14 -68.03 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -61.73 -24.63 66.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -1.149 . . . . 0.0 109.461 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 69' ' ' GLU . 19.5 mm -63.81 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 71' ' ' SER . 9.2 pt-20 37.74 36.27 0.09 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.224 0.535 . . . . 0.0 110.647 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 70' ' ' THR . 63.3 m 54.88 0.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.705 . . . . 0.0 110.606 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 69' ' ' GLU . 45.4 t -148.52 159.66 43.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.803 -1.186 . . . . 0.0 109.814 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 1.9 mm? -66.7 119.37 11.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.7 -26.36 3.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -172.8 -77.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -1.062 . . . . 0.0 109.077 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 76' ' ' GLU . 40.6 p90 -142.73 -10.68 0.8 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 14.3 tt0 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.08 -1.012 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.348 0.594 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.38 131.36 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.9 tp -156.67 79.49 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -79.9 158.09 26.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.083 -1.01 . . . . 0.0 108.753 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -124.85 -138.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.509 -0.744 . . . . 0.0 109.203 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -167.04 152.55 7.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.905 -1.122 . . . . 0.0 109.609 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.35 -53.12 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.482 1.455 . . . . 0.0 110.615 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -56.47 -25.47 51.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 15.7 mm-40 -84.86 -28.06 26.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 0.0 109.215 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' ASN . 50.0 mt -81.96 -23.91 35.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.193 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.96 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.692 -0.63 . . . . 0.0 111.093 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.6 m120 -145.41 -7.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.521 -1.362 . . . . 0.0 110.745 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' LEU . 17.6 mt -79.46 148.28 69.81 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.601 -1.312 . . . . 0.0 107.942 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.1 -64.12 0.12 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.889 1.059 . . . . 0.0 110.702 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.08 -38.3 4.72 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.9 mt -93.79 150.3 38.45 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.234 -1.156 . . . . 0.0 109.035 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.0 -178.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.804 1.002 . . . . 0.0 109.779 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.75 -7.78 27.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -117.3 129.81 56.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.655 -0.653 . . . . 0.0 109.284 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -53.24 -28.94 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.11 65.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.87 -35.23 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' ALA . 35.6 t -65.16 -56.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -1.157 . . . . 0.0 109.298 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.75 -43.56 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.173 -0.954 . . . . 0.0 108.969 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -61.2 -44.38 97.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.982 -1.074 . . . . 0.0 108.798 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.21 -19.09 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.779 . . . . 0.0 109.125 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.61 -33.25 74.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 108.84 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -70.16 -27.61 64.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.265 -0.897 . . . . 0.0 108.761 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -64.79 -4.25 4.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.313 -0.867 . . . . 0.0 109.039 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -150.11 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.73 59.45 1.26 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.8 m-90 -56.38 147.84 20.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.037 -1.272 . . . . 0.0 108.796 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.543 HE21 HD22 ' A' ' 49' ' ' ASN . 15.7 tt0 -50.33 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.2 p-10 -101.24 121.97 42.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -87.59 113.52 23.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.258 -0.901 . . . . 0.0 109.475 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.3 m -94.45 156.39 16.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -148.51 -54.63 0.19 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 109.376 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 77.78 102.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.523 -0.735 . . . . 0.0 109.295 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.46 -34.67 0.11 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.02 -4.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -172.95 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 51.76 1.32 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.03 28.37 0.81 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.7 mttm 55.49 96.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -1.04 . . . . 0.0 109.668 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.08 113.68 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.419 -0.801 . . . . 0.0 109.003 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -87.93 101.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.838 . . . . 0.0 109.913 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 29.5 mm-40 -84.52 171.57 12.4 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -135.45 127.29 29.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.543 HD22 HE21 ' A' ' 33' ' ' GLN . 48.8 t30 -77.69 116.36 18.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.067 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.39 -23.62 39.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.23 -25.17 63.26 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.081 -1.012 . . . . 0.0 109.544 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.7 m -91.86 -13.56 31.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.46 149.1 98.53 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.854 -1.154 . . . . 0.0 109.146 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.48 -155.95 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 120.973 1.115 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.7 -36.95 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.86 -39.05 83.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.31 -20.58 47.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -75.2 -58.27 3.39 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.17 -0.956 . . . . 0.0 109.212 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.51 -44.06 55.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.102 . . . . 0.0 108.955 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.1 74.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.445 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.78 -54.76 38.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.9 mt -54.86 -27.2 40.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 108.779 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.66 -29.33 69.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 108.857 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 24.8 mtp180 -73.09 -61.03 1.96 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.6 -163.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.213 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.23 -44.43 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 69' ' ' GLU . 22.9 mt-10 -79.47 -11.68 59.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -1.143 . . . . 0.0 109.557 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 68' ' ' ILE . 26.8 mm 52.61 7.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 67' ' ' GLU . 13.3 pt-20 -45.03 136.57 4.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.372 -0.83 . . . . 0.0 110.014 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 71' ' ' SER . 12.1 t -170.61 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 109.085 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 70' ' ' THR . 51.8 m -150.34 21.74 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.47 124.45 24.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 74' ' ' TYR . . . -69.51 -12.34 66.56 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 73' ' ' GLY . 78.0 m-85 -158.83 -82.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -1.186 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -160.83 23.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 0.0 109.309 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -88.72 166.74 13.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 39.1 tp -163.24 77.92 0.43 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.374 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -80.02 160.23 25.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.123 -0.986 . . . . 0.0 108.783 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 6' ' ' SER . 59.3 t -132.41 160.53 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.314 -0.866 . . . . 0.0 109.705 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -104.53 152.92 39.46 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.49 -43.83 55.17 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.421 1.414 . . . . 0.0 110.665 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -27.26 63.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 76.0 mm-40 -84.11 -22.66 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 109.317 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.5 mt -82.74 -23.17 34.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 0.0 109.288 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.95 29.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.154 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.646 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -148.3 -8.52 0.39 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.437 -1.414 . . . . 0.0 111.122 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.646 ' N ' HD22 ' A' ' 12' ' ' ASN . 29.1 mt -78.41 147.42 72.07 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.492 -1.38 . . . . 0.0 108.05 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.22 -66.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.989 1.126 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.04 -34.79 2.14 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.7 mt -95.17 150.47 37.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.275 -1.132 . . . . 0.0 108.86 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.08 -173.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.867 1.044 . . . . 0.0 110.071 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 27.7 mmtp -100.71 -17.58 16.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.372 -0.83 . . . . 0.0 109.564 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -109.57 130.14 55.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.55 -0.719 . . . . 0.0 109.391 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.35 -29.35 23.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -49.55 73.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.63 81.44 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.55 -64.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -1.173 . . . . 0.0 109.335 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.07 -39.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.174 -0.954 . . . . 0.0 109.117 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.79 -40.19 91.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 108.602 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.3 -27.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.07 -28.53 17.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.23 -0.919 . . . . 0.0 108.723 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -71.69 -32.96 68.4 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 -1.15 1.83 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.457 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -150.95 -65.43 0.19 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.96 49.6 1.74 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -51.52 136.71 25.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.038 -1.272 . . . . 0.0 109.006 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.584 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.79 110.89 0.4 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.006 -1.059 . . . . 0.0 108.582 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 10.1 p30 -105.09 122.13 45.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.424 -0.798 . . . . 0.0 109.624 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -87.59 96.59 10.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 109.151 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -92.69 154.56 18.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 109.074 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -150.06 -38.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.08 -1.013 . . . . 0.0 109.086 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 75.79 63.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.622 -0.674 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.23 11.18 1.02 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.6 t -86.43 -78.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -1.147 . . . . 0.0 109.279 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -103.31 -59.0 1.78 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.48 -0.762 . . . . 0.0 109.22 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.79 61.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.71 42.85 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 40.2 mttm 58.04 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -1.144 . . . . 0.0 109.577 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.87 112.91 21.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 mt -88.39 119.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 109.655 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -104.81 171.71 7.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -136.3 135.3 38.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -76.99 118.91 20.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.929 -1.107 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' LEU . . . -55.85 -29.45 59.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.379 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -69.58 -21.61 63.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.581 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 61.6 m -91.94 -15.14 28.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.21 150.28 97.79 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 109.321 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.4 151.37 75.03 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.033 1.156 . . . . 0.0 109.621 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.1 -38.7 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.3 -37.73 78.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.861 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.03 -35.41 37.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -60.89 -62.48 1.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.939 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.49 42.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.297 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.31 74.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.12 -45.1 94.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 108.886 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.44 -20.35 62.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.78 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.6 tp -68.42 -53.98 20.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.389 -0.819 . . . . 0.0 109.426 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -71.65 -41.16 69.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.158 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.01 39.64 0.38 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.799 -1.188 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.13 -137.71 1.43 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 1.4 pm0 -84.41 148.33 26.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.131 . . . . 0.0 109.562 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.7 mp -82.25 -28.07 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.059 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' THR . 13.3 pt-20 -162.55 37.67 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 71' ' ' SER . 92.8 m 54.07 168.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.587 -0.695 . . . . 0.0 109.692 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.614 ' N ' HG22 ' A' ' 70' ' ' THR . 1.2 m 166.99 -65.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.389 -0.819 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.14 143.96 25.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 109.356 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.73 7.84 0.95 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' C ' ' N ' ' A' ' 76' ' ' GLU . 94.7 m-85 -96.64 32.98 1.92 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.575 -0.956 . . . . 0.0 109.436 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 64.2 t80 53.55 13.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 74' ' ' TYR . 3.0 tm-20 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.371 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' N ' ' SD ' ' A' ' 1' ' ' MET . 35.2 mt-10 -150.69 142.3 23.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.5 tp -160.74 74.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.436 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -79.99 167.43 20.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 108.665 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.25 155.53 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.255 -0.903 . . . . 0.0 109.712 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -104.99 152.17 39.58 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.06 -46.88 30.77 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.377 1.385 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -58.37 -24.36 59.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.206 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 18.0 mm-40 -84.25 -27.65 27.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.968 -1.082 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 53.7 mt -83.0 -21.68 33.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 109.334 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.91 29.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.635 . . . . 0.0 111.133 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 21.7 p30 -148.48 -6.81 0.4 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.511 -1.368 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.5 mt -79.46 147.36 67.9 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.567 -1.333 . . . . 0.0 108.181 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.55 -67.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.056 1.171 . . . . 0.0 110.978 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.07 -36.14 2.62 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.8 mt -94.68 150.51 38.09 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.252 -1.146 . . . . 0.0 108.926 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.78 -176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 120.836 1.024 . . . . 0.0 110.055 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 11' ' ' ALA . 22.5 mtpt -101.34 -15.04 17.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.344 -0.848 . . . . 0.0 109.919 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 p -113.74 131.29 56.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.73 . . . . 0.0 109.408 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -52.88 -29.29 27.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.87 . . . . 0.0 109.251 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.71 65.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.69 -35.57 28.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.1 -56.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -1.147 . . . . 0.0 109.198 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.12 -43.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -61.14 -44.82 96.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 108.986 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.61 -25.47 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.429 -0.794 . . . . 0.0 109.059 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.4 -31.06 32.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.206 -0.934 . . . . 0.0 108.956 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -71.57 -28.83 64.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 109.057 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -64.73 -4.85 4.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 109.445 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.41 -58.15 0.18 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 108.879 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.8 51.62 2.26 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.4 m-90 -51.02 137.35 21.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.123 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -49.94 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.084 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -99.94 121.02 40.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.433 -0.792 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -88.87 120.73 30.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.858 . . . . 0.0 109.155 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.06 164.93 13.09 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.118 . . . . 0.0 109.021 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -152.0 -146.81 0.21 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.88 58.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.417 -0.802 . . . . 0.0 109.237 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -142.55 2.47 1.73 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 42' ' ' GLY . 11.0 p -79.53 28.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.26 . . . . 0.0 108.546 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 39' ' ' GLY . 34.1 mtpt 59.67 2.37 0.35 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.069 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -99.07 -68.64 0.9 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.14 -5.33 0.9 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -178.83 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.124 -1.221 . . . . 0.0 109.445 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.49 117.32 28.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 46' ' ' ILE . 17.1 tt -88.55 119.45 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.154 -0.966 . . . . 0.0 109.069 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 44.6 mm-40 -100.81 172.81 6.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 109.502 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.23 129.96 34.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.228 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -75.34 117.32 17.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.93 -1.106 . . . . 0.0 109.489 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.33 59.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 110.437 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -69.51 -17.83 63.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -1.0 . . . . 0.0 109.576 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m -90.66 -22.33 21.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -67.11 148.39 98.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 109.031 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.4 Cg_endo -56.41 -161.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.851 1.034 . . . . 0.0 109.654 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.9 t -93.6 -33.82 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 109.375 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.2 mp0 -59.32 -39.31 82.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 109.515 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -82.19 -34.53 28.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.874 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -58.94 -39.66 82.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 -52.57 20.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.121 -0.987 . . . . 0.0 108.96 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.13 -19.48 65.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.415 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 64' ' ' ARG . 19.5 tp -63.44 -72.53 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 108.956 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp -52.45 -29.0 22.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.094 -1.003 . . . . 0.0 108.604 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 63' ' ' LEU . 1.7 tt -65.76 -35.69 81.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.528 ' NE ' ' O ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -69.36 -46.25 67.44 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -46.41 110.07 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.304 -0.873 . . . . 0.0 109.421 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.57 15.55 0.22 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 69' ' ' GLU . 51.1 tt0 -153.96 -41.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -1.145 . . . . 0.0 109.369 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 68' ' ' ILE . 29.1 mt 53.76 3.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.404 -0.81 . . . . 0.0 109.773 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 67' ' ' GLU . 23.1 tt0 60.29 44.9 11.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 p -82.81 -165.93 1.19 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.265 -0.897 . . . . 0.0 109.275 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -161.25 59.22 0.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.39 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.98 175.04 2.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.14 -7.79 0.56 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -97.31 30.77 2.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.372 -1.075 . . . . 0.0 109.389 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 51.57 40.01 26.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.335 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.383 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 1' ' ' MET . 9.4 tmm? . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' N ' ' SD ' ' A' ' 1' ' ' MET . 8.0 tp10 -151.1 139.23 20.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 109.353 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -160.89 92.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.327 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -79.68 171.8 14.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 0.0 108.848 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.1 164.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 0.0 109.416 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -113.86 152.58 45.75 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.13 -47.94 24.81 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 121.229 1.286 . . . . 0.0 110.251 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -60.74 -24.5 65.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.985 . . . . 0.0 110.108 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 43.2 mm-40 -84.35 -27.15 27.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.088 -1.008 . . . . 0.0 109.488 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -82.41 -22.49 35.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 109.237 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.602 -0.686 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 35.4 m120 -145.68 -9.37 0.55 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.577 -1.327 . . . . 0.0 110.805 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.22 147.66 69.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.638 -1.289 . . . . 0.0 108.039 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.29 -65.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 120.994 1.13 . . . . 0.0 110.838 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.57 -36.82 3.47 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.4 mt -94.69 150.27 37.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.213 -1.169 . . . . 0.0 108.939 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.01 175.31 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.953 1.102 . . . . 0.0 109.99 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -97.89 5.71 48.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.417 -0.802 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 p -130.66 130.15 43.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.455 -0.778 . . . . 0.0 109.278 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 p -52.16 -30.99 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.433 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.57 70.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.33 -35.23 81.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 27' ' ' ALA . 61.4 t -65.32 -59.88 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.25 -43.26 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 108.933 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.49 -44.24 97.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.978 -1.076 . . . . 0.0 108.82 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.17 -18.24 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.67 -33.28 73.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.949 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 30' ' ' GLN . 6.0 mtpm? -70.55 -29.11 65.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 108.677 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -65.1 -1.57 2.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.444 -0.785 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 28' ' ' LYS . 36.2 mt-30 -150.39 -63.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.19 55.27 1.29 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -54.87 137.65 44.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.026 -1.279 . . . . 0.0 108.962 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.59 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.376 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 4.3 p30 -99.65 121.36 41.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.296 -0.878 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -85.73 112.95 21.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.177 -0.952 . . . . 0.0 109.167 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 45' ' ' ALA . 39.9 m -93.05 138.51 31.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 109.173 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -149.41 122.05 8.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 108.881 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.13 49.54 0.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.83 . . . . 0.0 109.965 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -91.72 -39.28 5.59 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 42' ' ' GLY . 3.1 t -61.32 -1.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' GLY . 19.4 ttpp 57.73 -5.21 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.57 -0.706 . . . . 0.0 110.533 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -67.32 -57.77 8.84 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.86 71.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mttm 58.24 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 36' ' ' THR . . . -86.66 -167.85 2.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -147.64 99.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.151 -0.968 . . . . 0.0 109.375 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 49.8 mm-40 -87.74 172.36 9.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 108.723 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.88 128.56 32.85 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.64 ' ND2' HD21 ' A' ' 51' ' ' ASN . 49.5 t-20 -75.68 114.17 13.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.899 -1.126 . . . . 0.0 109.092 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.32 -27.05 33.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.437 -0.789 . . . . 0.0 110.796 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.64 HD21 ' ND2' ' A' ' 49' ' ' ASN . 54.5 p30 -69.03 -17.53 63.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.895 -1.128 . . . . 0.0 110.052 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 13.5 m -90.58 -18.5 25.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.138 -0.976 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 92.1 mt -68.25 149.18 98.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.214 -0.929 . . . . 0.0 109.227 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.37 -156.38 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 120.918 1.079 . . . . 0.0 109.629 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.34 -36.47 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -59.35 -36.68 76.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.098 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.39 -34.41 41.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 109.572 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -55.79 -48.28 75.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.32 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.28 -57.29 11.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.64 -23.06 67.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.035 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp -64.62 -77.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp -51.69 -14.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.11 -51.94 33.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.954 -1.092 . . . . 0.0 109.222 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 11.4 ptm180 -75.61 7.76 3.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -91.01 74.98 6.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.071 -1.018 . . . . 0.0 109.13 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.14 4.56 70.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 69' ' ' GLU . 24.3 tt0 -72.28 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -1.184 . . . . 0.0 109.386 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 70' ' ' THR . 6.9 mt 56.12 0.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.968 -1.083 . . . . 0.0 109.583 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' H ' ' C ' ' A' ' 67' ' ' GLU . 23.9 mt-10 55.56 6.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.749 -1.22 . . . . 0.0 109.377 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 44.3 -167.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.401 -0.812 . . . . 0.0 109.893 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 76.19 -52.19 0.61 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 72' ' ' LEU . 9.2 mp 48.55 68.66 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -50.41 -13.23 0.7 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' N ' ' C ' ' A' ' 72' ' ' LEU . 21.2 t80 60.15 1.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -1.096 . . . . 0.0 109.427 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 73' ' ' GLY . 74.5 m-85 -145.81 6.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.177 -0.952 . . . . 0.0 109.415 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.493 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.4 pm0 -89.56 57.64 4.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp -95.53 83.7 3.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.386 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -80.31 161.59 25.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.26 152.99 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -97.68 154.72 37.79 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.83 . . . . 0.0 109.579 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.51 -51.5 10.98 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.611 1.541 . . . . 0.0 112.138 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -57.81 -17.25 14.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.81 -1.181 . . . . 0.0 110.705 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.576 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 26.1 mp0 -87.14 -28.12 22.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.679 -1.263 . . . . 0.0 108.884 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 48.7 mt -81.73 -22.35 37.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.855 . . . . 0.0 109.204 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 29.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.706 -0.621 . . . . 0.0 111.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.9 t-20 -146.7 -8.82 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.475 -1.39 . . . . 0.0 110.855 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.7 mt -78.94 147.82 70.94 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.551 -1.343 . . . . 0.0 108.006 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.67 -66.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 120.948 1.099 . . . . 0.0 110.923 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.81 -36.79 3.76 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.72 150.2 37.59 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.262 -1.14 . . . . 0.0 109.11 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.09 170.55 0.67 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 120.874 1.049 . . . . 0.0 110.063 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -94.17 2.89 55.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.868 . . . . 0.0 109.642 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -129.15 129.27 44.91 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.469 -0.769 . . . . 0.0 109.265 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 p -52.21 -30.46 27.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.12 -35.72 59.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.234 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.46 -35.8 25.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.84 -58.14 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -1.134 . . . . 0.0 109.439 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 20.8 mt -55.15 -47.07 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.187 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -61.26 -50.82 71.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.339 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 58.6 t -65.91 -22.32 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.44 -0.787 . . . . 0.0 109.394 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.27 -30.69 18.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.102 -0.999 . . . . 0.0 109.054 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.1 mptt -71.17 -30.07 65.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.136 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -63.94 -4.14 3.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -149.96 -61.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 108.972 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.78 48.98 2.81 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.03 138.63 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -1.23 . . . . 0.0 109.334 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -49.93 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.854 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.8 p-10 -98.77 125.28 44.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -86.79 131.66 34.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 137.4 32.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' CD ' ' H ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -88.09 -144.87 0.14 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' H ' ' CD ' ' A' ' 37' ' ' ARG . . . -172.36 71.71 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.658 -1.277 . . . . 0.0 110.604 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 159.49 -73.78 0.21 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 40' ' ' VAL . 7.3 p 33.17 30.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.548 0.69 . . . . 0.0 110.342 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 39' ' ' GLY . 6.0 pttt 71.62 -21.18 0.22 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . -95.96 -72.44 1.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.27 -16.5 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.051 -1.264 . . . . 0.0 110.639 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -171.31 99.86 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.331 . . . . 0.0 109.235 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.0 -169.61 2.65 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' ILE . 16.7 tt -150.07 128.62 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.9 mp0 -109.59 174.01 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.25 131.7 36.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.325 -0.859 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -75.07 114.31 13.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 109.104 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.14 57.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 110.227 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -68.33 -18.13 64.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.997 . . . . 0.0 109.834 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -89.77 -19.33 24.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 98.4 mt -67.11 149.62 98.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 108.941 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.9 Cg_endo -56.06 -162.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.71 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.36 -37.29 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.198 -0.939 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -60.15 -37.13 79.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.281 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.99 -30.09 49.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.063 . . . . 0.0 109.644 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -59.86 -54.51 45.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 109.117 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.87 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.028 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.07 -30.03 69.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.926 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 62' ' ' LEU . 2.0 tm? -64.82 -66.07 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 109.213 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 61' ' ' LEU . 2.0 pp -55.28 -21.19 13.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 109.224 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tp -65.68 -32.72 74.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 108.451 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 28.3 mtp180 -68.83 -37.74 79.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.573 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 64' ' ' ARG . 58.2 mm-40 -56.92 -107.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.38 66.85 2.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 66' ' ' GLY . 3.2 mp0 57.72 137.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.974 -0.721 . . . . 0.0 110.23 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.38 -90.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -170.96 25.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.845 . . . . 0.0 109.296 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 72' ' ' LEU . 10.4 t -165.1 -150.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.236 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 m 51.96 -93.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 74' ' ' TYR . 18.6 mt -76.44 9.53 2.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.602 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.05 19.36 1.28 Allowed Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' H ' ' C ' ' A' ' 72' ' ' LEU . 44.8 t80 -87.28 16.84 4.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -1.077 . . . . 0.0 109.446 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 50.2 34.77 9.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 109.763 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' CD ' ' HE1' ' A' ' 4' ' ' TRP . 23.4 tp10 -150.47 59.04 0.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.08 82.03 1.92 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.396 -0.815 . . . . 0.0 109.995 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.561 ' HE1' ' CD ' ' A' ' 2' ' ' GLU . 47.5 m95 -80.34 171.34 15.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.825 -1.172 . . . . 0.0 108.227 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.97 -137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -169.33 151.33 4.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 109.372 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.06 -49.15 16.32 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.352 1.368 . . . . 0.0 110.677 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -59.4 -27.81 66.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -0.987 . . . . 0.0 110.224 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.23 -26.57 28.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 0.0 109.442 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ASN . 25.5 mt -82.91 -18.77 38.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.38 32.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 0.0 110.971 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.3 t-20 -146.15 -9.02 0.52 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.476 -1.39 . . . . 0.0 110.921 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.1 mt -78.56 147.55 71.76 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.528 -1.358 . . . . 0.0 108.154 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.02 -65.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.996 1.13 . . . . 0.0 110.578 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.27 -37.06 4.44 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.3 mt -93.76 149.97 37.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.221 -1.164 . . . . 0.0 108.952 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.52 177.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 120.753 0.969 . . . . 0.0 109.779 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -99.08 -2.32 37.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -123.76 131.4 53.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.611 -0.681 . . . . 0.0 109.375 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -52.66 -30.32 31.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.17 53.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.69 -35.6 18.88 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.02 -45.85 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.17 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.71 -47.21 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.014 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.91 -41.82 96.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HE22 ' A' ' 30' ' ' GLN . 62.1 t -75.05 -29.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.262 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.52 -29.27 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 108.748 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -71.9 -33.44 68.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.444 -0.785 . . . . 0.0 109.05 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 15.1 mtpp -64.79 -1.74 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.57 HE22 HG12 ' A' ' 26' ' ' VAL . 2.2 mp0 -149.32 -68.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.358 -0.839 . . . . 0.0 108.765 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.0 55.88 1.35 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -51.3 152.08 2.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.253 . . . . 0.0 109.198 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -52.8 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.645 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -101.58 112.47 25.04 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.506 HH11 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -90.06 141.61 28.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.037 -1.039 . . . . 0.0 108.346 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.43 134.65 34.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.724 -1.235 . . . . 0.0 109.777 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -91.42 -147.08 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.69 49.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.085 -1.009 . . . . 0.0 109.973 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.76 70.95 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -126.47 -92.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.992 . . . . 0.0 108.454 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' H ' HG23 ' A' ' 40' ' ' VAL . 63.2 mmtt -107.09 -64.66 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.21 -61.59 1.81 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.44 33.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -177.25 94.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 0.0 109.772 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -87.84 155.68 19.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.207 -0.933 . . . . 0.0 108.749 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 47' ' ' GLU . 14.0 tt -96.95 -41.96 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.188 -0.945 . . . . 0.0 109.28 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 46' ' ' ILE . 42.5 mt-10 55.26 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.849 0.833 . . . . 0.0 110.797 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -134.01 133.03 40.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.435 -0.791 . . . . 0.0 108.941 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.57 116.66 17.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 109.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 -27.51 55.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.365 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 51' ' ' ASN . 4.7 m-80 -70.9 -23.12 62.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.004 . . . . 0.0 110.084 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.4 m -89.83 -12.87 37.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -0.965 . . . . 0.0 110.087 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.8 150.46 97.62 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.052 -1.03 . . . . 0.0 109.323 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 169.12 5.14 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.988 1.126 . . . . 0.0 109.424 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.23 -37.89 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.024 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.78 -39.15 80.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.054 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.11 -39.8 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.976 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.88 -57.86 11.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.607 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.87 58.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.083 -1.011 . . . . 0.0 109.33 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.26 -28.67 68.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -63.18 -49.76 72.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.386 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.5 -19.57 65.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.073 -1.017 . . . . 0.0 109.084 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -58.19 4.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.549 ' C ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -72.32 -41.26 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.515 ' N ' ' HE ' ' A' ' 64' ' ' ARG . 22.9 mt-30 -63.25 -101.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.753 -1.217 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 58.37 174.96 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 66' ' ' GLY . 42.4 mt-10 52.91 102.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.36 -1.082 . . . . 0.0 109.637 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.24 -63.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.468 -0.77 . . . . 0.0 109.075 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 71' ' ' SER . 7.6 tp10 -69.84 116.2 9.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.682 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 70' ' ' THR . 60.0 m 54.73 0.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.425 -0.797 . . . . 0.0 110.222 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 69' ' ' GLU . 34.4 t 47.42 31.44 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.939 -1.101 . . . . 0.0 109.65 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.5 mt 57.01 93.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.942 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.88 -20.47 79.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 38.1 t80 -165.39 26.6 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 52.2 t80 54.3 21.1 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.533 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 50.1 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.9 pm0 -89.86 -87.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.244 -0.91 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.4 tp 54.62 74.33 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 109.526 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.7 m95 -80.73 161.11 24.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 108.734 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 6' ' ' SER . 57.8 t -135.25 158.26 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -100.63 153.36 37.78 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.494 -0.754 . . . . 0.0 109.231 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -55.32 -40.04 87.75 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.114 1.209 . . . . 0.0 110.183 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -58.54 -27.24 64.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.63 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 34.3 mt-10 -83.57 -24.9 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 12' ' ' ASN . 91.5 mt -83.48 -23.93 31.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.99 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.625 -0.672 . . . . 0.0 111.21 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.734 HD21 HH12 ' A' ' 64' ' ' ARG . 1.3 p30 -149.42 -8.1 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.415 -1.428 . . . . 0.0 111.035 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 16.4 mt -78.75 147.89 71.72 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.618 -1.301 . . . . 0.0 108.118 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.97 -67.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.11 1.207 . . . . 0.0 110.989 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.16 2.19 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.35 150.36 37.47 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.29 -1.123 . . . . 0.0 108.882 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.44 -174.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 120.806 1.004 . . . . 0.0 110.021 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 11' ' ' ALA . 65.2 mmtt -101.08 -16.56 17.04 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.324 -0.86 . . . . 0.0 109.558 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -110.65 131.2 55.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.478 -0.763 . . . . 0.0 109.478 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -52.88 -29.56 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.48 -39.62 70.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.43 56.37 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.59 -62.73 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mt -49.94 -40.62 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 108.673 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.36 -42.2 98.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.124 -0.985 . . . . 0.0 108.678 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -76.66 -20.45 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.499 -0.751 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -52.2 -39.59 60.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.08 -1.013 . . . . 0.0 110.188 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLN . 4.8 ptmt -70.91 -23.14 62.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 109.262 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.99 -4.49 2.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 108.731 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.6 mt-30 -150.27 -58.99 0.19 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.79 48.01 2.01 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -54.99 133.89 48.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.832 -1.393 . . . . 0.0 108.633 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.601 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.41 108.83 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.98 -1.075 . . . . 0.0 108.761 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.31 121.81 44.12 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.416 -0.802 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 35' ' ' ARG . 20.2 ttm-85 -88.96 139.36 30.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 109.447 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 107.48 19.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 108.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -89.15 91.9 8.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.2 -0.938 . . . . 0.0 109.117 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.69 52.68 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.853 . . . . 0.0 109.651 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 37' ' ' ARG . . . -158.2 64.3 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.13 -85.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -1.146 . . . . 0.0 109.16 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -96.97 -9.4 28.36 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.293 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 56.99 1.96 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.0 35.82 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mttp 51.04 89.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -1.159 . . . . 0.0 109.523 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.95 138.79 31.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.256 -0.903 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.1 tt -90.19 155.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.95 . . . . 0.0 109.637 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' OG ' ' A' ' 6' ' ' SER . 68.4 mm-40 -139.98 175.35 9.66 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -136.3 134.24 37.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.414 -0.804 . . . . 0.0 109.31 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -75.87 114.18 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.138 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.54 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.305 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 1' ' ' MET . 1.7 m-80 -69.82 -20.77 63.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.915 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 27.8 m -90.58 -10.43 43.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.112 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 54' ' ' PRO . 76.1 mt -68.45 150.3 97.74 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.034 -1.041 . . . . 0.0 109.305 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -59.0 -155.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 120.968 1.112 . . . . 0.0 109.459 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.07 -36.62 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.48 -37.12 80.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.93 -25.49 40.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.363 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -62.02 -66.83 0.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.11 33.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.519 -0.738 . . . . 0.0 109.425 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.45 80.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.23 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.47 -24.21 67.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 108.695 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.87 -29.9 58.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.18 -36.39 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.734 HH12 HD21 ' A' ' 12' ' ' ASN . 20.1 mtp180 -72.52 -66.07 0.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -91.04 -128.5 0.09 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -0.782 . . . . 0.0 109.121 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.55 32.05 3.9 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.54 -9.38 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.173 . . . . 0.0 109.343 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 mm -82.72 -76.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.256 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -158.1 26.13 0.26 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.321 -0.862 . . . . 0.0 109.306 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 p -79.01 -64.37 1.2 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.132 -0.98 . . . . 0.0 109.529 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.2 t -160.74 81.73 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 74' ' ' TYR . 18.6 mt -72.13 -54.96 8.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' C ' ' N ' ' A' ' 75' ' ' PHE . . . 72.08 -17.69 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 72' ' ' LEU . 83.9 m-85 52.61 9.28 0.11 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -1.075 . . . . 0.0 109.334 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' N ' ' C ' ' A' ' 73' ' ' GLY . 52.4 t80 -142.44 3.85 1.53 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.321 -0.862 . . . . 0.0 109.615 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 6.7 tm-20 -150.18 -23.36 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.091 -1.006 . . . . 0.0 109.175 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.9 tp -125.36 81.27 1.96 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.58 -0.7 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -79.72 171.97 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.023 . . . . 0.0 108.26 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.64 145.65 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.112 -0.993 . . . . 0.0 109.874 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -95.46 153.28 39.58 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.348 -0.845 . . . . 0.0 109.321 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.49 -42.48 65.31 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.233 1.288 . . . . 0.0 110.458 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -59.22 -24.41 63.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.545 ' CD ' HH12 ' A' ' 64' ' ' ARG . 12.5 mm-40 -84.24 -24.39 30.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -83.2 -24.35 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.99 29.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 111.345 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -147.32 -9.23 0.44 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.467 -1.396 . . . . 0.0 110.919 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' LEU . 40.1 mt -79.13 147.13 68.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.533 -1.354 . . . . 0.0 108.061 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -65.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.097 1.198 . . . . 0.0 110.739 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.63 -35.63 3.09 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.5 mt -95.28 150.01 37.0 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.23 -1.159 . . . . 0.0 109.009 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.41 175.31 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 120.803 1.002 . . . . 0.0 109.787 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -97.16 6.59 48.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 109.749 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -133.6 130.74 38.78 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.521 -0.737 . . . . 0.0 109.205 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 p -52.57 -31.26 35.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.383 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.47 56.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.81 -38.39 20.05 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.14 -63.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.264 -1.139 . . . . 0.0 109.444 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.8 mt -47.87 -41.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.069 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.7 -48.35 81.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.184 -0.948 . . . . 0.0 108.703 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' HZ1' ' A' ' 29' ' ' LYS . 45.9 t -61.57 -28.65 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -49.74 -31.02 10.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.15 -0.969 . . . . 0.0 108.927 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.5 mptt -72.7 -38.46 67.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 108.687 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' A' ' 29' ' ' LYS . 4.9 ttpm? -65.36 -3.6 4.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -150.32 -70.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 108.894 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.68 54.41 1.23 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.532 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.5 m-90 -51.91 145.24 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.09 -1.241 . . . . 0.0 109.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -52.64 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.997 . . . . 0.0 109.056 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.8 p-10 -97.63 118.25 33.73 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -86.73 139.52 30.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.24 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -93.96 133.65 37.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 108.861 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 6.8 tpp180 -90.02 -65.37 1.02 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 109.18 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 76.6 40.49 0.21 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.562 -0.711 . . . . 0.0 109.552 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.98 15.5 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 40' ' ' VAL . 2.4 m -89.65 -37.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -1.219 . . . . 0.0 109.17 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -176.59 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.374 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.66 -111.85 1.36 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.31 17.6 0.21 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -179.73 96.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.18 -174.58 4.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 108.719 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.7 mm -139.91 75.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.125 -0.984 . . . . 0.0 108.971 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.4 168.72 15.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.121 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -133.58 132.43 40.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.384 -0.823 . . . . 0.0 109.534 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 51' ' ' ASN . 51.7 t-20 -76.12 117.23 17.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.179 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -36.28 65.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.325 -0.86 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.762 HD21 HD21 ' A' ' 49' ' ' ASN . 43.1 p30 -67.44 -16.43 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 109.896 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 74.0 m -90.0 -16.53 29.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.1 mt -67.96 149.67 98.1 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.115 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.65 -156.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.903 1.069 . . . . 0.0 109.5 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.67 -36.76 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 109.78 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -60.24 -36.81 78.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.95 43.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 109.8 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -65.34 -65.68 0.64 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 108.744 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.56 19.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.517 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.37 80.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 tp -62.38 -52.18 64.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 108.795 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 62' ' ' LEU . 47.1 mt -56.29 -27.51 55.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.659 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.98 -26.35 66.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.289 -0.882 . . . . 0.0 108.674 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.545 HH12 ' CD ' ' A' ' 9' ' ' GLU . 11.3 mtm180 -73.03 -69.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.0 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -46.24 160.63 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.605 -0.684 . . . . 0.0 109.908 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.15 -86.98 0.1 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.64 92.73 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 109.366 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 69' ' ' GLU . 17.6 mm -66.44 -40.7 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.41 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' ILE . 33.9 tt0 49.02 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 71' ' ' SER . 9.6 t -165.53 -45.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 70' ' ' THR . 38.6 t -137.93 -71.52 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.682 HD22 ' C ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -55.03 -3.29 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 110.324 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 71' ' ' SER . . . -78.53 52.59 3.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -72.13 -11.17 60.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -1.118 . . . . 0.0 109.057 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 74' ' ' TYR . 3.8 p90 175.9 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 75' ' ' PHE . 6.6 pt-20 . . . . . 0 N--CA 1.503 2.209 0 CA-C-O 121.304 0.573 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.1 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 5.3 mp0 -89.3 124.49 34.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.9 tp -158.34 100.52 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -99.83 171.1 8.09 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 108.691 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 61' ' ' LEU . 12.2 t -140.59 155.52 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.182 -0.949 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 m -101.27 153.04 38.04 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 121.446 -0.784 . . . . 0.0 109.289 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.19 -43.39 59.45 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 121.371 1.38 . . . . 0.0 110.555 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -58.37 -27.24 64.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 0.0 109.78 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.463 ' OE1' ' CZ ' ' A' ' 64' ' ' ARG . 35.2 mm-40 -84.78 -24.74 28.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.17 -0.956 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.1 mt -83.53 -21.36 32.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.106 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.1 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -146.42 -4.18 0.61 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.501 -1.375 . . . . 0.0 110.642 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' LEU . 12.0 mt -79.69 147.86 68.02 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.588 -1.32 . . . . 0.0 108.004 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.22 -64.52 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 120.882 1.054 . . . . 0.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.28 -35.94 7.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LEU . 30.0 mt -93.62 150.06 38.18 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.122 -1.222 . . . . 0.0 109.141 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.35 -175.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 120.876 1.051 . . . . 0.0 109.924 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -104.89 5.83 33.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.525 -0.734 . . . . 0.0 109.757 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 p -132.93 133.12 42.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 t -53.36 -30.62 40.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.57 62.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.82 -35.74 18.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.25 -49.72 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.7 mt -65.09 -44.79 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -60.75 -41.96 96.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 108.92 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.82 -27.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.43 -0.794 . . . . 0.0 109.024 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -51.86 -29.31 19.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.6 -29.93 65.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.37 -0.831 . . . . 0.0 108.897 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -64.35 -4.13 3.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.48 -61.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.368 -0.833 . . . . 0.0 108.88 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.37 54.48 1.57 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -55.44 141.2 37.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.075 -1.25 . . . . 0.0 108.844 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -47.93 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.232 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.9 p30 -101.45 116.76 33.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.466 -0.772 . . . . 0.0 110.106 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -89.32 147.7 23.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 109.058 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -94.9 133.97 38.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.0 -1.063 . . . . 0.0 109.088 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.413 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 5.9 tpt180 -92.31 -55.81 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.2 79.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.446 -0.784 . . . . 0.0 109.407 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.94 -26.66 0.09 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 41' ' ' LYS . 26.9 m -73.31 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.223 -1.163 . . . . 0.0 109.86 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.76 ' H ' HG23 ' A' ' 40' ' ' VAL . 28.7 pttt -177.28 75.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.938 . . . . 0.0 109.586 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 44' ' ' LYS . . . 169.72 -5.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.39 -2.53 1.6 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' GLY . 46.3 tttp -174.63 89.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.999 . . . . 0.0 108.981 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.79 -163.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.172 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.58 89.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.234 -0.916 . . . . 0.0 109.002 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -76.49 169.13 18.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 108.849 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -135.16 134.87 40.62 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.834 . . . . 0.0 109.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 17.6 t-20 -76.27 115.81 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 109.298 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.58 -34.16 64.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.374 -0.828 . . . . 0.0 110.61 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -69.98 -17.03 63.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.014 -1.054 . . . . 0.0 109.858 -179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.6 m -90.03 -15.46 31.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 109.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' PRO . 96.1 mt -67.96 148.96 98.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 109.128 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.0 Cg_exo -54.94 -164.79 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.967 1.111 . . . . 0.0 109.833 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.5 -38.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -0.931 . . . . 0.0 109.928 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -58.17 -40.3 81.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.628 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.24 -38.54 42.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.124 -0.985 . . . . 0.0 109.228 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -49.03 -60.7 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 109.725 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.26 63.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.599 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -23.41 67.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 109.586 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -65.98 -63.89 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.407 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.489 HD23 ' NE2' ' A' ' 65' ' ' GLN . 15.4 mt -44.93 -44.01 9.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 110.025 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.4 mt -66.3 -28.97 69.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 108.835 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -71.75 -44.77 63.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.489 ' NE2' HD23 ' A' ' 62' ' ' LEU . 65.5 mt-30 -43.07 154.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.976 . . . . 0.0 110.381 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.46 100.22 0.22 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' GLU . 37.2 mt-10 -48.78 -35.75 15.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -1.197 . . . . 0.0 109.256 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 68' ' ' ILE . 26.6 mt 54.73 -1.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.59 -0.694 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' GLU . 39.5 tt0 -92.43 -42.46 9.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.868 -1.145 . . . . 0.0 109.073 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 t -161.95 178.83 8.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 m 46.25 85.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.704 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -156.53 177.87 10.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.373 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.55 11.9 0.52 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 64.51 18.29 11.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.601 -0.94 . . . . 0.0 109.225 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 86.6 t80 -144.33 6.92 1.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 109.139 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 1.4 pm0 -151.14 47.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.3 tp -96.29 86.22 4.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.247 -0.908 . . . . 0.0 109.132 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -84.81 155.9 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 61' ' ' LEU . 57.5 t -130.62 163.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.472 -0.767 . . . . 0.0 109.644 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.6 m -108.2 153.11 42.06 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.486 -0.759 . . . . 0.0 109.05 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.15 -44.55 48.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.239 1.293 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -57.68 -25.65 60.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 45.8 mt-10 -84.43 -24.18 29.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.128 -0.983 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.8 mt -82.96 -22.93 33.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.09 29.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.64 -0.663 . . . . 0.0 111.232 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 10.0 t-20 -146.57 -7.47 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.513 -1.367 . . . . 0.0 110.892 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.4 mt -79.4 147.45 68.35 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 0.0 108.195 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.11 -63.97 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.962 1.108 . . . . 0.0 110.606 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.48 -38.22 5.2 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 26.2 mt -94.01 149.87 37.58 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.137 -1.214 . . . . 0.0 109.175 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.14 -178.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.875 1.05 . . . . 0.0 109.732 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -101.17 7.38 43.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.428 -0.795 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -133.19 130.17 38.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.408 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -52.5 -30.64 31.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.354 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.75 -37.0 62.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.28 19.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 t -64.84 -58.78 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.275 -1.132 . . . . 0.0 109.171 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 87.9 mt -52.4 -43.06 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -60.69 -41.76 95.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 108.933 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.96 -22.87 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.079 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.3 -29.81 66.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.192 -0.942 . . . . 0.0 108.497 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 30' ' ' GLN . 77.5 mttt -71.98 -32.79 67.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.444 -0.785 . . . . 0.0 109.065 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -65.03 2.92 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 108.888 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.1 mt-30 -150.85 -64.88 0.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.58 47.21 2.18 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -50.8 135.73 23.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.305 . . . . 0.0 108.961 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.27 112.21 0.55 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.008 -1.057 . . . . 0.0 108.617 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.758 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -107.51 119.55 39.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.502 -0.748 . . . . 0.0 109.832 -179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 20.7 ttm-85 -86.01 115.03 23.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.169 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.9 m -93.23 80.34 4.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' NE ' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -91.44 105.39 17.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.339 -0.85 . . . . 0.0 109.158 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' N ' ' NE ' ' A' ' 37' ' ' ARG . . . -75.2 59.96 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . -132.33 -35.31 0.33 Allowed Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 m -48.84 -12.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.054 -1.262 . . . . 0.0 109.831 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' GLY . 48.7 pttt -170.87 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 109.699 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.82 55.2 0.84 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.37 30.27 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp 51.02 77.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -1.127 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.07 138.95 30.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 109.254 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.43 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 6.1 tp -89.03 146.36 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 109.249 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 46' ' ' ILE . 8.5 mp0 -134.67 174.83 10.13 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.727 . . . . 0.0 109.149 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -136.4 134.61 37.96 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 0.0 109.237 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -76.89 119.85 21.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.904 -1.123 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.03 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.71 -19.13 64.35 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.012 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 44.4 m -92.0 -16.33 26.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.221 -0.925 . . . . 0.0 110.15 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.76 149.41 98.27 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 120.936 -1.103 . . . . 0.0 108.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.64 -166.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 120.864 1.043 . . . . 0.0 109.538 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.0 -35.49 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 109.263 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.4 mp0 -59.86 -39.47 85.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.407 -0.808 . . . . 0.0 109.515 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.6 14.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.625 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -50.34 -52.35 37.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.27 -51.96 64.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.48 67.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.453 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -64.84 -60.62 2.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 108.793 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.21 -34.01 5.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.696 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.38 -35.21 80.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 108.38 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 22.6 mtp180 -71.12 -58.92 3.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.188 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.82 -69.52 0.13 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.229 -0.92 . . . . 0.0 109.711 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.57 -78.31 1.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 6.9 pt-20 -166.04 109.01 0.77 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -1.148 . . . . 0.0 109.419 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm -134.91 -44.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.311 -0.868 . . . . 0.0 108.771 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 71' ' ' SER . 61.7 mm-40 -63.77 146.38 53.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.481 -0.762 . . . . 0.0 109.843 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 71' ' ' SER . 0.8 OUTLIER 57.24 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.823 -0.548 . . . . 0.0 110.807 179.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.577 ' N ' ' OG1' ' A' ' 70' ' ' THR . 11.1 t -50.19 87.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' THR . 68.0 mt -148.61 -164.77 2.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.266 -0.896 . . . . 0.0 109.028 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 72.82 -14.21 2.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 72' ' ' LEU . 52.9 m-85 52.94 8.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.452 -1.028 . . . . 0.0 109.08 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.496 ' H ' ' C ' ' A' ' 73' ' ' GLY . 65.8 t80 -154.56 14.67 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.417 -0.802 . . . . 0.0 109.401 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HB2' ' HE1' ' A' ' 4' ' ' TRP . 5.2 pt-20 -88.54 68.61 8.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.146 -0.971 . . . . 0.0 109.224 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD21 HE22 ' A' ' 65' ' ' GLN . 13.0 tp -91.25 84.48 5.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.404 ' HE1' ' HB2' ' A' ' 2' ' ' GLU . 59.1 m95 -79.79 167.09 21.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 108.729 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -136.71 -136.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.271 -0.893 . . . . 0.0 109.618 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.512 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -167.41 152.8 7.08 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.652 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.4 -51.89 8.97 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.596 1.531 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD2' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.13 -22.8 42.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -0.999 . . . . 0.0 110.067 -178.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -85.9 -25.97 25.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.034 -1.041 . . . . 0.0 109.251 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' ASN . 77.6 mt -82.6 -23.04 34.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 18' ' ' LYS . . . -64.1 32.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.766 -0.584 . . . . 0.0 111.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' LEU . 25.4 t-20 -147.67 -10.97 0.4 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.43 -1.419 . . . . 0.0 111.142 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' LEU . 26.5 mt -78.89 147.35 70.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.574 -1.329 . . . . 0.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.75 -61.68 0.24 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.012 1.141 . . . . 0.0 110.758 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.09 -38.73 4.91 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' LEU . 12.1 mt -94.94 151.05 38.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.275 -1.132 . . . . 0.0 108.755 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.41 -174.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 120.747 0.965 . . . . 0.0 110.081 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 28.8 mmtp -99.14 -15.67 18.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -111.09 132.31 54.37 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.599 -0.688 . . . . 0.0 109.451 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -53.23 -28.88 29.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -49.12 69.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.18 -34.18 89.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.38 -61.38 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -1.168 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.02 -43.01 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -60.19 -41.43 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 108.924 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.05 -25.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.46 -0.775 . . . . 0.0 108.991 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -54.32 -25.26 22.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.112 -0.993 . . . . 0.0 108.434 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -72.85 -32.76 65.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -65.19 -9.57 24.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.488 -0.757 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -150.07 -64.4 0.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.28 -0.887 . . . . 0.0 108.904 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.01 62.04 1.19 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.5 m-90 -54.71 148.33 12.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -1.211 . . . . 0.0 109.02 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.01 98.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' TRP . 7.2 p30 -108.4 117.75 34.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.99 121.01 28.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.542 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -93.22 125.95 38.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.98 -1.075 . . . . 0.0 108.949 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.658 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -90.92 -55.94 3.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 77.44 29.24 0.55 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.493 -0.755 . . . . 0.0 109.207 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.43 12.08 70.3 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 42' ' ' GLY . 2.9 m -88.39 33.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -1.028 . . . . 0.0 108.953 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 mttm 60.87 -0.89 0.27 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . 141.73 108.82 0.72 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' LYS . . . 165.59 -19.3 0.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' GLY . 22.6 mmtp 52.3 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -1.132 . . . . 0.0 109.073 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -173.95 4.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 108.922 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 mt -146.61 99.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.006 -1.059 . . . . 0.0 109.872 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.06 175.27 8.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -136.59 123.89 21.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.304 -0.872 . . . . 0.0 109.901 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.48 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 27.6 t-20 -74.06 114.73 12.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 108.532 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.22 22.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.805 . . . . 0.0 111.315 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -71.07 -21.87 62.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.684 -1.26 . . . . 0.0 110.52 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.677 ' N ' HD22 ' A' ' 51' ' ' ASN . 36.9 m -93.71 -8.27 41.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.905 -1.122 . . . . 0.0 110.552 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -68.97 149.51 97.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.872 -1.143 . . . . 0.0 109.724 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.26 140.77 84.94 Favored 'Trans proline' 0 C--O 1.21 -0.903 0 C-N-CA 121.173 1.249 . . . . 0.0 109.324 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' VAL . 17.5 t -42.27 -41.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.432 -0.793 . . . . 0.0 111.02 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -55.81 -48.03 76.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.005 -1.06 . . . . 0.0 109.991 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' LEU . . . -78.86 -43.09 25.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -46.02 -58.01 3.95 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.358 0.599 . . . . 0.0 109.415 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.01 61.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.04 -17.9 64.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.785 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -65.67 -75.71 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.116 -0.99 . . . . 0.0 109.182 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.68 -13.6 1.75 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.78 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.19 -49.55 64.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.325 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -74.23 5.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.015 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.4 HE22 HD21 ' A' ' 3' ' ' LEU . 77.4 mt-30 -98.71 148.52 23.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.305 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 67' ' ' GLU . . . 160.81 75.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.1 pt-20 32.81 55.73 0.42 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.059 -0.671 . . . . 0.0 111.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.92 -71.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.967 . . . . 0.0 108.574 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -110.96 40.53 2.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.608 -0.683 . . . . 0.0 109.498 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.0 m -79.97 -54.37 5.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.9 t -173.57 -89.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 109.43 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.9 mt 56.68 -142.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.6 1.28 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 45.5 t80 -168.32 33.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -1.122 . . . . 0.0 109.405 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 51.1 38.78 21.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.484 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.232 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' A' ' 1' ' ' MET . 1.7 tmt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -88.76 -168.31 2.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 109.377 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -165.29 76.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -80.28 158.61 26.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 6' ' ' SER . 99.8 t -131.77 162.84 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.3 m -103.78 153.44 38.73 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.2 -46.64 32.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 121.377 1.385 . . . . 0.0 110.924 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -59.56 -21.8 60.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.111 -0.993 . . . . 0.0 110.656 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 39.6 mm-40 -85.14 -25.73 27.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.884 -1.135 . . . . 0.0 109.69 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.6 mt -82.94 -22.66 33.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.637 -0.664 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 10' ' ' LEU . 41.6 m-80 -147.03 -10.8 0.44 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.621 -1.299 . . . . 0.0 110.936 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 16' ' ' LEU . 31.6 mt -78.27 146.89 71.6 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.531 -1.356 . . . . 0.0 108.103 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -64.86 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.028 1.152 . . . . 0.0 110.937 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.12 -36.86 2.93 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 13' ' ' LEU . 14.9 mt -96.02 150.46 37.3 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.249 -1.148 . . . . 0.0 108.972 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.34 176.52 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.864 1.043 . . . . 0.0 110.014 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -95.19 -13.09 25.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 109.61 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -106.15 130.83 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.662 . . . . 0.0 109.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -53.0 -29.3 28.46 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.89 -55.62 32.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.792 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -53.01 -36.66 52.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.89 -65.61 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.077 -1.249 . . . . 0.0 109.64 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 11.0 mt -48.83 -42.31 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.211 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.75 -49.15 77.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.849 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 22' ' ' GLY . 49.5 t -65.34 -22.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.49 -34.37 24.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 109.405 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -28.1 64.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 108.648 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -64.35 -5.27 4.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.247 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -151.25 -60.74 0.18 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.331 -0.856 . . . . 0.0 108.809 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.4 47.15 2.22 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -52.16 135.51 31.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.935 -1.333 . . . . 0.0 109.03 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -49.14 110.43 0.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.075 -1.016 . . . . 0.0 108.748 179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 1.2 p30 -105.84 124.33 49.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -86.17 115.08 23.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.56 108.81 20.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.291 -0.88 . . . . 0.0 108.688 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.49 -30.4 14.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 51.03 90.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.82 -20.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.218 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 40' ' ' VAL . 2.2 m -75.62 -42.09 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.027 -1.278 . . . . 0.0 109.666 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -157.09 -70.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.192 -0.943 . . . . 0.0 109.304 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.21 167.1 53.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' LYS . . . -72.65 -1.07 52.34 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 27.0 mtmm -157.93 92.89 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -1.074 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.04 110.08 19.26 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mt -82.93 100.4 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.072 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -87.26 175.99 7.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -136.1 133.72 37.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -76.54 117.58 18.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.961 -1.087 . . . . 0.0 108.991 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.93 61.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.32 -21.3 62.93 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.522 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 34.4 m -90.98 -13.72 32.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.022 -1.049 . . . . 0.0 110.191 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.0 mt -67.39 149.07 98.58 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.065 . . . . 0.0 108.986 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 3.3 Cg_exo -55.04 -165.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 120.982 1.121 . . . . 0.0 109.724 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.12 -37.61 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.35 -37.47 80.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.259 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.76 -31.62 40.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.703 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -60.93 -67.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.016 -1.052 . . . . 0.0 108.911 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.54 -42.81 16.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 109.568 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.41 84.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.51 -60.82 2.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.408 ' HA ' HE21 ' A' ' 65' ' ' GLN . 18.5 mt -49.53 -25.42 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 65' ' ' GLN . 9.1 tp -68.09 -56.4 8.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.491 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -75.54 28.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.838 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 63' ' ' LEU . 17.8 mt-30 -139.2 56.52 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.27 70.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -175.67 2.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -1.132 . . . . 0.0 109.484 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -85.38 -38.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 71' ' ' SER . 55.9 mm-40 -143.46 33.72 1.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 108.926 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 70' ' ' THR . 39.5 m 55.62 4.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.37 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 69' ' ' GLU . 1.3 m 65.96 58.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.526 -0.734 . . . . 0.0 109.709 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.3 mt 55.83 169.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.746 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 175.44 -13.89 0.03 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 55.06 7.58 0.19 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.455 -1.027 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' H ' ' C ' ' A' ' 73' ' ' GLY . 47.4 t80 -149.51 12.52 0.81 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.365 -0.835 . . . . 0.0 109.413 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mtp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -150.99 83.01 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 109.388 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.6 tp -97.34 91.42 5.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -86.99 165.85 15.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 108.863 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 6' ' ' SER . 48.0 t -139.05 162.42 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.431 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.5 m -110.56 152.64 43.52 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.52 -0.737 . . . . 0.0 109.049 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.62 -43.58 54.19 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.282 1.321 . . . . 0.0 110.606 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -59.65 -25.27 64.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 109.896 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -85.03 -24.68 28.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 94.5 mt -81.15 -24.6 37.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 109.003 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.04 29.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.669 -0.645 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 14.2 m120 -146.18 -6.8 0.56 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.566 -1.333 . . . . 0.0 110.835 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.3 mt -79.48 147.74 68.62 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.599 -1.313 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 120.908 1.072 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.46 -35.69 4.08 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 25.7 mt -93.9 149.28 36.73 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.135 -1.215 . . . . 0.0 109.117 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.64 178.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.882 1.055 . . . . 0.0 109.818 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -98.28 6.43 47.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.01 129.77 40.54 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.405 -0.81 . . . . 0.0 109.332 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -52.39 -30.58 29.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.419 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.44 66.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -72.94 -36.73 57.14 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.58 -64.04 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 109.394 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -49.78 -40.94 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.93 . . . . 0.0 109.095 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.93 -40.03 91.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 108.888 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.8 t -74.21 -27.82 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.92 -28.73 10.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.194 -0.941 . . . . 0.0 108.718 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 11.3 mptt -72.43 -39.78 67.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -65.48 -0.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.393 -0.817 . . . . 0.0 109.711 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -151.82 -69.98 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 109.055 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.31 53.95 1.53 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.2 m-90 -51.02 147.71 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.227 . . . . 0.0 109.283 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -49.47 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.935 . . . . 0.0 108.908 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.756 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -103.0 118.27 36.43 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -87.9 118.88 27.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.216 -0.928 . . . . 0.0 109.891 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.2 m -93.52 123.53 36.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.147 -0.971 . . . . 0.0 108.832 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 19.9 tpt180 -90.04 -62.98 1.35 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 76.82 87.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.54 -15.8 0.56 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.45 -71.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.046 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -100.14 -6.27 26.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 109.102 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.36 52.98 4.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.95 37.52 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 53.96 94.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 114.24 21.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.1 mm -86.47 113.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.661 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.27 174.06 6.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.462 -0.774 . . . . 0.0 109.057 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -135.17 126.9 29.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.452 -0.78 . . . . 0.0 109.47 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -75.33 113.97 13.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 0.0 109.033 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.8 -25.99 21.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.205 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 51' ' ' ASN . 1.4 m-80 -70.38 -22.97 62.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 0.0 109.792 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 m -90.45 -17.35 27.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.104 -0.998 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.18 148.71 98.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.955 -1.091 . . . . 0.0 109.014 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.58 -160.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.919 1.079 . . . . 0.0 109.693 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.74 -36.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -59.12 -39.09 81.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.308 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.03 36.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.7 -57.14 13.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.375 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.69 -47.58 76.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.44 70.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.895 . . . . 0.0 109.849 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.68 -32.63 73.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.3 mt -69.13 -45.14 70.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.04 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.9 mp -66.09 -27.35 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -72.52 -54.22 9.85 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 64' ' ' ARG . 38.2 mt-30 -47.99 173.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.533 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.58 -117.52 0.63 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -68.7 94.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 109.369 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -82.07 -75.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -172.72 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -166.82 -22.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.329 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.2 t -52.4 -35.3 51.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 74' ' ' TYR . 3.0 pp -171.83 -3.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.85 0.94 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 46.2 t80 -82.2 23.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 109.502 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 53.43 18.15 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.478 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.456 180.0 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -89.22 148.86 23.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.913 . . . . 0.0 109.567 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 33.4 tp -151.57 75.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -0.929 . . . . 0.0 108.922 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.3 m95 -81.98 159.7 23.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.12 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.97 152.29 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.47 -0.769 . . . . 0.0 109.628 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.47 153.49 37.75 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.843 . . . . 0.0 109.543 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.92 -44.24 50.15 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.307 1.338 . . . . 0.0 110.497 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -58.73 -25.08 62.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 61.1 mm-40 -84.63 -24.98 28.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.018 . . . . 0.0 109.302 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' ASN . 92.5 mt -80.97 -23.57 38.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.191 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.19 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.648 -0.658 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' LEU . 34.4 m120 -146.27 -9.1 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.544 -1.348 . . . . 0.0 110.827 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.8 mt -79.01 147.01 69.19 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.6 -1.312 . . . . 0.0 108.159 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.24 -64.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.019 1.146 . . . . 0.0 110.751 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.0 -36.9 4.04 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.8 mt -94.46 149.95 37.4 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.163 -1.198 . . . . 0.0 109.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.22 176.27 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 120.837 1.025 . . . . 0.0 109.837 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -97.64 7.28 46.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -133.18 129.99 38.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.406 -0.809 . . . . 0.0 109.29 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -52.51 -30.56 30.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.33 -39.85 64.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.21 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.95 -36.71 40.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.0 t -66.22 -61.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -1.135 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -51.37 -44.14 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 108.952 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.23 -45.0 96.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 108.925 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.15 -16.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.257 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.37 -31.1 71.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 108.747 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -71.04 -28.42 64.37 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.28 -0.888 . . . . 0.0 108.822 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -64.89 -3.07 3.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.177 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -150.2 -61.44 0.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 108.825 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.32 53.11 1.91 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -50.76 138.05 19.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.291 . . . . 0.0 109.148 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -48.64 99.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.132 -0.98 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 5.5 p30 -99.82 123.14 43.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.898 . . . . 0.0 109.653 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 38.7 ttm180 -87.16 115.22 24.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.887 . . . . 0.0 109.226 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 45' ' ' ALA . 22.5 m -93.25 84.47 4.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.227 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.41 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -91.45 121.81 33.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -0.9 . . . . 0.0 109.348 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.62 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.622 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -147.61 -40.51 0.04 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.6 m -52.43 -8.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.247 -1.149 . . . . 0.0 109.443 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 39' ' ' GLY . 37.9 ttpt -155.53 -32.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.539 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 47.35 2.31 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 44' ' ' LYS . . . 173.24 61.74 0.05 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 43' ' ' GLY . 14.7 ptmt 32.9 80.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 122.082 -0.658 . . . . 0.0 110.83 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 36' ' ' THR . . . -87.27 -153.27 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.812 . . . . 0.0 109.295 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.7 139.5 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.096 -1.002 . . . . 0.0 109.3 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 10.7 mp0 -132.81 175.99 8.86 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -136.11 133.56 37.41 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.339 -0.851 . . . . 0.0 109.439 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -76.6 117.9 18.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.018 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 3' ' ' LEU . . . -55.1 -31.31 61.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.203 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -69.94 -17.62 63.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.541 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.9 m -89.62 -21.31 22.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.684 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.59 148.41 98.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 108.903 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.83 -162.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 120.831 1.021 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.64 -38.36 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.21 -39.96 84.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.54 -48.35 11.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -54.39 -54.06 45.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.403 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.55 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.082 -1.011 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -29.02 69.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.53 -27.52 69.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -0.919 . . . . 0.0 109.248 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.63 -30.01 29.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -66.94 -47.83 70.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 109.653 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -71.87 -42.66 66.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.047 -1.033 . . . . 0.0 110.165 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -65.93 122.39 17.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 68' ' ' ILE . . . -175.83 172.28 45.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 58.11 3.29 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -1.115 . . . . 0.0 109.536 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.7 mt -74.26 -22.04 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 68' ' ' ILE . 8.7 pt-20 33.29 57.33 0.5 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.29 0.567 . . . . 0.0 111.013 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 p -74.54 -108.6 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -88.09 -28.93 21.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -85.95 177.43 7.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.2 -24.85 0.86 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 72' ' ' LEU . 34.7 t80 -85.69 13.29 7.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 109.473 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 53.58 26.71 5.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.473 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.05 135.64 33.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.489 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.8 tp -161.28 80.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -79.94 172.0 14.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.01 148.13 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.171 -0.956 . . . . 0.0 110.058 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -99.39 153.85 37.58 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.409 -0.807 . . . . 0.0 109.241 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.81 -41.33 75.41 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.219 1.28 . . . . 0.0 110.233 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -59.53 -27.02 65.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.35 -24.78 29.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.19 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.9 mt -82.33 -25.32 34.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.865 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.08 30.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.74 -0.6 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 12.1 m120 -146.54 -6.44 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.575 -1.328 . . . . 0.0 110.8 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -79.41 148.47 70.36 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.609 -1.307 . . . . 0.0 108.16 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.75 -61.06 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 120.818 1.012 . . . . 0.0 110.239 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -46.42 -39.25 9.87 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LEU . 36.6 mt -93.0 149.56 37.77 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.129 -1.218 . . . . 0.0 108.987 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -53.85 -177.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.782 0.988 . . . . 0.0 109.677 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -100.93 -3.34 29.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -119.54 129.46 54.69 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.653 -0.654 . . . . 0.0 109.338 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -52.81 -29.24 26.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.68 71.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.27 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -35.74 75.83 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.37 -64.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -1.143 . . . . 0.0 109.385 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -50.43 -41.27 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.939 . . . . 0.0 109.054 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.17 -43.41 95.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.018 . . . . 0.0 108.538 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.39 -21.38 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.48 -0.763 . . . . 0.0 109.008 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.93 -31.95 73.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 108.595 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.9 mttm -71.45 -31.89 67.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.265 -0.897 . . . . 0.0 108.685 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -65.67 -0.29 2.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.468 -0.77 . . . . 0.0 109.153 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 32.3 mt-30 -149.8 -65.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 108.78 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.31 56.57 1.19 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.1 m-90 -53.95 142.89 23.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.943 -1.327 . . . . 0.0 108.704 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -47.21 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.5 p30 -100.31 121.25 41.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.37 -0.831 . . . . 0.0 109.592 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 59.9 ttt180 -87.05 111.72 21.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 108.846 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.54 86.6 5.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.957 . . . . 0.0 109.341 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -89.76 107.49 19.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.38 54.79 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.602 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.51 5.28 1.81 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -87.69 -79.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 109.176 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -88.05 -11.12 48.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.438 -0.789 . . . . 0.0 109.173 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.19 36.99 10.27 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.31 49.93 0.29 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 53.52 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -1.179 . . . . 0.0 109.136 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.18 132.47 41.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 108.949 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.419 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 12.3 mt -89.63 144.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.98 -1.075 . . . . 0.0 109.688 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 8.9 mp0 -135.72 172.18 13.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -136.09 134.67 38.63 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.18 116.24 17.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.045 -1.034 . . . . 0.0 108.883 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB1' ' HZ1' ' A' ' 58' ' ' LYS . . . -53.78 -35.52 61.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.5 -18.77 65.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.994 -1.066 . . . . 0.0 109.637 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.46 -14.1 36.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 54' ' ' PRO . 86.4 mt -68.8 150.59 97.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.239 -0.913 . . . . 0.0 109.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.25 -156.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 120.933 1.089 . . . . 0.0 109.652 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -96.88 -36.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.62 -36.45 78.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.76 47.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.034 -1.041 . . . . 0.0 109.549 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HZ1' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mmtm -57.87 -60.71 3.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 109.019 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.57 -50.88 64.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.389 -0.82 . . . . 0.0 109.926 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.46 69.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 110.042 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.52 -43.86 95.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.005 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.35 -47.09 79.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.083 -1.011 . . . . 0.0 109.275 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.7 mp -66.26 -32.7 74.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.674 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -70.69 -36.17 73.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.601 -0.687 . . . . 0.0 109.674 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' ARG . 33.9 mt-30 -55.03 -168.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.943 -1.098 . . . . 0.0 109.73 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.74 4.49 69.8 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -160.02 90.06 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -1.152 . . . . 0.0 109.389 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.73 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.7 mp -85.04 -51.03 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 109.218 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 70' ' ' THR . 26.2 tt0 51.25 64.96 1.63 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 27.0 m -166.28 -32.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.332 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.2 p -171.72 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.537 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -87.99 -104.33 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.245 -0.91 . . . . 0.0 109.133 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.537 ' H ' HD13 ' A' ' 72' ' ' LEU . . . 80.64 -7.47 58.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -83.19 -46.89 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -1.205 . . . . 0.0 109.349 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' GLU . 42.7 t80 -74.65 -23.61 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.282 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 75' ' ' PHE . 36.5 tt0 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.13 158.65 17.85 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.282 -0.886 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.4 tp -167.35 78.69 0.19 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.238 -0.914 . . . . 0.0 109.223 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -79.74 167.65 20.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 108.826 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 17.7 t -139.28 165.48 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -114.14 152.37 45.8 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.76 -43.33 56.7 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.242 1.295 . . . . 0.0 110.471 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -59.56 -26.8 65.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.885 -179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' NH2' ' A' ' 64' ' ' ARG . 32.4 mm-40 -84.35 -25.68 28.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.051 -1.031 . . . . 0.0 109.449 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 12' ' ' ASN . 79.8 mt -82.39 -23.47 34.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.931 . . . . 0.0 109.187 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.81 28.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.71 -0.619 . . . . 0.0 111.069 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 10' ' ' LEU . 15.3 t-20 -147.39 -8.66 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.471 -1.393 . . . . 0.0 111.048 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LEU . 19.2 mt -78.7 147.51 71.19 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.538 -1.351 . . . . 0.0 108.329 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.76 -67.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.967 1.111 . . . . 0.0 111.0 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.36 -35.3 1.83 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' LEU . 15.6 mt -95.35 150.62 37.83 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.186 -1.185 . . . . 0.0 108.865 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.53 -178.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 120.778 0.986 . . . . 0.0 109.996 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 11' ' ' ALA . 4.4 mmmm -97.63 -17.46 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.241 -0.912 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 p -106.37 131.72 53.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.713 . . . . 0.0 109.413 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 p -53.27 -28.6 28.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.324 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.3 33.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.56 -35.33 66.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -65.63 -64.88 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.174 . . . . 0.0 109.398 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.5 mt -52.17 -41.61 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.09 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -60.17 -42.04 94.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.767 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.15 -24.34 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.076 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -56.26 -29.23 60.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.138 -0.976 . . . . 0.0 108.662 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -71.66 -34.98 70.17 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -6.23 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.9 mt-30 -145.84 -70.49 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.378 -0.827 . . . . 0.0 108.87 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.47 55.11 1.11 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.0 m-90 -52.64 142.23 18.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.02 -1.282 . . . . 0.0 108.896 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -47.31 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.507 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.762 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -100.5 121.15 41.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.366 -0.834 . . . . 0.0 109.803 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -88.02 126.89 35.33 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.159 -0.963 . . . . 0.0 109.158 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.5 135.79 33.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' CZ ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.28 -38.17 12.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.16 47.3 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' CZ ' ' A' ' 37' ' ' ARG . . . 165.32 75.44 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.34 -33.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.153 . . . . 0.0 109.408 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -156.34 -70.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.95 -109.19 1.0 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.43 5.32 1.0 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -171.87 95.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -1.197 . . . . 0.0 109.34 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.35 111.61 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 108.765 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.1 mt -84.37 104.3 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 109.852 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.6 mm-40 -90.77 173.78 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -135.35 128.82 32.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -75.73 117.15 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.024 . . . . 0.0 109.406 179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' HD22 ' A' ' 49' ' ' ASN . . . -54.78 -30.63 57.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 110.068 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 14.4 m120 -70.2 -19.93 63.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.0 m -89.91 -21.15 22.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.813 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.83 148.21 98.49 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.082 -1.011 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.36 -166.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 120.86 1.04 . . . . 0.0 109.78 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.4 -34.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 4.1 mp0 -58.77 -39.67 81.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.324 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.34 -40.26 21.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.671 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -57.59 -38.5 75.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.513 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.35 -56.89 6.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.01 -19.59 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.852 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -63.9 -76.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.089 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -53.89 -14.96 1.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 tp -69.03 -48.99 61.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 109.114 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' NH2' ' OE1' ' A' ' 9' ' ' GLU . 11.1 ptm180 -74.16 4.86 5.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.917 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -95.43 33.85 1.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.82 -41.79 14.02 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.63 152.92 5.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -1.155 . . . . 0.0 109.351 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.0 mm -76.39 -73.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.927 . . . . 0.0 109.09 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.15 -49.48 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.4 ' H ' ' H ' ' A' ' 71' ' ' SER . 46.9 m -166.34 -9.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' H ' ' H ' ' A' ' 70' ' ' THR . 42.9 t -50.21 -45.35 53.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 74' ' ' TYR . 21.9 mt -77.73 102.52 7.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.195 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.83 22.24 2.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' LEU . 3.4 t80 69.97 73.4 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -1.079 . . . . 0.0 109.07 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 28.9 t80 60.2 26.47 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.481 -0.762 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.434 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' N ' ' SD ' ' A' ' 1' ' ' MET . 36.4 tt0 -150.85 129.29 12.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.9 tp -160.02 84.38 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 109.326 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -81.72 167.04 19.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 108.911 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 t -138.96 153.74 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.347 -0.846 . . . . 0.0 109.904 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -102.46 152.69 38.39 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.743 . . . . 0.0 109.012 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.75 -45.24 41.9 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.164 1.243 . . . . 0.0 110.622 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -60.19 -25.86 65.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -84.24 -24.96 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.089 -1.007 . . . . 0.0 109.485 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -82.66 -19.1 38.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.168 -0.957 . . . . 0.0 109.227 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.47 32.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.642 -0.661 . . . . 0.0 111.038 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' LEU . 6.3 t-20 -145.9 -9.26 0.53 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.567 -1.333 . . . . 0.0 110.897 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.6 mt -78.68 147.32 70.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.569 -1.332 . . . . 0.0 108.127 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.93 -64.23 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.851 1.034 . . . . 0.0 110.484 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.95 -37.02 5.27 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 27.7 mt -93.8 149.58 37.27 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.105 -1.232 . . . . 0.0 109.1 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.0 174.75 0.19 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.826 1.017 . . . . 0.0 109.869 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -95.44 -1.74 50.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -0.883 . . . . 0.0 109.742 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -122.92 130.78 53.26 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.641 -0.662 . . . . 0.0 109.38 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.5 p -53.3 -28.97 30.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 0.0 109.616 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.67 65.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 -32.54 49.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' ALA . 56.9 t -65.97 -55.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -1.198 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.4 mt -58.58 -45.43 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.061 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -60.57 -44.41 96.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 108.901 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.3 -19.13 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -0.773 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -62.07 -36.24 81.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.146 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' GLN . 43.8 mtmt -70.48 -28.57 65.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.228 -0.92 . . . . 0.0 108.962 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 8.2 ttmm -64.63 -1.45 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.825 . . . . 0.0 108.906 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 28' ' ' LYS . 40.4 mt-30 -150.43 -62.76 0.2 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 108.82 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.68 50.86 2.25 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -49.28 146.77 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.244 . . . . 0.0 109.166 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.65 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.126 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.6 p30 -99.97 122.17 42.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -84.51 130.69 34.72 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.22 124.6 35.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 109.354 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -91.09 -173.89 3.8 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.48 57.12 0.11 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.334 -0.853 . . . . 0.0 109.259 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 171.64 -39.44 0.17 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.9 m -49.3 -13.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.128 -1.219 . . . . 0.0 109.49 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . 30.9 tttm -160.06 -32.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.02 146.19 20.42 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.87 27.96 22.48 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' NZ ' ' CB ' ' A' ' 44' ' ' LYS . 5.4 ttpm? 53.94 94.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.126 . . . . 0.0 109.487 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.56 -161.16 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -0.815 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 tt -150.56 162.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.951 -1.093 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.7 mt-10 -148.12 170.6 17.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -135.51 126.27 27.33 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.486 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 49.3 t-20 -77.1 119.69 21.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 108.963 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.47 32.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 111.017 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.88 -20.42 62.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.114 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.684 ' N ' HD22 ' A' ' 51' ' ' ASN . 33.0 m -90.86 -20.41 22.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.067 -1.021 . . . . 0.0 110.003 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 89.3 mt -67.76 148.77 98.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.088 -1.008 . . . . 0.0 109.085 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.91 -157.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.845 1.03 . . . . 0.0 109.673 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -92.93 -40.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.42 -39.35 79.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.623 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.25 -42.86 22.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.433 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -60.29 -64.78 0.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.86 -44.95 49.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.7 -31.94 73.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.24 -28.74 69.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.12 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -72.53 -46.64 53.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.4 mp -67.3 -37.21 83.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 109.352 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.17 -39.93 71.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.189 -0.944 . . . . 0.0 109.605 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -60.31 -0.98 0.28 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.731 -1.231 . . . . 0.0 109.419 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . -71.0 -77.99 0.46 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -79.73 101.2 8.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -1.17 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.39 -88.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -164.94 51.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.365 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 p -54.17 160.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.386 -0.821 . . . . 0.0 109.618 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -173.79 22.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.868 . . . . 0.0 109.295 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.67 95.12 5.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.29 10.02 62.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.98 -77.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -1.128 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -58.77 -40.78 84.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.854 . . . . 0.0 109.393 179.888 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.554 ' CD ' ' HE1' ' A' ' 4' ' ' TRP . 21.9 pt-20 -151.07 179.77 7.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 109.323 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.7 tp -155.44 92.18 1.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.948 . . . . 0.0 109.419 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.554 ' HE1' ' CD ' ' A' ' 2' ' ' GLU . 55.3 m95 -85.1 164.93 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.015 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 6' ' ' SER . 7.6 t -138.45 164.17 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.312 -0.868 . . . . 0.0 109.958 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -110.73 152.81 43.73 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.5 -45.75 38.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 121.391 1.394 . . . . 0.0 110.655 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.45 -28.12 65.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -84.34 -24.96 29.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.732 -1.23 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 12' ' ' ASN . 56.2 mt -82.62 -20.5 36.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.263 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.18 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.619 -0.675 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 10' ' ' LEU . 36.4 m120 -146.11 -8.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.376 . . . . 0.0 110.656 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 13.4 mt -79.13 147.32 69.25 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.0 107.954 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.7 -67.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.05 1.167 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.98 -34.12 2.92 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.7 mt -94.89 149.6 36.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.135 -1.215 . . . . 0.0 109.082 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.34 -179.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 120.882 1.055 . . . . 0.0 110.051 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -104.38 9.43 35.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.478 -0.763 . . . . 0.0 109.812 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -134.21 134.25 41.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.366 -0.834 . . . . 0.0 109.539 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -53.1 -31.43 41.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.883 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -51.47 64.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.423 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -65.83 -30.72 77.77 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.41 -54.52 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -1.204 . . . . 0.0 109.375 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.57 -44.97 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.288 -0.883 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.55 -41.48 94.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.079 -1.013 . . . . 0.0 108.935 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.1 t -74.78 -26.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 108.972 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.1 -33.32 51.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -70.43 -28.12 64.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.392 -0.818 . . . . 0.0 109.055 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.58 -2.72 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.133 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -150.57 -60.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.67 45.63 3.13 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -48.69 135.84 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.065 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.56 99.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.056 -1.028 . . . . 0.0 109.189 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.6 p30 -100.43 123.22 44.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.0 109.638 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -87.31 123.74 32.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.033 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.64 153.74 18.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.085 -1.009 . . . . 0.0 108.793 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -149.28 82.63 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.118 -0.989 . . . . 0.0 109.707 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.72 52.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.574 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.03 -8.52 0.55 Allowed Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -56.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.923 -1.339 . . . . 0.0 109.184 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -156.75 -69.23 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.43 165.55 22.78 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.12 -2.69 33.29 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.75 95.66 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -1.128 . . . . 0.0 109.589 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.76 115.81 24.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 108.81 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 tt -87.38 153.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.204 -0.935 . . . . 0.0 109.892 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 58.4 mt-10 -139.77 173.33 11.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -135.36 131.65 36.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.64 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -75.67 112.89 12.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.811 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.84 -26.28 23.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.435 HD22 ' H ' ' A' ' 51' ' ' ASN . 2.2 m-80 -69.44 -22.37 63.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.977 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 m -90.5 -10.4 43.77 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.082 -1.012 . . . . 0.0 110.072 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 54' ' ' PRO . 75.6 mt -67.32 149.97 98.13 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.066 -1.022 . . . . 0.0 108.828 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.0 Cg_endo -57.18 -159.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.89 1.06 . . . . 0.0 109.581 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.62 -37.52 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.75 -37.27 81.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -0.819 . . . . 0.0 110.236 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.0 -32.18 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.727 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -55.47 -70.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 109.041 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.09 -42.38 18.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.42 74.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.097 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -66.06 -71.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.206 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -44.63 -21.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.39 -0.819 . . . . 0.0 110.034 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 61' ' ' LEU . 8.3 tp -69.49 -55.74 9.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.078 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -72.92 -43.81 61.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.022 -1.049 . . . . 0.0 110.815 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -81.47 164.14 22.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.653 -1.279 . . . . 0.0 109.756 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 67' ' ' GLU . . . 155.17 126.17 0.99 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 73.72 -65.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -1.136 . . . . 0.0 109.322 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' GLU . 6.7 mt 57.92 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.0 pt-20 32.91 57.8 0.44 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.599 -0.688 . . . . 0.0 111.503 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 72' ' ' LEU . 11.0 t -169.94 -177.95 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.002 -1.062 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t 53.25 8.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.55 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 70' ' ' THR . 25.8 mt -71.73 166.17 22.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 109.536 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.81 6.89 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 76' ' ' GLU . 59.6 t80 -137.08 -31.3 0.83 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.643 -0.916 . . . . 0.0 109.403 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 76' ' ' GLU . 69.0 t80 -56.53 -6.83 0.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 74' ' ' TYR . 31.8 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.445 -0.784 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.66 123.64 33.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.7 tp -159.98 148.08 16.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.223 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 3' ' ' LEU . 44.3 m95 -141.15 165.74 26.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.393 -0.817 . . . . 0.0 108.808 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -135.98 -139.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -163.03 152.99 13.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.317 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -55.02 -50.69 12.36 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.422 1.415 . . . . 0.0 110.874 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -57.46 -23.17 48.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 47.9 mt-10 -84.87 -25.0 28.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 109.671 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 12' ' ' ASN . 78.3 mt -83.13 -21.65 33.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.571 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.736 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.706 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -148.86 -7.23 0.38 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.399 -1.438 . . . . 0.0 111.072 -179.355 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.706 ' N ' HD22 ' A' ' 12' ' ' ASN . 19.1 mt -78.27 147.39 72.5 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.642 -1.286 . . . . 0.0 108.16 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -67.42 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 120.939 1.093 . . . . 0.0 110.862 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.11 -34.23 3.1 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -95.26 149.89 36.83 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.238 -1.154 . . . . 0.0 109.29 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.72 -177.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.936 1.09 . . . . 0.0 109.814 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -103.17 3.16 35.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.39 -0.819 . . . . 0.0 109.962 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -129.12 131.07 47.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 t -52.38 -31.79 35.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.867 . . . . 0.0 109.346 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -33.79 59.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.49 -36.81 22.4 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.64 -60.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.5 mt -48.96 -40.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 108.733 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -62.55 -39.47 93.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.01 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 26' ' ' VAL . 54.3 t -77.37 -10.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.34 -0.85 . . . . 0.0 109.68 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -60.04 -38.0 81.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.981 -1.075 . . . . 0.0 110.453 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.61 -27.33 61.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.794 -1.191 . . . . 0.0 109.261 -179.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -63.59 -4.41 2.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 109.044 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.405 HE22 ' CG1' ' A' ' 26' ' ' VAL . 2.5 mp0 -149.07 -60.89 0.23 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 94.19 59.86 1.15 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -65.0 133.72 52.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.979 -1.306 . . . . 0.0 108.927 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -49.12 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.68 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 3.8 p30 -103.68 121.53 43.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.436 -0.79 . . . . 0.0 109.45 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 35' ' ' ARG . 29.5 ttm-85 -84.74 121.77 28.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 108.56 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.5 160.76 14.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -0.98 . . . . 0.0 109.521 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.58 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -147.78 179.12 7.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.911 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.74 75.41 0.28 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.01 -28.68 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -55.72 -16.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.235 -1.156 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -160.51 -73.26 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.313 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.86 72.57 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.48 30.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.6 mttt 56.47 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -1.166 . . . . 0.0 109.341 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.14 111.89 22.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.327 -0.858 . . . . 0.0 109.617 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.36 157.69 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 23.3 mm-40 -139.99 168.86 18.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -135.14 129.01 33.18 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.373 -0.829 . . . . 0.0 109.407 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.589 HD21 HD22 ' A' ' 51' ' ' ASN . 22.9 t-20 -75.52 112.18 11.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.81 . . . . 0.0 109.301 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.11 -31.3 61.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.797 . . . . 0.0 110.708 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.589 HD22 HD21 ' A' ' 49' ' ' ASN . 7.3 m-80 -68.13 -17.28 64.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.985 -1.072 . . . . 0.0 109.63 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.2 m -90.91 -16.04 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 54' ' ' PRO . 79.3 mt -67.21 149.36 98.49 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.065 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.6 Cg_endo -57.66 -157.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.894 1.062 . . . . 0.0 109.554 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.74 -39.87 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.86 -42.76 94.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.92 -11.66 59.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.842 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -75.59 -69.94 0.46 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.04 -41.41 16.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.075 -1.015 . . . . 0.0 109.104 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.28 79.68 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.303 -0.873 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.97 -38.89 92.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.03 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.26 -38.03 73.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.953 . . . . 0.0 109.264 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.2 -32.65 74.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' NE ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -74.44 -62.61 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 108.927 179.522 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -61.68 140.38 58.19 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.18 -0.95 . . . . 0.0 109.531 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 166.35 -101.36 0.18 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -76.3 60.06 1.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.482 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.01 -44.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 109.613 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' OE1' ' OG1' ' A' ' 70' ' ' THR . 1.6 tm-20 -108.71 -31.02 7.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.431 -0.793 . . . . 0.0 109.428 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 ' OG1' ' OE1' ' A' ' 69' ' ' GLU . 4.4 m -161.94 -126.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.384 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -173.2 123.32 0.4 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.997 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -78.08 69.98 4.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.291 -0.88 . . . . 0.0 109.022 179.805 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 29.15 2.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 72' ' ' LEU . 69.0 m-85 -87.47 -79.05 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -1.169 . . . . 0.0 109.212 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 53.4 t80 -163.56 21.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 75' ' ' PHE . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' CB ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 36.5 tt0 -152.42 76.44 1.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 109.354 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -161.73 75.81 0.49 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 42.8 m95 -79.62 161.72 25.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 108.713 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 6' ' ' SER . 2.5 t -132.24 -141.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.419 -0.801 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.617 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -162.81 153.58 14.3 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.126 -0.984 . . . . 0.0 109.454 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.26 -48.15 20.79 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.344 1.363 . . . . 0.0 110.624 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -58.82 -23.42 60.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 110.007 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 44.4 mt-10 -84.94 -29.62 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 12' ' ' ASN . 52.5 mt -80.52 -24.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.269 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.14 29.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.569 -0.707 . . . . 0.0 110.92 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.501 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.6 m120 -145.69 -9.73 0.54 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.543 -1.348 . . . . 0.0 110.795 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.3 mt -78.78 147.48 70.85 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.601 -1.312 . . . . 0.0 108.061 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -65.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.006 1.137 . . . . 0.0 110.849 -179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.14 -37.37 4.4 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 16.3 mt -94.3 150.16 37.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.22 -1.165 . . . . 0.0 109.134 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.12 171.04 0.41 Allowed 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.876 1.051 . . . . 0.0 109.786 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ALA . 51.1 mttm -91.5 -10.18 41.7 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.712 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -114.62 128.59 56.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.512 -0.743 . . . . 0.0 109.314 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -52.59 -28.97 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -33.72 56.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.239 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -80.16 -37.11 22.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.78 -59.96 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 109.392 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.01 -45.48 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.047 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -61.28 -42.82 99.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.3 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' GLY . 54.3 t -74.39 -14.63 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.58 -31.2 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.21 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' H ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -71.74 -27.83 63.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 108.576 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -63.92 -8.11 10.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.862 . . . . 0.0 109.245 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -150.18 -59.46 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.318 -0.864 . . . . 0.0 108.98 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.69 55.4 1.91 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -50.88 148.37 4.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.062 -1.258 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.68 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.63 114.43 28.11 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.314 -0.867 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -88.83 108.97 19.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.183 -0.948 . . . . 0.0 109.767 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 45' ' ' ALA . 52.7 m -93.89 147.95 22.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 108.872 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 4.4 tmt_? -148.72 -23.32 0.32 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 109.589 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 64.23 92.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 41' ' ' LYS . . . -170.47 -32.35 0.02 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -56.38 -6.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -1.148 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 39' ' ' GLY . 46.3 tttp -158.49 -75.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.5 51.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.48 -83.1 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -179.49 102.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -1.055 . . . . 0.0 109.267 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 36' ' ' THR . . . -84.76 -152.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.181 -0.949 . . . . 0.0 109.239 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 47' ' ' GLU . 13.2 tt -150.73 -41.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.187 -0.946 . . . . 0.0 109.479 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 46' ' ' ILE . 80.2 mt-10 56.04 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.597 0.713 . . . . 0.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -135.5 130.71 35.08 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.484 ' CG ' ' ND2' ' A' ' 51' ' ' ASN . 28.9 t-20 -77.16 112.62 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 108.947 179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.53 -22.95 23.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.369 -0.832 . . . . 0.0 111.029 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.788 -1.195 . . . . 0.0 109.843 -179.291 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.7 ' N ' HD22 ' A' ' 51' ' ' ASN . 5.1 m -92.47 -13.1 30.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.62 148.92 98.52 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.981 -1.074 . . . . 0.0 109.012 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -158.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 120.991 1.127 . . . . 0.0 109.734 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.2 -37.37 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.378 -0.826 . . . . 0.0 109.363 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.01 -40.24 84.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.96 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.28 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -58.02 -69.65 0.17 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.104 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -43.38 15.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.789 . . . . 0.0 109.682 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.7 78.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.71 -25.74 68.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 109.495 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.76 -32.5 57.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.491 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -67.42 -52.89 34.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.835 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 9.5 ptm180 -72.12 -11.68 60.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -93.24 -112.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.644 -1.285 . . . . 0.0 109.236 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 50.6 83.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 66' ' ' GLY . 27.2 mt-10 53.77 106.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.539 -0.977 . . . . 0.0 109.83 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 69' ' ' GLU . 10.2 tp -159.67 -46.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 109.318 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' N ' HG23 ' A' ' 68' ' ' ILE . 43.6 mt-10 -45.75 169.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.598 -0.688 . . . . 0.0 109.737 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -55.29 121.62 9.3 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 p -175.86 -26.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.45 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.581 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -81.68 108.02 14.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.132 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.19 2.47 56.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -171.74 -50.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -1.137 . . . . 0.0 109.532 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 71.2 t80 -161.1 38.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.376 -0.827 . . . . 0.0 109.291 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.862 . . . . 0.0 109.309 -179.979 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -88.95 162.33 16.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.395 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 tp -160.69 77.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.36 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 47.1 m95 -79.95 158.08 26.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.286 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 6' ' ' SER . 95.1 t -138.33 165.28 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.341 -0.85 . . . . 0.0 110.198 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -104.52 153.76 38.91 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.458 -0.776 . . . . 0.0 109.348 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.02 -44.13 47.33 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.388 1.392 . . . . 0.0 110.83 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -23.22 45.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 109.814 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 25.6 mm-40 -84.56 -23.08 29.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 12' ' ' ASN . 96.6 mt -82.97 -22.49 33.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 0.0 109.094 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 32.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.762 -0.586 . . . . 0.0 111.336 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' LEU . 8.4 t-20 -146.64 -9.04 0.48 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.519 -1.363 . . . . 0.0 110.775 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.1 mt -79.45 147.58 68.39 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.681 -1.262 . . . . 0.0 108.229 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.69 -61.83 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 120.871 1.047 . . . . 0.0 110.527 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -45.26 -38.87 6.79 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.9 mt -93.98 149.64 37.24 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 0.0 109.108 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.59 177.78 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.722 0.948 . . . . 0.0 109.712 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -98.47 9.06 44.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.258 -0.901 . . . . 0.0 109.63 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -134.17 130.52 37.41 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 0.0 109.323 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 p -53.13 -29.62 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.51 65.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.8 28.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -65.51 -59.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.266 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.4 mt -52.12 -43.03 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.078 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.97 -39.9 87.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -74.99 -27.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.05 -32.74 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.0 108.799 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -71.8 -33.4 68.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.831 . . . . 0.0 109.131 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.15 -3.28 3.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.538 ' OE1' ' NE1' ' A' ' 32' ' ' TRP . 27.5 mt-30 -145.19 -63.42 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.41 -0.806 . . . . 0.0 108.935 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 95.4 51.84 1.8 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.538 ' NE1' ' OE1' ' A' ' 30' ' ' GLN . 3.4 m-90 -51.63 146.46 7.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.251 . . . . 0.0 109.076 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.49 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.064 . . . . 0.0 109.306 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.759 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -98.8 117.16 32.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.499 -0.751 . . . . 0.0 109.75 -179.742 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -89.59 121.22 31.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.932 . . . . 0.0 108.604 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 m -90.17 74.33 7.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.763 -1.211 . . . . 0.0 109.696 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -91.01 113.88 26.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -0.851 . . . . 0.0 109.141 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.57 55.17 0.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.686 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.2 -2.47 7.06 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.29 -46.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -1.184 . . . . 0.0 109.393 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -168.92 -63.37 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.886 . . . . 0.0 109.419 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.89 114.56 0.36 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.36 17.24 1.12 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HZ2' ' HB3' ' A' ' 44' ' ' LYS . 13.9 mtpp 52.53 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.123 -1.222 . . . . 0.0 109.422 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.0 156.99 20.21 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' GLU . 9.8 tt -91.19 -39.54 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.263 -0.898 . . . . 0.0 109.797 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 46' ' ' ILE . 78.2 mt-10 55.7 152.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.756 0.789 . . . . 0.0 110.655 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -135.81 136.72 40.9 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.799 HD22 ' H ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -77.54 114.78 16.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.082 -1.011 . . . . 0.0 109.334 -179.965 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.12 35.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.473 -0.767 . . . . 0.0 111.193 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.799 ' H ' HD22 ' A' ' 49' ' ' ASN . 5.6 m-20 -69.69 -17.94 63.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.895 -1.128 . . . . 0.0 110.089 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -91.83 -14.7 29.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.135 -0.978 . . . . 0.0 110.216 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt -66.89 148.17 98.9 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.056 . . . . 0.0 108.992 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -56.81 -161.86 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 121.01 1.14 . . . . 0.0 109.618 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.6 t -91.39 -38.81 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -59.37 -40.22 85.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.09 11.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.626 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -48.24 -50.9 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.775 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.81 -53.72 54.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 109.463 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.16 66.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 109.083 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -65.26 -66.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 0.0 108.914 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -49.54 -25.51 2.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.43 -0.794 . . . . 0.0 109.166 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.2 tp -66.82 -34.51 77.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 109.059 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 29.2 mtp180 -71.3 -50.91 27.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -45.33 117.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.933 . . . . 0.0 109.957 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.52 -65.65 0.14 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.57 129.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.385 -1.067 . . . . 0.0 109.348 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.3 mt -114.93 -80.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -96.34 99.36 11.06 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.138 -0.976 . . . . 0.0 109.156 179.964 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 51.2 p -49.43 120.46 4.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.198 -0.938 . . . . 0.0 109.461 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 72' ' ' LEU . 2.4 t 177.58 -99.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 74' ' ' TYR . 7.1 mt 50.21 92.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . 66.95 -7.37 1.63 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.548 ' H ' ' C ' ' A' ' 72' ' ' LEU . 97.9 m-85 54.67 4.74 0.07 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.632 -0.922 . . . . 0.0 109.573 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 73' ' ' GLY . 53.2 m-85 -95.33 -12.42 26.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 72' ' ' LEU . 14.8 mp0 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.34 141.72 28.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.496 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -168.56 83.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.662 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -79.87 165.5 22.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 108.564 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -135.24 -140.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.1 m -163.11 154.0 14.25 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 0.0 109.449 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.59 -50.56 12.97 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 121.345 1.363 . . . . 0.0 110.871 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -58.14 -24.33 58.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.123 -0.985 . . . . 0.0 110.131 -179.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB2' HG12 ' A' ' 5' ' ' VAL . 37.4 mt-10 -84.69 -28.46 26.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 109.447 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 60.9 mt -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.28 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.15 30.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 64.0 m-80 -145.71 -7.38 0.58 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.574 -1.329 . . . . 0.0 110.698 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.2 mt -79.19 147.81 69.93 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.669 -1.269 . . . . 0.0 108.04 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.03 -66.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 120.839 1.026 . . . . 0.0 110.635 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.56 -36.39 4.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.6 mt -93.79 149.92 37.82 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.182 -1.187 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.8 171.13 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 120.763 0.975 . . . . 0.0 109.756 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.41 7.8 45.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.869 . . . . 0.0 109.779 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -133.62 129.63 37.19 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 p -53.0 -29.64 30.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 0.0 109.383 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.1 -35.83 62.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.7 -35.12 20.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.6 t -65.86 -53.17 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -1.135 . . . . 0.0 109.34 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -57.29 -48.47 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.11 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -60.02 -44.84 94.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -75.15 -18.36 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -61.96 -30.41 70.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.51 -29.22 64.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -64.83 -3.21 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -149.81 -61.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 90.74 53.51 2.24 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -50.19 143.81 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.938 -1.33 . . . . 0.0 108.912 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.711 HE21 HD22 ' A' ' 49' ' ' ASN . 10.9 tt0 -46.97 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.156 -0.965 . . . . 0.0 109.527 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.3 p30 -106.14 117.17 33.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.522 -0.736 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -88.24 130.37 35.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.15 93.03 6.7 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.904 -1.123 . . . . 0.0 109.334 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -89.08 99.68 12.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 0.0 109.303 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 43' ' ' GLY . . . -75.67 54.56 0.79 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.95 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' H ' ' HD2' ' A' ' 37' ' ' ARG . . . -164.53 51.99 0.28 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.64 -36.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -1.214 . . . . 0.0 109.283 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -143.33 -69.99 0.32 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.278 -0.889 . . . . 0.0 109.58 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.79 -121.63 4.11 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HB1' ' A' ' 38' ' ' ALA . . . -130.95 11.25 5.65 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -179.5 74.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.79 31.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.1 tt -89.15 155.08 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.632 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 30.8 mt-10 -137.17 171.47 14.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.64 126.49 27.5 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.166 -0.959 . . . . 0.0 109.891 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.711 HD22 HE21 ' A' ' 33' ' ' GLN . 50.5 t-20 -76.15 112.72 12.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 108.811 179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.08 15.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.992 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -71.2 -22.97 61.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.5 m -89.55 -11.78 41.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.082 -1.012 . . . . 0.0 110.272 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 93.6 mt -68.39 148.98 98.2 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.932 -1.105 . . . . 0.0 109.283 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.4 Cg_endo -58.02 -155.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.019 1.146 . . . . 0.0 109.643 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.11 -36.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.169 -0.957 . . . . 0.0 109.689 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.35 -38.16 82.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.698 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.95 47.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.186 -0.946 . . . . 0.0 109.574 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -59.92 -71.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 108.984 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.78 -42.3 11.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.444 -0.785 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.15 -35.48 80.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.264 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.2 tp -65.96 -48.12 72.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.2 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -61.81 -38.67 88.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.117 -0.99 . . . . 0.0 110.484 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.2 mt -67.65 -50.4 58.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.396 -179.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -28.01 63.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.944 -1.097 . . . . 0.0 110.963 -178.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -83.55 -88.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.591 -1.318 . . . . 0.0 109.637 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.11 157.51 31.69 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.12 128.26 36.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -1.134 . . . . 0.0 109.652 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 70' ' ' THR . 4.5 pt -121.44 -35.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 57.28 2.92 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.425 -0.797 . . . . 0.0 109.771 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 42.88 -154.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 110.047 179.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.503 ' N ' ' OG1' ' A' ' 70' ' ' THR . 6.9 t 57.31 44.81 21.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.566 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.57 170.45 16.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 74' ' ' TYR . . . 155.71 -0.85 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CG ' ' O ' ' A' ' 73' ' ' GLY . 42.2 m-85 -156.65 19.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -1.101 . . . . 0.0 109.469 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 51.66 17.23 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 179.967 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 2.9 mp0 -89.03 138.93 30.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 109.457 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.0 tp -171.26 148.51 2.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.253 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -136.88 171.22 14.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.61 145.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -96.76 152.29 38.38 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.09 -44.99 44.38 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.235 1.29 . . . . 0.0 110.297 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -60.57 -25.44 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 109.88 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -84.36 -27.07 27.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 12' ' ' ASN . 44.4 mt -81.97 -23.66 35.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 109.213 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.27 31.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.598 -0.688 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' LEU . 72.1 m-80 -144.83 -8.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.568 -1.333 . . . . 0.0 110.682 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' LEU . 15.0 mt -78.93 147.61 70.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.689 -1.257 . . . . 0.0 108.04 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -64.93 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.888 1.058 . . . . 0.0 110.663 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.66 -36.99 4.89 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.3 mt -93.76 149.84 37.72 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.132 -1.217 . . . . 0.0 109.156 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.77 175.11 0.16 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.956 1.104 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -98.84 7.18 46.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.32 -0.862 . . . . 0.0 109.658 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -132.31 130.71 41.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.468 -0.77 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -52.37 -30.75 30.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.42 62.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.35 -36.93 25.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.88 -55.83 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.03 -44.64 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.153 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.75 -43.02 98.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.067 . . . . 0.0 108.735 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 22' ' ' GLY . 53.6 t -75.03 -22.11 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.66 -30.33 60.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 108.739 179.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -71.3 -30.68 66.54 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -65.37 -3.66 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.422 -0.799 . . . . 0.0 109.279 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -151.29 -63.44 0.18 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.027 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 92.3 54.36 1.86 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.509 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.8 m-90 -49.65 151.28 1.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.286 . . . . 0.0 109.378 179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.614 HE21 HD22 ' A' ' 49' ' ' ASN . 20.3 tt0 -54.8 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 32' ' ' TRP . 2.0 p30 -96.69 114.6 26.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.39 129.74 34.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.125 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -91.28 114.56 27.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.978 -1.076 . . . . 0.0 109.321 -179.342 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -90.76 101.58 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 53.78 0.77 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.356 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.11 37.82 0.46 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.08 -87.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -1.108 . . . . 0.0 108.575 179.762 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' H ' HG23 ' A' ' 40' ' ' VAL . 15.4 ptmt -178.88 -28.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.246 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.57 -23.9 59.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 44' ' ' LYS . . . 102.02 90.35 2.11 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 34.2 tttp 81.6 101.74 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 36' ' ' THR . . . -86.68 -150.58 0.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 109.545 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' GLU . 17.1 mt -149.94 -61.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 46' ' ' ILE . 46.9 mt-10 56.04 154.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.416 0.627 . . . . 0.0 109.801 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -135.45 131.66 36.46 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.614 HD22 HE21 ' A' ' 33' ' ' GLN . 43.7 t-20 -75.38 116.36 16.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.019 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.84 -24.72 24.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 52' ' ' SER . 49.8 p30 -70.76 -18.83 62.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.953 -1.092 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 19.4 m -92.5 -14.88 27.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.003 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.32 149.71 98.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.63 -155.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 121.035 1.157 . . . . 0.0 109.371 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 t -97.61 -37.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.152 -0.968 . . . . 0.0 109.329 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -61.04 -35.53 77.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.04 -47.0 15.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 0.0 109.803 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -53.73 -54.51 37.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 109.535 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.07 -51.37 53.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.182 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.93 -27.09 68.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.875 . . . . 0.0 109.203 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -62.95 -59.22 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.619 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -46.88 -36.22 7.28 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.917 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.49 -31.29 71.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.117 -0.989 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.641 HH11 ' CB ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -72.17 -58.66 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.029 179.556 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -73.06 68.68 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.53 -73.3 1.17 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.84 5.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -1.111 . . . . 0.0 109.42 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -75.73 -70.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.041 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 31.8 mp0 -64.45 77.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.253 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 68' ' ' ILE . 7.7 m -167.72 160.14 12.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' LEU . 4.7 t -83.6 17.32 2.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.5 mt 58.96 118.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.762 . . . . 0.0 109.855 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -70.26 11.99 1.95 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 72' ' ' LEU . 11.6 t80 69.06 -12.2 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.954 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 73' ' ' GLY . 33.4 t80 -66.24 -22.31 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.005 179.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.297 -0.877 . . . . 0.0 109.323 179.954 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.236 0.541 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.89 -31.63 18.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.433 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 26.6 tp 52.78 75.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -80.13 164.4 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 108.483 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 6' ' ' SER . 52.1 t -135.55 160.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -178.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.0 m -106.27 153.78 40.16 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 109.377 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.85 -43.49 57.59 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 121.337 1.358 . . . . 0.0 110.559 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -58.23 -26.48 62.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 109.833 -179.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 42.8 mt-10 -84.57 -25.55 28.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 86.1 mt -82.8 -22.64 34.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 28.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.664 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.702 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -147.25 -5.7 0.5 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.477 -1.389 . . . . 0.0 110.901 -179.642 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.702 ' N ' HD22 ' A' ' 12' ' ' ASN . 33.2 mt -79.4 147.65 68.74 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.558 -1.339 . . . . 0.0 108.061 179.261 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.92 -62.31 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 120.966 1.111 . . . . 0.0 110.791 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.63 -40.74 6.63 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' LEU . 47.4 mt -93.91 150.06 37.97 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.236 -1.155 . . . . 0.0 109.04 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -52.21 -178.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 120.844 1.029 . . . . 0.0 109.915 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -100.51 -7.23 24.38 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.301 -0.874 . . . . 0.0 109.661 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -116.42 128.11 55.21 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.186 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -52.22 -29.22 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.13 66.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.291 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.66 -35.88 34.92 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.01 -59.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 109.243 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.65 -44.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 0.0 109.107 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -61.16 -45.59 93.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.116 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.57 -22.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.286 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -55.79 -32.99 63.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 30' ' ' GLN . 23.7 mmtp -71.01 -29.02 64.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.052 179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -64.34 -0.6 1.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 28' ' ' LYS . 42.2 mt-30 -150.86 -62.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.23 47.74 2.15 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.231 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -51.75 134.38 30.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.94 -1.329 . . . . 0.0 108.944 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -48.33 112.79 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.992 -1.068 . . . . 0.0 108.568 179.555 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 10.3 p30 -110.03 120.51 42.69 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.584 -0.697 . . . . 0.0 109.832 -179.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -86.31 127.29 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.112 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.16 168.21 11.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 108.87 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -148.19 -156.89 0.76 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.17 83.19 0.11 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.537 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.88 34.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.82 -86.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.237 . . . . 0.0 108.901 -179.936 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' H ' HG23 ' A' ' 40' ' ' VAL . 38.7 mmtm -63.52 -29.89 71.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.61 -78.87 0.07 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.51 12.83 0.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -171.63 76.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -1.104 . . . . 0.0 109.373 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.23 139.48 30.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.4 tt -90.13 163.59 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 0.0 109.376 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 40.4 mt-10 -147.6 172.83 13.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.964 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.4 132.76 35.93 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.426 -0.796 . . . . 0.0 109.334 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -77.45 120.18 22.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.92 -30.03 57.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.3 -0.875 . . . . 0.0 110.54 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -71.35 -18.71 62.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.523 ' OG ' ' NE2' ' A' ' 33' ' ' GLN . 35.9 m -89.74 -22.91 21.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.049 -1.032 . . . . 0.0 110.278 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.44 148.02 98.73 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.957 -1.09 . . . . 0.0 108.983 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.7 -164.44 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 120.899 1.066 . . . . 0.0 109.74 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 t -89.28 -37.02 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.45 -39.43 79.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.914 . . . . 0.0 109.567 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.76 -44.32 17.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.099 -1.0 . . . . 0.0 109.573 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.96 -42.33 72.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 109.829 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.91 -56.9 10.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.711 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.35 -19.96 65.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 62' ' ' LEU . 2.0 tm? -65.47 -66.0 0.6 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 61' ' ' LEU . 2.9 pp -64.22 -13.95 52.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.0 109.758 -178.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 63' ' ' LEU . 3.7 tt -69.12 -57.03 5.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.24 5.8 3.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.029 -1.045 . . . . 0.0 110.286 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -86.12 3.76 41.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 0.0 108.928 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 48.26 32.45 9.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' GLY . 39.9 tt0 48.35 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -1.185 . . . . 0.0 109.56 179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 69' ' ' GLU . 4.0 tp -76.9 -47.76 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.491 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 68' ' ' ILE . 14.3 mm-40 45.45 -166.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 109.636 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -81.12 -32.16 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' LEU . 45.9 m -78.9 -174.67 4.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' SER . 13.7 mt 53.18 104.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.423 -0.798 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.25 23.5 1.4 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -155.72 -84.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.171 . . . . 0.0 109.377 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 62.4 t80 -165.61 20.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.381 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.551 179.948 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 mtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.349 0.595 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' A' ' 2' ' ' GLU . 1.3 pp20? -150.77 146.63 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 tp -157.12 76.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -80.15 164.05 23.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.004 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 6' ' ' SER . 60.1 t -138.12 160.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.379 -0.826 . . . . 0.0 109.882 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.2 m -107.7 153.73 41.31 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.726 . . . . 0.0 109.362 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.92 -43.59 56.75 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.271 1.314 . . . . 0.0 110.503 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -57.72 -26.14 61.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' A' ' 64' ' ' ARG . 38.0 mm-40 -84.13 -26.87 28.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.142 -0.974 . . . . 0.0 109.154 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.8 mt -82.91 -19.97 36.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.817 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.92 29.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' LEU . 32.0 m120 -146.83 -7.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.544 -1.347 . . . . 0.0 110.907 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.22 147.71 69.6 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.603 -1.31 . . . . 0.0 108.215 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.72 -64.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.96 1.107 . . . . 0.0 110.511 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.88 -38.9 6.02 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 13' ' ' LEU . 57.8 mt -93.18 149.6 37.72 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.224 -1.163 . . . . 0.0 109.087 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -53.57 175.6 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 120.867 1.045 . . . . 0.0 109.88 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -98.6 -5.7 31.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -116.47 129.06 56.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 109.258 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -52.62 -29.49 26.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.428 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.56 -37.59 68.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -77.64 -35.41 36.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.93 -50.11 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.52 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.419 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.65 -42.7 93.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.062 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' GLY . 73.3 t -75.06 -24.29 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.243 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.78 -31.39 66.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 0.0 108.737 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.8 mmmp? -71.05 -30.4 66.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -64.41 -0.98 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 0.0 109.231 179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 28' ' ' LYS . 39.5 mt-30 -150.76 -63.23 0.19 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 108.768 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.33 49.7 2.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.9 m-90 -48.95 147.82 2.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.3 . . . . 0.0 109.01 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -47.54 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.997 . . . . 0.0 109.33 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.747 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.36 119.31 38.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.48 -0.763 . . . . 0.0 110.183 -179.359 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -87.15 124.31 33.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.234 -0.916 . . . . 0.0 108.962 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 150.35 20.78 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.974 -1.079 . . . . 0.0 108.995 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -150.17 100.43 2.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.327 -0.858 . . . . 0.0 109.229 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.19 53.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.814 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.49 13.08 0.68 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.74 -49.79 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.253 -1.145 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -158.73 -70.28 0.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.6 -108.67 0.05 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.17 8.46 1.07 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -172.15 79.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -1.099 . . . . 0.0 109.345 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.83 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.277 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.6 tt -89.88 155.51 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.692 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.93 174.68 10.31 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -136.46 126.51 26.09 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.26 -0.9 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 50.0 t-20 -76.31 120.46 21.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.06 -30.28 47.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 0.0 110.698 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 50.9 p30 -71.45 -19.22 62.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.93 -1.106 . . . . 0.0 110.106 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 70.3 m -90.05 -22.06 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.974 -179.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 80.0 mt -67.66 148.35 98.57 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.993 -1.067 . . . . 0.0 108.764 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.9 Cg_endo -57.32 -158.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 120.879 1.052 . . . . 0.0 109.766 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -93.87 -37.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.09 -39.86 79.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -36.01 33.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.693 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -59.91 -39.11 84.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.01 18.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 0.0 109.179 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.02 -21.42 66.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -62.61 -57.78 9.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.88 . . . . 0.0 109.045 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -52.7 -42.77 65.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.36 -28.21 68.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.097 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 9' ' ' GLU . 0.8 OUTLIER -74.63 -61.19 1.96 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.012 179.693 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -50.7 162.16 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.421 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.685 ' H ' HD13 ' A' ' 68' ' ' ILE . . . -164.67 95.65 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' C ' HD12 ' A' ' 68' ' ' ILE . 28.1 tt0 57.44 62.56 2.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -1.109 . . . . 0.0 110.501 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.685 HD13 ' H ' ' A' ' 66' ' ' GLY . 1.4 mp -100.59 -56.8 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -142.22 -26.32 0.64 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.277 -0.889 . . . . 0.0 109.121 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.7 m -73.57 -21.48 60.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.385 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.9 m 53.23 36.45 22.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.59 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 72' ' ' LEU . 1.5 pt? -71.21 -160.15 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 109.623 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.0 21.57 17.85 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -50.14 61.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.408 -1.054 . . . . 0.0 109.074 -179.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -85.71 -6.24 59.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.158 -0.964 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.995 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 2.3 mp0 -88.96 108.88 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.0 tp -158.65 81.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -82.72 162.65 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.377 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 6' ' ' SER . 43.7 t -137.28 157.87 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.381 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 5' ' ' VAL . 5.4 m -105.16 153.15 39.74 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.413 -0.804 . . . . 0.0 109.24 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.49 -42.88 62.22 Favored 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.24 1.294 . . . . 0.0 110.397 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -58.2 -27.0 63.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.603 -179.546 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -84.63 -24.47 29.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.137 -0.977 . . . . 0.0 109.119 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 12' ' ' ASN . 98.3 mt -82.42 -22.85 35.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.87 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.68 . . . . 0.0 111.394 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 10' ' ' LEU . 23.4 m120 -148.34 -7.03 0.41 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.465 -1.397 . . . . 0.0 111.089 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -79.9 148.11 67.73 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.594 -1.316 . . . . 0.0 108.253 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.4 -67.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.039 1.159 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.97 -35.67 2.36 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' LEU . 21.4 mt -95.19 150.61 37.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.21 -1.17 . . . . 0.0 109.015 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.9 -174.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 120.759 0.972 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -105.29 4.37 30.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.448 -0.782 . . . . 0.0 109.84 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.3 p -132.71 132.42 42.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.414 -0.804 . . . . 0.0 109.413 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -53.1 -30.83 38.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.324 -0.86 . . . . 0.0 109.324 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.31 61.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.275 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -36.84 15.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.92 -53.95 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -1.146 . . . . 0.0 109.398 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.04 -43.25 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 108.929 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HE2' ' HZ1' ' A' ' 29' ' ' LYS . 91.5 t80 -61.46 -44.13 97.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.38 -24.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.446 -0.784 . . . . 0.0 109.187 179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.46 -29.52 36.13 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.163 -0.961 . . . . 0.0 108.692 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' GLN . 7.4 mtpm? -72.14 -35.36 69.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HZ1' ' HE2' ' A' ' 25' ' ' TYR . 1.8 mptm? -64.68 0.73 1.02 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' LYS . 32.2 mt-30 -151.94 -68.77 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 108.905 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.08 52.42 1.62 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.514 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.6 m-90 -51.47 141.55 15.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.271 . . . . 0.0 109.115 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -50.51 91.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.4 p-10 -97.83 118.47 34.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.331 -0.855 . . . . 0.0 109.303 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.31 126.09 34.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.667 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.02 155.93 16.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 108.773 179.365 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 37' ' ' ARG . 14.0 ttm-85 -150.71 -111.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -0.796 . . . . 0.0 109.312 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 40' ' ' VAL . . . -167.37 31.31 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -11.88 2.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG21 ' H ' ' A' ' 44' ' ' LYS . 6.3 m -91.08 38.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -1.07 . . . . 0.0 108.987 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp 65.28 -13.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.998 -0.439 . . . . 0.0 110.516 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 40' ' ' VAL . . . 150.81 82.83 0.04 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.437 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -170.69 -83.22 0.05 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' H ' HG21 ' A' ' 40' ' ' VAL . 6.7 ttpm? -178.27 93.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.698 -0.884 . . . . 0.0 109.088 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.25 120.94 32.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -84.96 156.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 42.3 mt-10 -147.34 170.75 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.97 127.63 28.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 0.0 109.301 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.686 ' ND2' HD21 ' A' ' 51' ' ' ASN . 46.9 t-20 -75.37 123.5 25.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.997 . . . . 0.0 109.296 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.12 63.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.828 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.686 HD21 ' ND2' ' A' ' 49' ' ' ASN . 42.2 p30 -69.83 -16.53 63.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.941 -1.1 . . . . 0.0 109.82 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 49.7 m -89.95 -23.88 21.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.63 148.31 98.59 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 108.948 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.83 -168.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.892 1.061 . . . . 0.0 109.676 179.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.0 -35.36 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 6.0 mp0 -59.28 -39.43 82.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.81 -29.03 32.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.61 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -63.79 -46.82 83.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.302 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.0 77.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 108.807 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.24 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.068 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -62.14 -35.77 79.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 108.589 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.73 -45.32 83.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.788 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.4 mp -65.81 -26.84 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' HG3' ' NH1' ' A' ' 64' ' ' ARG . 2.3 tpm_? -74.08 -63.34 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -63.12 -179.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 109.049 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.69 -57.71 0.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 69' ' ' GLU . 48.2 mt-10 -56.97 -75.94 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -1.147 . . . . 0.0 109.438 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 68' ' ' ILE . 35.9 mt 54.67 -2.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.523 -0.735 . . . . 0.0 110.368 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 67' ' ' GLU . 7.0 mp0 53.12 172.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.07 -1.019 . . . . 0.0 109.2 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' SER . 90.0 m 44.64 -95.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -0.957 . . . . 0.0 109.784 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.2 t 60.4 142.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.888 . . . . 0.0 110.0 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.994 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -81.81 177.99 8.57 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.246 -0.909 . . . . 0.0 109.17 179.883 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.9 21.23 1.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 72' ' ' LEU . 42.6 p90 -69.71 -12.45 61.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 109.076 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -173.11 -27.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.847 . . . . 0.0 109.387 179.967 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.35 0.595 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.76 134.62 33.86 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -0.94 . . . . 0.0 109.229 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.611 ' CD2' HE22 ' A' ' 65' ' ' GLN . 12.5 tp -161.03 78.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -79.6 166.73 21.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.086 -1.009 . . . . 0.0 108.381 179.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 6' ' ' SER . 2.4 t -136.05 -140.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.23 -0.919 . . . . 0.0 109.979 -179.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.608 ' H ' HG12 ' A' ' 5' ' ' VAL . 4.9 m -162.83 153.0 13.65 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.46 -48.6 19.66 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 121.463 1.442 . . . . 0.0 110.959 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -57.25 -24.79 57.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -0.999 . . . . 0.0 109.968 -179.054 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 36.8 mt-10 -85.05 -26.06 27.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.185 -0.947 . . . . 0.0 109.417 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' ASN . 85.2 mt -81.9 -21.59 37.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.02 30.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' LEU . 57.2 m-80 -146.69 -7.0 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.523 -1.361 . . . . 0.0 110.933 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 16' ' ' LEU . 10.5 mt -79.49 147.79 68.66 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.629 -1.295 . . . . 0.0 108.176 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -66.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.867 1.045 . . . . 0.0 110.707 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.36 -36.43 4.28 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' LEU . 23.6 mt -93.68 149.95 37.95 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.173 -1.192 . . . . 0.0 109.18 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 172.77 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.821 1.014 . . . . 0.0 109.787 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -94.36 6.6 48.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.735 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -131.86 129.66 40.68 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.506 -0.746 . . . . 0.0 109.309 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -52.71 -29.86 29.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.34 -35.57 29.35 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.43 -58.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.391 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.8 mt -52.39 -44.52 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.937 . . . . 0.0 109.146 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.71 -44.35 96.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.982 . . . . 0.0 109.063 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.28 -24.04 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 109.215 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.28 -32.95 67.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 108.884 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -71.78 -33.52 68.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 108.966 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -65.15 -3.88 4.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.396 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.601 ' NE2' ' HE1' ' A' ' 32' ' ' TRP . 30.5 mt-30 -150.18 -67.58 0.2 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 108.779 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 96.88 59.04 1.01 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.601 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 2.5 m-90 -55.74 147.81 17.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.083 -1.245 . . . . 0.0 108.732 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.697 HE21 HD22 ' A' ' 49' ' ' ASN . 15.9 tt0 -49.24 90.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.148 -0.97 . . . . 0.0 109.537 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -102.98 121.2 42.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.876 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 35' ' ' ARG . 23.4 ttm-85 -86.7 117.5 25.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.42 112.07 23.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.05 . . . . 0.0 109.89 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -150.43 131.42 14.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -68.53 -107.49 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.36 -32.72 0.56 Allowed Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 178.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -78.34 -75.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -1.12 . . . . 0.0 108.926 179.984 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' H ' HG23 ' A' ' 40' ' ' VAL . 34.0 ttmt -161.82 -34.23 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.43 174.74 44.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.65 -17.82 79.99 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 pttm -176.04 100.32 0.07 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -1.092 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.59 137.73 32.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.729 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 46' ' ' ILE . 16.7 tt -91.4 123.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.263 -0.898 . . . . 0.0 109.703 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 5' ' ' VAL . 12.1 mm-40 -101.89 170.57 8.05 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.05 128.42 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.452 -0.78 . . . . 0.0 109.596 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.697 HD22 HE21 ' A' ' 33' ' ' GLN . 57.3 t-20 -76.47 114.77 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.266 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.815 ' C ' ' HZ2' ' A' ' 58' ' ' LYS . . . -54.7 -30.82 56.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.12 -19.67 63.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.7 m -89.18 -17.96 28.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 109.766 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' PRO . 95.4 mt -67.71 149.2 98.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.046 -1.033 . . . . 0.0 109.032 179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.66 -158.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.914 1.076 . . . . 0.0 110.031 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.11 -38.62 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -57.79 -41.45 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.52 -33.75 47.8 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.815 ' HZ2' ' C ' ' A' ' 50' ' ' ALA . 1.2 tpmt? -56.98 -53.67 55.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.15 67.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.61 78.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.111 -0.993 . . . . 0.0 109.375 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -51.23 65.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HA ' HE21 ' A' ' 65' ' ' GLN . 75.3 mt -44.2 -31.24 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.449 -0.782 . . . . 0.0 109.569 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.96 -68.09 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.162 179.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 11.1 ptm180 -78.22 59.6 2.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.404 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.611 HE22 ' CD2' ' A' ' 3' ' ' LEU . 33.4 mm-40 -78.16 32.48 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.932 -1.105 . . . . 0.0 109.489 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 64' ' ' ARG . . . 47.02 -172.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -81.34 107.73 14.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.289 -1.124 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mt -71.0 -19.43 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -50.02 -29.2 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 p -62.67 -39.95 95.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t -68.15 -84.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.371 -0.831 . . . . 0.0 109.538 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -49.25 128.9 17.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -79.1 14.45 14.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 t80 65.96 -6.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.562 -0.963 . . . . 0.0 109.412 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 73' ' ' GLY . 41.3 t80 -75.35 -8.16 55.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.112 -0.993 . . . . 0.0 109.014 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 75' ' ' PHE . 24.2 mt-10 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.0 109.602 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 ttt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.01 158.49 18.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 109.337 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.8 tp -160.98 81.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -81.62 167.03 19.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.129 -0.982 . . . . 0.0 108.819 179.421 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -138.33 148.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 109.545 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -97.44 153.0 38.52 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 109.189 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -51.81 -48.15 22.89 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.381 1.387 . . . . 0.0 110.869 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -58.74 -23.74 60.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.29 -179.194 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 24.0 mm-40 -85.03 -24.01 28.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.947 -1.096 . . . . 0.0 109.51 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASN . 82.5 mt -82.02 -23.18 36.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.134 -0.979 . . . . 0.0 108.8 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -146.89 -6.19 0.51 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.544 -1.347 . . . . 0.0 110.844 -179.466 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.66 ' N ' HD22 ' A' ' 12' ' ' ASN . 37.2 mt -78.9 147.3 70.1 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.558 -1.339 . . . . 0.0 108.02 179.241 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.96 -67.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.066 1.177 . . . . 0.0 110.756 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.71 -34.73 2.85 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' LEU . 17.2 mt -94.57 149.94 37.3 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.152 -1.205 . . . . 0.0 109.031 -179.673 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.5 -176.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 120.921 1.081 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -102.57 -2.85 27.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.429 -0.794 . . . . 0.0 109.486 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -119.65 126.15 50.46 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -52.27 -29.15 21.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.344 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.09 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.391 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -76.9 -36.16 37.21 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.78 -60.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -1.152 . . . . 0.0 109.36 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.0 mt -50.82 -42.42 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 108.97 179.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.41 -39.24 86.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.479 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' GLY . 55.9 t -74.32 -28.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 108.976 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -50.57 -31.56 16.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 108.763 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 30' ' ' GLN . 56.5 mmtt -72.5 -39.63 67.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 0.0 109.008 179.412 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -64.99 1.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 28' ' ' LYS . 33.5 mt-30 -152.0 -70.43 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 108.975 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.44 51.18 1.6 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.3 m-90 -50.0 141.54 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -48.06 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.009 . . . . 0.0 109.117 179.784 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 32' ' ' TRP . 1.3 p-10 -100.57 122.8 43.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.422 -0.799 . . . . 0.0 110.19 -179.313 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -90.71 123.2 34.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.347 -0.846 . . . . 0.0 109.343 179.31 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -93.21 116.2 28.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.888 -1.133 . . . . 0.0 109.24 179.712 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.64 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 21.9 ttm-85 -90.69 -68.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.57 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 37' ' ' ARG . . . 78.39 87.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.506 0.67 . . . . 0.0 109.304 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.79 -41.81 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 m -64.24 -33.23 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.274 -1.133 . . . . 0.0 109.373 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 43' ' ' GLY . 71.7 tttt -132.88 -9.97 3.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.487 -0.758 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.67 -13.4 4.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 41' ' ' LYS . . . -83.4 25.61 4.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 34.8 mttm 57.06 94.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -1.131 . . . . 0.0 109.451 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.71 122.37 31.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.262 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 46' ' ' ILE . 20.2 tt -88.68 121.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.251 -179.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 56.5 mm-40 -100.65 174.21 6.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.264 -0.897 . . . . 0.0 109.307 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -135.72 130.72 34.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -76.23 116.75 17.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.985 -1.072 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.99 -30.57 59.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.121 -179.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -70.44 -19.35 62.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.99 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.4 m -89.65 -19.86 24.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 54' ' ' PRO . 88.5 mt -67.59 149.05 98.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.103 -0.998 . . . . 0.0 108.859 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 53' ' ' LEU . 2.2 Cg_endo -56.69 -160.34 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 120.769 0.98 . . . . 0.0 109.661 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.6 t -92.03 -38.71 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.39 -39.33 83.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.724 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.86 -38.75 27.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.23 -59.73 4.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 109.373 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.43 -44.53 65.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.14 73.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.93 -58.91 5.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.136 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.47 -24.85 48.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.375 -179.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 tp -69.51 -53.41 19.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.775 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.693 HH12 ' NE2' ' A' ' 65' ' ' GLN . 3.4 ptm180 -74.83 8.63 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.693 ' NE2' HH12 ' A' ' 64' ' ' ARG . 6.0 mm-40 -92.52 123.39 35.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.994 . . . . 0.0 109.221 179.554 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.77 41.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.65 35.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -1.156 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 68' ' ' ILE . 1.9 mp -66.94 -65.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.411 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 55.58 82.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 0.0 109.549 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.3 m -163.57 -94.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.461 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.3 m -83.82 -37.88 21.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 109.408 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 74' ' ' TYR . 14.2 mt -70.36 -36.14 73.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.364 -0.835 . . . . 0.0 109.481 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.55 -6.88 1.12 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 72' ' ' LEU . 9.9 t80 68.79 71.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.954 . . . . 0.0 109.11 -179.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' GLU . 21.5 t80 63.3 24.44 14.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.709 . . . . 0.0 109.437 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 75' ' ' PHE . 30.9 mt-10 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.65 179.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -145.96 80.41 1.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.7 tp -92.22 78.65 5.14 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -79.95 171.0 15.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.053 . . . . 0.0 108.657 179.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.05 153.08 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.79 -179.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -103.84 153.43 38.76 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.203 -179.749 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.95 -46.21 35.33 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.27 1.313 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -59.28 -23.92 62.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.948 . . . . 0.0 110.06 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB3' HH11 ' A' ' 64' ' ' ARG . 74.3 mm-40 -84.87 -25.99 27.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' ASN . 62.9 mt -83.13 -21.29 33.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.892 . . . . 0.0 109.488 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -64.06 29.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.616 -0.677 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' LEU . 18.8 m-80 -148.03 -8.7 0.4 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.435 -1.416 . . . . 0.0 111.011 -179.411 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' LEU . 14.7 mt -79.19 147.28 68.89 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.559 -1.338 . . . . 0.0 108.231 179.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -67.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.718 0 C-N-CA 121.087 1.191 . . . . 0.0 111.054 -179.182 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.91 -34.66 2.01 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' LEU . 18.1 mt -95.37 150.06 37.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.197 -1.178 . . . . 0.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -52.34 179.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 120.875 1.05 . . . . 0.0 110.177 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.1 mmtt -96.56 -17.87 20.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.284 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 p -109.68 130.97 55.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.633 -0.667 . . . . 0.0 109.356 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -53.05 -29.31 29.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.16 -32.87 56.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -79.06 -36.0 29.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.96 -58.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.411 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.6 mt -49.52 -46.05 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.052 179.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.61 -56.65 17.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 108.954 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG12 HE22 ' A' ' 30' ' ' GLN . 78.3 t -57.94 -15.09 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.449 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -57.1 -35.57 69.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.303 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 10.6 mptt -70.87 -28.71 64.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.129 179.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -64.2 -4.6 3.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.51 HE22 HG12 ' A' ' 26' ' ' VAL . 2.4 mp0 -149.22 -61.19 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.55 49.59 2.52 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.323 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -52.22 142.89 15.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.064 -1.257 . . . . 0.0 109.385 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -57.03 96.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 108.961 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.9 p30 -99.45 123.81 44.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.369 -0.832 . . . . 0.0 109.944 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -89.13 116.66 27.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -95.03 164.53 12.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.955 . . . . 0.0 108.868 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.74 -42.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.627 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.39 74.76 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.072 -1.018 . . . . 0.0 109.435 179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.29 -44.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 41' ' ' LYS . 10.5 m -62.74 -45.73 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.313 -1.11 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 40' ' ' VAL . 1.5 tmtp? -89.4 -73.55 0.51 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 52.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.99 -69.23 0.1 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -173.99 95.7 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -1.161 . . . . 0.0 109.362 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.41 104.74 16.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 109.024 179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 46' ' ' ILE . 16.8 tt -87.83 121.53 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 109.508 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 12.3 mm-40 -101.83 171.2 7.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.432 -0.792 . . . . 0.0 109.191 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -135.3 128.66 32.19 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.243 179.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -74.66 117.7 16.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.06 . . . . 0.0 109.169 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -26.73 60.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -68.57 -20.74 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.554 -179.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -91.24 -15.14 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.871 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.4 149.58 98.31 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 0.0 108.879 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.7 Cg_endo -57.29 -157.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 120.954 1.103 . . . . 0.0 109.638 179.297 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.98 -37.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.72 -35.83 77.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 110.316 -179.389 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.91 -31.22 45.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.943 -1.098 . . . . 0.0 109.389 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -58.59 -68.8 0.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.22 -45.7 17.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.397 -0.814 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.13 -32.21 73.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.381 -0.824 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.7 -33.71 76.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.321 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.7 mt -61.89 -47.99 82.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 108.91 179.668 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 2.4 mm? -65.72 -28.61 69.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.114 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.582 ' C ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -70.65 -44.76 66.46 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -41.54 117.84 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.782 . . . . 0.0 110.432 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' H ' ' H ' ' A' ' 67' ' ' GLU . . . -160.8 -13.69 0.03 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' H ' ' H ' ' A' ' 66' ' ' GLY . 47.1 tt0 -158.3 86.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -1.028 . . . . 0.0 108.937 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 mt -69.76 -24.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.839 -179.668 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' A' ' 70' ' ' THR . 34.9 mt-10 -147.74 -43.12 0.17 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.089 -1.007 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 69' ' ' GLU . 31.6 m -166.31 -43.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -171.74 -165.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.409 -0.807 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -162.12 -178.69 6.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 179.91 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.85 11.14 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 72' ' ' LEU . 46.7 m-85 54.81 65.57 1.47 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.494 -1.003 . . . . 0.0 108.916 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.59 17.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.961 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.629 ' N ' HD21 ' A' ' 51' ' ' ASN . 62.0 mtm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.19 -92.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.973 . . . . 0.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.5 tp 48.29 71.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.43 162.08 21.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 108.508 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -134.63 150.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.378 -0.826 . . . . 0.0 109.58 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 m -98.34 153.01 38.22 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.434 -0.791 . . . . 0.0 109.488 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.68 -45.02 40.63 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.351 1.367 . . . . 0.0 110.582 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -58.19 -26.8 63.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.525 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 45.4 mt-10 -84.14 -24.93 30.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.696 -179.729 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' ASN . 81.8 mt -81.87 -23.5 36.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 108.997 179.889 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' LYS . . . -63.96 28.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 111.021 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' LEU . 11.5 m-80 -147.42 -7.06 0.46 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.481 -1.387 . . . . 0.0 110.881 -179.377 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' LEU . 22.3 mt -79.16 147.42 69.31 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.648 -1.283 . . . . 0.0 108.181 179.412 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.77 -68.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.019 1.146 . . . . 0.0 110.796 -179.441 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -42.8 -34.56 1.91 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 13' ' ' LEU . 22.1 mt -95.23 150.6 37.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.202 -1.175 . . . . 0.0 108.976 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.95 -179.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.762 0.975 . . . . 0.0 109.853 179.485 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 19.9 mmmt -98.73 -16.03 19.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.064 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 p -105.28 132.38 51.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.682 . . . . 0.0 109.305 -179.851 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.88 -28.56 37.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.83 -54.19 47.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.913 . . . . 0.0 109.749 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.62 -35.85 63.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.707 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.21 -65.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -1.21 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mt -51.27 -41.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.149 -179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -61.67 -42.7 99.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.363 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 22' ' ' GLY . 48.7 t -75.07 -22.81 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 0.0 109.297 179.758 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -53.24 -29.16 31.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.0 108.842 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 3.3 mptp? -71.43 -32.51 68.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 108.872 179.59 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -64.64 -4.87 4.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.294 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -150.26 -67.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 108.946 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 97.08 54.14 1.31 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' ASN . 2.9 m-90 -52.07 137.99 26.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.117 -1.225 . . . . 0.0 109.018 179.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -47.19 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.713 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -103.11 115.74 31.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.358 -0.838 . . . . 0.0 109.472 179.918 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 35' ' ' ARG . 4.2 ptt-85 -88.54 139.97 29.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.33 133.1 44.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.144 -0.973 . . . . 0.0 108.436 179.218 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -144.98 101.4 3.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.245 -0.909 . . . . 0.0 109.018 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.681 ' HB2' ' H ' ' A' ' 44' ' ' LYS . . . -75.17 51.35 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.81 . . . . 0.0 109.753 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.21 -19.84 6.15 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 40' ' ' VAL . 7.2 p -80.77 -8.66 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 109.657 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 9.8 ptmm? -166.57 -30.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.818 -179.897 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.27 46.46 2.01 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.31 33.14 0.59 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.681 ' H ' ' HB2' ' A' ' 38' ' ' ALA . 9.4 mtmp? 51.54 89.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -1.141 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.2 143.7 26.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 179.75 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.402 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 13.7 mt -86.96 145.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.025 . . . . 0.0 109.683 -179.796 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 7.5 mp0 -132.28 171.63 13.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -136.36 128.96 30.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.193 -0.942 . . . . 0.0 109.796 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -76.09 114.34 14.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 108.984 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -26.36 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.465 -179.254 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.629 HD21 ' N ' ' A' ' 1' ' ' MET . 22.0 m-20 -70.28 -21.1 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.3 m -90.0 -18.62 25.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' PRO . 84.7 mt -67.54 149.17 98.47 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.014 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 1.3 Cg_endo -57.8 -156.26 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 120.939 1.093 . . . . 0.0 109.42 179.228 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -98.21 -37.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.1 -35.52 77.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.05 -39.01 30.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.059 -1.026 . . . . 0.0 109.698 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.73 -59.17 5.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.971 . . . . 0.0 109.449 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.81 -45.42 50.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.917 -1.114 . . . . 0.0 109.16 179.688 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.34 -33.11 74.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 108.99 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.56 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.152 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 mt -47.68 -23.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 109.299 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -70.1 -57.76 4.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 0.0 109.471 179.971 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 10.2 ptm180 -74.62 6.55 3.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.19 -0.944 . . . . 0.0 110.45 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 11.5 mm100 -83.26 63.0 6.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.348 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.24 36.44 1.11 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 65' ' ' GLN . 15.7 mt-10 -73.56 -1.93 20.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -1.134 . . . . 0.0 109.605 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -50.46 -17.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.9 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 67' ' ' GLU . 51.2 mt-10 -58.59 161.57 4.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 0.0 109.355 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.9 p -55.05 118.3 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -179.62 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 pp -72.86 150.64 42.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.719 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' PHE . . . -154.82 -0.14 0.16 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.17 15.61 0.55 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.533 -0.98 . . . . 0.0 109.315 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 43.8 t80 55.06 14.1 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.528 -179.963 . . . . . . . . 0 0 . 1 stop_ save_